Authors,Title,Year,Source title,Volume,Issue,Art. No.,Page start,Page end,Page count,Cited by,DOI,Link,Affiliations,Authors with affiliations,Abstract,Author Keywords,Index Keywords,Molecular Sequence Numbers,Chemicals/CAS,Tradenames,Manufacturers,Funding Details,References,Correspondence Address,Editors,Sponsors,Publisher,Conference name,Conference date,Conference location,Conference code,ISSN,ISBN,CODEN,PubMed ID,Language of Original Document,Abbreviated Source Title,Document Type,Source,EID
"Teitelbaum, S.L., Belpoggi, F., Reinlib, L.","Advancing research on endocrine disrupting chemicals in breast cancer: Expert panel recommendations",2015,"Reproductive Toxicology","54",,,"141","147",,,10.1016/j.reprotox.2014.12.015,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84941315633&partnerID=40&md5=f75fa0d0a7f74489febb4846c63654ff","Department of Preventive Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bentivoglio,Bologna, Italy; National Institute of Environmental Health Sciences, National Institutes of Health, US Department of Health and Human Services, Research Triangle Park, NC, United States","Teitelbaum, S.L., Department of Preventive Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Belpoggi, F., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bentivoglio,Bologna, Italy; Reinlib, L., National Institute of Environmental Health Sciences, National Institutes of Health, US Department of Health and Human Services, Research Triangle Park, NC, United States","Breast cancer incidence continues to increase in the US and Europe, a reflection of the growing influence of environment factors that interact with personal genetics. The US Environmental Protection Agency estimates that there are approximately 10,000 endocrine disrupting chemicals among the common daily exposures that could affect the risk of disease. The daunting tasks of identifying, characterizing, and elucidating the mechanisms of endocrine disrupting chemicals in breast cancer need to be addressed to produce a comprehensive model that will facilitate preventive strategies and public policy. An expert panel met to describe and bring attention to needs linking common environmental exposures, critical windows of exposure, and optimal times of assessment in investigating breast cancer risk. The group included investigators with extensive experience in the use of rodent models and in leading population studies and produced a set of recommendations for effective approaches to gaining insights into the environmental origins of breast cancer across the lifespan. © 2015 .","Breast cancer; Endocrine disrupting chemicals; Mammary gland biology; Windows of susceptibility","diethylstilbestrol; dioxin; endocrine disruptor; perfluorooctanesulfonic acid; perfluorooctanoic acid; phenol derivative; phthalic acid derivative; Article; breast cancer; breast carcinogenesis; breast development; cancer research; cancer risk; cancer susceptibility; chemical carcinogenesis; concentration (parameters); disease association; environmental exposure; genotype environment interaction; hormonal regulation; human; mammary gland; menopause; nonhuman; pregnancy; puberty",,"diethylstilbestrol, 30498-85-2, 56-53-1; perfluorooctanoic acid, 335-67-1",,,"NIEHS, National Institute of Environmental Health Sciences; NIH, National Institute of Environmental Health Sciences","(2013) Interagency Breast Cancer and Environmental Research Coordinating Committee Breast cancer and the environment: prioritizing prevention, , Interagency Breast Cancer and Environmental Research Coordinating Committee, National Institutes of Health, Bethesda, MD; Biro, F.M., Deardoff, J., Identifying opportunities for cancer prevention during preadolescence and adolescence: puberty as a window of susceptibility (2013) J Adolesc Health, 52 (5), pp. S15-S20; Wolff, M.S., Teitelbaum, S.L., McGovern, K., Windham, G.C., Pinney, S.M., Galvez, M., Phthalate exposure and pubertal development in a longitudinal study of US girls (2014) Hum Reprod, , [Epub ahead of print]; Buttke, D.E., Sircar, K., Martin, C., Exposures to endocrine-disrupting chemicals and age of menarche in adolescent girls in NHANES (2003-2008) (2012) Environ Health Perspect, 120, pp. 1613-1618; Reed, C.E., Fenton, S.E., Exposure to diethylstilbestrol during sensitive life stages: a legacy of heritable health effects (2013) Birth Defects Res C: Embryo Today, 99, pp. 134-146; Soto, A.M., Sonnenshein, C., Environmental causes of cancer: endocrine disruptors as carcinogens (2010) Nat Rev Endocrinol, 6, pp. 363-370; Selevan, S.G., Kimmel, C.A., Mendola, P., Identifying critical windows of exposure for children's health (2000) Environ Health Perspect, 108 (3), pp. 451-455; Land, C.E., Tokunaga, M., Koyama, K., Soda, M., Preston, D.L., Nishimori, I., Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990 (2003) Radiat Res, 160, pp. 707-717; Barker, D.J., Winter, P.D., Osmond, C., Margetts, B., Simmonds, S.J., Weight in infancy and death from ischaemic heart disease (1989) Lancet, 2, pp. 577-580; Dontu, G., El-Ashry, D., Wicha, M.S., Breast cancer, stem/progenitor cells and the estrogen receptor (2004) Trends Endocrinol Metab, 15, pp. 193-197; Russo, J., Lynch, H., Russo, I.H., Mammary gland architecture and susceptibility of human breast to cancer (2001) Breast J, 7, pp. 278-291; Nakshatri, H., Srour, E.F., Badve, S., Breast cancer stem cells and intrinsic subtypes: controversies rage on (2009) Curr Stem Cell Res Ther, 4, pp. 50-60; Anderson, L.M., Diwan, B.A., Fear, N.T., Roman, E., Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models (2000) Environ Health Perspect, 108, pp. 573-594; Soto, A.M., Brisken, C., Schaeberle, C., Sonnenschein, C., Does cancer start in the womb? Altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors (2013) J Mammary Gland Biol Neoplasia, 18, pp. 199-208; Moral, R., Santucci-Pereira, J., Wang, R., Russo, I.H., Lamartiniere, C.A., Russo, J., In utero exposure to butyl benzyl phthalate induces modifications in the morphology and the gene expression profile of the mammary gland: an experimental study in rats (2011) Environ Health, 10, p. 5; Hilakivi-Clark, L., de Assis, S., Warri, A., Exposures to synthetic estrogens at different times during the life, and their effects on breast cancer risk (2013) J Mammary Gland Biol Neoplasia, 18, pp. 25-42; Ho, S.-M., Johnson, A., Tarapore, P., Janakiram, V., Zhang, X., Leung, Y.-K., Environmental epigenetics and its implication on disease risk and health outcomes (2012) IALR J, 53, pp. 289-305; Warri, A., Saarinen, N.M., Makela, S., Hilakivi-Clarke, L., The role of early life genistein exposures in modifying breast cancer risk (2008) Br J Cancer, 98, pp. 1485-1493; Biro, F.M., Pinney, S.M., Huang, B., Baker, E.R., Chandler, D.W., Dorn, L.D., Hormone changes in peripubertal girls (2014) J Clin Endocrinol Metab, 99, pp. 3829-3835; Lyons, T.R., O'Brien, J., Borges, V.F., Conklin, M.W., Keely, P.J., Eliceiri, K.W., Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2 (2011) Nat Med, 17, pp. 1109-1116; Howlader, N., Noone, A.M., Krapcho, M., Garshell, ., Miller, D., Altekruse, S.F., National Cancer Institute, pp. 1975-2011. , http://seer.cancer.gov/csr/1975_2011/, editors. SEER Cancer Statistics Review, Bethesda, MD, based on November 2013 SEER data submission, posted to the SEER web site, April 2014 [accessed 01.12.14]; Key, T.J., Appleby, P.N., Reeves, G.K., Roddam, A.W., Helzlsouer, K.J., Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies (2011) Br J Cancer, 105, pp. 709-722; Beral, V., Banks, E., Reeves, G., Appleby, P., Use of HRT and the subsequent risk of cancer (1999) J Epidemiol Biostat, 4, pp. 191-210; Lamartiniere, C.A., Jenkins, S., Betancourt, A.M., Wang, J., Russo, J., Exposure to the endocrine disruptor bisphenol A Alters susceptibility for mammary cancer (2011) Horm Mol Biol Clin Investig, 5, pp. 45-52; Tang, W.Y., Morey, L.M., Cheung, Y.Y., Birch, L., Prins, G.S., Ho, S.M., Neonatal exposure to estradiol/bisphenol A alters promoter methylation and expression of Nsbp1 and Hpcal1 genes and transcriptional programs of Dnmt3a/b and Mbd2/4 in the rat prostate gland throughout life (2012) Endocrinology, 153, pp. 42-55; Betancourt, A.M., Eltoum, I.A., Desmond, R.A., Russo, J., Lamartiniere, C.A., In utero exposure to bisphenol A shifts the window of susceptibility for mammary carcinogenesis in the rat (2010) Environ Health Perspect, 118, pp. 1614-1619; US Environmental Protection Agency., , http://www.epa.gov/endo/index.htm#universe, [accessed 20.10.14]; Huang, R., Sakamuru, S., Martin, M.T., Reif, D.M., Judson, R.S., Houck, K.A., Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathway (2014) Sci Rep, 4, pp. 5664-5672; Palmer, J.R., Wise, L.A., Hatch, E.E., Troisi, R., Titus-Ernstoff, L., Strohsnitter, W., Prenatal diethylstilbestrol exposure and risk of breast cancer (2006) Cancer Epidemiol Biomarkers Prev, 15, pp. 1509-1514; Verloop, J., van Leeuwen, F.E., Helmerhorst, T.J.M., van Boven, H.H., Rookus, M.A., Cancer risk in DES daughters (2010) Cancer Causes Control, 21, pp. 999-1007; Adami, H.O., Lagiou, P., Trichopoulos, D., Breast cancer following diethylstilbestrol exposure in utero: insights from a tragedy (2012) Eur J Epidemiol, 27, pp. 1-3; (2011) Nancy Langston, toxic bodies: hormonal disruptors and the legacy of DES, , Yale University Press, New Haven; Polychlorinated biphenyls CAS No. 1336-36-3. Report on carcinogens, Thirteenth Edition, US Department of Health and Human Services, National Toxicology ProgramSalehi, F., Turner, M.C., Phillips, K.P., Wigle, D.T., Krewski, D., Aronson, K.J., Review of the etiology of breast cancer with special attention to organochlorines as potential endocrine disruptors (2008) J Toxicol Environ Health B Crit Rev, 11, pp. 276-300; Warner, M., Eskenazi, B., Mocarelli, P., Gerthoux, P.M., Samuels, S., Needham, L., Serum dioxin concentrations and breast cancer risk in the Seveso Women's Health Study (2002) Environ Health Perspect, 110, pp. 625-628; Warner, M., Mocarelli, P., Samuels, S., Needham, L., Brambilla, P., Eskenazi, B., Dioxin exposure and cancer risk in the Seveso Women's Health Study (2011) Environ Health Perspect, 119, pp. 1700-1705; Ohtake, F., Takeyama, K., Matsumoto, T., Kitagawa, H., Yamamoto, Y., Nohara, K., Modulation of oestrogen receptor signaling by association with the activated dioxin receptor (2003) Nature, 423, pp. 545-550; Brunnberg, S., Andersson, P., Poellinger, L., Hanberg, A., The constitutively active Ah receptor (CA-AhR) mouse as a model for dioxin exposure - effects in reproductive organs (2011) Chemosphere, 85, pp. 1701-1706; La Merrill, M., Harper, R., Birnbaum, L.S., Cardiff, R.D., Threadgill, D.W., Maternal dioxin exposure combined with a diet high in fat increases mammary cancer incidence in mice (2010) Environ Health Perspect, 118, pp. 596-601; Maisonet, M., Terrell, M.L., McGeehin, M.A., Christensen, K.Y., Holmes, A., Calafat, A.M., Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls (2012) Environ Health Perspect, 120, pp. 1432-1437; Oberg, S., Cnattingius, S., Sandin, S., Lichtenstein, P., Iliadou, A., Birth weight-breast cancer revisited: is the association confounded by familial factors? (2009) Cancer Epidemiol Biomarkers Prev, 18, pp. 244-252; Kaijser, M., Lichtenstein, P., Granath, F., Erlandsson, G., Cnattingius, S., Ekbom, A., In utero exposures and breast cancer: a study of opposite-sexed twins (2001) J Natl Cancer Inst, 93, pp. 60-62; White, S.S., Fenton, S.E., Hines, E.P., Endocrine disrupting properties of perfluorooctanoic acid (2011) J Steroid Biochem Mol Biol, 127, pp. 16-26; Zhao, Y., Tana, Y.S.S., Strynard, M.J.J., Pereza, G., Haslam, S.Z., Yang, C., Perfluorooctanoic acid effects on ovaries mediate its inhibition of peripubertal mammary gland development in Balb/c and C57Bl/6 mice (2012) Reprod Toxicol, 33, pp. 563-576; Macon, M.B., Vallanueva, L.R., Tatum-Gibbs, K., Zehr, R.D., Strynar, M.J., Stanko, J.P., Prenatal perfluorooctanoic acid exposure in CD-1 mice: low-dose developmental effects and internal dosimetry (2011) Toxicol Sci, 122, pp. 134-145; Frederiksen, H., Sørensen, K., Mouritsen, A., Aksglaede, L., Hagen, C.P., Petersen, J.H., High urinary phthalate concentration associated with delayed pubarche in girls (2012) Int J Androl, 35, pp. 216-226; López-Carrillo, L., Hernández-Ramírez, R.U., Calafat, A.M., Torres-Sánchez, L., Galván-Portillo, M., Needham, L.L., Exposure to phthalates and breast cancer risk in Northern Mexico (2010) Environ Health Perspect, 118, pp. 539-544; Holmes, A.K., Koller, K.R., Kieszak, S.M., Sjodin, A., Calafat, A.M., Sacco, F.D., Case-control study of breast cancer and exposure to synthetic environmental chemicals among Alaska Native women (2014) Int J Circumpolar Health, 73, p. 25760; Moral, R., Wang, R., Russo, I.H., Mailo, D.A., Lamartiniere, C.A., Russo, J., The plasticizer butyl benzyl phthalate induces genomic changes in rat mammary gland after neonatal/prepubertal exposure (2007) BMC Genomics, 8, p. 453; Singh, S., Li, S.S., Epigenetic effects of environmental chemicals bisphenol A and phthalates (2012) Int J Mol Sci, 13, pp. 10143-10153; Hsieh, T.H., Tsai, C.F., Hsu, C.Y., Kuo, P.L., Lee, J.N., Chai, C.Y., Phthalates induce proliferation and invasiveness of estrogen receptor-negative breast cancer through the AhR/HDAC6/c-Myc signaling pathway (2012) FASEB J, 26, pp. 778-787; Chen, F.P., Chien, M.H., Lower concentrations of phthalates induce proliferation in human breast cancer cells (2014) Climacteric, 17, pp. 377-384; Davis, B.J., Fenton, S.E., The mammary gland (2013) Haschek and Rousseaux's handbook of toxicologic pathology, pp. 2665-2694. , Elsevier, Inc, Academic Press, USA, [chapter 61], W.M. Haschek, C.G. Rousseaux, M.A. Wallig (Eds.); Sholl, D.A., Dendritic organization in the neurons of the visual and motor cortices of the cat (1953) J Anatomy, 87, pp. 387-406; Stanko, J.P., Easterling, M.R., Fenton, S.E., Application of Sholl analysis to quantify changes in growth and development in rat mammary gland whole mounts (2015) Reprod Toxicol, 54, pp. 129-135; Soffritti, M., Belpoggi, F., Degli Esposti, D., Cancer prevention: the lesson from the lab (2006) Cancer medicine at the dawn of the 21st century: the view from Bologna, pp. 49-64. , Bononia University Press, Bologna, G. Biasco, S. Tanneberger (Eds.); Silvestri, F., Bussani, R., Giarelli, L., Changes in underlying causes of death during 85 years of autopsy practice in Trieste (1991) IARC Sci Publ, 112, pp. 3-23; Quinn, R., Comparing rat's to human's age: how old is my rat in people years? (2005) Nutrition, 21, pp. 775-777; Adams, N., Boice, R., A longitudinal study of dominance in an outdoor colony of domestic rats (1983) J Comp Psychol, 97, pp. 24-33; Sengupta, P., The laboratory rat: relating its age with human's (2013) Int J Prev Med, 4, pp. 624-630; Tentler, J.J., LaPaglia, N., Steiner, J., Williams, D., Castelli, M., Kelley, M.R., Ethanol, growth hormone and testosterone in peripubertal rats (1997) J Endocrinol, 2, pp. 477-487; Maltoni, C., Minardi, F., Soffritti, M., Chemoprevention of experimental mammary cancer by Tamoxifen (1992) Progress and perspectives in chemoprevention of cancer, 79. , Serono Symposia Publications; Davis, J.A., Gift, J.S., Zhaob, Q.J., Introduction to benchmark dose methods and U.S. EPA's benchmark dose software (BMDS) version 2.1.1 (2011) Toxicol Appl Pharmacol, 254, pp. 181-191; Acevedo, N., Davis, B., Schaeberle, C.M., Sonnenschein, C., Soto, A.M., Perinatally administered bisphenol A as a potential mammary gland carcinogen in rats (2013) Environ Health Perspect, 121, pp. 1040-1046; Miller, G.W., Jones, D.P., The nature of nurture: refining the definition of the exposome (2014) Toxicol Sci, 137, pp. 1-2; (2011) Advancing Research on Mixtures: New Perspectives and Approaches for Predicting Adverse Human Health Effects., 28. , http://www.niehs.nih.gov/about/visiting/events/pastmtg/2011/mixtures/pdf_workshop_report_508.pdf#search=mixtures, NIEHS Workshop Summary. Chapel Hill, North Carolina. September 27 &[accessed 25.06.14]; Han, X., Price, P.S., Applying the maximum cumulative ratio methodology to biomonitoring data on dioxin-like compounds in the general public and two occupationally exposed populations (2013) J Expos Sci Environ Epidemiol, 23, pp. 343-349","Reinlib, L.; Division of Extramural Research, NIEHS, NIH, 530 Davis Drive,Room 3072, United States",,,"Elsevier Inc.",,,,,08906238,,REPTE,,"English","Reprod. Toxicol.",Article,Scopus,2-s2.0-84941315633
"Manservisi, F., Gopalakrishnan, K., Tibaldi, E., Hysi, A., Iezzi, M., Lambertini, L., Teitelbaum, S., Chen, J., Belpoggi, F.","Effect of maternal exposure to endocrine disrupting chemicals on reproduction and mammary gland development in female Sprague-Dawley rats",2015,"Reproductive Toxicology","54",,,"110","119",,,10.1016/j.reprotox.2014.12.013,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84941316489&partnerID=40&md5=fc1533f71a54f78b2d129445027186ff","Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Immuno-Oncology Laboratory Aging Research Center (CeSI), G. D'Annunzio University Foundation, Department of Medicine and Aging Sciences, Italy; Department of Preventive Medicine, Icahn School of Medicine, Mount Sinai, NY, United States","Manservisi, F., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Gopalakrishnan, K., Department of Preventive Medicine, Icahn School of Medicine, Mount Sinai, NY, United States; Tibaldi, E., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Hysi, A., Immuno-Oncology Laboratory Aging Research Center (CeSI), G. D'Annunzio University Foundation, Department of Medicine and Aging Sciences, Italy; Iezzi, M., Immuno-Oncology Laboratory Aging Research Center (CeSI), G. D'Annunzio University Foundation, Department of Medicine and Aging Sciences, Italy; Lambertini, L., Department of Preventive Medicine, Icahn School of Medicine, Mount Sinai, NY, United States; Teitelbaum, S., Department of Preventive Medicine, Icahn School of Medicine, Mount Sinai, NY, United States; Chen, J., Department of Preventive Medicine, Icahn School of Medicine, Mount Sinai, NY, United States; Belpoggi, F., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy","The aim of the study is to determine whether low doses of ""endocrine disrupting chemicals"" (EDCs) affect the development and proliferative activity of the mammary glands (MGs). Adult parous/nulliparous female Sprague-Dawley (SD) rats were treated from post-natal day (PND) 1 until PND 180 with diethylphthalate (DEP), methylparaben (MPB), triclosan (TCS) and a mixture at doses comparable to human exposure. The doses (mg/kg b.w./day) were: DEP = 0.173; MPB = 0.105; TCS = 0.05. EDC treatment resulted in mortality rates >20% in pups as early as lactation day 7. Significant morphological/histological changes were observed at the end of lactation in the MGs of EDC-treated dams. The total transcriptome profile as well as lactation-related genes in MGs also corroborate the morphological findings as more profound gene expression changes are present only at the weaning period. The study highlights the heightened sensitivity of the MGs during critical windows of exposure, particularly pregnancy and lactation, with an impact on pups' survival. © 2014 Elsevier Inc.","Endocrine disruptors; Mammary glands; Rats; Windows of susceptibility","endocrine disruptor; methyl paraben; phthalic acid diethyl ester; transcriptome; triclosan; adult; animal cell; animal experiment; animal tissue; Article; breast development; concentration (parameters); controlled study; down regulation; environmental exposure; female; female fertility; gene expression profiling; gene expression regulation; histopathology; hypotrophy; involution; lactation; litter size; mammary gland; molecular pathology; morphology; mortality; multipara; newborn; nonhuman; nullipara; perinatal period; pregnancy; progeny; rat; reproduction; survival; transcriptomics; upregulation; weaning",,"methyl paraben, 99-76-3; phthalic acid diethyl ester, 84-66-2; triclosan, 3380-34-5",,,"U01 ES019451, NIH, National Institutes of Health","(2002) Global assessment of the state-of-the-science of endocrine, disruptors, , International Programme on Chemical Safety (IPCS); Schug, T.T., Janesick, A., Blumberg, B., Heindel, J.J., Endocrine disrupting chemicals and disease susceptibility (2011) J Steroid Biochem Mol Biol, 127, pp. 204-215; Diamanti-Kandarakis, E., Bourguignon, J.P., Giudice, L.C., Hauser, R., Prins, G.S., Soto, A.M., Endocrine-disrupting chemicals: an Endocrine Society scientific statement (2009) Endocr Rev, 30, pp. 293-342; Vandenberg, L.N., Colborn, T., Hayes, T.B., Heindel, J.J., Jacobs, D.R., Lee, D.H., Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses (2012) Endocr Rev, 33, pp. 378-455; Brisken, C., Endocrine disruptors and breast cancer (2008) Chimia, 62, pp. 406-409; Macon, M.B., Fenton, S.E., Endocrine disruptors and the breast: early life effects and later life disease (2013) J Mammary Gland Biol Neoplasia, 18, pp. 43-61; Fenton, S.E., Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences (2006) Endocrinology, 147, pp. S18-S24; Du, K., Chu, S., Xu, X., Stimulation of MCF-7 cell proliferation by low concentrations of Chinese domestic polychlorinated biphenyls (2000) J Toxicol Environ Health A, 61, pp. 201-207; Payne, J., Rajapakse, N., Wilkins, M., Kortenkamp, A., Prediction and assessment of the effects of mixtures of four xenoestrogens (2000) Environ Health Perspect, 108, pp. 983-987; Payne, J., Scholze, M., Kortenkamp, A., Mixtures of four organochlorines enhance human breast cancer cell proliferation (2001) Environ Health Perspect, 109, pp. 391-397; Suzuki, T., Ide, K., Ishida, M., Response of MCF-7 human breast cancer cells to some binary mixtures of oestrogenic compounds in-vitro (2001) J Pharm Pharmacol, 53, pp. 1549-1554; Rider, C.V., Furr, J.R., Wilson, V.S., Gray, L.E., Cumulative effects of in utero administration of mixtures of reproductive toxicants that disrupt common target tissues via diverse mechanisms of toxicity (2010) Int J Androl, 33, pp. 443-462; Hass, U., Scholze, M., Christiansen, S., Dalgaard, M., Vinggaard, A.M., Axelstad, M., Combined exposure to anti-androgens exacerbates disruption of sexual differentiation in the rat (2007) Environ Health Perspect, 115, pp. 122-128; Kelsey, J.L., Gammon, M.D., Jhon, E.M., Reproductive factors and breast cancer (1993) Epidemiol Rev, 15, pp. 36-47; Lanfranchi, A., Normal breast physiology: the reasons hormonal contraceptives and induced abortion increase breast-cancer risk (2014) Issues Law Med, 29 (SPRING 1), pp. 135-146; Valentini, A., Lubinski, J., Byrski, T., Ghadirian, P., Moller, P., Lynch, H.T., The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation (2013) Breast Cancer Res Treat, 142 (NOVEMBER 1), pp. 177-185; Shan, L., He, M., Yu, M., Qiu, C., Lee, N.H., Liu, E.T., CDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene (2002) Carcinogenesis, 23, pp. 1561-1568; Chan, M.M., Lu, X., Merchant, F.M., Iglehart, J.D., Miron, P.L., Gene expression profiling of NMU-induced rat mammary tumors: cross species comparison with human breast cancer (2005) Carcinogenesis, 26 (8), pp. 1343-1353; Decreto Legislativo 116, 1992. Attuazione della direttiva. 86/609/CEE in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici (1992) Gazzetta Ufficiale, pp. 5-25. , [in Italian]; Teitelbaum, S., Lambertini, L., Li, Q., Belpoggi, F., Falcioni, L., Bua, L., Identification of endocrine disrupting chemical doses in rats to reproduce human urinary metabolite concentrations Environment and Health - Bridging South, North, East and West. Basel, Switzerland 19-23 August, 2013 Oral presentation and ISEE Seattle Washington 24-28 August, 2014 Abstract number: 5107; ID: P-1-13-10Hvid, H., Thorup, I., Oleksiewicz, M.B., Sjogren, I., Jensen, H.E., An alternative method for preparation of tissue sections from the rat mammary gland (2011) Exp Toxicol Pathol, 63, pp. 317-324; Sholl, D.A., Dendritic organization in the neurons of the visual and motor cortices of the cat (1953) J Anat, 87, pp. 387-406; Enoch, R., Stanko, J., Greiner, S., Youngblood, G., Rayner, J., Fenton, S.E., Mammary gland development as a sensitive end point after acute prenatal exposure to an atrazine metabolite mixture in female Long-Evans rats (2007) Environ Health Perspect, 115 (4), pp. 541-547; von Heydebreck, A., Huber, W., Gentleman, R., (2004) Differential expression with the bioconductor project. Encyclopedia of genetics, genomics, proteomics and bioinformatics, , John Wiley & Sons, Ltd; Bourgon, R., Gentleman, R., Huber, W., Independent filtering increases detection power for high-throughput experiments (2010) Proc Natl Acad Sci U S A, 107, pp. 9546-9551; Gentleman, R., Carey, V., Huber, W.F.H., (2014) Genefilter: methods for filtering genes from microarray experiments. R package 1.46.1 ed; Lemay, D.G., Lynn, D.J., Martin, W.F., Neville, M.C., Casey, T.M., Rincon, G., The bovine lactation genome: insights into the evolution of mammalian milk (2009) Genome Biol, 10, p. R43; White, S.S., Calafat, A.M., Kuklenyik, Z., Villanueva, L., Zehr, R.D., Helfant, L., Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring (2007) Toxicol Sci, 96, pp. 133-144; Lemay, D.G., Neville, M.C., Rudolph, M.C., Pollard, K.S., German, J.B., Gene regulatory networks in lactation: identification of global principles using bioinformatics (2007) BMC Syst Biol, 1, p. 56; Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing (1995) J R Stat Soc Ser B (Methodol), 57, pp. 289-300; Warri, A., Saarinen, N.M., Makela, S., Hilakivi-Clarke, L., The role of early life genistein exposures in modifying breast cancer risk (2008) Br J Cancer, 98, pp. 1485-1493; Rudel, R.A., Fenton, S.E., Ackerman, J.M., Euling, S.Y., Makris, S.L., Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations (2011) Environ Health Perspect, 119, pp. 1053-1061; (2012) Fourth report on human exposure to environmental chemicals; Richert, M.M., Schwertfeger, K.L., Ryder, J.W., Anderson, S.M., An atlas of mouse mammary gland development (2000) J Mammary Gland Biol Neoplasia, 5 (APRIL 2), pp. 227-241; White, S.S., Stanko, J.P., Kato, K., Calafat, A.M., Hines, E.P., Fenton, S.E., Gestational and chronic low-dose PFOA exposures and mammary gland growth and differentiation in three generations of CD-1 mice (2011) Environ Health Perspect, 119, pp. 1070-1076; Latendresse, J.R., Bucci, T.J., Olson, G., Mellick, P., Weis, C.C., Thorn, B., Genistein and ethinyl estradiol dietary exposure in multigenerational and chronic studies induce similar proliferative lesions in mammary gland of male Sprague-Dawley rats (2009) Reprod Toxicol, 28, pp. 342-353; Kumar, V., Chakraborty, A., Kural, M.R., Roy, P., Alteration of testicular steroidogenesis and histopathology of reproductive system in male rats treated with triclosan (2009) Reprod Toxicol, 27, pp. 177-185; Goldstein, J.L., Brown, M.S., Regulation of the mevalonate pathway (1990) Nature, 343, pp. 425-430; Hidaka, Y., Satoh, T., Kamei, T., Regulation of squalene epoxidase in HepG2 cells (1990) J Lipid Res, 31, pp. 2087-2094; Clarenburg, R., Chaikoff, I.L., Origin of milk cholesterol in the rat: dietary versus endogenous sources (1966) J Lipid Res, 7, pp. 27-37; Gibbons, G.F., Pullinger, C.R., Munday, M.R., Williamson, D.H., Regulation of cholesterol synthesis in the liver and mammary gland of the lactating rat (1983) Biochem J, 212, pp. 843-848; Hachey, D.L., Silber, G.H., Wong, W.W., Garza, C., Human lactation. II: Endogenous fatty acid synthesis by the mammary gland (1989) Pediatr Res, 25, pp. 63-68; Mohammad, M.A., Haymond, M.W., Regulation of lipid synthesis genes and milk fat production in human mammary epithelial cells during secretory activation (2013) Am J Physiol Endocrinol Metab, 305, pp. E700-E716; Lu, S., Archer, M.C., Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer (2005) Carcinogenesis, 26, pp. 153-157; Flavin, R., Peluso, S., Nguyen, P.L., Loda, M., Fatty acid synthase as a potential therapeutic target in cancer (2010) Future Oncol (Lond, Engl), 6, pp. 551-562; Kelleher, S.L., Velasquez, V., Croxford, T.P., McCormick, N.H., Lopez, V., MacDavid, J., Mapping the zinc-transporting system in mammary cells: molecular analysis reveals a phenotype-dependent zinc-transporting network during lactation (2012) J Cell Physiol, 227, pp. 1761-1770; Kelleher, S.L., Lonnerdal, B., Zn transporter levels and localization change throughout lactation in rat mammary gland and are regulated by Zn in mammary cells (2003) J Nutr, 133, pp. 3378-3385; McCormick, N.H., Kelleher, S.L., ZnT4 provides zinc to zinc-dependent proteins in the trans-Golgi network critical for cell function and Zn export in mammary epithelial cells (2012) Am J Physiol Cell Physiol, 303, pp. C291-C297","Belpoggi, F.; Ramazzini Institute, Cesare Maltoni Cancer Research Center, Castello di Bentivoglio, Via Saliceto, 3, Italy",,,"Elsevier Inc.",,,,,08906238,,REPTE,,"English","Reprod. Toxicol.",Article,Scopus,2-s2.0-84941316489
"Soffritti, M., Tibaldi, E., Bua, L., Padovani, M., Falcioni, L., Lauriola, M., Manservigi, M., Manservisi, F., Belpoggi, F.","Life-span carcinogenicity studies on Sprague-Dawley rats exposed to γ-radiation: Design of the project and report on the tumor occurrence after post-natal radiation exposure (6 weeks of age) delivered in a single acute exposure",2015,"American Journal of Industrial Medicine","58","1",,"46","60",,,10.1002/ajim.22391,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84918569116&partnerID=40&md5=c5a535cfb14274b74ce0cd12e5e25d95","Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy","Soffritti, M., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Tibaldi, E., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Bua, L., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Padovani, M., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Falcioni, L., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Lauriola, M., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Manservigi, M., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Manservisi, F., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Belpoggi, F., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy","Background: Experimental long-term carcinogenicity bioassays conducted on rats and mice proved that ionizing radiation can induce a variety of tumor types. However few studies have been conducted on rats. Methods: This report deals with the effects of γ-radiation in groups of 416-1,051 6-weeks old Sprague-Dawley rats exposed to 0, 0.1, 1, or 3Gy of γ-radiation delivered in a single acute exposure. The experiment lasted for the animals' lifespan and all were necropsied and underwent full histopathological evaluation. Results: The results confirm the dose-related carcinogenic effects of γ-radiation for several organs and tissues. Moreover they indicate that exposure to 0.1Gy induces a statistically significant increased incidence in Zymbal gland carcinomas and pancreas islet cell carcinomas in females. Conclusions: Our data show that exposure to γ-radiation induces carcinogenic effects at all tested doses. © 2014 Wiley Periodicals, Inc.","Carcinogenicity; Life-span bioassay; Low-dose; Rat; γ-radiation","adverse effects; animal; autopsy; carcinogen testing; classification; comparative study; disease model; female; gamma radiation; male; methodology; Neoplasms; proportional hazards model; radiation dose; radiation response; rat; Sprague Dawley rat; Animals; Autopsy; Carcinogenicity Tests; Disease Models, Animal; Dose-Response Relationship, Radiation; Female; Gamma Rays; Male; Neoplasms; Proportional Hazards Models; Radiation Dosage; Rats; Rats, Sprague-Dawley; Research Design",,,,,,"Abouzeid Ali, H.E., Barber, R.C., Dubrova, Y.E., The effects of maternal irradiation during adulthood on mutation induction and transgenerational instability in mice (2012) Mutat Res, 732, pp. 21-25; Averbeck, D., Non-targeted effects as a paradigm breaking evidence (2010) Mutat Res, 687, pp. 7-12; Barber, R.C., Dubrova, Y.E., The offspring of irradiated parents, are they stable (2006) Mutat Res, 598, pp. 50-60; Bartel-Friedrich, S., Friedrich, R.E., Arps, H., Rat tumors following fractionated irradiation (1999) Anticancer Res, 19, pp. 2725-2726; Bartstra, R.W., Bentvelzen, P.A., Zoetelief, J., Mulder, A.H., Broerse, J.J., van Bekkum, D.W., Induction of mammary tumors in rats by single-dose gamma irradiation at different ages (1998) Radiat Res, 150, pp. 442-450; Bond, V.P., Cronkite, E.P., Lippincott, S.W., Shellabarger, C.J., Studies on radiation-induced mammary gland neoplasia in the rat. III. Relation of the neoplastic response to dose of total-body radiation (1960) Radiat Res, 12, pp. 276-285; Boorman, G.A., Eustis, S.L., Elwell, M.R., Montgomery, C., (1990) Pathology of the fischer rat: Reference and atlas, , London: Accademic Press; Brenner, D.J., Slowing the increase in the population dose resulting from CT scans (2010) Radiat Res, 174, pp. 809-815; Broerse, J.J., Hennen, L.A., Klapwijk, W.M., Solleveld, H.A., Mammary carcinogenesis in different rat strains after irradiation and hormone administration (1987) Int J Radiat Biol Relat Stud Phys Chem Med, 51, pp. 1091-1100; Broerse, J.J., Hennen, L.A., Solleveld, H.A., Actuarial analysis of the hazard for mammary carcinogenesis in different rat strains after X- and neutron irradiation (1986) Leuk Res, 10, pp. 749-754; Cardis, E., Vrijheid, M., Blettner, M., Gilbert, E., Hakama, M., Hill, C., Howe, G., Schubauer-Berigan, M., The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: Estimates of radiation-related cancer risks (2007) Radiat Res, 167, pp. 396-416; Decreto Legislativo 116, 1992. Attuazione della direttiva. 86/609/CEE in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici [in Italian] (1992) Gazz Ufficiale Suppl Ordinario, 33, pp. 5-25; Di Majo, V., Rebessi, S., Pazzaglia, S., Saran, A., Covelli, V., Carcinogenesis in laboratory mice after low doses of ionizing radiation (2003) Radiat Res, 159, pp. 102-108; Fitzgibbons, P.L., Henson, D.E., Hutter, R.V., Benign breast changes and the risk for subsequent breast cancer: An update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists (1998) Arch Pathol Lab Med, 122, pp. 1053-1055; Hanahan, D., Weinberg, R.A., The hallmarks of cancer (2000) Cell, 100, pp. 57-70; Harris, N.L., Jaffe, E.S., Vardiman, J.W., Stein, H., Diebold, J., Muller-Hermelink, H.K., WHO classification of tumors of hematopoietic and lymphoid tissues: Introduction (2001) Tumors of hematopoietic and lymphoid tissues, pp. 12-13. , Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Lyon: World Health Organization, International Agency for Research on Cancer; Hosmer, J.D., Lemeshow, S., (1999) Applied survival analysis: Regression modeling of time to event data, , 2nd edition. New York: John Wiley & Sons; Hsu, W.L., Preston, D.L., Soda, M., Sugiyama, H., Funamoto, S., Kodama, K., Kimura, A., Tomonaga, M., The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001 (2013) Radiat Res, 179, pp. 361-382; Huff, J., Long-term chemical carcinogenesis bioassays predict human cancer hazards. Issues, controversies, and uncertainties (1999) Ann NY Acad Sci, 895, pp. 56-79; (2000) Monograph-Ionizing radiation, part 1: X- and gamma-radiation, and neutrons, 75. , Lyon: World Health Organization, International Agency for Research on Cancer; (2012) Monograph-A review of human carcinogens: Radiation, 100 (D). , Lyon: World Health Organization, International Agency for Research on Cancer; Jacob, P., Ruhm, W., Walsh, L., Blettner, M., Hammer, G., Zeeb, H., Is cancer risk of radiation workers larger than expected (2009) Occup Environ Med, 66, pp. 789-796; Jeggo, P., The role of the DNA damage response mechanisms after low-dose radiation exposure and a consideration of potentially sensitive individuals (2010) Radiat Res, 174, pp. 825-832; Lafuma, J., Chmelevsky, D., Chameaud, J., Morin, M., Masse, R., Kellerer, A.M., Lung carcinomas in Sprague-Dawley rats after exposure to low doses of radon daughters, fission neutrons, or gamma rays (1989) Radiat Res, 118, pp. 230-245; Linet, M.S., Kim, K.P., Miller, D.L., Kleinerman, R.A., Simon, S.L., Berrington de Gonzalez, A., Historical review of occupational exposures and cancer risks in medical radiation workers (2010) Radiat Res, 174, pp. 793-808; Maltoni, C., Soffritti, M., Belpoggi, F., The scientific and methodological bases of experimental studies for detecting and quantifying carcinogenic risks (1999) Ann NY Acad Sci, 895, pp. 10-26; Mullenders, L., Atkinson, M., Paretzke, H., Sabatier, L., Bouffler, S., Assessing cancer risks of low-dose radiation (2009) Nat Rev Cancer, 9, pp. 596-604; Ozasa, K., Shimizu, Y., Suyama, A., Kasagi, F., Soda, M., Grant, E.J., Sakata, R., Kodama, K., Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: An overview of cancer and noncancer diseases (2012) Radiat Res, 177, pp. 229-243; Preston, D.L., Ron, E., Tokuoka, S., Funamoto, S., Nishi, N., Soda, M., Mabuchi, K., Kodama, K., Solid cancer incidence in atomic bomb survivors: 1958-1998 (2007) Radiat Res, 168, pp. 1-64; Russo, I.H., Russo, J., Mammary gland neoplasia in long-term rodent studies (1996) Environ Health Perspect, 104, pp. 938-967; Russo, J., Russo, I.H., (2004) Molecular basis of breast cancer prevention and treatment, , Berlin: Springer-Verlag; Shellabarger, C.J., Bond, V.P., Aponte, G.E., Cronkite, E.P., Results of fractionation and protraction of total-body radiation on rat mammary neoplasia (1966) Cancer Res, 26, pp. 509-513; Shellabarger, C.J., Chmelevsky, D., Kellerer, A.M., Induction of mammary neoplasms in the Sprague-Dawley rat by 430keV neutrons and X-rays (1980) J Natl Cancer Inst, 64, pp. 821-833; Shellabarger, C.J., Chmelevsky, D., Kellerer, A.M., Stone, J.P., Holtzman, S., Induction of mammary neoplasms in the ACI rat by 430-keV neutrons, X-rays, and diethylstilbestrol (1982) J Natl Cancer Inst, 69, pp. 1135-1146; Shellabarger, C.J., Cronkite, E.P., Bond, V.P., Lippincott, S.W., The occurrence of mammary tumors in the rat after sublethal whole-body irradiation (1957) Radiat Res, 6, pp. 501-512; Soffritti, M., Belpoggi, F., Minardi, F., Bua, L., Maltoni, C., Mega-experiments to identify and assess diffuse carcinogenic risks (1999) Ann NY Acad Sci, 895, pp. 34-55; Soffritti, M., Belpoggi, F., Minardi, F., Maltoni, C., Ramazzini Foundation cancer program: History and major projects, life-span carcinogenicity bioassay design, chemicals studied, and results (2002) Ann NY Acad Sci, 982, pp. 26-45; Tanaka, I.B., III, Tanaka, S., Ichinohe, K., Matsushita, S., Matsumoto, T., Otsu, H., Oghiso, Y., Sato, F., Cause of death and neoplasia in mice continuously exposed to very low dose rates of gamma rays (2007) Radiat Res, 167, pp. 417-437; Travis, L.B., Hauptmann, M., Gaul, L.K., Storm, H.H., Goldman, M.B., Nyberg, U., Berger, E., Monson, R.R., Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast (2003) Radiat Res, 160, pp. 691-706; Tubiana, M., Aurengo, A., Averbeck, D., Masse, R., Recent reports on the effect of low doses of ionizing radiation and its dose-effect relationship (2006) Radiat Environ Biophys, 44, pp. 245-251; Ullrich, R.L., Storer, J.B., Influence of gamma irradiation on the development of neoplastic disease in mice. I. Reticular tissue tumors (1979) Radiat Res, 80, pp. 303-316; Ullrich, R.L., Storer, J.B., Influence of gamma irradiation on the development of neoplastic disease in mice. II. Solid tumors (1979) Radiat Res, 80, pp. 317-324; Ullrich, R.L., Storer, J.B., Influence of gamma irradiation on the development of neoplastic disease in mice. III. Dose-rate effects (1979) Radiat Res, 80, pp. 325-342; Upton, A., Radiation carcinogenesis (1968) Methods in cancer research, pp. 53-82. , Busch H, editor. New York: Academic Press; Upton, A.C., Randolph, M.L., Conklin, J.W., Kastenbaum, M.A., Slater, M., Melville, G.S., Jr., Conte, F.P., Sproul, J.A., Jr., Late effects of fast neutrons and gamma-rays in mice as influenced by the dose rate of irradiation: Induction of neoplasia (1970) Radiat Res, 41, pp. 467-491; Watanabe, H., Kamiya, K., The induction of insulinomas by X-irradiation to the gastric region in Otsuka Long-Evans Tokushima Fatty rats (2008) Oncol Rep, 19, pp. 987-991; (2003) WHO classification of breast tumors and tumors of the female genital organs: Pathology and genetics, , Lyon: IARC Press","Soffritti, M.; Cesare Maltoni Cancer Research Center, Ramazzini Institute, Castello di Bentivoglio, Via Saliceto, 3, Italy",,,"Wiley-Liss Inc.",,,,,02713586,,AJIMD,25351660,"English","Am. J. Ind. Med.",Article,Scopus,2-s2.0-84918569116
"Soffritti, M., Padovani, M., Tibaldi, E., Falcioni, L., Manservisi, F., Belpoggi, F.","The carcinogenic effects of aspartame: The urgent need for regulatory re-evaluation",2014,"American Journal of Industrial Medicine","57","4",,"383","397",,8,10.1002/ajim.22296,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84896705152&partnerID=40&md5=a33c1b1788defa20c003c37a5d4c1e92","Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy","Soffritti, M., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Padovani, M., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Tibaldi, E., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Falcioni, L., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Manservisi, F., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Belpoggi, F., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy","Aspartame (APM) is an artificial sweetener used since the 1980s, now present in >6,000 products, including over 500 pharmaceuticals. Since its discovery in 1965, and its first approval by the US Food and Drugs Administration (FDA) in 1981, the safety of APM, and in particular its carcinogenicity potential, has been controversial. The present commentary reviews the adequacy of the design and conduct of carcinogenicity bioassays on rodents submitted by G.D. Searle, in the 1970s, to the FDA for market approval. We also review how experimental and epidemiological data on the carcinogenic risks of APM, that became available in 2005 motivated the European Commission (EC) to call the European Food and Safety Authority (EFSA) for urgent re-examination of the available scientific documentation (including the Searle studies). The EC has further requested that, if the results of the evaluation should suggest carcinogenicity, major changes must be made to the current APM specific regulations. Taken together, the studies performed by G.D. Searle in the 1970s and other chronic bioassays do not provide adequate scientific support for APM safety. In contrast, recent results of life-span carcinogenicity bioassays on rats and mice published in peer-reviewed journals, and a prospective epidemiological study, provide consistent evidence of APM's carcinogenic potential. On the basis of the evidence of the potential carcinogenic effects of APM herein reported, a re-evaluation of the current position of international regulatory agencies must be considered an urgent matter of public health. Am. J. Ind. Med. 57:383-397, 2014. © 2014 Wiley Periodicals, Inc.","Animal models; Aspartame; Carcinogenicity; Long-term experimental bioassays; Public health","aspartame; carcinogen; nonnutritive sweetener; animal; Animal models; article; carcinogen testing; carcinogenicity; chemically induced disorder; Europe; food and drug administration; human; long-term experimental bioassays; neoplasm; product safety; public health; standard; United States; animal models; aspartame; carcinogenicity; long-term experimental bioassays; public health; Animals; Aspartame; Carcinogenicity Tests; Carcinogens; Consumer Product Safety; Europe; Humans; Neoplasms; Non-Nutritive Sweeteners; United States; United States Food and Drug Administration",,"aspartame, 22839-47-0, 5910-52-1",,,,"Belpoggi, F., Soffritti, M., Padovani, M., Degli Esposti, D., Lauriola, M., Minardi, F., Results of long-term carcinogenicity bioassay on Sprague-Dawley rats exposed to aspartame administered in feed (2006) Ann NY Acad Sci, 1076, pp. 559-577; Bucher, J.R., The National Toxicology Program rodent bioassay: Designs, interpretations, and scientific contributions (2002) Ann NY Acad Sci, 982, pp. 198-207; Caldwell, J.C., Jinot, J., DeVoney, D., Gift, J.S., Evaluation of evidence for infection as a mode of action for induction of rat lymphoma (2008) Environ Mol Mutagen, 49, pp. 155-164; Cogliano, V.J., Use of carcinogenicity bioassays in the IARC monographs (2006) Ann NY Acad Sci, 1076, pp. 592-600; De la Peña, C., (2010) Empty pleasures the story of artificial sweeteners from saccharin to splenda, , Chapel Hill, NC: University of North Carolina Press; (1992), Decreto Legislativo 116 1992. Attuazione della direttiva. 86/609/CEE in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici [in Italian]. Gazzetta Ufficiale Supplemento ordinario. pp. 5-25Scientific opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in contact with Food (AFC) on a request from the Commission related to a new long-term carcinogenicity study on aspartame (2006) EFSA J Eur Food Safety Authority, 356, pp. 1-44; Updated opinion on a request from the European Commission related to the 2nd ERF carcinogenicity study on aspartame, taking into consideration study data submitted by the Ramazzini Foundation in February 2009 (2009) EFSA J Eur Food Safety Authority, 945, pp. 1-18; (2011), http://www.efsa.europa.eu/en/dataclosed/call/110601.htm, EFSA. Call for scientific data on Aspartame (E 951)Statement on the scientific evaluation of the studies related to the safety of artificial sweeteners (2011) EFSA J Eur Food Safety Authority, 9, pp. 2089-2105; Statement on two recent scientific articles on the safety of artificial sweeteners (2011) EFSA J Eur Food Safety Authority, 9, pp. 1996-2001; (2013), http://www.efsa.europa.eu/en/consultationsclosed/call/130108.pdf, EFSA. DRAFT Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive(1984), EPA. Good Laboratory Practices Standards in Environmental Protection Agency-Fungicides, Insecticides and Rodenticides Act. 48 Federal Register 53946. Environmental Protection Agency(1994), European Parliament and Council. Directive 94/35/EC of 30 June 1994 on sweeteners for use in foodstuffs OJ L 237 10.9.199. pp. 3-12Aspartame: Commissioner's final decision (1981) Fed Reg (Food and Drug Administration), 46, pp. 38285-38308; Food additives permitted for direct addition to food for human consumption: Aspartame (1983) Fed Reg (Food and Drug Administration), 48, pp. 31376-31382; Food additives permitted for direct addition to food for human consumption: Aspartame (1996) Fed Reg (Food and Drug Administration), 61, pp. 33654-33656; (2000) Toxicological principles for the safety assessment of food ingredients: FDA Redbook 2000: Section IV.B.1. General guidelines for designing and conducting toxicity studies. November 2003, p. 18. , FDA. Washington, DC: Food and Drug Administration. p; (2007), http://www.foodnavigator.com/, FDA. Center for Food Safety and Applied Nutrition. FDA Statement on European Aspartame Study. April 20, 2007: Food and Drug Administration. Food NavigatorGift, J.S., Caldwell, J.C., Jinot, J., Evans, M.V., Cote, I., Vandenberg, J.J., Scientific Considerations for Evaluating Cancer Bioassays Conducted by the Ramazzini Institute (2013) Environ Health Perspect, 12 (11-12), pp. 1253-1263; Goodman, J.E., Beyer, L.A., Beck, B.D., Comment on ""Evaluation of evidence for infection as the mode of action for induction of rat lymphoma"" by Caldwell [2008] (2009) Environ Mol Mutagen, 50, pp. 4-5. , author reply 6-9; Hayes, A.W., Dayan, A.D., Hall, W.C., Kodell, R.L., Williams, G.M., Waddell, W.D., Slesinski, R.S., Kruger, C.L., A review of mammalian carcinogenicity study design and potential effects of alternate test procedures on the safety evaluation of food ingredients (2011) Regul Toxicol Pharmacol, 60, pp. S1-S34; Huff, J., Chemicals studied and evaluated in long-term carcinogenesis bioassays by both the Ramazzini Foundation and the National Toxicology Program: In tribute to Cesare Maltoni and David Rall (2002) Ann NY Acad Sci, 982, pp. 208-230; Huff, J., Predicting chemicals causing cancer in animals as human carcinogens (2010) Occup Environ Med, 67, p. 720; Huff, J., LaDou, J., Aspartame bioassay findings portend human cancer hazards (2007) Int J Occup Environ Health, 13, pp. 446-448; Ishii, H., Incidence of brain tumors in rats fed aspartame (1981) Toxicol Lett, 7, pp. 433-437; Ishii, H., Koshimizu, T., Usami, S., Fujimoto, T., Toxicity of aspartame and its diketopiperazine for Wistar rats by dietary administration for 104 weeks (1981) Toxicology, 21, pp. 91-94; Iwata, H., (2006) Histopathological examination in a carcinogenicity study of SC-18862 in Wistar rats. [Non-GLP study]. Experiment No. 9748 (258-049). Unpublished report, pp. 1-877. , Ajinomoto Co., Inc. p. Citation retrived in Efsa 2013 Draft Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive; Landrigan, P.J., Risk assessment for children and other sensitive populations (1999) Ann NY Acad Sci, 895, pp. 1-9; Lim, U., Subar, A.F., Mouw, T., Hartge, P., Morton, L.M., Stolzenberg-Solomon, R., Campbell, D., Schatzkin, A., Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies (2006) Cancer Epidemiol Biomarkers Prev, 15, pp. 1654-1659; Littlefield, N.A., Farmer, J.H., Gaylor, D.W., Sheldon, W.G., Effects of dose and time in a long-term, low-dose carcinogenic study (1980) J Environ Pathol Toxicol, 3, pp. 17-34; Magnuson, B.A., Burdock, G.A., Doull, J., Kroes, R.M., Marsh, G.M., Pariza, M.W., Spencer, P.S., Williams, G.M., Aspartame: A safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies (2007) Crit Rev Toxicol, 37, pp. 629-727; Maltoni, C., Soffritti, M., Belpoggi, F., The scientific and methodological bases of experimental studies for detecting and quantifying carcinogenic risks (1999) Ann NY Acad Sci, 895, pp. 10-26; Marinovich, M., Galli, C.L., Bosetti, C., Gallus, S., La Vecchia, C., Aspartame, low-calorie sweeteners and disease: Regulatory safety and epidemiological issues (2013) Food Chem Toxicol, 60, pp. 109-115; Maronpot, R.R., Flake, G., Huff, J., Relevance of animal carcinogenesis findings to human cancer predictions and prevention (2004) Toxicol Pathol, 32 (SUPPL. 1), pp. 40-48; Mehlman, M.A., The power of the industrial lobby: Controversy, doupt, contradiction, lies and deceit and attacks on the Ramazzini Institute (2009) Eur J Oncol, 14, pp. 223-229; Melnick, R.L., Thayer, K.A., Bucher, J.R., Conflicting views on chemical carcinogenesis arising from the design and evaluation of rodent carcinogenicity studies (2008) Environ Health Perspect, 116, pp. 130-135; Misra, H., Soni, M., Silawat, N., Mehta, D., Mehta, B.K., Jain, D.C., Antidiabetic activity of medium-polar extract from the leaves of Stevia rebaudiana Bert. (Bertoni) on alloxan-induced diabetic rats (2011) J Pharm Bioallied Sci, 3, pp. 242-248; Mitsumori, K., Boorman, G.A., Spinal cord and peripheral nerves. Benign and malignant schwannoma (neurilemoma) (1990) Pathology of the Fischer rat, pp. 179-191. , In: Boorman, GAES, Elwell MR, Montgomery CA, MacKenzie WF Jr, editors. San Diego, CA: Academic Press. pp; (2005), National Toxicology Program. NTP report on the toxicology studies of aspartame (CAS No. 22839-47-0) in genetically modified (FVB Tg.AC hemizygous) and B6.129-Cdkn2atm1Rdp (N2) deficient mice and carcinogenicity studies of aspartame in genetically modified [B6.129-Trp53tm1Brd (N5) haploinsufficient] mice (feed studies). National Toxicology Program genetically modified model report: 1-222(2011), http://ntp.niehs.nih.gov/NTP/About_NTP/Partnerships/International/SummaryPWG_Report_RI_Bioassays.pdf, NTP and EPA. Summary Report of the National Toxicology Program and Environmental Protection Agency-Sponsored Review of pathology Materials from Selected Ramazzini Institute Rodent cancer Bioassays(2009), OECD. Guideline for the testing of chemicals. Test guideline 451: Carcinogenicity studies: Organization for Economic Cooperation and Development. p. 15(2004), Pathology Working Group. Chairperson's Report: lifetime study in rats conducted by the Ramazzini Foundation. Prepared by JR Hailey (Pathology Working Group Chair) NIEHS and submitted to F.elpoggi November 30, 2004Rao, G.N., Haseman, J.K., Edmondson, J., Influence of viral infections on body weight, survival, and tumor prevalence in Fischer 344/NCr rats on two-year studies (1989) Lab Anim Sci, 39, pp. 389-393; Rao, G.N., Piegorsch, W.W., Crawford, D.D., Edmondson, J., Haseman, J.K., Influence of viral infections on body weight, survival, and tumor prevalence of B6C3F1 (C57BL/6N x C3H/HeN) mice in carcinogenicity studies (1989) Fundam Appl Toxicol, 13, pp. 156-164; Schernhammer, E.S., Bertrand, K.A., Birmann, B.M., Sampson, L., Willett, W.W., Feskanich, D., Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women (2012) Am J Clin Nutr, 96, pp. 1419-1428; Schoeb, T.R., McConnell, E.E., Juliana, M.M., Davis, J.K., Davidson, M.K., Lindsey, J.R., Mycoplasma pulmonis and lymphoma in bioassays in rats (2009) Vet Pathol, 46, pp. 952-959; Simon, F.R., Fortune, J., Iwahashi, M., Sutherland, E., Sexual dimorphic expression of ADH in rat liver: Importance of the hypothalamic-pituitary-liver axis (2002) Am J Physiol Gastrointest Liver Physiol, 283, pp. G646-G655; Soffritti, M., Belpoggi, F., Degli Esposti, D., Falcioni, L., Bua, L., Consequences of exposure to carcinogens beginning during developmental life (2008) Basic Clin Pharmacol Toxicol, 102, pp. 118-124; Soffritti, M., Belpoggi, F., Degli Esposti, D., Lambertini, L., Aspartame induces lymphomas and leukaemias in rats (2005) Eur J Oncol, 10, pp. 107-116; Soffritti, M., Belpoggi, F., Degli Esposti, D., Lambertini, L., Tibaldi, E., Rigano, A., First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats (2006) Environ Health Perspect, 114, pp. 379-385; Soffritti, M., Belpoggi, F., Manservigi, M., Tibaldi, E., Lauriola, M., Falcioni, L., Bua, L., Aspartame administered in feed, beginning prenatally through life span, induces cancers of the liver and lung in male Swiss mice (2010) Am J Ind Med, 53, pp. 1197-1206; Soffritti, M., Belpoggi, F., Minardi, F., Bua, L., Maltoni, C., Mega-experiments to identify and assess diffuse carcinogenic risks (1999) Ann NY Acad Sci, 895, pp. 34-55; Soffritti, M., Belpoggi, F., Minardi, F., Maltoni, C., Ramazzini Foundation cancer program: History and major projects, life-span carcinogenicity bioassay design, chemicals studied, and results (2002) Ann NY Acad Sci, 982, pp. 26-45; Soffritti, M., Belpoggi, F., Tibaldi, E., Degli Esposti, D., Lauriola, M., Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats (2007) Environ Health Perspect, 115, pp. 1293-1297; Sontag, J.M., Page, N.P., Saffiotti, U., Sontag, J.M., Page, N.P., Saffiotti, U., (1976) Guidelines for carcinogen bioassay in small rodents, , Washington, DC: National Institutes of Health; Swenberg, J.A., Hoel, D.G., Magee, P.N., Mechanistic and statistical insight into the large carcinogenesis bioassays on N-nitrosodiethylamine and N-nitrosodimethylamine (1991) Cancer Res, 51, pp. 6409-6414; Talbot, J.M., Fisher, K.D., The need for special foods and sugar substitutes by individuals with diabetes mellitus (1978) Diabetes Care, 1, pp. 231-240; Tomatis, L., The predictive value of rodent carcinogenicity tests in the evaluation of human risks (1979) Ann Rev Pharmacol Toxicol, 19, pp. 511-530","Soffritti, M.; Cesare Maltoni Cancer Research Center, Ramazzini Institute, Castello di Bentivoglio, Via Saliceto, 3, 40010 Bentivoglio, Bologna, Italy; email: soffrittim@ramazzini.it",,,,,,,,02713586,,AJIMD,24436139,"English","Am. J. Ind. Med.",Article,Scopus,2-s2.0-84896705152
"Panzacchi, S., Boiani, S., Mandrioli, D., Piccioli, M., Belpoggi, F.","Applying immunohistochemistry to alcohol-fixed paraffinembedded tissues: An innovative technique to reduce use of formaldehyde [Applicazioni d'immunoistochimica su tessuti fissati in alcol e inclusi in paraffina: Una tecnica innovativa per ridurre l'uso di formaldeide]",2013,"European Journal of Oncology","18","2",,"75","83",,,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84891722085&partnerID=40&md5=a6dabce2f1a31003dbac30256d2fff6a","Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Section of Haematopathology, Department of Experimental, Diagnostic and Specialty Medicine, Bologna University School of Medicine, Bologna, Italy","Panzacchi, S., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Boiani, S., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Mandrioli, D., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Piccioli, M., Section of Haematopathology, Department of Experimental, Diagnostic and Specialty Medicine, Bologna University School of Medicine, Bologna, Italy; Belpoggi, F., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy","Recent advances in molecular biology and pathology have opened new opportunities for refining our knowledge of pathophysiologic events and biomarkers. Particular interest in applying these novel methods to current and archived tissues collected in experimental and epidemiological/clinical studies is evident. Until now, it has not always been possible to use archived alcohol-fixed paraffin-embedded (AFPE) tissues for immunohistochemisty (IHC), because AFPE slices and blocks were not often amenable to standard IHC methods. In order to solve this problem, we developed a simple method of post-fixation, which allows to use, on AFPE slices, standard IHC protocols already used for formalin-fixed paraffin-embedded (FFPE) samples. For the assessment of post-fixation processing and to test the feasibility of IHC, we selected the spleen from Sprague-Dawley rats as a demonstrative tissue. Antibodies to PAX5, CD3, CD68 and Ki- 67, were tested on FFPE, AFPE and AFPE post-fixed spleen samples. The specificity of antibodies to bind different epitopes expressed in spleen tissue was maintained in FFPE and AFPE post-fixed sections, according to anatomical localization. Post-fixation of AFPE samples did not affect tissue morphology and IHC results were comparable to the FFPE sections in terms of sensitivity, specificity and intensity of staining. In addition to providing an opportunity to use archived tissues, this new post-fixation method would dramatically reduce the use of formaldehyde during histopathology procedures, thus minimizing worker exposure to this dangerous carcinogenic substance. © Mattioli 1885.","AFPE post-fixation; Alcohol-fixation; FFPE; Formalin fixation; IHC","alcohol; carcinogen; CD3 antigen; CD68 antigen; epitope; formaldehyde; Ki 67 antigen; paraffin; transcription factor PAX5; analytic method; animal tissue; antibody specificity; antigen expression; article; feasibility study; histopathology; immunohistochemistry; nonhuman; occupational exposure; rat; risk reduction; sensitivity and specificity; spleen; Sprague Dawley rat; tissue fixation",,"alcohol, 64-17-5; formaldehyde, 50-00-0",,,,"Painter, J.T., Clayton, N.P., Herbert, R.A., Useful immunohistochemical markers of tumor differentiation (2010) Toxicol Pathol, 38, pp. 131-141; Ward, J.M., Hardisty, J.F., Hailey, J.R., Peer Review in Toxicologic Pathology (1995) Toxicol Pathol, 23, pp. 226-234; Swerdlow, S.H., Campo, E., Harris, N.L., (2008) IARC WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, , Fourth Edition; Peterson, R.A., Krull, D.L., Butler, L., Applications of laser scanning cytometry in immunohistochemistry and routine histopathology (2008) Toxicol Pathol, 36, pp. 117-132; Nietner, T., Jarutat, T., Mertens, A., Systematic comparison of tissue fixation with alternative fixatives to conventional tissue fixation with buffered formalin in a xenograft-based model (2012) Virchows Arch, 461, pp. 259-269; Zanini, C., Gerbaudo, E., Ercole, E., Evaluation of two commercial and three home-made fixatives for the substitution of formalin: A formaldehyde-free laboratory is possible (2012) Environ Health, 11, p. 5; Vollmer, E., Galle, J., Lang, D.S., The HOPE technique opens up a multitude of new possibilities in pathology (2006) J Morphol Embryol, 47, pp. 15-19; Benerini Gatta, L., Cadei, M., Balzarini, P., Application of alternative fixatives to formalin in diagnostic pathology (2012) Eur J Histochem, 56, pp. 63-70; Fox, C.H., Johnson, F.B., Whiting, J., Formaldehyde Fixation (1985) J Histochem Cytochem, 33, pp. 845-853; Werner, M., Chott, A., Fabiano, A., Effect of formalin tissue fixation and processing on immunohistochemistry (2000) Am J Surg Pathol, 24, pp. 1016-1019; Srinivasan, M., Sedmak, D., Jewell, S., Effect of fixatives and tissue processing on the content and integrity of nucleic acids (2002) Am J Pathol, 161, pp. 1961-1971; Cox, M.L., Schray, C.L., Luster, C.N., Assessment of fixatives, fixation, and tissue processing on morphology and RNA integrity (2006) Exp Mol Pathol, 80, pp. 183-191; Korga, A., Wilkołaska, K., Korobowicz, E., Difficulties in using archival paraffin-embedded tissues for RNA expression analysis. [Article in Polish] (2007) Postepy Hig Med Dosw, 61, pp. 151-155; Formaldehyde (2012) A review of human carcinogens: Chemical agents and related occupations, pp. 401-435. , http://monographs.iarc.fr/ENG/Monographs/vol100F/mono100F-29.pdf, International Agency for Research on Cancer (IARC), 100F; Monographs on the evaluation of carcinogenic risks to humans (2006) Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan, 2 (88), pp. 36-325. , International Agency for Research on Cancer (IARC), Lyon, France; Soffritti, M., Belpoggi, F., Lambertini, L., Results of long-term experimental studies on the carcinogenicity of formaldehyde and acetaldehyde in rats (2002) Ann NY Acad Sci, 982, pp. 87-105; Zhang, L., Freeman, L.E., Nakamura, J., Formaldehyde and leukemia: Epidemiology, potential mechanisms, and implications for risk assessment (2010) Environ Mol Mutagen, 51, pp. 181-189; Formaldehyde (2011) NTP report on carcinogens, pp. 195-205. , http://ntp.niehs.nih.gov/ntp/roc/twelfth/profiles/Formaldehyde.pdf, National Toxicology Program (NTP), Twelfth Edition, Department of Health and Human Services, Public Health Service, National Toxicology Program. Research Triangle Park, NC, [Accessed March 2013]. Web site: http://ntp.niehs.nih.gov/go/roc12; Buesa, R.J., Histology without formalin? (2008) Ann Diagn Pathol, 12, pp. 387-396; Ahram, M., Flaig, M.J., Gillespie, J.W., Evaluation of ethanol-fixed, paraffin-embedded tissues for proteomic applications (2003) Proteomics, 3, pp. 413-421; Shao, Q., Fan, Y., Yang, L., From protein denaturant to protectant: Comparativemolecular dynamics study of alcohol/ protein interactions (2012) J Chem Phys, 136, p. 115101; Milcheva, R., Janega, P., Celec, P., Alcohol based fixatives provide excellent tissue morphology, protein immunoreactivity and RNA integrity in paraffin embedded tissue specimens (2012) Acta Histochem, , [Epub ahead of print]; Gillespie, J.W., Best, C.J.M., Bichsel, V.E., Evaluation of non-formalin tissue fixation for molecular profiling studies. Technical Advance (2002) Am J Pathol, 160, pp. 449-457; Soffritti, M., Belpoggi, F., Tibaldi, E., Life-Span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats (2007) Environ Health Perspect, 115, pp. 1293-1297; Belpoggi, F., Soffritti, M., Guarino, M., Results of longterm experimental studies on the carcinogenicity of ethylene-bis-dithiocarbamate (Mancozeb) in rats (2002) Ann NY Acad Sci, 982, pp. 123-136; Belpoggi, F., Soffritti, M., Minardi, F., Results of longterm carcinogenicity bioassays on tert-amyl-methyl-ether (TAME) and di-isopropyl-ether (DIPE) in rats (2002) Ann NY Acad Sci, 982, pp. 70-86; Soffritti, M., Belpoggi, F., Padovani, M., Life-time carcinogenicity bioassay of toluene given by stomach tube to Sprague-Dawley rats (2004) Eur J Oncol, 9, pp. 91-102; Soffritti, M., Belpoggi, F., Cevolani, D., Results of longterm experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats (2002) Ann NY Acad Sci, 982, pp. 46-69; Belpoggi, F., Soffritti, M., Maltoni, C., Methyl-tertiary-butyl ether (MTBE), a gasoline additive, causes testicular and lymphohaematopoietic cancers in rats (1995) Toxicol Ind Health, 11, pp. 119-149; Belpoggi, F., Soffritti, M., Padovani, M., Results of longterm carcinogenicity bioassay on Sprague-Dawley rats exposed to aspartame administered in feed (2006) Ann NY Acad Sci, 1076, pp. 559-577; Soffritti, M., Belpoggi, F., Degli Esposti, D., Aspartame induces lymphomas and leukaemias in rats (2005) Eur J Oncol, 10, pp. 107-116; Soffritti, M., Belpoggi, F., Degli Esposti, D., Cancer Prevention: The lesson from the lab (2006) Cancer Medicine at the Dawn of the 21st, pp. 49-64. , In, Century: the view from Bologna, eds Biasco G, Tanneberger S, Bonomia University; National Toxicology Program Summary Report of the Environmental Protection Agency Sponsored Review of Pathology Materials from Selected Ramazzini Institute Rodent Cancer Bioassays (November 29, 2011)Implementation of Directive n. 86/609/CEE on the protection of animals used for experimental and other scientific purposes [in Italian] Ordinary Supplement to the Official Journal, 40, pp. 5-25. , Decreto Legislativo n. 116/1992; Cesta, M.F., Normal structure, function, and histology of the spleen (2006) Toxicol Pathol, 34, pp. 455-465; Ward, J.M., Erexson, C.R., Faucette, L.J., Immunohistochemical markers for the rodent immune system (2006) Toxicol Pathol, 34, pp. 616-630; Randall, K.J., Pearse, G., A Dual-label Technique for the immunohistochemical demonstration of T-lymphocyte subsets in formalin-fixed, paraffin-embedded rat lymphoid tissue (2008) Toxicol Pathol, 36, pp. 795-804; Rehg, J.E., Bush, D., Ward, J.M., The utility of immunohistochemistry for the identification of hematopoietic and lymphoid cells in normal tissues and interpretation of proliferative and inflammatory lesions of mice and rats (2012) Toxicol Pathol, 40, pp. 345-374; Luna, L.G., (1968) Manual of histologic staining methods of the Armed Forces Institute of Pathology, , 3rd ed. Ed. New York: McGraw Hill Publications; Moelans, C.B., Oostenrijk, D., Moons, M.J., Formaldehyde substitute fixatives: Effects on nucleic acid preservation (2011) J Clin Pathol, 64, pp. 960-967; Nowell, P.C., The clonal evolution of tumor cell populations (1976) Science, 194, pp. 23-28; Rezuke, W.N., Abernathy, E.C., Tsongalis, G.J., Molecular diagnosis of B-and T-cell lymphomas: Fundamental principles and clinical applications (1997) Clin Chem, 43, pp. 1814-1823; Harris, N.L., Stein, H., Coupland, S.E., New approaches to lymphoma diagnosis (2001) Am Soc Hematol Educ Program, pp. 194-220; Kocjan, G.J., Cytological and molecular diagnosis of lymphoma (2005) J Clin Pathol, 58, pp. 561-567; Greaves, M., Maley, C.C., Clonal evolution in cancer (2012) Nature, 481, pp. 306-313","Belpoggi, F.; Cesare Maltoni Cancer Research Center, Via Saliceto, 3 - Bentivoglio, Bologna, Italy",,,,,,,,11286598,,EJOUA,,"English; Italian","Eur. J. Oncol.",Article,Scopus,2-s2.0-84891722085
"Soffritti, M., Falcioni, L., Bua, L., Tibaldi, E., Manservigi, M., Belpoggi, F.","Potential carcinogenic effects of world trade center dust after intratracheal instillation to Sprague-Dawley rats: First observation",2013,"American Journal of Industrial Medicine","56","2",,"155","162",,2,10.1002/ajim.22109,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84872423598&partnerID=40&md5=221648332e43e7dd116309dd516c84ca","Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy","Soffritti, M., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Falcioni, L., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Bua, L., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Tibaldi, E., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Manservigi, M., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Belpoggi, F., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy","Background: More than 10 years have passed since the terrorist attack on the New York City World Trade Center on September 11, 2001. It is well known that long-term carcinogenic bioassays on rodents can predict the potential carcinogenic effects of chemical and physical agents for humans. Objective: A life-span carcinogenicity bioassay was conducted on Sprague-Dawley rats at the CMCRC of the Ramazzini Institute to test the potential carcinogenic effects of settled dust collected at the WTC immediately after the terrorist attack. Methods: The WTC material tested is a complex mixture of coarse particles (95%) contain pulverized cement, glass fibres, asbestos, lead, polycyclic aromatic hydrocarbons (PAHS), polychlorinated biphenyls (PCBS) and polychlorinated furans, and dioxin. The test matter was suspended in sterile saline and administered by intratracheal instillation (IT) to 8-week-old Sprague-Dawley rats (100 animals/sex), 3-4 days/week for 4 weeks. A group of 200 male and female rats served as controls. The animals were kept under observation until natural death. Results: Histopathological evaluation of the lungs (target organ) of instilled control and treated male and female rats, did not show any significant increased incidence of lung tumors. Two hemangiomas (one with endothelial atypia) and one hemangiosarcoma were found in the lungs of treated males. Moreover a modest increased incidence of terminal bronchiolar hyperplasia (TBH) and squamous metaplasia occurred in the lung of treated males and females compared to the controls. Conclusion: Hemangioma and hemangiosarcoma are extremely rare tumors in the lung of our colony and we believe they are caused by WTC dust. © 2012 Wiley Periodicals, Inc.","Carcinogenicity; Pulmonary effects; Sprague-Dawley rats; WTC dust","carcinogen; air pollutant; angiosarcoma; animal; article; drug instillation; dust; evaluation; female; hemangioma; lung; lung tumor; male; pathology; rat; Sprague Dawley rat; terrorism; toxicity testing; trachea; Air Pollutants; Animals; Carcinogens, Environmental; Dust; Female; Hemangioma; Hemangiosarcoma; Instillation, Drug; Lung; Lung Neoplasms; Male; Rats; Rats, Sprague-Dawley; September 11 Terrorist Attacks; Toxicity Tests, Chronic; Trachea",,"Air Pollutants; Carcinogens, Environmental; Dust",,,,"Injuries and illnesses among New York City Fire Department rescue workers after responding to the World Trade Center attacks (2002) Morbid Mortal Weekly Rep, 5, pp. 1-5. , Center for Disease Control Prevention; Clark, R.N., Green, R.D., Swayze, G.A., Meeker, G., Sutley, S., Hoefen, T.M., (2003), http//pubs.usgs.gov/of/2001/ofr-01-0429, Environmental studies of the World Trade Center. Area after the September 11, 2001 attack. (Accessed March 25, 2004)Attuazione della direttiva n. 86/609/CEE in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici [in Italian] (1992) Suppl Ordinario Gazz Ufficiale, 40, pp. 5-25. , Decreto Legislativo 116; Friedman, S., Cone, J., Eros-Sarnyai, M., Prezant, D.J., Szeinuk, J., Clark, N., Milek, D., Gillio, R., (2011), http://www.nyc.gov/html/doh/downloads/pdf/chi/chi27-6.pdf.2008, Clinical guidelines for adults exposed to the World trade Center disaster. New York City Health Information Web site Accessed July 8Guidotti, T.L., Prezant, D., de la Hoz, R.E., Miller, A., The evolving spectrum of pulmonary disease in responders to the World Trade Center Tragedy (2011) Am J Ind Med, 54, pp. 649-660; Kakegawa, S., Kawashima, O., Takashi, I., Ujita, M., Iwashina, M., Nakano, T., Shimizu, K., A case of primary angiosarcoma of the lung presenting as hemorrhagic bronchiolar tumor (2012) Ann Thorac Cardiovasc Surg, 18 (4), pp. 347-351; Landrigan, P.J., Lioy, P.J., Thurston, G., Berkowitz, G., Chen, L.C., Chillrud, S.N., Gavett, S.H., Health and environmental consequences of the World Trade Center disaster (2004) Environ Health Perspect, 112 (6), pp. 731-739; Lioy, P.J., (2010) DUST: The inside story of it role in the September 11th Aftermath, pp. 1-250. , Lanham, Maryland: Rowman and Littlefield Publishers, Inc; Lioy, P.J., Weasel, C.P., Millette, J.R., Eisenreich, S., Vallero, D., Offenberg, J., Characterization of the dust/smoke aerosol that settled east of the World Trade Center (WTC) in Lower Manhattan after the collapse of the WTC 11 September 2001 (2002) Environ Health Perspect, 110, pp. 703-714; Maltoni, C., Lefemine, G., Ciliberti, A., Cotti, G., Carretti, D., Experimental research on vinyl chloride carcinogenesis (1984) Archives of research on industrial carcinogenesis, 11. , Maltoni C, Mehlman MA, editors. Princeton, NJ: Princeton Scientific Publishers; Mc Gee, J.K., Chen, L.C., Cohen, M.D., Chee, G.R., Prophete, C.M., Haykal-Coates, N., Chemical analysis of World Trade Center fine particulate matter for use in toxicological assessment (2003) Environ Health Perspect, 111, pp. 972-980; Offenberg, J.H., Eisenreich, S.J., Chen, L.C., Cohen, M.D., Chee, G., Prophete, C., Persistent organic pollutants in the dusts that settled across lower Manhattan after September 11, 2001 (2003) Environ Sci Technol, 37, pp. 502-508; Stellman, J.M., Smith, R.P., Katz, C.L., Sherma, V., Cherney, D.S., Herbert, R., Moline, J., Southwick, S., Enduring mental health morbidity and social function impairment in World Trade Center rescue, recovery, and cleanup workers: The psychological dimension of an environmental health disaster (2008) Environ Health Perspect, 116 (9), pp. 1248-1253","Soffritti, M.; Cesare Maltoni Cancer Research Center, Ramazzini Institute, Castello di Bentivoglio, Via Saliceto, 3, 40010 Bentivoglio, Bologna, Italy; email: soffrittim@ramazzini.it",,,,,,,,02713586,,AJIMD,22996685,"English","Am. J. Ind. Med.",Article,Scopus,2-s2.0-84872423598
"Lauriola, M., Bua, L., Chiozzotto, D., Manservisi, F., Panetta, A., Martorana, G., Belpoggi, F.","Urinary apparatus tumours and asbestos: The Ramazzini Institute caseload",2012,"Archivio Italiano di Urologia e Andrologia","84","4",,"189","196",,,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84872786489&partnerID=40&md5=292b6296e2c6751feaffb6b72264b037","Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bentivoglio, Bologna, Italy; Departmental Operative Unit in the Oncology Department, Palliative Care, Bentivoglio Hospital, Bentivoglio, Bologna, Italy; Department of Urology, University of Bologna, Italy","Lauriola, M., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bentivoglio, Bologna, Italy; Bua, L., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bentivoglio, Bologna, Italy; Chiozzotto, D., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bentivoglio, Bologna, Italy; Manservisi, F., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bentivoglio, Bologna, Italy; Panetta, A., Departmental Operative Unit in the Oncology Department, Palliative Care, Bentivoglio Hospital, Bentivoglio, Bologna, Italy; Martorana, G., Department of Urology, University of Bologna, Italy; Belpoggi, F., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bentivoglio, Bologna, Italy","Many studies have drawn attention to the possible association between occupational exposure to asbestos and tumours of the urinary apparatus. Besides the main etiological agents recognised today - such as smoking, obesity and hypertension - experimental and epidemiological evidence converges on the view that tumours of the kidney and bladder are largely due to occupational exposure to industrial agents: these and their transformation products linger in the body and are eventually eliminated by those organs. That one such agent targeting the urinary system is asbestos has found confirmation in the discovery of asbestos fibres in the urine of populations at risk. We here present 23 cases of work exposure to asbestos in a range of exposure scenarios where the workers developed tumours of the kidney and bladder. The cases came to the attention of the Ramazzini Institute casually.","Asbestos; Occupational exposure; Renal cancer","asbestos; article; bladder tumor; gastrointestinal tumor; human; hypertension; incidence; kidney carcinoma; kidney pelvis tumor; kidney tumor; larynx tumor; nephroblastoma; obesity; occupational exposure; oropharynx tumor; peritoneum mesothelioma; pleura mesothelioma; risk factor; smoking; ureter carcinoma; Academies and Institutes; Asbestos; Humans; Italy; Occupational Exposure; Urologic Neoplasms",,"asbestos, 1332-21-4; Asbestos, 1332-21-4",,,,"Volkheimer, G., Persorption (1973) Acta Hep-Gastroenterol, 20, pp. 361-362; Schreiber, G., Ingested dyed cellulose in the blood and urine of man (1974) Arch Environ Health, 29, pp. 39-42; Volkheimer, G., Passage of particles trough the wall of the gastrointestinal tract (1974) Environ Health Perspect, 9, pp. 215-225; (1977) Asbestos. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, 14. , International Agency for Research on Cancer (IARC) Lyon, France: International Agency for Research on Cancer; Graham, S., Blanchet, M., Rohrer, T., Cancer in asbestos-mining and other areas of Quebec (1977) Journal of the National Cancer Institute, 59 (4), pp. 1139-1145; Weiss, A., Cancer of pleura in pulmonary asbestosis determined morphologically in vivo (1953) Medizinische, 6, pp. 93-94. , Article in Undetermined Language; Finn, M.B., Hallenbeck, W.H., Detection of chrysotile asbestos in workers urine (1985) American Industrial Hygiene Association Journal, 46 (3), pp. 162-169; Guillemin, M.P., Litzistorf, G., Buffat, P.A., Urinary fibres in occupational exposure to asbestos (1989) Annals of Occupational Hygiene, 33 (2), pp. 219-233; Cook, P.M., Olson, G.F., Ingested mineral fibers: elimination in human urine (1979) Science, 204 (4389), pp. 195-198; Bellis, D., Belluso, E., Capella, S., Coverlizza, S., Ferraris, G., Mineral fibres and bladder cancer. Morphological and mineralogical study in a subject without professional exposure (2003) Pathologica, 95 (3), pp. 157-161; Kanazawa, K., Birbeck, M.S.C., Carter, R.L., Roe, F.J.C., Migration of asbestos fibers from subcutaneous injection sites in mice (1970) Br J Cancer, 24, pp. 96-106; Kanazawa, K., Roe, F.J.C., Yamamoto, T., Milky spots (taches laiteuses) as structures which trap asbestos in mesothelial layers and their significance in the pathogenesis of mesothelial neoplasia (1979) International Journal of Cancer, 23 (6), pp. 858-865. , DOI 10.1002/ijc.2910230619; Huang, J., Hisanaga, N., Sakai, K., Asbestos fibers in human pulmonary and extrapulmonary tissues (1988) Am J Ind Med, 14, pp. 331-339; Smith, A.H., Shearn, V.I., Wood, R., Asbestos and kidney cancer: The evidence supports a causal association (1989) American Journal of Industrial Medicine, 16 (2), pp. 159-166; Auerbach, O., Conston, A.S., Garfinkel, L., Presence of asbestos bodies in organs other than the lung (1980) Chest, 77 (2), pp. 133-137; Miserocchi, G., Sancini, G., Mantegazza, F., Chiappino, G., Translocation pathways for inhaled asbestos fibers (2008) Environ Health, 7, p. 4; Parkin, C.M., Whelan, S.L., Ferlay, J., Cancer Incidence in Five Continents (2002) IARC Scientific Publications No. 155, 8. , Lyon, France: International Agency for Research on Cancer; Lipworth, L., Tarone, R.E., Lund, L., McLaughlin, J.K., Epidemiologic characteristics and risk factors for renal cell cancer (2009) Clin Epidemiol, 1, pp. 33-43; (2011) Cancer Facts & Figures 2011, , American Cancer Society. Atlanta: American Cancer Society; Kidney Cancer - UK Incidence Statistics, , http://info.cancerresearchuk.org/cancerstats/types/kidney/incidence/, Last updated: 10/08/2011. Posted at; Ferlay, J., Bray, F., Pisani, P., Parkin, D.M., (2004) Globocan 2002 Cancer Incidence, Mortality and Prevalence Worldwide IARC Cancer Base No. 5, , IARC press, Lyon, France; Curado, M.P., Edwards, B., Shin, H.R., Storm, H., Cancer Incidence in Five Continents (2007) IARC Scientific Publications No. 160, 9. , Lyon, France: International Agency for Research on Cancer; Chow, W.H., Dong, L.M., Devesa, S.S., Epidemiology and risk factors for kidney cancer (2010) Nat Rev Urol, 7, pp. 245-257; Ries, L.A.G., Melbert, D., Krapcho, M., (2007) SEER Cancer Statistics Review, 1975-2004, , http://seer.cancer.gov/csr/1975_2004/, Bethesda, MD, based on November 2006 SEER data submission, posted to the SEER web site, Posted at; Howlader, N., Noone, A.M., Krapcho, M., (2011) SEER Cancer Statistics Review, 1975-2008, , http://seer.cancer.gov/csr/1975_2008/, Bethesda, MD, based on November 2010 SEER data submission, posted to the SEER web site, Posted at; Kuper, H., Boffetta, P., Adami, H.O., Tobacco use and cancer causation: Association by tumour type (2002) J Intern Med, 252, pp. 206-224; Dhote, R., Thiounn, N., Debre, B., Vidal-Trecan, G., Risk factors for adult renal cell carcinoma (2004) Urologic Clinics of North America, 31 (2), pp. 237-247. , DOI 10.1016/j.ucl.2004.01.004, PII S0094014304000229; Renehan, A.G., Tyson, M., Egger, M., Heller, R.F., Zwahlen, M., Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies (2008) The Lancet, 371 (9612), pp. 569-578. , DOI 10.1016/S0140-6736(08)60269-X, PII S014067360860269X; Lee, J.E., Männistö, S., Spiegelman, D., Intakes of fruit vegetables, and carotenoids and renal cell cancer risk: A pooled analysis of 13 prospective studies (2009) Cancer Epidemiol Biomarkers Prev, 18, pp. 1730-1739; Maltoni, C., Minardi, F., Soffritti, M., Epidemiologia e fattori di rischio, con particolare attenzione a quelli industriali, dei tumori maligni del rene (1992) Congresso Straordinario per Il Ventennale della SIPDTT Bologna, 15-17 Novembre 1992, 1, pp. 55-96. , Corrado F, Maltoni C, Corrado G, et al. I tumori urologici: recenti progressi e nuovi obiettivi della ricerca. Monduzzi Editore, In Italian; Soffritti, M., Belpoggi, F., Manservigi, M., Aspartame administered in feed, beginning prenatally through life span, induces cancers of the liver and lung in male Swiss mice (2010) Am J Ind Med, 53, pp. 1197-1206; Saarni, H., Pentti, J., Pukkala, E., Cancer at sea: A case-control study among male Finnish seafarers (2002) Occupational and Environmental Medicine, 59 (9), pp. 613-619. , DOI 10.1136/oem.59.9.613; Chemicals that produced ""clear"", ""some"", and ""equivocal"" evidence of carcinogenicity Numbers of Chemicals Associated with Site-Specific Neoplasia, , http://ntp.niehs.nih.gov/index.cfm?objectid=9EA39B85-E4CE-1437- 7575FADEA9B9DDF3, Posted at: Last updated on December 17, 2009; Lemen, A.R., Asbestos-related disease risks still exist (2005) Eur J Oncol, 10, pp. 9-30; Gibel, W., Lohs, K., Horn, K.H., Experimental study on cancerogenic activity of asbestos filters (1976) Arch Geschwulstforsch, 46, pp. 437-442. , In German; NTP Toxicology and Carcinogenesis Studies of Chrysotile Asbestos (CAS No. 12001-29-5) in F344/N Rats (Feed Studies) (1985) Natl Toxicol Program Tech Rep ser, 295, pp. 1-390. , National Toxicology Program; Boor, P., Casper, S., Celec, P., Renal, vascular and cardiac fibrosis in rats exposed to passive smoking and industrial dust fibre amosite (2009) J Cell Mol Med, 13, pp. 4484-4491; Selikoff, I.J., Hammond, E.C., Seidman, H., Mortality experience of insulation workers in the United States and Canada, 1943-1976 (1979) Annals of the New York Academy of Sciences, VOL. 330, pp. 91-116; Selikoff, I.J., Seidman, H., Asbestos-associated deaths among insulation workers in the United States, and Canada, 1967-1987 (1991) Ann NY Acad Sci, 643, pp. 1-14; Enterline, P.E., Hartley, J., Henderson, V., Asbestos and cancer: A cohort followed up to death (1987) British Journal of Industrial Medicine, 44 (6), pp. 396-401; Harber, P., Mohsenifar, Z., Oren, A., Lew, M., Pleural plaques and asbestos-associated malignancy (1987) Journal of Occupational Medicine, 29 (8), pp. 641-644; Mac Lure, M., Asbestos and renal adenocarcinoma: A case-control study (1987) Environ Res, 42, pp. 353-361; McCredie, M., Stewart, J.H., Risk factors for kidney cancer in New South Wales. IV. Occupation (1993) British Journal of Industrial Medicine, 50 (4), pp. 349-354; McDonald, J.C., Liddell, F.D.K., Dufresne, A., McDonald, A.D., The 1891-1920 birth cohort of Quebec chrysotile miners and millers: Mortality 1976-88 (1993) British Journal of Industrial Medicine, 50 (12), pp. 1073-1081; Mellemgaard, A., Engholm, G., McLaughlin, J.K., Olsen, J.H., Occupational risk factors for renal-cell carcinoma in Denmark (1994) Scandinavian Journal of Work, Environment and Health, 20 (3), pp. 160-165; Mandel, J.S., McLaughlin, J.K., Schlehofer, B., International renalcell cancer study. IV. Occupation (1995) Int J Cancer, 61, pp. 601-605; Gamble, J.F., Lewis, R.J., Jorgensen, G., Mortality among three refinery/petrochemical plant cohorts. II. Retirees (2000) Journal of Occupational and Environmental Medicine, 42 (7), pp. 730-736; Lewis, R.J., Gamble, J.F., Jorgensen, G., Mortality among three refinery/petrochemical plant cohorts. I. 1970 to 1982 active/terminated workers (2000) Journal of Occupational and Environmental Medicine, 42 (7), pp. 721-729; Metts, M.C., Metts, J.C., Milito, S.J., Thomas Jr., C.R., Bladder cancer: A review of diagnosis and management (2000) J Natl Med Assoc, 92, pp. 285-294; Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., Thun, M.J., Cancer statistics, 2008 (2008) CA Cancer Journal for Clinicians, 58 (2), pp. 71-96. , http://caonline.amcancersoc.org/cgi/reprint/58/2/71, DOI 10.3322/CA.2007.0010; Silverman, D.T., Morrison, A.S., Devesa, S.S., Bladder Cancer (1996) Cancer Epidemiology and Prevention, pp. 1156-1179. , 2nd ed. (eds Schottenfeld D, Fraumeni JF Jr.). Oxford University Press, New York; SEER Cancer Statistics Review, 1975-2006, , http://seer.cancer.gov/csr/1975_2006/, Bethesda, MD. Posted at; Levi, F., Lucchini, F., Negri, E., Boyle, P., La, V.C., Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960 (2004) International Journal of Cancer, 110 (2), pp. 155-169. , DOI 10.1002/ijc.20097; Levi, F., Lucchini, F., Boyle, P., Cancer incidence and mortality in Europe, 1988-92 (1998) J Epidemiol Biostat, 3, pp. 295-373; Foote, M., Racial disparities in cancer incidence and mortality: Wisconsin and United States, 1996-2000 (2003) Wisconsin Medical Journal, 102 (5), pp. 27-35; Olfert, S.N., Felknor, S.A., Delclos, G.L., An update review of the literature: Risk factors for bladder cancer with focus on occupational exposures (2006) Southern Med J, 99, pp. 1256-1264; Matanoski, G.M., Elliott, E.A., Bladder cancer epidemiology (1981) Epidemiologic Reviews, 3, pp. 203-229; Stewart, B.W., Kleihues, P., (2003) World Cancer Report, pp. 33-36. , IARC Lyon, France; Negri, E., La, V.C., Epidemiology and prevention of bladder cancer (2001) European Journal of Cancer Prevention, 10 (1), pp. 7-14. , DOI 10.1097/00008469-200102000-00002; Bravo, M.P., Del Rey-Calero, J., Conde, M., Bladder cancer and asbestos in Spain (1988) Rev Epidemiol Sante Publique, 36, pp. 10-14; Kunze, E., Chang-Claude, J., Frentzel-Beyme, R., Life style and occupational risk factors for bladder cancer in Germany (1992) Cancer, 69, pp. 1776-1790; Kannio, A., Ridanpaa, M., Koskinen, H., A molecular and epidemiological study on bladder cancer: P53 mutations, tobacco smoking, and occupational exposure to asbestos (1996) Cancer Epidemiol Biomarkers Prev, 5, pp. 33-39; Puntoni, R., Merlo, F., Borsa, L., Reggiardo, G., Garrone, E., Ceppi, M., A historical cohort mortality study among shipyard workers in Genoa, Italy (2001) American Journal of Industrial Medicine, 40 (4), pp. 363-370. , DOI 10.1002/ajim.1110; Ugnat, A.-M., Luo, W., Semenciw, R., Mao, Y., Occupational exposure to chemical and petrochemical industries and bladder cancer risk in four western Canadian provinces (2004) Chronic Diseases in Canada, 25 (2), pp. 7-15; Budroni, M., Sechi, O., Cesaraccio, R., Cancer incidence among petrochemical workers in the Porto Torres industrial area, 1990-2006 (2010) Med Lav, 101, pp. 189-198; Davies, J.M., Bladder tumours in the electric-cable industry (1965) Lancet, 2, pp. 143-146; Wynder, E.L., Goldsmith, R., Epidemiology of bladder cancer (1977) Cancer, 40, pp. 1246-1268; Howe, G.R., Burch, J.D., Miller, A.B., Tobacco use, occupation, coffee, various nutrients, and bladder cancer (1980) Journal of the National Cancer Institute, 64 (4), pp. 701-713; Claude, J.C., Frentzel-Beyme, R.R., Kunze, E., Occupation and risk of cancer of the lower urinary tract among men. A case-control study (1988) International Journal of Cancer, 41 (3), pp. 371-379; Kogevinas, M., 'T Mannetje, A., Cordier, R., Occupation and bladder cancer among man in Western Europe (2003) Cancer Causes Control, 14, pp. 907-914; Samanic, C.M., Kogevinas, M., Silverman, D.T., Tardon, A., Serra, C., Malats, N., Real, F.X., Dosemeci, M., Occupation and bladder cancer in a hospital-based case-control study in Spain (2008) Occupational and Environmental Medicine, 65 (5), pp. 347-353. , DOI 10.1136/oem.2007.035816; Cassidy, A., Wang, W., Wu, X., Lin, J., Risk of urinary bladder cancer: A case-control analysis of industry and occupation (2009) BMC, 9, p. 443; Colt, J.S., Karagas, M.R., Schwenn, M., Occupation and bladder cancer in a population-based case-control study in Northern New England (2011) Occup Environ Med, 68, pp. 239-249; (2012) Monographs on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens: Arsenic, Metals, Fibers and Dusts, 100 C. , http://monographs.iarc.fr/ENG/Monographs/PDFs/index.php, Lyon, France, Posted at","Belpoggi, F.; Centro di Ricerca sul Cancro Cesare Maltoni, Istituto Ramazzini, Castello di Bentivoglio, Via Saliceto 3, 40010 Bentivoglio (BO), Italy; email: belpoggif@ramazzini.it",,,,,,,,11243562,,AIUAF,23427742,"English","Arch. Ital. Urol. Androl.",Article,Scopus,2-s2.0-84872786489
"Bua, L., Lauriola, M., Virzì, S., Iusco, D., Balbi, T., Chiozzotto, D., Belpoggi, F.","Peritoneal mesothelioma in petrochemical plant worker exposed to asbestos [Mesotelioma peritoneale da amianto in lavoratore di uno stabilimento petrolchimico]",2011,"European Journal of Oncology","16","4",,"241","246",,,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84860685080&partnerID=40&md5=96284a8b653fde482c71908d317587b3","Centro di Ricerca sul Cancro Cesare Maltoni, Istituto Ramazzini, Bentivoglio, Bologna, Italy; Unità Operativa di Chirurgia Generale, Ospedale di Bentivoglio, Bentivoglio, Bologna, Italy; Istituto di Anatomia Patologica, Policlinico Sant'Orsola Malpighi, Bologna, Italy","Bua, L., Centro di Ricerca sul Cancro Cesare Maltoni, Istituto Ramazzini, Bentivoglio, Bologna, Italy; Lauriola, M., Centro di Ricerca sul Cancro Cesare Maltoni, Istituto Ramazzini, Bentivoglio, Bologna, Italy; Virzì, S., Unità Operativa di Chirurgia Generale, Ospedale di Bentivoglio, Bentivoglio, Bologna, Italy; Iusco, D., Unità Operativa di Chirurgia Generale, Ospedale di Bentivoglio, Bentivoglio, Bologna, Italy; Balbi, T., Istituto di Anatomia Patologica, Policlinico Sant'Orsola Malpighi, Bologna, Italy; Chiozzotto, D., Centro di Ricerca sul Cancro Cesare Maltoni, Istituto Ramazzini, Bentivoglio, Bologna, Italy; Belpoggi, F., Centro di Ricerca sul Cancro Cesare Maltoni, Istituto Ramazzini, Bentivoglio, Bologna, Italy","This work reports a case of mesothelioma in a worker exposed to asbestos, attending the computer process in a petrochemical facility. The latency time, i.e. the period elapsing between the start of exposure and the onset of early symptoms and signs of the neoplasia, was 36 years. This is the second case of seven which was brough to our attention by a report by the Operational Unit of Surgery of the Hospital of Bentivoglio, treated with cytoreductive surgery and with hyperthermic intraperitoneal chemotherapy (HIPEC). After two years from the surgical treatment, the patient is still in good health. Following histology and immunohistochemical characterization, the initial clinical diagnosis of peritoneal carcinosis was optimized in peritoneal mesothelioma.","Asbestos; Cytoreductive surgery with chemo-hyperthermia; Mesothelioma; Petrochemical plant","asbestos; article; case report; cytoreductive surgery; human; nonmedical occupations; occupational cancer; peritoneum mesothelioma; petrochemical plant worker",,"asbestos, 1332-21-4",,,,"Survival Rates for Mesothelioma 2009, , http://www.cancer.org/docroot/CRI/content/CRI_2_2_3X_Survival_rates_for_meosothelioma_29.asp?sitearea, American Cancer Society, Available at; Peto, J., Decarli, A., la Vecchia, C., The European mesothelioma epidemic (1999) Br J Cancer, 79 (3-4), pp. 666-672; (2010), http://www.ispesl.it/renam/Report.asp, ISPESL Istituto Superiore per la Prevenzione e la Sicurezza del Lavoro. Dipartimento di Medicina del Lavoro: III Rapporto Re.Na.M, Available at(2006), http://www.ispesl.it/renam/Report.asp, ISPESL Istituto Superiore per la Prevenzione e la Sicurezza del Lavoro. Dipartimento di Medicina del Lavoro: II Rapporto Re.Na.M, Available atMarinaccio, A., Montanaro, F., Mastrantonio, M., Predictions of mortality from pleural mesothelioma in Italy: A model based on asbestos consumption figures supports results from age-period-cohort models (2005) Int J Cancer, 115, pp. 142-147; Dodson, R.F., O'Sullivan, M.F., Brooks, D.R., Asbestos content of omentum and mesentery in nonoccupationally exposed individuals (2001) Toxicol Ind Health, 17, pp. 138-143; Sugarbaker, P.H., Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: The Washington Cancer Institute approach (2009) Expert Opin Pharmacother, 10 (12), pp. 1965-1977; Virzì, S., Iusco, D., Bonomi, S., Chirurgia citoridutiva e chemioipertermia: Un valido trattamento per la carcinosi peritoneale (2010) Eur J Oncol, 15 (1), pp. 25-32. , [Article in Italian]; Albin, M., Magnani, C., Krstev, S., Asbestos and cancer: An overview of current trends in Europe (1999) Environ Health Perspect, 107 (SUPPL. 2), pp. 289-298; Analysis of occupational exposure to asbestos in cases of mesothelioma registered in Romagna (1986-1998) (2000) Med Lav, 91 (6), pp. 575-586. , Gruppo di lavoro per la sorveglianza del mesotelioma in Romagna, [Article in Italian]; Haber, S.E., Haber, J.M., Malignant Mesothelioma: A Clinical Study of 238 Cases (2011) Ind Health, 49, pp. 166-172; Mussa, B., Goss, M., Moscato, R., Mesotelioma peritoneale in operaia addetta alla tessitura di manufatti a base di asbesto (1999) Eur J Oncol, 4 (1), pp. 57-64. , [Article in Italian]","Belpoggi, F.; Centro di Ricerca sul Cancro Cesare Maltoni, Istituto Ramazzini, Castello di Bentivoglio, Via Saliceto 3, 40010 Bentivoglio (BO), Italy; email: belpoggif@ramazzini.it",,,,,,,,11286598,,EJOUA,,"English; Italian","Eur. J. Oncol.",Article,Scopus,2-s2.0-84860685080
"Soffritti, M., Belpoggi, F.","Medicine today: Rôle of the doctor and of prevention. Remembering Cesare Maltoni 10 years on from his untimely demise [La medicina oggi: Il ruolo del medico e della prevenzione. Per ricordare Cesare Maltoni a 10 anni dalla prematura scomparsa]",2011,"European Journal of Oncology","15","3-4",,"137","144",,,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-79954497045&partnerID=40&md5=275d752edc67be8e9b643b66988a3837","Centro di Ricerca sul Cancro Cesare Maltoni, Istituto Ramazzini, Castello di Bentivoglio Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy","Soffritti, M., Centro di Ricerca sul Cancro Cesare Maltoni, Istituto Ramazzini, Castello di Bentivoglio Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy; Belpoggi, F., Centro di Ricerca sul Cancro Cesare Maltoni, Istituto Ramazzini, Castello di Bentivoglio Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy",[No abstract available],,"editorial; medical practice; physician; prophylaxis; public health; publication",,,,,,"Cancer Statistics 2005, , http://www.cancer.org, American Cancer Society, available on; (1984) Toxicity testing. Strategies to determine needs and priorities, p. 144. , US National Academy of Sciences, Washington DC: National Academy Press","Soffritti, M.; Centro di Ricerca sul Cancro Cesare Maltoni, Istituto Ramazzini, Castello di Bentivoglio Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy; email: soffrittim@ramazzini.it",,,,,,,,11286598,,EJOUA,,"English; Italian","Eur. J. Oncol.",Editorial,Scopus,2-s2.0-79954497045
"Belpoggi, F., Tibaldi, E., Lauriola, M., Bua, L., Falcioni, L., Chiozzotto, D., Manservisi, F., Manservigi, M., Soffritti, M.","The efficacy of long-term bioassays in predicting human risks: Mesotheliomas induced by fluoro-edenitic fibres present in lava stone from the Etna volcano in Biancavilla, Italy [L'efficacia dei saggi a lungo termine nel predire i rischi per l'uomo: Mesoteliomi indotti dalle fibre di fluoroedenite presenti nella roccia lavica dell'Etna, Biancavilla, Italia]",2011,"European Journal of Oncology","16","4",,"185","195",,2,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84860660862&partnerID=40&md5=88055c3e104e6258973726402a4851d3","Cesare Maltoni Cancer Research Center (CMCRC), Ramazzini Institute (RI), Castello di Bentivoglio, via Saliceto, 3, 40010 Bentivoglio (BO), Italy","Belpoggi, F., Cesare Maltoni Cancer Research Center (CMCRC), Ramazzini Institute (RI), Castello di Bentivoglio, via Saliceto, 3, 40010 Bentivoglio (BO), Italy; Tibaldi, E., Cesare Maltoni Cancer Research Center (CMCRC), Ramazzini Institute (RI), Castello di Bentivoglio, via Saliceto, 3, 40010 Bentivoglio (BO), Italy; Lauriola, M., Cesare Maltoni Cancer Research Center (CMCRC), Ramazzini Institute (RI), Castello di Bentivoglio, via Saliceto, 3, 40010 Bentivoglio (BO), Italy; Bua, L., Cesare Maltoni Cancer Research Center (CMCRC), Ramazzini Institute (RI), Castello di Bentivoglio, via Saliceto, 3, 40010 Bentivoglio (BO), Italy; Falcioni, L., Cesare Maltoni Cancer Research Center (CMCRC), Ramazzini Institute (RI), Castello di Bentivoglio, via Saliceto, 3, 40010 Bentivoglio (BO), Italy; Chiozzotto, D., Cesare Maltoni Cancer Research Center (CMCRC), Ramazzini Institute (RI), Castello di Bentivoglio, via Saliceto, 3, 40010 Bentivoglio (BO), Italy; Manservisi, F., Cesare Maltoni Cancer Research Center (CMCRC), Ramazzini Institute (RI), Castello di Bentivoglio, via Saliceto, 3, 40010 Bentivoglio (BO), Italy; Manservigi, M., Cesare Maltoni Cancer Research Center (CMCRC), Ramazzini Institute (RI), Castello di Bentivoglio, via Saliceto, 3, 40010 Bentivoglio (BO), Italy; Soffritti, M., Cesare Maltoni Cancer Research Center (CMCRC), Ramazzini Institute (RI), Castello di Bentivoglio, via Saliceto, 3, 40010 Bentivoglio (BO), Italy","Subsequent to an increased mortality for malignant pleural neoplasms in Biancavilla near the Etna volcano (Sicily, Italy), 17 cases of pleural mesothelioma were ascertained from 1980 to 1997. An occupational exposure to asbestos was considered possible in 7 cases and an environmental exposure for the other 10 cases. The epidemiological study was carried out by the Italian Superior Institute of Health (Rome, Italy). On the basis of this finding, the Earth Sciences Institute of ""La Sapienza"" University (Rome, Italy) carried out a careful mineralogical and environmental study in the area of Biancavilla, where incohesive volcanic materials had been widely used by the building industry and in road paving, particularly in the 1960-70s. This research brought to the identification of fluoroedenitic prismatic crystals composed of calcium amphiboles with microgranular feldspars, haematite and pyroxenes. In order to acquire further information on the relationship between the exposure to these fibres and the onset of mesotheliomas, a long-term bioassay was performed on Sprague-Dawley rats at the Cesare Maltoni Cancer Research Center of the Ramazzini Institute (CMCRC/RI). The preliminary results of this study, published in this Journal in 2004, showed that fluoro-edenitic fibres induce peritoneal and pleural mesotheliomas, with an incidence comparable to asbestos fibres. In this article we reported the final results of this study and the characterization of the types of the observed mesothelioma. Once again the CMCRC/RI experimental animal model demonstrates to be an effective tool to predict or confirm human risks.","Asbestiform amphiboles; Fluoroedenite; Lava stone; Long-term bioassays; Mesothelioma; Rat","amphibole; asbestos; calcium; ferric oxide; animal experiment; animal model; article; bioassay; cancer mortality; controlled study; crystal; environmental exposure; female; fiber; fluoroedenitric fiber; Italy; male; malignant mesothelioma; mouse; nonhuman; occupational exposure; prediction; rat; volcano",,"amphibole, 1318-09-8; asbestos, 1332-21-4; calcium, 14092-94-5, 7440-70-2; ferric oxide, 1309-37-1, 56449-54-8",,,,"Di Paola, M., Mastrantonio, M., Carboni, M., (1996) La Mortalità Per Tumore Maligno Della Pleura in Italia Negli Anni 1988-1992, , Istituto Superiore di Sanità, Roma: Rapporti ISTISAN 96/40; Paoletti, L., Battisti, D., Bruno, C., Unusually high incidence of malignant pleural mesothelioma in a town of eastern Sicily: An epidemiological and environmental study (2000) Arch Environ Health, 55, pp. 392-398; Pasetto, R., Bruni, B., Bruno, C., Problematiche sanitarie della fibra anfibolica di Biancavilla. Aspetti epidemiologici, clinici e sperimentali (2004) Notiziario Istituto Superiore Di Sanità, 17 (1), pp. 8-12; Cernigliaro, A., Fano, V., Addario, S.P., Mortality and hospital discharges in the population of Biancavilla (Sicily) contaminated by natural fibres (2006) Epidemiol Prev, 30 (4-5), pp. 227-231; Fazzo, L., Comba, P., The role of high risk groups in environmental health research (2004) Ann Ist Super Sanità, 40 (4), pp. 417-426; Putzu, M.G., Bruno, C., Zona, A., Fluoro-edenitic fibres in the sputum of subjects from Biancavilla (Sicily): A pilot study (2006) Environ Health, 16 (5), p. 20; Bruno, C., Belli, S., Cernigliaro, A., An estimate of pleural mesothelioma incidence in Biancavilla, Sicily, Italy, 1998-2004 (2007) Eur J Oncol, 12 (3), pp. 183-187; Gianfagna, A., Paoletti, L., Ventura, P., Segnalazione di fibre di amianto anfibolico nei prodotti lavici metasomatizzati di Monte Calvario, Biancavilla (Sicilia orientale). Plinius, suppl (1997) Eur J Mineral, 18, pp. 117-119; Gianfagna, A., Oberti, R., Fluoro-edenite from Biancavilla (Catania, Sicily, Italy): Crystal chemistry of a new amphibole end-member (2001) Am Mineral, 86, pp. 1489-1493; Gianfagna, A., Ballirano, P., Bellatreccia, F., Characterization of amphibole fibres linked to mesothelioma in the area of Biancavilla, Eastern Sicily, Italy (2003) Mineral Magazine, 67 (6), pp. 1221-1229; Soffritti, M., Minardi, F., Bua, L., First experimental evidence of peritoneal and pleural mesotheliomas induced by fluoro-edenite fibres present in Etnean volcanic material from Biancavilla (Sicily, Italy) (2004) Eur J Oncol, 9, pp. 169-175; Attuazione della direttiva n. 86/609/CEE in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici [in Italian] (1992) Suppl Ordinario Gazz Ufficiale, 40, pp. 5-25. , Governo Italiano. Decreto Legislativo 116; Maltoni, C., Minardi, F., Recent results of carcinogenicity bioassays of fibres and other particulate materials (1989) Non-occupational Exposure to Mineral Fibres, pp. 46-53. , In Bignon J, Peto J, Saracci R, eds., Lyon: IARC Scientific Publications No. 90","Belpoggi, F.; Cesare Maltoni Cancer Research Center (CMCRC), Ramazzini Institute (RI), Castello di Bentivoglio, via Saliceto, 3, 40010 Bentivoglio (BO), Italy; email: belpoggif@ramazzini.it",,,,,,,,11286598,,EJOUA,,"English; Italian","Eur. J. Oncol.",Article,Scopus,2-s2.0-84860660862
"Chiozzotto, D., Soffritti, M., Falcioni, L., Tibaldi, E., Manservisi, F., Manservigi, M., Bua, L., Belpoggi, F.","Results of life span carcinogenicity bioassay on Sprague-Dawley rats exposedto aspartame since foetal life [Risultati dell'esperimento di cancerogenesi a lungo termine su ratti sprague-dawley esposti ad aspartame a partire dalla vita fetale]",2011,"European Journal of Oncology","16","2",,"81","97",,1,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-79961158091&partnerID=40&md5=fb3f6238accd6f7353bb222ffd30a33a","Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy","Chiozzotto, D., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Soffritti, M., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Falcioni, L., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Tibaldi, E., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Manservisi, F., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Manservigi, M., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Bua, L., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy; Belpoggi, F., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bologna, Italy","The artificial sweetener aspartame (APM), over two hundred times sweeter than sucrose, is an additive contained in over 6,000 products, including almost 500 drugs. As part of the Ramazzini Institute's mega-experiment projectto test the carcinogenic potential of numerous products commonly used in the diet of millions of people, the Authors report the full results of the lifespan carcinogenicity bioassay on APM administeredin animal feed from foetal life untilnatural death. A total of 470 Sprague-Dawley (SD)rats were divided by number and sex into three different groups of 70-95 animals. APM was administered in their feed at concentrations of2,000, 400 or 0 ppm to simulate a daily APM intake of 100, 20 or 0 mg/kg b.w., respectively. The results have shown: 1) a significantly increased dose-related incidence (p≤0.05) of females bearing benign tumours, particularly in the group of 2,000 ppm (p≤0.05); a significantly increased dose-related incidence (p≤0.01) of males bearing malignant tumours, in particular in the 2,000 ppm group (p≤0.01); 2) a significantly increased dose-related incidence (p≤0.05)of mammary adenocarcinomas in females, particularly in the 2,000 ppm group (p≤0.05); 3)a significantly increased incidence (p≤0.05) of lymphomas/leukaemias in males treated at 2,000ppm; and 4) a significantly increased doserelated incidence (p≤0.01) of lymphomas/leukaemias in females, particularly in the 2,000 ppm group (p≤0.01). Our experimental conditions confirm the carcinogenic potential of APM n rats. The data also show that when the lifespan treatment starts from foetal life the carcinogenic effects are heightened.","Artificial sweetener; Aspartame; Carcinogenicity; Life span observation; Prenatal exposure; Sprague-dawley rats","aspartame; animal experiment; animal model; animal tissue; article; benign tumor; bioassay; breast adenocarcinoma; cancer incidence; carcinogenicity; concentration response; controlled study; dietary intake; female; fetus; histopathology; leukemia; lifespan; lymphoma; male; nonhuman; prenatal exposure; rat; Sprague Dawley rat",,"aspartame, 22839-47-0, 5910-52-1",,,,"Soffritti, M., Belpoggi, F., Cevolani, D., Results oflong-term experimental studies on the carcinogenicity ofMethyl Alcohol and Ethyl Alcohol in rats (2002) Ann NY Acad Sci, 982, pp. 46-69; Belpoggi, F., Soffritti, M., Tibaldi, E., Results of longtermcarcinogenicity bioassays on Coca-Cola administered to Sprague-Dawley rats (2006) Ann NY Acad Sci, 1076, pp. 736-52; Soffritti, M., Mobiglia, A., Pinto, C., Results of experimental bioassays on the chemopreventive effects ofvitamin A and N-(4-hydroxyphenyl)-retinamide (HPR) on mammary cancer The Scientific Bases of Cancer Chemoprevention, , Davis W, Soffritti M, Maltoni C. 1996. International Congress Series 1120, ExcerptaMedica 1996; Belpoggi, F., Soffritti, M., Bua, L., Results of longtermexperimental studies on the carcinogenicity ofethylene-bis-dithiocarbamate (Mancozeb) in rats (2002) AnnNY Acad Sci, 982, pp. 123-36; Soffritti, M., Belpoggi, F., Lambertini, L., Results oflong-term experimental studies on the carcinogenicity of formaldehyde and acetaldehyde in rats (2002) Ann NY AcadSci, 982, pp. 87-105; Soffritti, M., Belpoggi, F., Degli, E.D., Aspartameinduces lymphomas and leukaemias in rats (2005) Eur J Oncol, 10 (2), pp. 107-16; Mazur, R.H., Discovery of aspartame (1984) Aspartame Physiologyand Biochemistry, pp. 3-9. , Stegink LD & Filer LJ, Jr., Eds. Dekker. New York, NY; Butchko, H.H., Stargel, W.W., Comer, C.P., Aspartame:Review of safety (2002) Regul Toxicol Pharmacol, 35 (2 PART 2), pp. S1-S93; Stegink, L.D., Aspartate and glutamate metabolism (1984) Aspartame Physiology and Biochemistry, pp. 47-76. , Stegink LD & Filer LJ, Jr., Eds. Dekker. New York, NY; Harper, A.E., Phenylalanine metabolism (1984) Aspartame Physiology and Biochemistry, pp. 77-109. , Stegink LD & Filer LJ,Jr., Eds. Dekker. New York, NY; Opperman, J.A., Aspartame metabolism in animals (1984) InAspartame Physiology and Biochemistry, pp. 141-159. , Stegink LD& Filer LJ, Jr., Eds. Dekker. New York, NY; Barceloux, D.G., Bond, G.R., Krenzelok, E.P., American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning (2002) J ToxicolClin Toxicol, 40 (4), pp. 415-46; Haschemeyer, R.H., Haschemeyer, A.E.V., (1973) Proteins, pp. 11-30. , JohnWiley & Sons, Eds. New York,NY; Metzler, D.E., (1977) Biochemistry, pp. 90-107. , Academic Press. New York,NY; Trocho, C., Pardo, R., Rafecas, I., Formaldehydederived from dietary aspartame binds to tissue components in vivo (1998) Life Sci, 63, pp. 337-49; Ranney, R.E., Opperman, J.A., Maldoon, E., Comparative metabolism of aspartame in experimental animals and humans (1976) J Toxicol Environ Health, 2, pp. 441-51; Mukhopadhyay, M., Mukherjee, A., Chakrabarti, J., In vivo cytogenetic studies on blends of aspartame and acesulfame- K (2000) Food Chem Toxicol, 38, pp. 75-77; Rencüzoǧullari, E., Tüylü, B.A., Topaktas, M., Genotoxicity of aspartame (2004) Drug Chem Toxicol, 27 (3), pp. 257-268; National Toxicology Program. NTP report on the Toxicology Studies of Aspartame (Cas No. 22839-47-0) in genetically modified (FVB Tg.AC hemizygous) and B6.129-Cdkn2atm1rdp (N2) deficient mice and carcinogenicity studies of aspartame in genetically modified [B6.129-Trp53tm1brd (N5) haploinsufficient] mice (feed studies). NTP GMM 1 NIH Publication No. 06-44590 October 2005; U.S. Department of Health and Human Services Public Health Service National Institutes of Health, NC 27709Bandyopadhyay, A., Ghoshal, S., Mukherjee, A., Genotoxicity testing of low-calorie sweeteners: Aspartame,acesulfame-K, and saccharin (2008) Drug Chem Toxicol, 31 (4), pp. 447-457; Lim, U., Subar, A.M., Mouw, T., Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies (2006) Cancer Epidemiol Biomarkers Prev, 15, pp. 1654-1659; Gallus, S., Scotti, L., Negri, E., Artificial sweeteners and cancer risk in a network of case-control studies (2007) Ann Oncol, 18, pp. 40-44; Olney, J.W., Farber, N.B., Spitznagel, E., Increasing brain tumour rates: Is there a link to aspartame? (1996) J Neuropathol Exp Neurol, 55, pp. 1115-1123; Aspartame: Commissioner's final decision (1981) Fed Reg, 46, pp. 38285-38308. , FDA (Food and Drug Administration); Food additives permitted in food for human consumption: Aspartame (1974) Fed Reg, 39, pp. 27317-27319. , FDA (Food and Drug Administration); Food additivespermitted for direct addition to food for human consumption: Aspartame (1983) Fed Reg, 48, pp. 31376-31382. , FDA (Food and Drug Administration); Food additives permitted for direct addition to food for human consumption: Aspartame (1996) Fed Reg, 61, pp. 33654-33656. , FDA (Food and Drug Administration); (1994) Official Journal, pp. 3-12. , Directive 94/35/EC of 30 June 1994 on sweeteners for use in foodstuffs; Opinion of the Scientific Panel on food additives, flavourings (2006) The EFSA Journal, 356, pp. 1-44. , EFSA (European Food Safety Authority, processing aids and materials in contact with food (AFC) related to a new long-term carcinogenicity study on aspartame. Question number EFSA-Q-2005-122. Adopted on 3 May 2006; Ishii, H., Incidence of brain tumours in rats fed aspartame (1981) Toxicol Lett, 7, pp. 433-437; Ishii, H., Koshimizu, T., Usami, S., Toxicity of aspartame and its diketopiperazine for Wistar rats by dietary administration for 104 weeks (1981) Toxicology, 21, pp. 91-94; Soffritti, M., Belpoggi, F., Degli, E.D., First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats (2006) Environ Health Perspect, 114 (3), pp. 379-385; Belpoggi, F., Soffritti, M., Padovani, M., Results of long-term carcinogenicity bioassay on Sprague-Dawley rats exposed to aspartame administered in feed (2006) Ann NY Acad Sci, 1076, pp. 559-577; Soffritti, M., Belpoggi, F., Tibaldi, E., Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats Environ Health Perspect, 115 (9), pp. 1293-1297. , 2007 Sep; Soffritti, M., Belpoggi, F., Manservigi, M., Aspartame administered in feed, beginning prenatally through life span, induces cancers of the liver and lung in male Swiss mice (2010) Am J Ind Med, 53, pp. 1197-1206; Transplacental induction of tumours and malformations in rats treated with some chemical carcinogens (1973) IARC Sci Publ, 4, pp. 100-111. , IARC (International Agency for Research on Cancer; Attuazione della direttiva n. 86/609/CEE in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici [in Italian] (1992) Supplemento Ordinario Alla Gazzetta Ufficiale, 40, pp. 5-25. , Decreto Legislativo 116; Cox, D.R., Regression models and life tables (1972) J Roy StatSoc Ser, pp. 187-220; Jaffe, E.S., Harris, N.L., Stein, H., World Health Organization Classification of Tumours (2001) Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues, , Lyon: IARCPress; (2007) FDA Statement On European Aspartame Study, , FDA (Food and Drug Administration), Center for Food Safety and Applied Nutrition, FDA, April 20; ScientificOpinion of the Panel on Food Additives and Nutrient Sources added to Food The EFSA Journal, 1015, pp. 1-18. , EFSA (European Food Safety Authority). Updated opinion on a request from the European Commission related to the 2nd ERF carcinogenicity study on aspartame, taking into consideration study data submitted by the Ramazzini Foundation in February 2009, (EFSA-Q-2009-00474). Adopted on 19 March 2009; Schoeb, T.R., McConnell, E.E., Juliana, M.M., Mycoplasma pulmonis and lymphoma in bioassays in rats (2009) Vet Pathol, 46, pp. 952-959; Soffritti, M., Belpoggi, F., Minardi, F., Ramazzini Foundation Cancer Program (2002) Ann NY Acad Sci, 982, pp. 26-45. , History and major projects, life-span carcinogenicity bioassay design, chemical studied and results; Abdo, K.M., Camargo, C.A., Davis, D., Letter to the editor (2007) Int J Occup Environ Health, 13, pp. 449-450; Huff, J., Ladou, J., Aspartame bioassay finding portendhuman cancer hazards (2007) Int J Occup Environ Health, 13, pp. 446-448; Davis, D.L., Ganter, L., Weinkle, J., Letters to the editor (2008) Cancer Epidemiol Biomarkers Prev, 17 (5), pp. 1295-1296; Caldwell, J.C., Jinot, J., Devoney, D., Evaluation of evidence for infection as a mode of action for induction of rat lymphoma (2008) Environ Mol Mutagen, 49, pp. 155-164; Caldwell, J.C., Jinot, J., Devoney, D., Letter to the editor (2009) Environ Mol Mutagen, 50, pp. 6-9","Soffritti, M.; Cesare Maltoni Cancer Research Center, Ramazzini Institute, Castello di Bentivoglio, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy; email: crcdir@ramazzini.it-www.ramazzini.it",,,,,,,,11286598,,EJOUA,,"English; Italian","Eur. J. Oncol.",Article,Scopus,2-s2.0-79961158091
"Thoolen, B., Maronpot, R.R., Harada, T., Nyska, A., Rousseaux, C., Nolte, T., Malarkey, D.E., Kaufmann, W., Küttler, K., Deschl, U., Nakae, D., Gregson, R., Vinlove, M.P., Brix, A.E., Singh, B., Belpoggi, F., Ward, J.M.","Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system",2010,"Toxicologic Pathology","38","7 SUPPL.",,"5S","81S",,83,10.1177/0192623310386499,"http://www.scopus.com/inward/record.url?eid=2-s2.0-79751488721&partnerID=40&md5=0fa1142ded54f27261f9e23588e89b71","Global Pathology Support, The Hague, Netherlands; Maronpot Consulting LLC, Raleigh, NC, United States; Institute of Environmental Toxicology, Joso-shi, Ibaraki, Japan; Haharuv 18, Timrat, Israel; Boehringer Ingelheim Pharma GmbH and Co., Biberach An der Riss, Germany; National Toxicology Program, Cellular and Molecular Pathology Branch, Research Triangle Park, NC, United States; Merck KGaA, Darmstadt, Germany; BASF Aktiengesellschaft, Ludwigshafen, Germany; Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach Risskov, Germany; Tokyo Metropolitan Institute of Public Health, Shinjuku, Tokyo, Japan; Charles River Laboratories, Pathology Department, Senneville, QC, Canada; Pathology Associates, Charles River, Frederick, MD, United States; Experimental Pathology Laboratories Inc., Research Triangle Park, NC, United States; DuPont Haskell Global Centers for Health and Environmental Science, Newark, DE, United States; Ramazzini Institute, Bentivoglio (BO), Italy; Global VetPathology, Montgomery Village, MD, United States; Liver INHAND Committee, Netherlands","Thoolen, B., Global Pathology Support, The Hague, Netherlands; Maronpot, R.R., Maronpot Consulting LLC, Raleigh, NC, United States, Liver INHAND Committee, Netherlands; Harada, T., Institute of Environmental Toxicology, Joso-shi, Ibaraki, Japan; Nyska, A., Haharuv 18, Timrat, Israel; Rousseaux, C.; Nolte, T., Boehringer Ingelheim Pharma GmbH and Co., Biberach An der Riss, Germany; Malarkey, D.E., National Toxicology Program, Cellular and Molecular Pathology Branch, Research Triangle Park, NC, United States; Kaufmann, W., Merck KGaA, Darmstadt, Germany; Küttler, K., BASF Aktiengesellschaft, Ludwigshafen, Germany; Deschl, U., Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach Risskov, Germany; Nakae, D., Tokyo Metropolitan Institute of Public Health, Shinjuku, Tokyo, Japan; Gregson, R., Charles River Laboratories, Pathology Department, Senneville, QC, Canada; Vinlove, M.P., Pathology Associates, Charles River, Frederick, MD, United States; Brix, A.E., Experimental Pathology Laboratories Inc., Research Triangle Park, NC, United States; Singh, B., DuPont Haskell Global Centers for Health and Environmental Science, Newark, DE, United States; Belpoggi, F., Ramazzini Institute, Bentivoglio (BO), Italy; Ward, J.M., Global VetPathology, Montgomery Village, MD, United States","The INHAND Project (International Harmonization of Nomenclature and Diagnostic Criteria for Lesions in Rats and Mice) is a joint initiative of the Societies of Toxicologic Pathology from Europe (ESTP), Great Britain (BSTP), Japan (JSTP) and North America (STP) to develop an internationally-accepted nomenclature for proliferative and non-proliferative lesions in laboratory animals. The purpose of this publication is to provide a standardized nomenclature and differential diagnosis for classifying microscopic lesions observed in the hepatobiliary system of laboratory rats and mice, with color microphotographs illustrating examples of some lesions. The standardized nomenclature presented in this document is also available for society members electronically on the internet (http://goreni.org). Sources of material included histopathology databases from government, academia, and industrial laboratories throughout the world. Content includes spontaneous and aging lesions as well as lesions induced by exposure to test materials. A widely accepted and utilized international harmonization of nomenclature for lesions of the hepatobiliary system in laboratory animals will decrease confusion among regulatory and scientific research organizations in different countries and provide a common language to increase and enrich international exchanges of information among toxicologists and pathologists. © 2010 by The Author(s).","Diagnostic pathology; Hepatobiliary system; Histopathology; Liver; Nomenclature; Rodent pathology","amphophile; glycogen; hemosiderin; iron; lipofuscin; porphyrin; xenobiotic agent; acinar cell carcinoma; aging; amyloidosis; angiosarcoma; apoptosis; article; autolysis; autopsy; basophil; bile; bile duct dilatation; bile duct tumor; bile flow; cell damage; cell death; cell degeneration; cell proliferation; cell vacuole; cellular immunity; cholecystitis; cholestasis; chronic inflammation; clinical feature; crystal; cytoplasm; dendritic cell; differential diagnosis; disease classification; disease severity; endothelium cell; eosinophil; epithelium; extramedullary hematopoiesis; fatty liver; Helicobacter hepaticus; hemangioma; hepatitis virus; hepatobiliary disease; hepatobiliary system; hepatobiliary system lesion; hepatoblastoma; hepatomegaly; histiocytic sarcoma; histiocytosis; histopathology; hyperlipidemia; immunohistochemistry; inflammatory infiltrate; intrahepatic bile duct; ischemia; Ito cell; Kupffer cell; lipid peroxidation; lipidosis; liver adenoma; liver atrophy; liver blood flow; liver cell; liver cell carcinoma; liver cyst; liver fibrosis; liver hemorrhage; liver hypertrophy; liver necrosis; lymphoma; microphotography; microscopy; monocyte; mononuclear cell; mouse; myeloid leukemia; myofibroblast; neutrophil chemotaxis; nomenclature; nonhuman; pathogenesis; pigment disorder; polyploidy; priority journal; protein folding; rat; smooth muscle fiber; solid tumor; standardization; stellate cell; storage disease; thrombosis; virus hepatitis; Animals; Animals, Laboratory; Biliary Tract Diseases; Europe; Great Britain; International Agencies; Japan; Liver; Liver Diseases; Mice; North America; Rats; Rodent Diseases; Terminology as Topic; Toxicity Tests; Animalia; Mus; Rattus; Rattus norvegicus; Rodentia",,"glycogen, 9005-79-2; hemosiderin, 9011-92-1; iron, 14093-02-8, 53858-86-9, 7439-89-6; porphyrin, 24869-67-8",,,,"Aigelsreiter, A., Janig, E., Stumptner, C., Fuchsbichler, A., Zatloukal, K., Denk, H., How a cell deals with abnormal proteins: Pathogenetic mechanisms in protein aggregation diseases (2007) Pathobiology, 74 (3), pp. 145-158. , DOI 10.1159/000103374; Atzori, L., Congiu, L., Effect of verapamil on allyl alcohol hepatotoxicity (1996) Drug Metabolism and Drug Interactions, 13 (2), pp. 87-98; Aydin, G., Ozcelik, N., Cicek, E., Soyoz, M., Histopathologic changes in liver and renal tissues induced by Ochratoxin A and melatonin in rats (2003) Human and Experimental Toxicology, 22 (7), pp. 383-391; Babich, M.A., Chen, S.-B., Greene, M.A., Kiss, C.T., Porter, W.K., Smith, T.P., Wind, M.L., Zamula, W.W., Risk assessment of oral exposure to diisononyl phthalate from children's products (2004) Regulatory Toxicology and Pharmacology, 40 (2), pp. 151-167. , DOI 10.1016/j.yrtph.2004.06.005, PII S0273230004000972; Bach, U., Hailey, J.R., Hill, G.D., Kaufmann, W., Latimer, K.S., Malarkey, D.E., Maronpot, R.M., Elmore, S.A., Proceedings of the 2009 national toxicology program satellite symposium (2010) Toxicol Pathol, 38, pp. 9-36; Bannasch, P., Comments on R. Karbe and R. L. Kerlin (2002). Cystic degeneration/ spongiosis hepatis (Toxicol Pathol 30, 216-227) (2003) Toxicol Pathol, 5, pp. 566-70; Bannasch, P., Bloch, M., Zerban, H., Spongiosis hepatis. Specific changes of the perisinusoidal liver cells induced in rats by N-nitrosomorpholine (1981) Laboratory Investigation, 44 (3), pp. 252-264; Bannasch, P., Brenner, U., Zerban, H., Cholangiofibroma and cholangiocarcinoma, liver, rat (1985) Monographs on Pathology of Laboratory Animals. Digestive System, pp. 52-65. , T. C. Jones, U. Mohr, and R. D. Hunt, eds.), pp. Springer, New York; Bannasch, P., Wayss, K., Zerban, H., Peliosis hepatis, rodents (1997) Digestive System, pp. 154-60. , T. C. Jones, U. Mohr, and R. D. Hunt, eds.), pp. Springer-Verlag, Berlin, New York; Bannasch, P., Zerban, H., Tumours of the liver (1990) Tumours of the Rat, 1, pp. 199-240. , Pathology of Tumours in Laboratory Animals. (V. S. Turusov and U. Mohr, eds.), 2nd edition. IARC Scientific Publications No. 99, Lyon, France; Bannasch, P., Zerban, H., Hacker, H.J., Foci of altered hepatocytes, rat (1985) Monographs on Pathology of Laboratory Animals. Digestive System, pp. 10-30. , T. C. Jones, U. Mohr, and R. D. Hunt, eds.), pp Springer, New York; Barni, S., Bernocchi, G., Internalization of erythrocytes into liver parenchymal cells in naturally hibernating frogs (Rana esculenta L.) (1991) J Exp Zoology, 258, pp. 143-50; Belloni, A.S., Rebuffat, P., Gottardo, G., Meneghelli, V., Coi, A., Mazzocchi, G., Nussdorfer, G.G., A morphometric study of the effects of short-term starvation on rat hepatocytes (1988) Journal of Submicroscopic Cytology and Pathology, 20 (4), pp. 751-757; Beregi, E., Penzes, L., Regius, O., Izsak, J., Biological changes and diseases in aged CBA/Ca mice (1987) Compr Gerontol, 1, pp. 72-4; Bergs, V.V., Scotti, T.M., Virus-induced peliosis hepatitis in rats (1967) Science, 158, pp. 377-78; Binhazim, A.A., Coghlan, L.G., Walker, C., Spontaneous hemangiosarcoma in the tail of a Long-Evans rat carrying the Eker mutation (1994) Lab Anim Sci, 44, pp. 191-94; Booth, C.J., Sundberg, J.P., Hemangiomas and hemangiosarcomas (1996) Pathobiology of the Aging Mouse, 1, pp. 393-401. , U. Mohr, D. L. Dungworth, C. C. Capen, W. W. Carlton, J. P. Sundberg, and J. M. Ward, eds.), pp ILSI Press, Washington, DC.Cardiovascular System; Bourdeau, A., Faughnan, M.E., McDonald, M.-L., Paterson, A.D., Wanless, I.R., Letarte, M., Potential role of modifier genes influencing transforming growth factor-β1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia (2001) American Journal of Pathology, 158 (6), pp. 2011-2020; Boyd, M.R., Toxicity mediated by reactive metabolites of furans (1981) Adv Exp Med Biol, 136, pp. 865-79; Breitschwerdt, E.B., Kordick, D.L., Bartonella infection in animals: Carriership, reservoir potential, pathogenicity, and zoonotic potential for human infection (2000) Clinical Microbiology Reviews, 13 (3), pp. 428-438. , DOI 10.1128/CMR.13.3.428-438.2000; Brooks, P.N., Roe, F.J.C., Hepatocellular adenoma, liver, rat (1985) Monographs on Pathology of Laboratory Animals. Digestive System, pp. 47-52. , T. C. Jones, U. Mohr, and R. D. Hunt, eds.), pp. Springer, New York; Browning, F.M., Schroeder, C.R., Berringer, O.M., (1974) An Atlas and Dissection Manual of Rhesus Monkey Anatomy. 2nd Printing, , Rose Printing Company Inc., Tallahassee, Florida; Bruguera, M., Biopsia hepática en las enfermedades hepáticas por depósito (1999) Gastroenterología y Hepatología, 22, pp. 20-4; Bruguera, M., Aranguibel, F., Ros, E., Rodes, J., Incidence and clinical significance of sinusoidal dilatation in liver biopsies (1978) Gastroenterology, 75 (3), pp. 474-478; Bruni, C., Hyaline degeneration of rat liver cells studied with the electron microscope (1960) Lab Invest, 9, pp. 209-15; (2007) Modular Education Programme in Toxicological Pathology, 8. , Bstp. Module 8: Liver. Cambridge University, Department of Pathology, Cambridge, UK; Burek, J.D., (1978) Pathology of Aging Rats, , CRC Press, West Palm Beach, Florida; Burt, A.D., Portmann, B.C., MacSween, R.N.M., Liver pathology associated with diseases of other organs or systems (2002) Pathology of the Liver, pp. 827-83. , R. N. M. MacSween, ed.). 4th edition, pp. Churchill Livingstone, London; Carlton, W.W., Ernst, H., Faccini, J.M., Greaves, P., Krinke, G.J., Long, P.H., Maekawa, A., Weisse, G., Soft tissue and musculoskeletal system 2 (1992) International Classification of Rodent Tumours-Part 1-The Rat, p. 31. , U. Mohr, ed.), p. WHO IARC Scientific Publications, Lyon, France; Carter, R.L., Tumours of the soft tissues (1973) Tumours of the Rat, Part 1, pp. 151-68. , Pathology of Tumours in Laboratory Animals. (V. S. Turusov, ed.). IARC Scientific Publications, Lyon, France; Chang, H.J., Suh, J.I., Kwon, S.Y., Gallstone formation and gallbladder mucosal changes in mice fed a lithogenic diet (1999) J Korean Med Sci, 14, pp. 286-92; Chatman, L.A., Morton, D., Johnson, T.O., Anway, S.D., A strategy for risk management of drug-induced phospholipidosis (2009) Toxicol Pathol, 37, pp. 997-1005; Cheng, K.K., Experimental studies on the mechanism of the zonal distribution of beryllium liver necrosis (1956) J Pathol Bacteriol, 71, pp. 265-76; Chengelis, C.P., Changes in hepatic glutathione concentrations during carbon disulfide induced hepatotoxicity in the rat (1988) Res Commun Chem Pathol Pharmacol, 61, pp. 97-109; Chipchase, M.D., O'Neill, M., Melton, D.W., Characterization of premature liver polyploidy in DNA repair (Ercc1)-deficient mice (2003) Hepatology, 38 (4), pp. 958-966. , DOI 10.1053/jhep.2003.50421; Churukian, C.J., (2002) Pigments and Minerals in Theory and Practice of Histological Techniques, pp. 243-67. , J. D. Bancroft and M. Gamble, eds.), pp. Churchill Livingstone, Edinburgh, Scotland; Clemens, M., Jost, J.O., Kautz, G., Caroli syndrome (1980) Chirurg, 51 (4), pp. 219-222; Coe, J.E., Ross, M.J., Amyloidosis and female protein in the Syrian hamster. Concurrent regulation by sex hormones (1990) Journal of Experimental Medicine, 171 (4), pp. 1257-1267; Comporti, M., Lipid peroxidation and cellular damage in toxic liver injury (1985) Laboratory Investigation, 53 (6), pp. 599-623; Copple, B.L., Banes, A., Ganey, P.E., Roth, R.A., Endothelial cell injury and fibrin deposition in rat liver after monocrotaline exposure (2002) Toxicological Sciences, 65 (2), pp. 309-318. , DOI 10.1093/toxsci/65.2.309; Cullen, J.M., Mechanistic classification of liver injury (2005) Toxicologic Pathology, 33 (1), pp. 6-8. , DOI 10.1080/01926230590522428; Datta, K., Chin, A., Ahmed, T., Qing, W.-G., Powell, K.L., Simhambhatla, P., MacLeod, M.C., Kehrer, J.P., Mixed effects of 2,6-dithiopurine against cyclophosphamide mediated bladder and lung toxicity in mice (1998) Toxicology, 125 (1), pp. 1-11. , DOI 10.1016/S0300-483X(97)00149-2, PII S0300483X97001492; Davenport, M., Gonde, C., Redkar, R., Koukoulis, G., Tredger, M., Mieli-Vergani, G., Portmann, B., Howard, E.R., Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia (2001) Journal of Pediatric Surgery, 36 (7), pp. 1017-1025. , DOI 10.1053/jpsu.2001.24730; Denda, A., Kitayama, W., Kishida, H., Murata, N., Tsutsumi, M., Tsujiuchi, T., Nakae, D., Konishi, Y., Development of hepatocellular adenomas and carcinomas associated with fibrosis in C57BL/6J male mice given a choline-deficient, L-amino acid-defined diet (2002) Japanese Journal of Cancer Research, 93 (2), pp. 125-132; DePass, L.R., Garman, R.H., Woodside, M.D., Chronic toxicity and oncogenicity studies of ethylene glycol in rats and mice (1986) Fundamental and Applied Toxicology, 7 (4), pp. 547-565. , DOI 10.1016/0272-0590(86)90105-3; Derelanko, M.J., Acute/chronic toxicology (2000) Toxicologist's Pocket Handbook, p. 13. , CRC Press, Boca Raton, Florida; Deschl, U., Cattley, R., Harada, T., Küttler, K., Hailey, J.R., Hartig, F., Leblanc, B., Shirai, T., Liver, gallbladder, and exocrine pancreas (2001) International Classification of Rodent Tumours: The Mouse, pp. 59-86. , U. Mohr, ed.), pp. Springer, New York; Deschl, U., Ernst, H., Frantz, J.D., Goodman, D.G., Hartig, F., Konishi, Y., Küttler, K., Whiteley, L.O., Digestive system (1997) International Classification of Rodent Tumours Part 1-The Rat, pp. 65-98. , U. Mohr, ed.), pp. WHO IARC Scientific Publications, Lyon, France; Diwan, B.A., Ward, J.M., Ramljak, D., Anderson, L.M., Promotion by Helicobacter hepaticus-induced hepatitis of hepatic tumors initiated by N-nitrosodimethylamine in male A/JCr mice (1997) Toxicologic Pathology, 25 (6), pp. 597-605; Diwan, B.A., Ward, J.M., Rice, J.M., Promotion of malignant 'embryonal' liver tumors by phenobarbital: Increased incidence and shortened latency of hepatoblastomas in (DBA/2 x C57BL/6)F1 mice initiated with N-nitrosodiethylamine (1989) Carcinogenesis, 10 (7), pp. 1345-1348; Dixon, D., Yoshitomi, K., Boorman, G.A., Maronpot, R.R., ""Lipomatous"" lesions of unknown cellular origin in the liver of B6C3F1 mice (1994) Vet Pathol, 31, pp. 173-82; Dowling, R.H., Review: Pathogenesis of gallstones (2000) Alimentary Pharmacology and Therapeutics, Supplement, 14 (2), pp. 39-47; Edwards, R., Colombo, T., Greaves, P., ""Have you seen this?"" peliosis hepatis (2002) Toxicol Pathol, 30, pp. 521-23; Elmore, S., Apoptosis: A Review of Programmed Cell Death (2007) Toxicologic Pathology, 35 (4), pp. 495-516. , DOI 10.1080/01926230701320337, PII 779478428; Emerson, Q.B., Nachtnebel, K.L., Penkava, R.R., Rothenberg, J., Oral-contraceptive-associated liver tumors (1980) Lancet, 1, p. 1251; Engelhardt, N.V., Oval cells in rodent liver, mouse, rat (1997) Digestive System, pp. 162-66. , C. Jones, J. A. Popp, and U. Mohr, eds.), pp. ILSI Monograph, ILSI Press, Washington, DC; Enomoto, M., Naoe, S., Harada, M., Miyata, K., Saito, M., Noguchi, Y., Carcinogenesis in extrahepatic bile duct and gallbladder-carcinogenic effect of N-hydroxy-2-acetamidofluorene in mice fed a ""gallstone- inducing"" diet (1974) Jpn J Exp Med, 44, pp. 37-54; Enzan, H., Proliferation of ito cells (fat-storing cells) in acute carbon tetrachloride liver injury. A light and electron microscopic autoradiographic study (1985) Acta Pathologica Japonica, 35 (6), pp. 1301-1308; Eustis, S.L., Boorman, G.A., Harada, T., Popp, J.A., (1990) Pathology of the Fischer Rat. Reference and Atlas, pp. 71-92. , G. A. Boorman, S. L. Eustis, M. R. Elwell, C. A. Montgomery, Jr, and W. F. MacKenzie, eds.), pp. Academic Press, San Diego, California; Evans, J.G., Collins, M.A., Lake, B.G., Butler, W.H., The histology and development of hepatic nodules and carcinoma in C3H/He and C57BL/6 mice following chronic phenobarbitone administration (1992) Toxicologic Pathology, 20 (4), pp. 585-594; Evans, J.G., Lake, B.G., (1998) The Digestive System II: The Hepatobiliary System, pp. 61-97. , Target Organ Pathology-A Basic Text ( J. Turton and J. Hooson, eds.), pp. Taylor & Francis Ltd., London; Faa, G., Van Eyken, P., Roskams, T., Miyazaki, H., Serreli, S., Ambu, R., Desmet, V.J., Expression of cytokeratin 20 in developing rat liver and in experimental models of ductular and oval cell proliferation (1998) Journal of Hepatology, 29 (4), pp. 628-633. , DOI 10.1016/S0168-8278(98)80158-X; Faccini, J.M., Abbott, D.P., Paulus, G.J.J., Mouse histopathology (1990) A Glossary for Use in Toxicity and Carcinogenicity Studies, , Elsevier, Oxford, UK; Feldmann, G., Liver apoptosis (1997) J Hepatol, 26 (2), pp. 1-11; Foster, J.R., Cell death and cell proliferation in the control of normal and neoplastic tissue growth (2000) Toxicologic Pathology, 28 (3), pp. 441-446; Fox, J.G., Anderson, L.C., Loew, F.M., Quimby, F.W., (2002) Laboratory Animal Science, , 2nd edition. Academic Press, San Diego, California; Fremond, B., Jouan, H., Sameh, A.H., Hepatic tumors secondary to androgenotherapy. A report of 2 cases in children (1987) Chirurgie Pediatrique, 28 (2), pp. 97-101; Frith, C.H., Ward, J.M., A morphologic classification of proliferative and neoplastic hepatic lesions in mice (1979) J Environ Pathol Toxicol, 3, pp. 329-51; Frith, C.H., Ward, J.M., (1988) Color Atlas of Neoplastic and NonNeoplastic Lesions in Aging Mice, , Elsevier, Oxford, UK; Frith, C.H., Ward, J.M., Turusov, V.S., Tumours of the liver (1994) Tumours of the Mouse, , 2nd edition. IARC Scientific Publications, Lyon, France; Frith, C.H., Wiley, L., Spontaneous hepatocellular neoplasms and hepatic hemangiosarcomas in several strains of mice (1982) Laboratory Animal Science, 32 (2), pp. 157-162; Gad, S.C., Rousseaux, C.G., Use and misuse of statistics as an aid in study interpretation (2002) Handbook of Toxicologic Pathology, pp. 327-. , W. M. Haschek, C. G. Rousseaux, and M. A. Wallig, eds.), Vol. 1, pp. Academic Press, San Diego, California. 418; Gebbia, N., Leto, G., Gagliano, M., Lysosomal alterations in heart and liver of mice treated with doxorubicin (1985) Cancer Chemotherapy and Pharmacology, 15 (1), pp. 26-30; Geller, S.A., Dhall, D., Alsabeh, R., Application of immunohistochemistry to liver and gastrointestinal neoplasms liver, stomach, colon, and pancreas (2008) Archives of Pathology and Laboratory Medicine, 132 (3), pp. 490-499; Gerlyng, P., Abyholm, A., Grotmol, T., Erikstein, B., Huitfeldt, H.S., Stokke, T., Seglen, P.O., Binucleation and polyploidization patterns in developmental and regenerative rat liver growth (1993) Cell Proliferation, 26 (6), pp. 557-565; Giddens, W.E., Renne, R.A., Haemangiosarcoma, nasal cavity, mouse (1985) Monographs on Pathology of Laboratory Animals. Respiratory Systems, pp. 72-4. , T. C. Jones, U. Mohr, and R. D. Hunt, eds.), pp Springer, New York; Gkretsi, V., Mars, W.M., Bowen, W.C., Barua, L., Yang, Y., Guo, L., St-Arnaud, R., Michalopoulos, G.K., Loss of integrin linked kinase from mouse hepatocytes in vitro and in vivo results in apoptosis and hepatitis (2007) Hepatology, 45 (4), pp. 1025-1034. , DOI 10.1002/hep.21540; Goel, S.K., Lalwani, N.D., Reddy, J.K., Peroxisome proliferation and lipid peroxidation in rat liver (1986) Cancer Research, 46 (3), pp. 1324-1330; Gokalp, O., Gulle, K., Sulak, O., Cicek, E., Altuntas, I., The effects of methidathion on liver: Role of vitamins E and C (2003) Toxicology and Industrial Health, 19 (2-6), pp. 63-67. , DOI 10.1191/0748233703th176oa; Goldfarb, S., Pugh, T.D., Koen, H., He, Y.Z., Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy (1983) Environmental Health Perspectives, 50, pp. 149-161; Gonzalez-Quintela, A., Mella, C., Perez, L.F., Abdulkader, I., Caparrini, A.M., Lojo, S., Increased serum tissue polypeptide specific antigen (TPS) in alcoholics: A possible marker of alcoholic hepatitis (2000) Alcoholism: Clinical and Experimental Research, 24 (8), pp. 1222-1226; Goodman, D.G., Maronpot, R.R., Newberne, P.M., Popp, J.A., Squire, R.A., Proliferative and selected other lesions in the liver of rats (1994) Guides for Toxicologic Pathology (STP/ARP/AFIP), pp. 1-24. , Society of Toxologic Pathology, Washington, DC; Goodman, Z.D., Ishak, K.G., Hepatobiliary system and pancreas (2006) Surgical Pathology and Cytopathology, pp. 1465-526. , S. G. Silverberg, ed.), Vol. 2, 4th ed., pp. Elsevier, Oxford, UK; Gopinath, C., Prentice, D.E., Lewis, D.J., The liver (1987) Atlas of Experimental Toxicological Pathology, pp. 43-60. , G. A. Grasham, ed.), Vol. 13, pp. MTP Press Limited, Lancaster, England; Goto, K., Ohashi, H., Takakura, A., Itoh, T., Current status of Helicobacter contamination of laboratory mice, rats, gerbils, and house musk shrews in Japan (2000) Curr Microbiol, 41, pp. 161-66; Graewin, S.J., Lee, K.-H., Tran, K.Q., Goldblatt, M.I., Svatek, C.L., Nakeeb, A., Pitt, H.A., Leptin-resistant obese mice do not form biliary crystals on a high cholesterol diet (2004) Journal of Surgical Research, 122 (2), pp. 145-149. , DOI 10.1016/j.jss.2004.04.012, PII S002248040400174X; Graham, M.J., Lake, B.G., Induction of drug metabolism: Species differences and toxicological relevance (2008) Toxicology, 254, pp. 184-91; Gray, H., Williams, P.L., Bannister, L.H., (1995) Gray's Anatomy: The Anatomical Basis of Medicine and Surgery, pp. 1795-802. , L. H. Bannister, M. M. Berry, P. Collins, M. Dyson, J. E. Dusch, and M. W. J. Ferguson, eds.), pp Churchill Livingstone, New York; Greaves, P., Liver and pancreas (2007) Histopathology of Preclinical Toxicity Studies, pp. 457-514. , 3rd edition. pp Elsevier, Oxford, UK; Greaves, P., Barsoum, N., Tumours of soft tissues (1990) Tumours of the Rat, 1, pp. 597-23. , 2nd edition (V. S. Turusov and U. Mohr, eds), pp IARC Scientific Publications, Lyon, France; Greaves, P., Edwards, R., Cohen, G.M., MacFarlane, M., ""Have you seen this?"" Diffuse hepatic apoptosis (2001) Toxicologic Pathology, 29 (3), pp. 398-400. , DOI 10.1080/019262301316905363; Greaves, P., Faccini, J.M., (1984) Rat Histopathology. A Glossary for Use in Toxicity and Carcinogenicity Studies, Pp 88-97, , Elsevier, Oxford, UK; Greaves, P., Faccini, J.M., Digestive system (1992) Rat Histopathology: A Glossary for Use in Toxicity and Carcinogenicity Studies, pp. 105-48. , Elsevier, Oxford, UK; Greaves, P., Irisarri, E., Monro, A.M., Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: Their rate of onset and their reversibility (1986) Journal of the National Cancer Institute, 76 (3), pp. 475-484; Gruttadauria, S., Mandala, L., Miraglia, R., Caruso, S., Minervini, M.I., Biondo, D., Volpes, R., Gridelli, B., Successful treatment of small-for-size syndrome in adult-to-adult living-related liver transplantation: Single center series (2007) Clinical Transplantation, 21 (6), pp. 761-766. , DOI 10.1111/j.1399-0012.2007.00735.x; Guzman, R.E., Solter, P.F., Characterization of sublethal microcystin-LR exposure in mice (2002) Vet Pathol, 39, pp. 17-26; Hailey, J.R., Haseman, J.K., Bucher, J.R., Radovsky, A.E., Malarkey, D.E., Miller, R.T., Nyska, A., Maronpot, R.R., Impact of Helicobacter hepaticus infection in B6C3F1 mice from twelve National Toxicology Program two-year carcinogenesis studies (1998) Toxicologic Pathology, 26 (5), pp. 602-611; Hailey, J.R., Walker, N.J., Sells, D.M., Brix, A.E., Jokinen, M.P., Nyska, A., Classification of proliferative hepatocellular lesions in Harlan Sprague-Dawley rats chronically exposed to dioxin-like compounds (2005) Toxicologic Pathology, 33 (1), pp. 165-174. , DOI 10.1080/01926230590888324; Halliwell, W.H., Cationic amphiphilic drug-induced phospholipidosis (1997) Toxicologic Pathology, 25 (1), pp. 53-60; Handley, D.A., Chien, S., Arbeeny, C.M., Ultrastructure of hepatic cholesterol crystals in the hypercholesterolemic-diabetic rat (1983) Pathol Res Pract, 177, pp. 13-21; Hanigan, M.H., Winkler, M.L., Drinkwater, N.R., Induction of three histochemically distinct populations of hepatic foci in C57BL/6J mice (1993) Carcinogenesis, 14 (5), pp. 1035-1040; Harada, T., Maronpot, R.R., Enomoto, A., Tamano, S., Ward, J.M., Changes in the liver and gallbladder (1996) Pathobiology of the Aging Mouse, pp. 207-41. , U. Mohr, D. L. Dungworth, C. C. Capen, W. W. Carlton, J. P. Sundberg, and J. M. Ward, eds.), pp ILSI Press, Washington, DC; Harada, T., Maronpot, R.R., Morris, R.W., Boorman, G.A., Observations on altered hepatocellular foci in national toxicology program two-year carcinogenicity studies in rats (1989) Toxicologic Pathology, 17 (4), pp. 690-708; Harada, T., Maronpont, R.R., Morris, R.W., Stitzel, K.A., Boorman, G.A., Morphological and stereological characterization of hepatic foci of cellular alteration in control Fischer 344 rats (1989) Toxicologic Pathology, 17 (4), pp. 579-593; Harada, T., Enomoto, A., Boorman, G.A., Maronpot, R.R., (1999) Liver and Gallbladder, in Pathology of the Mouse, pp. 119-83. , R. R. Maronpot, ed.), pp. Cache River Press, Vienna, IL; Harbord, M., Novelli, M., Canas, B., Power, D., Davis, C., Godovac-Zimmermann, J., Roes, J., Segal, A.W., Ym1 is a neutrophil granule protein that crystallizes in p47 phox-deficient mice (2002) Journal of Biological Chemistry, 277 (7), pp. 5468-5475. , DOI 10.1074/jbc.M110635200; Harbrecht, B.G., Stadler, J., Demetris, A.J., Simmons, R.L., Billiar, T.R., Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia (1994) Am J Physiol, 266, pp. 1004-010; Hardisty, J.F., Elwell, M.R., Ernst, H., Greaves, P., Kolenda-Roberts, H., Malarkey, D.E., Mann, P.C., Tellier, P.A., Histopathology of hemangiosarcomas in mice and hamsters and liposarcomas/fibrosarcomas in rats associated with PPAR agonists (2007) Toxicol Pathol, 35, pp. 928-41; Hardisty, J.F., Eustis, S.L., Toxicologic pathology: A critical stage in study interpretation (1990) Progress in Predictive Toxicology, , D. B. Clay-son, ed.). CRC Press, Boca Raton, Florida; Helyer, B.J., Petrelli, M., Cytoplasmic inclusions in spontaneous hepatomas of CBA/H-T6T6 mice. Histochemistry and electron microscopy (1978) Journal of the National Cancer Institute, 60 (4), pp. 861-869; Heider, K., Eustis, S.L., Tumours of the soft tissues (1994) Tumours of the Mouse, 2, pp. 611-49. , 2nd edition (V. Turusov and U. Mohr, eds.), pp. IARC Scientific Publications, Lyon, France; Homberger, F.R., Mouse hepatitis virus (1996) Schweizer Archiv fur Tierheilkunde, 138 (4), pp. 183-188; Herman, J.R., Dethloff, L.A., McGuire, E.J., Parker, R.F., Walsh, K.M., Gough, A.W., Masuda, H., De La Iglesia, F.A., Rodent carcinogenicity with the thiazolidinedione antidiabetic agent troglitazone (2002) Toxicological Sciences, 68 (1), pp. 226-236. , DOI 10.1093/toxsci/68.1.226; Hruban, R.H., Argani, P., Ali, S.Z., The pancreas and extrahepatic biliary system (2006) Silverberg's Principles and Practice of Surgical Pathology and Cytopathology, pp. 1576-593. , G. G. Silverberg, ed.), pp. Churcill Livingstone, Oxford, UK; Hruban, Z., Slesers, A., Hopkins, E., Drug-induced and naturally occurring myeloid bodies (1972) Lab Invest, 27, pp. 62-70; Hsu, L., Diwan, B., Ward, J.M., Noguchi, C.T., Pathology of ""Berkeley"" sickle-cell mice includes gallstones and priapism (2006) Blood, 107, pp. 3414-415; Huang, J., Ren, R.-N., Chen, X.-M., Ye, L.-Y., An experimental study on hepatotoxicity of topiramate in young rats (2007) Chinese Journal of Contemporary Pediatrics, 9 (1), pp. 54-58; Hurlimann, J., Gardiol, D., Immunohistochemistry in the differential diagnosis of liver carcinomas (1991) Am J Surg Pathol, 15, pp. 280-88; Hurst, E.W., Paget, G.E., Protoporphyrin, cirrhosis and hepatoma in livers of mice given griseofulvin (1963) Br J Dermatol, 75, pp. 105-12; Husztik, E., Lazar, G., Szabo, E., Immunologically induced peliosis hepatis in rats (1984) British Journal of Experimental Pathology, 65 (3), pp. 313-318; Ichikawa, H., Imano, M., Takeyama, Y., Shiozaki, H., Ohyanagi, H., Involvement of osteopontin as a core protein in cholesterol gallstone formation (2009) J Hepatobiliary Pancreat Surg, 16, pp. 197-203; Histologic typing of liver tumors of the rat (1980) J Natl Cancer Inst, 64, pp. 177-206. , Institute of Laboratory Animal Resources, National Research Council, National Academy of Sciences; Irisarri, E., Hollander, C.F., Digestive system-Aging of the liver (1994) Pathobiology of the Aging Rat, pp. 341-49. , U. Mohr, D. L. Dungworth, and C. C. Capen, eds.), pp. ILSI Press, Washington, DC; Jang, J.J., Weghorst, C.M., Henneman, J.R., Devor, D.E., Ward, J.M., Progressive atypia in spontaneous and N-nitrosodiethylamine-induced hepatocellular adenomas of C3H/HeNCr mice (1992) Carcinogenesis, 13, pp. 1541-547; Jones, G., Butler, W.H., Morphology and spontaneous neoplasia (1975) Mouse Hepatic Neoplasia, pp. 21-59. , W. M. Butler and P. M. Newberne, eds.), pp Elsevier, Oxford, UK; Jones, G., Butler, W.H., Light microscopy of rat hepatic neoplasia (1978) Rat Hepatic Neoplasia, pp. 114-35. , P. M. Newberne and W. H. Butler, eds.), pp MIT Press, Cambridge, Massachusetts; Jones, M.L., (2002) Lipids in Theory and Practice of Histological Techniques, pp. 201-30. , J. D. Bancroft and M. Gamble, eds.), pp. Churchill Livingstone, Edinburgh, Scotland; Kakizoe, S., Goldfarb, S., Pugh, T.D., Focal impairment of growth in hepatocellular neoplasms of C57BL/6 mice: A possible explanation for the strain's resistance to hepatocarcinogenesis (1989) Cancer Research, 49 (14), pp. 3985-3989; Kanel, G.C., Korula, J., (2005) Atlas of Liver Pathology, , 2nd edition. Elservier Saunders, Los Angeles, California; Karbe, E., Kerlin, R.L., Cystic degeneration/spongiosis hepatis in rats (2002) Toxicologic Pathology, 30 (2), pp. 216-227. , DOI 10.1080/019262302753559551; Kari, F., Bucher, J., Haseman, J., Eusti, S., Huff, J., Long-term exposure to the anti-inflammatory agent phenylbutazone induces kidney tumors in rats and liver tumors in mice (1995) Jpn J of Cancer Res, 86, pp. 252-63; Kashiwagi, R., Kaidoh, T., Inoué, T., Immunohistochemical study of derndritic cells and kupffer cells in griseofulvin-induced protoporhyric mice (2001) Yonago Act Med, 44, pp. 7-16; Katoh, M., Sugimoto, T., Effect of malotilate on chronic liver injury induced by carbon tetrachloride in rats (1982) Folia Pharmacologica Japonica, 80 (1), pp. 83-91; Kiernan, F., The anatomy and physiology of the liver (1883) Philosophical Transactions of the Royal Society of London Series B, Biol Sci, 123, pp. 711-70; Kim, J.C., Kaminsky, L.S., 2,2,2-Trifluoroethanol toxicity in aged rats (1988) Toxicol Pathol, 16, pp. 35-45; Kim, J.C., Shin, D.H., Kim, S.H., Kim, J.K., Park, S.C., Son, W.C., Lee, H.S., Chung, M.K., Subacute toxicity evaluation of a new camptothecin anticancer agent CKD-602 administered by intravenous injection to rats (2004) Regulatory Toxicology and Pharmacology, 40 (3), pp. 356-369. , DOI 10.1016/j.yrtph.2004.09.002, PII S027323000400131X; Kimbrough, R.D., Pancreatic-type tissue in livers of rats fed polychlorinated biphenyls (1973) J Natl Cancer Inst, 51, pp. 679-81; Kimbrough, R.D., Linder, R.E., Induction of adenofibrosis and hepatomas of the liver in BALB-cJ mice by polychlorinated biphenyls (Aroclor 1254) (1974) J Natl Cancer Inst, 53, pp. 547-52; Kimbrough, R.D., Linder, R.E., Burse, V.W., Jennings, R.W., Adenofibrosis in the rat liver, with persistence of polychlorinated biphenyls in adipose tissue (1973) Arch Environ Health, 27, pp. 390-95; Kimura, M., Abe, M., Histology of postmortem changes in rat livers to ascertain hour of death (1994) International Journal of Tissue Reactions, 16 (3), pp. 139-150; Kitamura, K., Iwasaki, H.O., Yasoshima, A., Yoshikawa, H., Yoshikawa, T., Okaniwa, A., Pathology of chemically induced chronic active hepatitis in mice (1992) Exp Mol Pathol, 57, pp. 153-66; Klaunig, J.E., Kamendulis, L.M., Mode of action of butoxyethanol-induced mouse liver hemangiosarcomas and hepatocellular carcinomas (2005) Toxicology Letters, 156 (1 SPEC. ISS.), pp. 107-115. , DOI 10.1016/j.toxlet.2003.08.012; Knasmuller, S., Parzefall, W., Helma, C., Kassie, F., Ecker, S., Schulte-Hermann, R., Toxic effects of griseofulvin: Disease models, mechanisms, and risk assessment (1997) Critical Reviews in Toxicology, 27 (5), pp. 495-537; Koen, H., Pugh, T.D., Goldfarb, S., Centrilobular distribution of diethylnitrosamine-induced hepatocellular foci in the mouse (1983) Laboratory Investigation, 49 (1), pp. 78-81; König, H.E., Sautet, J., Liebich, H.G., Digestive system (apparatus digetorius) (2004) Veterinary Anatomy of Domestic Mammals: Textbook and Colour Atlas, pp. 332-37. , H. E. König, H.-G. Liebich, and. H. Bragulla, eds.), pp. Schattauer, Stuttgart; Kuriki, J., Murakami, H., Kakumu, S., Experimental autoimmune hepatitis in mice after immunization with syngeneic liver proteins together with the polysaccharide of Klebsiella pneumoniae (1983) Gastroenterology, 84 (3), pp. 596-603; Laifenfeld, D., Gilchrist, A., Drubin, D., Jorge, M., Eddy, S.F., Frushour, B.P., Ladd, B., Lawton, M.P., The role of Hypoxia in 2-butoxyethanol-induced hemangiosarcoma (2010) Toxicol Sci, 113, pp. 254-66; Lalich, J.J., Johnson, W.D., Raczniak, T.J., Shumaker, R.C., Fibrin thrombosis in monocrotaline pyrrole-induced cor pulmonale in rats (1977) Archives of Pathology and Laboratory Medicine, 101 (2), pp. 69-73; Lalwani, N.D., Dethloff, L.A., Haskins, J.R., Robertson, D.G., De La Iglesia, F.A., Increased nuclear ploidy, not cell proliferation, is sustained in the peroxisome proliferator-treated rat liver (1997) Toxicologic Pathology, 25 (2), pp. 165-176; Lee, K.P., Peliosis hepatis-like lesion in aging rats (1983) Vet Pathol, 20, pp. 410-23; Lee, S.P., Scott, A.J., The evolution of morphologic changes in the gallbladder before stone formation in mice fed a cholesterol-cholic acid diet (1982) American Journal of Pathology, 108 (1), pp. 1-8; Levin, S., Commentary: Implementation of the STP recommendations on the nomenclature of cell death (1999) Toxicologic Pathology, 27 (4), p. 491; Levin, S., Bucci, T.J., Cohen, S.M., Fix, A.S., Hardisty, J.F., LeGrand, E.K., Maronpot, R.R., Trump, B.F., The nomenclature of cell death: Recommendations of an ad hoc Committee of the Society of Toxicologic Pathologists (1999) Toxicologic Pathology, 27 (4), pp. 484-490; Levine, S., Sowinski, R., Splenic infarcts produced in rats by vasoconstrictor drugs (1985) Experimental Pathology, 28 (1), pp. 13-19; Lewis, D.J., Spontaneous lesions of the mouse biliary tract""' (1984) Journal of Comparative Pathology, 94 (2), pp. 263-271. , DOI 10.1016/0021-9975(84)90045-8; Li, X., Elwell, M.R., Ryan, A.M., Ochoa, R., Morphogenesis of post mortem hepatocyte vacuolation and liver weight increases in Sprague-Dawley rats (2003) Toxicologic Pathology, 31 (6), pp. 682-688; Lin, C.-C., Chang, C.-H., Yang, J.-J., Namba, T., Hattori, M., Hepatoprotective effects of emodin from Ventilago leiocarpa (1996) Journal of Ethnopharmacology, 52 (2), pp. 107-111. , DOI 10.1016/0378-8741(96)01397-9; Lipman, R.D., Gaillard, E.T., Harrison, D.E., Bronson, R.T., Husbandry factors and the prevalence of age-related amyloidosis in mice (1993) Laboratory Animal Science, 43 (5), pp. 439-444; Lipsky, M.M., Tanner, D.C., Hinton, D.E., Trump, B.F., Reversibility, persistence, and progression of safrole-induced mouse liver lesions following cessation of exposure (1984) Mouse Liver Neoplasia, pp. 161-77. , J. A. Popp, ed.), pp Hemisphere Publishing Corporation, Washington, DC; Liu, Y., Cui, D., Hoshii, Y., Kawano, H., Une, Y., Gondo, T., Ishihara, T., Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides (2007) Scandinavian Journal of Immunology, 66 (5), pp. 495-500. , DOI 10.1111/j.1365-3083.2007.02005.x; Mahon, D.C., Altered hepatic foci in rat liver as weight of evidence of carcinogenicity: The Canadian perspective (1989) Toxicologic Pathology, 17 (4), pp. 709-715; Maita, K., Hirano, M., Harada, T., Mitsumori, K., Yoshida, A., Takahashi, K., Nakashima, N., Shirasu, Y., Mortality, major cause of moribundity, and spontaneous tumors in CD-1 mice (1988) Toxicologic Pathology, 16 (3), pp. 340-349; Malarkey, D.E., Devereux, T.R., Dinse, G.E., Mann, P.C., Maronpot, R.R., Hepatocarcinogenicity of chlordane in B6C3F1 and B6D2F1 male mice: Evidence for regression in B6C3F1 mice and carcinogenesis independent of ras proto-oncogene activation (1995) Carcinogenesis, 16, pp. 2617-625; Malarkey, D.E., Johnson, K., Ryan, L., Boorman, G., Maronpot, R.R., New insights into functional aspects of liver morphology (2005) Toxicologic Pathology, 33 (1), pp. 27-34. , DOI 10.1080/01926230590881826; Malhotra, V., Sakhuja, P., Gondal, R., Immunohistochemistry in liver diseases (2004) J Gastroenterol Hepatol, 19, pp. 364-69; Maronpot, R.R., Biological basis of differential susceptiblity to hepatocarcinogenesis amoung mouse strains (2009) J Toxicol Pathol, 22, pp. 11-33; Maronpot, R.R., Harada, T., Murthy, A.S.K., Boorman, G.A., Documenting foci of hepatocellular alteration in two-year carcinogenicity studies: Current practices of the national toxicology program (1989) Toxicologic Pathology, 17 (4), pp. 675-684; Maronpot, R.R., Montgomery Jr., C.A., Boorman, G.A., McConnell, E.E., National toxicology program nomenclature for hepatoproliferative lesions of rats (1986) Toxicologic Pathology, 14 (2), pp. 263-273; Marsman, D.S., NTP Technical Report on Toxicity Studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F? Mice (1995) Toxicity Report Series, (30). , U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, North Carolina; Marsman, D.S., Popp, J.A., Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643 (1994) Carcinogenesis, 15 (1), pp. 111-117; Martignoni, M., Groothuis, G.M.M., De Kanter, R., Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction (2006) Expert Opinion on Drug Metabolism and Toxicology, 2 (6), pp. 875-894. , DOI 10.1517/17425255.2.6.875; Martin, N.C., McGregor, A.H., Sansom, N., Gould, S., Harrison, D.J., Phenobarbitone-induced ploidy changes in liver occur independently of p53 (2001) Toxicology Letters, 119 (2), pp. 109-115. , DOI 10.1016/S0378-4274(00)00299-X, PII S037842740000299X; Masson, R., Roome, N.O., Spontaneous iron overload in Sprague-Dawley rats (1997) Toxicologic Pathology, 25 (3), pp. 308-316; Masyuk, T.V., Huang, B.Q., Masyuk, A.I., Ritman, E.L., Torres, V.E., Wang, X., Harris, P.C., LaRusso, N.F., Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease (2004) American Journal of Pathology, 165 (5), pp. 1719-1730; Masyuk, T.V., Masyuk, A.I., Torres, V.E., Harris, P.C., Larusso, N.F., Octreotide Inhibits Hepatic Cystogenesis in a Rodent Model of Polycystic Liver Disease by Reducing Cholangiocyte Adenosine 3′,5′-Cyclic Monophosphate (2007) Gastroenterology, 132 (3), pp. 1104-1116. , DOI 10.1053/j.gastro.2006.12.039, PII S0016508506026898; Matsumoto, M., Aiso, S., Umeda, Y., Arito, H., Nagano, K., Yamamoto, S., Matsushima, T., Thirteen-week oral toxicity of para- and ortho- chloronitrobenzene in rats and mice (2006) Journal of Toxicological Sciences, 31 (1), pp. 9-22. , http://www.jstage.jst.go.jp/article/jts/31/1/9/_pdf, DOI 10.2131/jts.31.9; McCaughan, G.W., Bilous, M.J., Gallagher, N.D., Long-term survival with tumor regression in androgen-induced liver tumors (1985) Cancer, 56 (11), pp. 2622-2626. , DOI 10.1002/1097-0142(19851201)56 :11<2622::AID-CNCR2820561115>3.0. CO;2-0; Meierhenry, E.F., Ruebner, B.H., Gershwin, M.E., Dieldrin-induced Mallory bodies in hepatic tumors of mice of different strains (1983) Hepatology, 3 (1), pp. 90-95; Mendenhall, C.L., Chedid, A., Peliosis hepatis. Its relationship to chronic alcoholism, aflatoxin B1, and carcinogenesis in male Holtzman rats (1980) Digestive Diseases and Sciences, 25 (8), pp. 587-592. , DOI 10.1007/BF01318871; Mitsumori, K., Blood and lymphatic vessels (1990) Pathology of the Fischer Rat. Reference and Atlas, pp. 473-84. , G. A. Boorman, S. L. Eustis, M. R. Elwell, C. A. Montgomery, Jr., and W. F. MacKenzie, eds.), pp. Academic Press, San Diego, California; Miyai, K., The discovery of new diseases by utilizing laboratory data for clinical research (1991) Perspectives in Biology and Medicine, 34, pp. 542-48; Miyazaki, M., Makowka, L., Falk, R.E., Protection of thermochemotherapeutic-induced lethal acute hepatic necrosis in the rat by 16,16-dimethyl prostaglandin E2 (1983) Journal of Surgical Research, 34 (5), pp. 415-426; Moore, M.A., Thamavit, W., Bannasch, P., Tumours of the liver (1996) Pathology of Tumours in Laboratory Animals, 3, pp. 79-125. , IARC, Lyon, France; Morgan, K.T., Frith, C.H., Swenberg, J.A., A morphologic classification of brain tumors found in several strains of mice (1984) Journal of the National Cancer Institute, 72 (1), pp. 151-160; Muff, M.A., Masyuk, T.V., Stroope, A.J., Huang, B.Q., Splinter, P.L., Lee, S.-O., LaRusso, N.F., Development and characterization of a cholangiocyte cell line from the PCK rat, an animal model of Autosomal Recessive Polycystic Kidney Disease (2006) Laboratory Investigation, 86 (9), pp. 940-950. , DOI 10.1038/labinvest.3700448, PII 3700448; Naeim, F., Copper, P.H., Semion, A.A., Peliosis hepatis. Possible etiologic role of anabolic steroids (1973) Arch Pathol, 95, pp. 284-85; Nagano, K., Sasaki, T., Umeda, Y., Nishizawa, T., Ikawa, N., Ohbayashi, H., Arito, H., Fukushima, S., Inhalation carcinogenicity and chronic toxicity of carbon tetrachloride in rats and mice (2007) Inhalation Toxicology, 19 (13), pp. 1089-1103. , DOI 10.1080/08958370701628770, PII 783397132; Narama, I., Imaida, K., Iwata, H., Nakae, D., Nishikawa, A., Harada, T., A review of nomenclature and diagnostic criteria for proliferative lesions in the liver of rats by a working group of the Japanese Society of Toxicologic Pathology (2003) J Toxicol Pathol, 16, pp. 1-17; Newton, P.E., Wooding, W.L., Bolte, H.F., Derelanko, M.J., Hardisty, J.F., Rinehart, W.E., A chronic inhalation toxicity/oncogenicity study of methylethylketoxime in rats and mice (2001) Inhalation Toxicology, 13 (12), pp. 1093-1116. , DOI 10.1080/08958370152647636; Nishimura, J., Dewa, Y., Muguruma, M., Kuroiwa, Y., Yasuno, H., Shima, T., Jin, M., Mitsumori, K., Effect of fenofibrate on oxidative DNA damage and on gene expression related to cell proliferation and apoptosis in rats (2007) Toxicological Sciences, 97 (1), pp. 44-54. , DOI 10.1093/toxsci/kfm011; Nonomura, A., Kono, N., Yoshida, K., Mizukami, Y., Nakanuma, Y., Matsubara, F., Histological changes of the liver in experimental graft-versus-host disease across minor histocompatibility barriers. V. A light and electron microscopic study of the intralobular changes (1991) Liver, 11, pp. 149-57; Nonoyama, T., Fullerton, F., Reznik, G., Bucci, T.J., Ward, J.M., Mouse hepatoblastomas: A histologic, ultrastructural, and immunohistochemical study (1988) Vet Pathol, 25, pp. 286-96; Nonoyama, T., Reznik, G., Bucci, T.J., Fullerton, F., Hepatoblastoma with squamous differentiation in a B6C3F1 mouse (1986) Vet Pathol, 23, pp. 619-22; (2010) Pathology Potpourri, , NTP Satellite Symposium. Chicago Marriott Downtown, Chicago, Illinois; NTP technical report on the toxicology and carcinogenesis studies of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies) (2006) Natl Toxicol Program Tech Rep ser, 521, pp. 4-232; NTP technical report on the toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS no. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (CAS no. 31508-00-6) in female Harlan Sprague-Dawley rats (Gavage studies)(2006) Natl Toxicol Program Tech Rep ser, 531 (7-4467); NTP toxicology and carcinogenesis studies of ethylene glycol (CAS No. 107-21-1) in B6C3F1 mice (feed studies) (1993) Natl Toxicol. Program Tech Rep ser, 413 (93-3144); NTP toxicology and carcinogenesis studies of 3, 3′ , 4, 4′ , 5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies) (2006) Natl Toxicol Program Tech Rep ser, 520, pp. 4-246; NTP toxicology and carcinogenesis studies of theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 mice (Feed and Gavage Studies) (1998) Natl Toxicol Program Tech Rep ser, 473; Numan, F., Cokyuksel, O., Camuscu, S., Demir, K., Duren, M., Caroli syndrome (1986) Rontgenblatter, 39, pp. 191-92; Nyska, A., Moomaw, C.R., Foley, J.F., Maronpot, R.R., Malarkey, D.E., Cummings, C.A., Peddada, S., Chan, P.C., The hepatic endothelial carcinogen riddelliine induces endothelial apoptosis, mitosis, S phase, and p53 and hepatocytic vascular endothelial growth factor expression after short-term exposure (2002) Toxicology and Applied Pharmacology, 184 (3), pp. 153-164. , DOI 10.1006/taap.2002.9485; Nyska, A., Waner, T., Wormser, U., Gur, E., Kuttin, E., Dayan, D., Possible pitfalls in rat extended dermal toxicity testing: An hepatic-ocular syndrome (1992) Arch Toxicol, 66, pp. 339-46; Obert, L.A., Sobocinski, G.P., Bobrowski, W.F., Metz, A.L., Rolsma, M.D., Altrogge, D.M., Dunstan, R.W., An immunohistochemical approach to differentiate hepatic lipidosis from hepatic phospholipidosis in rats (2007) Toxicol Pathol, 35, pp. 728-34; Ohnishi, T., Arnold, L.L., Clark, N.M., Wisecarver, J.L., Cohen, S.M., Comparison of endothelial cell proliferation in normal liver and adipose tissue in B6C3F1 mice, F344 rats, and humans (2007) Toxicol Pathol, 35, pp. 904-09; Omar, A., Elmesallamy, G.-S., Eassa, S., Comparative study of the hepatotoxic, genotoxic and carcinogenic effects of praziquantel distocide & the natural myrrh extract Mirazid on adult male albino rats (2005) J Egypt Soc Parasitol, 35, pp. 313-29; Parker, G.A., Gibson, W.B., Liver lesions in rats associated with wrapping of the torso (1995) Toxicol Pathol, 23, pp. 507-12; Peckham, J.C., Heider, K., Skin and subcutis. in Pathology of the Mouse (1999) Reference and Atlas, pp. 555-12. , Cache River Press, Vienna; Peichoto, M.E., Teibler, P., Ruiz, R., Leiva, L., Acosta, O., Systemic pathological alterations caused by Philodryas patagoniensis colubrid snake venom in rats (2006) Toxicon, 48 (5), pp. 520-528. , DOI 10.1016/j.toxicon.2006.06.013, PII S0041010106002157; Peraino, C., Staffeldt, E.F., Carnes, B.A., Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or benzo(a)pyrene within one day after birth (1984) Cancer Research, 44 (8), pp. 3340-3347; Percy, D.H., Barthold, S.W., Hamster (2001) Pathology of Laboratory Rodents and Rabbits, pp. 194-95. , Blackwell Publishing, Ames, Iowa; Percy, D.H., Barthold, S.W., (2007) Pathology of Laboratory Rodents and Rabbits, p. 356. , 3rd edition, p. Blackwell Publishing, Ames, Iowa; Peters, M., Liebman, H.A., Tong, M.J., Tinberg, H.M., Alcoholic hepatitis: Granulocyte chemotactic factor from mallory body-stimulated human peripheral blood mononuclear cells (1983) Clinical Immunology and Immunopathology, 28 (3), pp. 418-430; Pitt, C.G., Gupta, G., Estes, W.E., The selection and evaluation of new chelating agents for the treatment of iron overload (1979) Journal of Pharmacology and Experimental Therapeutics, 208 (1), pp. 12-18; Popp, J.A., (1984) Mouse Liver Neoplasia. Current Perspectives, , Hemisphere Publishing Co., New York; Popp, J.A., Hepatocellular carcinoma, liver, rat (1985) Monographs on Pathology of Laboratory Animals. Digestive System, pp. 39-46. , T. C. Jones, U. Mohr, and R. D. Hunt, eds.), pp. Springer, New York; Popp, J.A., Cattley, R.C., Hepatobiliary system (1991) Handbook of Toxicologic Pathology, pp. 279-314. , W. M. Haschek and C. G. Rousseaux, eds.), pp. Academic Press, San Diego, California; Popper, H., Maltoni, C., Selikoff, J., Vinyl chloride-induced hepatic lesions in man and rodents. A comparison (1981) Liver, 1 (1), pp. 7-20; Pozharisski, K.M., Turusov, V.S., Angiosarcoma of the renal capsule, mouse (1991) Monographs on Pathology of Laboratory Animals. Cardiovascular and Musculoskeletal Systems, pp. 91-7. , T. C. Jones, U. Mohr, and R. D. Hunt, eds.), pp. Springer, New York; Rabstein, L.S., Peters, R.L., Spahn, G.J., Spontaneous tumors and pathologic lesions in SWR-J mice (1973) J Natl Cancer Inst, 50, pp. 751-58; Rajtová, V., Horák, J., Popesko, P., (2002) A Colour Atlas of the Anatomy of Small Laboratory Animals, , Saunders, London; Ramot, Y., Lewis, D.A., Ortel, T.L., Streicker, M., Moser, G., Elmore, S., Ward, S.M., Nyska, A., Age and dose sensitivities in the 2-butoxyethanol F344 rat model of hemolytic anemia and disseminated thrombosis (2007) Experimental and Toxicologic Pathology, 58 (5), pp. 311-322. , DOI 10.1016/j.etp.2006.11.003, PII S0940299306001126; Rank, J.M., Straka, J.G., Bloomer, J.R., Liver in disorders of porphyrin metabolism (1990) Journal of Gastroenterology and Hepatology, 5 (5), pp. 573-585; Rappaport, A.M., Borowy, Z.J., Lougheed, W.M., Lotto, W.N., Subdivision of hexagonal liver lobules into a structural and functional unit; Role in hepatic physiology and pathology (1954) Anat Rec, 119, pp. 11-33; Reasor, M.J., Hastings, K.L., Ulrich, R.G., Drug-induced phospholipidosis: Issues and future directions (2006) Expert Opinion on Drug Safety, 5 (4), pp. 567-583. , DOI 10.1517/14740338.5.4.567; Reddy, J.K., Lalwani, N.D., Kumudavalli Reddy, M., Qureshi, S.A., Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators (1982) Cancer Research, 42 (1), pp. 259-266; Reed, D.J., (1998) Evaluation of Chemical-inducedoxidative Stress As A Mechanism of Hepatocyte Death in Toxicology of the Liver, pp. 187-220. , G. L. Plaa and W. R. Hewitt, eds.), pp. Taylor & Francis, Washington, DC; Rege, R.V., Prystowsky, J.B., Inflammation and a thickened mucus layer in mice with cholesterol gallstones (1998) Journal of Surgical Research, 74 (1), pp. 81-85. , DOI 10.1006/jsre.1997.5213; Rijhnsinghani, K., Krakower, C., Swerdlow, M., Alpha1-antitrypsin in intracellular inclusions of diethyl-nitrosamine induced hepatomas of C57BLxC3H F 1 mice (1980) Carcinogenesis, 1 (6), pp. 473-479; Robison, R.L., Van Ryzin, R.J., Stoll, R.E., Chronic toxicity/carcinogenesis study of temazepam in mice and rats (1984) Fundamental and Applied Toxicology, 4 (3), pp. 394-405. , DOI 10.1016/0272-0590(84)90197-0; Rogers, A.B., Fox, J.G., Inflammation and cancer. I. Rodent models of infectious gastrointestinal and liver cancer (2004) Am J Physiol Gastrointest Liver Physiol, 286, pp. 361-66; Ruebner, B.H., Watanabe, K., Wand, J.S., Lytic necrosis resembling peliosis hepatis produced by lasiocarpine in the mouse liver. A light and electron microscopic study (1970) Am J Pathol, 60, pp. 247-71; Ruehl-Fehlert, C., Kittel, B., Morawietz, G., Deslex, P., Keenan, C., Mahrt, C.R., Nolte, T., Deschl, U., Revised guides for organ sampling and trimming in rats and mice-Part 1 (2003) Exp and Toxicol Pathol, 55, pp. 91-106; Sakamoto, M., Takayama, S., Hosoda, Y., Hemangioendothelial sarcoma in brown adipose tissue of mouse induced by carcinogenic heterocyclic amine, Glu-P-1 (1989) Toxicologic Pathology, 17 (4), pp. 754-758; Sasse, D., Maly, I.P., Studies on the periportal hepatotoxicity of allyl alcohol (1991) Prog Histochem Cytochem, 23, pp. 146-49; Sato, Y., Harada, K., Furubo, S., Kizawa, K., Sanzen, T., Yasoshima, M., Ozaki, S., Nakanuma, Y., Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib (2006) American Journal of Pathology, 169 (4), pp. 1238-1250. , http://ajp.amjpathol.org/cgi/reprint/169/4/1238, DOI 10.2353/ajpath.2006.051136; Sato, Y., Harada, K., Kizawa, K., Sanzen, T., Furubo, S., Yasoshima, M., Ozaki, S., Nakanuma, Y., Activation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli's disease (2005) American Journal of Pathology, 166 (1), pp. 49-60; Satoh, M., Kobayashi, K., Ishii, M., Igarashi, T., Toyota, T., Midzonal necrosis of the liver after concanavalin A-injection (1996) The Tohoku J Exp Med, 180, pp. 139-52; Schoental, R., Magee, P.N., Further observations on the subacute and chronic liver changes in rats after a single dose of various pyrrolizidine (Senecio) alkaloids (1959) J Pathol Bacteriol, 78, pp. 471-82; Schulte-Hermann, R., Kraupp-Grasl, B., Bursch, W., Gerbracht, U., Timmermann-Trosiener, I., Effects of non-genotoxic hepatocarcinogens phenobarbital and nafenopin on phenotype and growth of different populations of altered foci in rat liver (1989) Toxicologic Pathology, 17 (4), pp. 642-650; Seawright, A.A., A metabolic basis for midzonal necrosis of the liver (1972) J Pathol, p. 107; Seehafer, S.S., Pearce, D.A., You say lipofuscin, we say ceroid: Defining autofluorescent storage material (2006) Neurobiology of Aging, 27 (4), pp. 576-588. , DOI 10.1016/j.neurobiolaging.2005.12.006, PII S0197458005004276, Protein Misfolding in Alzheimer's and Other Age-Related Neurodegenerative Diseases; Serra, C.A., Recalde, E.B., Martellotto, G.I., Caroli's disease: Congenital cystic and segmentary dilatation of the intrahepatic bile ducts (1987) Rev Fac Cien Med Univ Nac Cordoba, 45, pp. 28-30; Shea, S.M., The method of paired comparisons in histopathological ranking; Hyaline degeneration of liver cells (1958) A M A Arch Pathol, 65, pp. 77-80; Shio, H., Fowler, S., Bhuvaneswaran, C., Morris, M.D., Lysosome lipid storage disorder in NCTR-BALB/c mice. II. Morphologic and cytochemical studies (1982) American Journal of Pathology, 108 (2), pp. 150-159; Sigal, S.H., Rajvanshi, P., Gorla, G.R., Sokhi, R.P., Saxena, R., Gebhard Jr., D.R., Reid, L.M., Gupta, S., Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events (1999) The Am J of Physiol, 276, pp. 1260-272; Singh, N.D., Sharma, A.K., Dwivedi, P., Patil, R.D., Kumar, M., Citrinin and endosulfan induced maternal toxicity in pregnant Wistar rats: Pathomorphological study (2007) Journal of Applied Toxicology, 27 (6), pp. 589-601. , DOI 10.1002/jat.1242; Sirica, A.E., (1992) The Role of Cell Types in Hepatocarcinogenesis, , CRC Press, Boca Raton, Florida; Slehria, S., Rajvanshi, P., Ito, Y., Sokhi, R.P., Bhargava, K.K., Palestro, C.J., McCuskey, R.S., Gupta, S., Hepatic sinusoidal vasodilators improve transplanted cell engraftment and ameliorate microcirculatory perturbations in the liver (2002) Hepatology, 35 (6), pp. 1320-1328. , DOI 10.1053/jhep.2002.33201; Solleveld, H.A., Miller, R.A., Banas, D.A., Boorman, G.A., Primary cardiac hemangiosarcomas induced by 1,3-butadiene in B6C3F1 hybrid mice (1988) Toxicol Pathol, 16, pp. 46-52; Spencer, A.J., Wilson, S.A., Batchelor, J., Reid, A., Rees, J., Harpur, E., Gadolinium chloride toxicity in the rat (1997) Toxicologic Pathology, 25 (3), pp. 245-255; Squire, R.A., Evaluation and grading of rat liver foci in carcinogenicity tests (1989) Toxicologic Pathology, 17 (4), pp. 685-689; Squire, R.A., Levitt, M.H., Report of a workshop on classification of specific hepatocellular lesions in rats (1975) Cancer Res, 35, pp. 3214-223; Srinivasan, S., Hanes, M.A., Dickens, T., Porteous, M.E.M., Oh, S.P., Hale, L.P., Marchuk, D.A., A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2 (2003) Human Molecular Genetics, 12 (5), pp. 473-482. , DOI 10.1093/hmg/ddg050; Steinbrecher, U.P., Lisbona, R., Huang, S.N., Mishkin, S., Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives (1981) Digestive Diseases and Sciences, 26 (11), pp. 1045-1050; Stejskal, R., Itabashi, M., Stanek, J., Hruban, Z., Experimental porphyria induced by 3-(2,4,6-trimethylphenyl)-thioethyl)-4 methylsydnone (1975) Virchows Arch B Cell Pathol, 18, pp. 83-100; Stewart, H.L., Tumours of the soft tissues (1979) Pathology of Tumours in Laboratory Animals, 2, pp. 487-526. , Tumours of the Mouse V. S. Turusov, ed.), pp. IARC Scientific Publications, Lyon, France; Stewart, H.L., Williams, G., Keysser, C.H., Lombard, L.S., Montali, R.J., Histologic typing of liver tumors of the rat (1980) J Natl Cancer Inst, 64, pp. 179-206; Stinson, S.F., Hoover, K.L., Ward, J.M., Quantitation of differences between spontaneous and induced liver tumors in mice with an automated image analyzer (1981) Cancer Letters, 14 (2), pp. 143-150; Stout, M.D., Kissling, G.E., Suárez, F.A., Malarkey, D.E., Herbert, R.A., Bucher, J.R., Influence of Helicobacter hepaticus infection on the chronic toxicity and carcinogenicity of triethanolamine in B6C3F1 mice (2008) Toxicol Pathol, 36, pp. 783-94; Tasaki, M., Umemura, T., Inoue, T., Okamura, T., Kuroiwa, Y., Ishii, Y., Maeda, M., Nishikawa, A., Induction of characteristic hepatocyte proliferative lesion with dietary exposure of Wistar Hannover rats to tocotrienol for 1 year (2008) Toxicology, 250, pp. 143-50; Tepperman, J., Caldwell, F.T., Tepperman, H.M., Induction of gallstones in mice by feeding a cholesterol-cholic acid containing diet (1964) Am J Physiol, 206, pp. 628-34; Teredesai, A., Wohrmann, T., Schlage, W., Hepatocholangiocellular carcinoma in a rat-Case report (2002) J Vet Med A Physiol Pathol Clin Med, 49, pp. 541-44; Teutsch, H.F., The modular microarchitecture of human liver (2005) Hepatology, 42 (2), pp. 317-325. , DOI 10.1002/hep.20764; Teutsch, H.F., Schuerfeld, D., Groezinger, E., Three-dimensional reconstruction of parenchymal units in the liver of the rat (1999) Hepatology, 29 (2), pp. 494-505. , DOI 10.1002/hep.510290243; Tian, X.F., Fan, X.G., Fu, C.Y., Huang, Y., Zhu, C., Experimental study on the pathological effect of Helicobacter pylori on liver tissues (2005) Zhonghua Gan Zang Bing Za Zhi, 13, pp. 780-83; Tillmann, T., Kamino, K., Dasenbrock, C., Ernst, H., Kohler, M., Morawietz, G., Campo, E., Mohr, U., Subcutaneous soft tissue tumours at the site of implanted microchips in mice (1997) Experimental and Toxicologic Pathology, 49 (3-4), pp. 197-200; Travlos, G.S., Mahler, J., Ragan, H.A., Chou, B.J., Bucher, J.R., Thirteen-week inhalation toxicity of 2- and 4-chloronitrobenzene in F344/N rats and B6C3F1 mice (1996) Fund and Appl Toxicol, 30, pp. 75-92; Trotman, B.W., Bernstein, S.E., Balistreri, W.F., Martin, R.A., Interaction of hemolytic anemia and genotype on hemolysis-induced gallstone formation in mice (1983) Gastroenterology, 84 (4), pp. 719-724; Tschudy, D.P., Biochemical studies of experimental porphyria (1962) Metabolism, 11, pp. 1287-301; Tsokos, M., Erbersdobler, A., Pathology of peliosis (2005) Forensic Science International, 149 (1), pp. 25-33. , DOI 10.1016/j.forsciint.2004.05.010; Turusov, V.S., Day, N.E., Tomatis, L., Gati, E., Charles, R.T., Tumors in CF-1 mice exposed for six consecutive generations to DDT (1973) J Natl Cancer Inst, 51, pp. 983-97; Turusov, V.S., Deringer, M.K., Dunn, T.B., Stewart, H.L., Malignant mouse-liver tumors resembling human hepatoblastomas (1973) J Natl Cancer Inst, 51, pp. 1689-695; Ungar, H., Venoocclusive disease of the liver and phlebectatic peliosis in the golden hamster exposed to dimethylnitrosamine (1986) Pathology Research and Practice, 181 (2), pp. 180-187; Ungar, H., Sullman, S.F., Zuckerman, A.J., Acute and protracted changes in the liver of Syrian hamsters induced by a single dose of aflatoxin B1. Observations on pathological effects of the solvent (dimethylformamide) (1976) Brit J of Exp Pathol, 57, pp. 157-64; Van Zwieten, M.J., Hollander, C.F., Intranuclear and intracytoplasmic inclusions, liver, rat (1997) Monographs on Pathology of Laboratory Animals: Digestive System, pp. 133-39. , T. C. Jones, J. A. Popp, and U. Mohr eds.), pp. Springer, New York; Vesselinovitch, S.D., Mihailovich, N., Rao, K.V.N., Morphology and metastatic nature of induced hepatic nodular lesions in C57BL x C3H F1 mice (1978) Cancer Research, 38 (7), pp. 2003-2010; Vollmar, B., Siegmund, S., Richter, S., Menger, M.D., Microvascular consequences of Kupffer cell modulation in rat liver fibrogenesis (1999) Journal of Pathology, 189 (1), pp. 85-91. , DOI 10.1002/(SICI)1096-9896(19990 9)189:1<85::AID-PATH399>3.0.CO;2- 1; Vons, C., Beaudoin, S., Helmy, N., Dagher, I., Weber, A., Franco, D., First description of the surgical anatomy of the cynomolgus monkey liver (2009) Am J of Primatol, 71, pp. 400-08; Vowles, G.H., Francis, R.J., Amyloid (2002) Theory and Practice of Histological Techniques, pp. 303-. , J. D. Bancroft and M. Gamble, eds.), pp. Churchill Livingstone, Edinburgh, Scotland. 24; Walker, R.M., Racz, W.J., McElligott, T.F., Acetaminophen-induced hepatotoxic congestion in mice (1985) Hepatology, 5 (2), pp. 233-240. , DOI 10.1002/hep.1840050213; Wang, J., Zhou, G., Chen, C., Yu, H., Wang, T., Ma, Y., Jia, G., Chai, Z., Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration (2007) Toxicology Letters, 168 (2), pp. 176-185. , DOI 10.1016/j.toxlet.2006.12.001, PII S0378427406013798; Ward, J.M., Morphology of foci of altered hepatocytes and naturally-occurring hepatocellular tumors in F344 rats (1981) Virchows Archiv - Abteilung A Pathologische Anatomie, 390 (3), pp. 339-345; Ward, J.M., Cirrhosis, mouse (1997) Monographs on Pathology of Laboratory Animals: Digestive System, pp. 151-54. , T. C. Jones, J. A. Popp, and U. Mohr, eds.), pp. 2nd Edition. Springer, New York; Ward, J.M., Anver, M.R., Haines, D.C., Benveniste, R.E., Chronic active hepatitis in mice caused by Helicobacter hepaticus (1994) American Journal of Pathology, 145 (4), pp. 959-968; Ward, J.M., Collins Jr., M.J., Parker, J.C., Naturally occurring mouse hepatitis virus infection in the nude mouse (1977) Laboratory Animal Science, 27 (3), pp. 372-376; Ward, J.M., Diwan, B.A., Ohshima, M., Tumor-initiating and promoting activities of di(2-ethylhexyl) phthalate in vivo and in vitro (1986) Environmental Health Perspectives, VOL. 65, pp. 279-291; Ward, J.M., Fox, J.G., Anver, M.R., Haines, D.C., George, C.V., Collins Jr., M.J., Gorelick, P.L., Rice, J.M., Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species (1994) Journal of the National Cancer Institute, 86 (16), pp. 1222-1227; Ward, J.M., Goodman, D.G., Squire, R.A., Neoplastic and nonneoplastic lesions in aging (C57BL/6N x C3H/HeN)F 1 (B6C3F1) mice (1979) Journal of the National Cancer Institute, 63 (3), pp. 849-854; Ward, J.M., Lynch, P., Riggs, C., Rapid development of hepatocellular neoplasms in aging male C3H/HeNCr mice given phenobarbital (1988) Cancer Letters, 39 (1), pp. 9-18. , DOI 10.1016/0304-3835(88)90035-3; Ward, J.M., Rice, J.M., Creasia, D., Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice (1983) Carcinogenesis, 4 (8), pp. 1021-1029; Ward, J.M., Wobus, C.E., Thackray, L.B., Erexson, C.R., Faucette, L.J., Belliot, G., Barron, E.L., Green, K.Y., Pathology of immunodeficient mice with naturally occurring murine norovirus infection (2006) Toxicologic Pathology, 34 (6), pp. 708-715. , DOI 10.1080/01926230600918876, PII H57843X754684587; Ward, J.M., Yoon, M., Anver, M.R., Haines, D.C., Kudo, G., Gonzalez, F.J., Kimura, S., Hyalinosis and Ym1/Ym2 gene expression in the stomach and respiratory tract of 129S4/SvJae and wild-type and CYP1A2-null B6, 129 mice (2001) American Journal of Pathology, 158 (1), pp. 323-332; Wilson, D.M., Goldsworthy, T.L., Popp, J.A., Butterworth, B.E., Evaluation of genotoxicity, pathological lesions, and cell proliferation in livers of rats and mice treated with furan (1992) Environ Mol Mutagen, 19, pp. 209-22; Wilson, D.W., Lame, M.W., Dunston, S.K., Segall, H.J., DNA damage cell checkpoint activities are altered in monocrotaline pyrrole-induced cell cycle arrest in human pulmonary artery endothelial cells (2000) Toxicology and Applied Pharmacology, 166 (2), pp. 69-80. , DOI 10.1006/taap.2000.8966; Wolstenholme, J.T., Gardner, W.U., Sinusoidal dilatation occurring in livers of mice with a transplanted testicular tumor (1950) Proc Soc Exp Biol Med, 74, pp. 659-61; Wong, A.K., Alfert, M., Castrillon, D.H., Shen, Q., Holash, J., Yancopoulos, G.D., Chin, L., Excessive tumor-elaborated VEGF and its neutralization define a lethal paraneoplastic syndrome (2001) Proceedings of the National Academy of Sciences of the United States of America, 98 (13), pp. 7481-7486. , DOI 10.1073/pnas.121192298; (1978) Principles and Methods for Evaluating the Toxicity of Chemicals. Part i, , World Health Organization, Geneva; Wright, P.F., Stacey, N.H., A species/strain comparison of hepatic natural lymphocytotoxic activities in rats and mice (1991) Carcinogenesis, 12, pp. 1365-370; Xie, Y., Newberry, E.P., Kennedy, S.M., Luo, J., Davidson, N.O., Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein (L-Fabp) knockout mice (2009) J Lipid Res, 50, pp. 977-87; Xu, C., Li, C.Y.-T., Kong, A.-N.T., Induction of phase I, II and III drug metabolism/transport by xenobiotics (2005) Archives of Pharmacal Research, 28 (3), pp. 249-268. , http://apr.psk.or.kr/home/journal/include/downloadPdf.asp?articleuid= {076E6550-76FB-47E2-8B0A-70960C2EBA91}; Xu, S.X., Zheng, D., Sun, Y.M., Wang, S.H., Shao, L.Q., Huang, Q.Y., Xiang, D.L., Subchronic toxicity studies of fenbendazole in rats (1992) Vet Hum Toxicol, 34, pp. 411-13; Yamate, J., Tajima, M., Ihara, M., Shibuya, K., Kudow, S., Spontaneous vascular endothelial cell tumors in aged B6C3F1 mice (1988) Jpn J Vet Sci, 50, pp. 453-61; Yang, Y.H., Campbell, J.S., Crystalline excrements in bronchitis and cholescystitis of mice (1964) Am J Pathol, 45, pp. 337-45; Yasui, M., Yase, Y., Ota, K., Distribution of calcium in central nervous system tissues and bones of rats maintained on calcium-deficient diets (1991) J Neurol Sci, 105, pp. 206-10; Yoshitomi, K., Alison, R.H., Boorman, G.A., Adenoma and adenocarcinoma of the gallbladder in aged laboratory mice (1986) Vet Pathol, 23, pp. 523-27; Yoshitomi, K., Boorman, G.A., Tumours of the gallbladder (1994) Pathology of Tumours in Laboratory Animals, 2, pp. 271-79. , V. Turusov and U. Mohr, eds.), pp. 2nd edition. IARC Scientific Publications, Lyon, France. Tumours of the Mouse; Yu, W., Wan, X., Wright Jr., J.R., Coddington, D., Bitter-Suermann, H., Heterotopic liver transplantation in rats: Effect of intrahepatic islet isografts and split portal blood flow on liver integrity after auxiliary liver isotransplantation (1994) Surgery, 115 (1), pp. 108-117; Zatloukal, K., Stumptner, C., Lehner, M., Denk, H., Baribault, H., Eshkind, L.G., Franke, W.W., Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies (2000) American Journal of Pathology, 156 (4), pp. 1263-1274; Zenner, L., Pathology, diagnosis and epidemiology of the rodent Helicobacter infection (1999) Comparative Immunology, Microbiology and Infectious Diseases, 22 (1), pp. 41-61. , DOI 10.1016/S0147-9571(98)00018-6, PII S0147957198000186; Zimmerman, H.J., Drug-induced hepatic disease (1998) Toxicology of the Liver, pp. 3-60. , G. L. Plaa, and W. R. Hewitt, eds.), pp. Taylor & Francis, Washington, DC; Zwicker, G.M., Eyster, R.C., Sells, D.M., Gass, J.H., Spontaneous vascular neoplasms in aged Sprague-Dawley rats (1995) Toxicol Pathol, 23, pp. 518-26","Thoolen, B.; Global Pathology Support, The Hague, Netherlands; email: bob.thoolen@gpstoxpath.com",,,,,,,,01926233,,TOPAD,21191096,"English","Toxicol. Pathol.",Article,Scopus,2-s2.0-79751488721
"Soffritti, M., Belpoggi, F., Manservigi, M., Tibaldi, E., Lauriola, M., Falcioni, L., Bua, L.","Aspartame administered in feed, beginning prenatally through life span, induces cancers of the liver and lung in male Swiss mice",2010,"American Journal of Industrial Medicine","53","12",,"1197","1206",,29,10.1002/ajim.20896,"http://www.scopus.com/inward/record.url?eid=2-s2.0-78649538952&partnerID=40&md5=d41c2e018125a88329a55969c14d99a6","Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bentivoglio, Bologna, Italy","Soffritti, M., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bentivoglio, Bologna, Italy; Belpoggi, F., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bentivoglio, Bologna, Italy; Manservigi, M., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bentivoglio, Bologna, Italy; Tibaldi, E., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bentivoglio, Bologna, Italy; Lauriola, M., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bentivoglio, Bologna, Italy; Falcioni, L., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bentivoglio, Bologna, Italy; Bua, L., Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bentivoglio, Bologna, Italy","Aspartame (APM) is a well-known intense artificial sweetener used in more than 6,000 products. Among the major users of aspartame are children and women of childbearing age. In previous lifespan experiments conducted on Sprague-Dawley rats we have shown that APM is a carcinogenic agent in multiple sites and that its effects are increased when exposure starts from prenatal life.Objective: The aim of this study is to evaluate the potential of APM to induce carcinogenic effects in mice.Methods: Six groups of 62-122 male and female Swiss mice were treated with APM in feed at doses of 32,000, 16,000, 8,000, 2,000, or 0 ppm from prenatal life (12 days of gestation) until death. At death each animal underwent complete necropsy and all tissues and organs of all animals in the experiment were microscopically examined.Results: APM in our experimental conditions induces in males a significant dose-related increased incidence of hepatocellular carcinomas (P < 0.01), and a significant increase at the dose levels of 32,000 ppm (P < 0.01) and 16,000 ppm (P < 0.05). Moreover, the results show a significant dose-related increased incidence of alveolar/bronchiolar carcinomas in males (P < 0.05), and a significant increase at 32,000 ppm (P < 0.05).Conclusions: The results of the present study confirm that APM is a carcinogenic agent in multiple sites in rodents, and that this effect is induced in two species, rats (males and females) and mice (males). No carcinogenic effects were observed in female mice. © 2010 Wiley-Liss, Inc.","Artificial sweeteners; Aspartame; Cancers; Carcinogenicity; Hepatocarcinomas; Lung adenocarcinomas; Prenatal exposure; Rats; Swiss mice","aspartame; carcinogen; sweetening agent; age; animal; animal disease; article; catering service; female; liver tumor; lung tumor; male; mouse; pathology; pregnancy; prenatal exposure; proportional hazards model; randomization; rat; Sprague Dawley rat; time; Age Factors; Animals; Aspartame; Carcinogens; Female; Food Supply; Liver Neoplasms; Lung Neoplasms; Male; Mice; Pregnancy; Prenatal Exposure Delayed Effects; Proportional Hazards Models; Random Allocation; Rats; Rats, Sprague-Dawley; Sweetening Agents; Time Factors",,"aspartame, 22839-47-0, 5910-52-1; Aspartame, 22839-47-0; Carcinogens; Sweetening Agents",,,,"Butchko, H.H., Stargel, W.W., Comer, C.P., Mayhew, D.A., Benninger, C., Blackburn, G.L., de Sonneville, L.M.J., Trefz, F.K., Intake of aspartame vs the acceptable daily intake (2002) Regul Toxicol Pharmacol, 35, pp. S13-S16; Attuazione della direttiva n. 86/609/CEE in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici [in Italian] (1992) Suppl Ordinario Gazz Ufficiale, 40, pp. 5-25. , Decreto Legislativo 116; Dixon, D., Herbert, R.A., Kissling, G.E., Brix, A.E., Miller, R.A., Maronpot, R.R., Summary of chemically induced pulmonary lesions in the National Toxicology Program (NTP) toxicology and carcinogenesis studies (2008) Toxicol Pathol, 36, pp. 428-439; Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in contact with Food (AFC) on a request from the Commission related to a new long-term carcinogenicity study on aspartame. Question number EFSA-Q-2005-122. Adopted on 3 May 2006 (2006) EFSA J, 356, pp. 1-44. , European Food Safety Authority (EFSA); Aspartame: Commissioner's final decision (1981) Fed Reg, 46, pp. 38285-38308. , Food and Drug Administration (FDA); Food additives permitted for direct addition to food for human consumption: Aspartame (1983) Fed Reg, 48, pp. 31376-31382. , Food and Drug Administration (FDA); Food additives permitted for direct addition to food for human consumption: Aspartame (1996) Fed Reg, 61, pp. 33654-33656. , Food and Drug Administration (FDA); Frith, C.H., Kodell, R.L., Littlefield, N.A., Innovations in cancer risk assessment (ED01 study) (1979) Biologic and morphologic characteristics of hepatocellular lesions in BALB/c female mice fed 2-acetylaminofluorene, pp. 121-138. , In, Staffa JA, Mehlman MA, editors., Park Forest South, IL, Pathotox Publishers, Inc., p; Hahn, F.F., Gigliotti, A., Hutt, J.A., Comparative oncology of lung tumors (2007) Toxicol Pathol, 35, pp. 130-135; Haschemeyer, R.H., Haschemeyer, A.E.V., Proteins (1973), pp. 11-30. , New York, John Wiley & Sons, pHaseman, J., Value of historical controls in the interpretation of rodent neoplasm data (1992) Drug Inf J, 26, pp. 191-200; Haseman, J., Data analysis: Statistical analysis and use of historical control data (1995) Regul Toxicol Pharmacol, 21, pp. 52-59; Haseman, J., Huff, J.E., Boorman, G.A., Use of historical control data in carcinogenicity studies in rodents (1984) Toxicol Pathol, 12, pp. 126-135; Haseman, J., Melnick, R., Tomatis, L., Huff, J., Carcinogenesis bioassays: Study duration and biological relevance (2001) Food Chem Toxicol, 39 (7), pp. 739-744; (2005), Hazardous Substances Data Bank., TOXNET: Toxicological Data Network. Available: [accessed August 3, 2005]Huff, J., Chemicals studied and evaluated in long-term carcinogenesis bioassays by both the Ramazzini Foundation and the National Toxicology Program. In tribute to Cesare Maltoni and David Rall (2002) Ann N Y Acad Sci, 982, pp. 208-230; Huff, J., Absence of carcinogenic activity in Fischer rats and B6C3F1 mice following 103-week inhalation exposures to toluene (2003) Int J Occup Environ Health, 9 (2), pp. 138-146; Huff, J., Jacobson, M.F., Davis, D.L., The limits of two-year bioassay exposure regimens for identifying chemical carcinogens (2008) Environ Health Perspect, 116 (11), pp. 1439-1442; Huff, J., Hejtmancik, M., Eastin, W., Carcinogenic activity of industrial grade mixed xylenes (2010) Environ Health Perspect, , (in press); Transplacental induction of tumors and malformations in rats treated with some chemical carcinogens (1973) IARC Sci Publ, 4, pp. 100-111. , International Agency for Research on Cancer (IARC); Maltoni, C., Ciliberti, A., Pinto, C., Soffritti, M., Belpoggi, F., Menarini, L., Results of long-term experimental carcinogenicity studies of the effects of gasoline, correlated fuels and major gasoline aromatics on rats (1997) Ann N Y Acad Sci, 837, pp. 15-52; Maronpot, R.R., Biological basis of differential susceptibility to hepatocarcinogenesis among mouse strains (2009) J Toxicol Pathol, 22, pp. 11-33; Mattews, D.M., Aspartame physiology and biochemistry (1984) Absorption of peptides, amino acids, and their methylated derivatives, pp. 29-46. , In, Stegink LD, Filer LJ, Jr., editors., New York, Dekker, p; Mazur, R.H., Aspartame physiology and biochemistry (1984) Discovery of aspartame, pp. 3-9. , In, Stegink LD, Filer LJ, Jr., editors., New York, Dekker, p; Metzler, D.E., Biochemistry (1977), pp. 90-107. , New York, Academic Press, pMolinary, S.V., Aspartame physiology and biochemistry (1984) Preclinical studies of aspartame in nonprimate animals, pp. 289-306. , In, Stegink LD, Filer LJ, Jr., editors., New York, Dekker, p; (2005), National Toxicology Program (NTP)., Genetically Modified Model Report. Toxicology Studies of Aspartame (CAS NO. 22839-47-0) in Genetically Modified (FVB Tg.AC Hemizygous) and B6.129-Cdkn2atm1Rdp (N2) Deficient Mice and Carcinogenicity Studies of Aspartame in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Feed Studies). NTP GMM1. National Toxicology Program, Research Triangle Park. Available at: Olney, J.W., Farber, N.B., Spitznagel, E., Robins, L.N., Increasing brain tumor rates: Is there a link to aspartame? (1996) J Neuropathol Exp Neurol, 55, pp. 1115-1123; Pritchard, J.B., French, J.E., Davis, B.J., Haserman, J.K., The role of transgenic mouse models in carcinogen identification (2003) Environ Health Perspect, 111, pp. 444-454; Ranney, R.E., Opperman, J.A., Maldoon, E., McMahon, F.G., Comparative metabolism of aspartame in experimental animals and humans (1976) J Toxicol Environ Health, 2, pp. 441-451; Soffritti, M., Belpoggi, F., Minardi, F., Bua, L., Maltoni, C., Mega-experiments to identify and assess diffuse carcinogenic risks (1999) Ann N Y Acad Sci, 895, pp. 34-55; Soffritti, M., Belpoggi, F., Minardi, F., Maltoni, C., Ramazzini Foundation cancer program: History and major projects, life-span carcinogenicity bioassay design, chemicals studied, and results (2002) Ann N Y Acad Sci, 982, pp. 26-45; Soffritti, M., Belpoggi, F., Padovani, M., Lauriola, M., Degli Esposti, D., Minardi, F., Life-time carcinogenicity bioassays of toluene given bay stomach tube to Sprague-Dawley rats (2004) Eur J Oncol, 9, pp. 91-102; Soffritti, M., Belpoggi, F., Degli Esposti, D., Lambertini, L., Aspartame induces lymphomas and leukaemias in rats (2005) Eur J Oncol, 10, pp. 107-116; Soffritti, M., Belpoggi, F., Degli Esposti, D., Lambertini, L., Tibaldi, E., Rigano, A., First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats (2006) Environ Health Perspect, 114, pp. 379-385; Soffritti, M., Belpoggi, F., Tibaldi, E., Esposti, D.D., Lauriola, M., Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats (2007) Environ Health Perspect, 115, pp. 1293-1297; Soffritti, M., Belpoggi, F., Esposti, D.D., Falcioni, L., Bua, L., Consequences of exposure to carcinogens beginning during developmental life (2008) Basic Clin Pharmacol Toxicol, 102 (2), pp. 118-124; Trocho, C., Pardo, R., Rafecas, I., Virgili, J., Remesar, X., Fernandez-Lopez, J.A., Alemany, M., Formaldehyde derived from dietary aspartame binds to tissue components in vivo (1998) Life Sci, 63, pp. 337-349","Soffritti, M.; Cesare Maltoni Cancer Research Center, Ramazzini Institute, Bentivoglio, Bologna, Italy; email: soffrittim@ramazzini.it",,,,,,,,02713586,,AJIMD,20886530,"English","Am. J. Ind. Med.",Article,Scopus,2-s2.0-78649538952
"Belpoggi, F., Virzì, S., Iusco, D., Balbi, T., Pierini, G., Tibaldi, E., Bua, L.","Peritoneal mesothelioma in an insulation worker exposed to asbestos [Mesotelioma peritoneale da amianto in operaio addetto al montaggio di pannelli isolanti]",2010,"European Journal of Oncology","15","1",,"43","49",,,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-77955614918&partnerID=40&md5=65d7f9822a59df399dd483a41e85a720","Centro di Ricerca Sul Cancro Cesare Maltoni, Istituto Ramazzini, Castello di Bentivoglio, Via saliceto 3, 40010 Bentivoglio (BO), Italy; Unità Operativa di Chirurgia Generale, Ospedale di Bentivoglio, Bentivoglio, Bologna, Italy; Istituto di Anatomia Patologica, Policlinico Sant'Orsola Malpighi, Bologna, Italy; Istituto di Medicina Legale, Università di Bologna, Bologna, Italy","Belpoggi, F., Centro di Ricerca Sul Cancro Cesare Maltoni, Istituto Ramazzini, Castello di Bentivoglio, Via saliceto 3, 40010 Bentivoglio (BO), Italy; Virzì, S., Unità Operativa di Chirurgia Generale, Ospedale di Bentivoglio, Bentivoglio, Bologna, Italy; Iusco, D., Unità Operativa di Chirurgia Generale, Ospedale di Bentivoglio, Bentivoglio, Bologna, Italy; Balbi, T., Istituto di Anatomia Patologica, Policlinico Sant'Orsola Malpighi, Bologna, Italy; Pierini, G., Istituto di Medicina Legale, Università di Bologna, Bologna, Italy; Tibaldi, E., Centro di Ricerca Sul Cancro Cesare Maltoni, Istituto Ramazzini, Castello di Bentivoglio, Via saliceto 3, 40010 Bentivoglio (BO), Italy; Bua, L., Centro di Ricerca Sul Cancro Cesare Maltoni, Istituto Ramazzini, Castello di Bentivoglio, Via saliceto 3, 40010 Bentivoglio (BO), Italy","This report refers to a case of peritoneal mesothelioma arising in an insulation worker. The latency time, i.e. the period elapsing between the start of exposure and the onset of the early symptoms and signs of the neoplasia, was 52 years. This is the first case of a series of 7 cases which underwent to our observation through the Surgery Unit of the Bentivoglio Hospital, Bologna, Italy, where they were treated with cytoreductive surgery and intraoperative chemohyperthermia (HIPEC). Scanning electron microscopy photographs of the neoplastic tissue confirm the correlation of the neoplasia with the exposure to asbestos, through the observation of spheric and fibrous matter in the neoplasia, probably chrysotile.","Chemohyperthermia; Cytoreductive surgery; Insulator; Mesothelioma; Scanning electron microscopy","asbestos; chrysotile; cisplatin; doxorubicin; anamnesis; article; cytoreductive surgery; human; hyperthermic therapy; industrial worker; occupational exposure; peritoneum mesothelioma; scanning electron microscopy",,"asbestos, 1332-21-4; chrysotile, 12001-29-5; cisplatin, 15663-27-1, 26035-31-4, 96081-74-2; doxorubicin, 23214-92-8, 25316-40-9",,,,"Survival Rates for Mesothelioma 2009, , http://www.cancer.org/docroot/CRI/content/ CRI_2_2_3X_Survival_rates_for_meosothelioma_29.asp?sitearea, Available at; Peto, J., Decarli, A., La Vecchia, C., The European mesothelioma epidemic (1999) Br J Can, 79 (3-4), pp. 666-672; (2006) Dipartimento di Medicina del Lavoro: II Rapporto Re.Na.M., , http://www.ispesl.it/renam/Report.asp, Available at; Marinaccio, A., Montanaro, F., Mastrantonio, M., Uccelli, R., Altavista, P., Nesti, M., Costantini, A.S., Gorini, G., Predictions of mortality from pleural mesothelioma in Italy: A model based on asbestos consumption figures supports results from age-period-cohort models (2005) International Journal of Cancer, 115 (1), pp. 142-147. , DOI 10.1002/ijc.20820; Dodson, R.F., O'Sullivan, M.F., Brooks, D.R., Asbestos content of omentum and mesentery in nonoccupationally exposed individuals (2001) Toxicol Ind Health, 17, pp. 138-143; Sugarbaker, P.H., Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: The Washington Cancer Institute approach (2009) Expert Opin Pharmacother, 10 (12), pp. 1965-1977; Virzì, S., Iusco, D., Bonomi, S., Chirurgia citoriduttiva e chemioipertermia: Un valido trattamento per la carcinosi peritoneale (2010) Eur J Oncol, 15 (1), pp. 33-41; Selikoff, I.J., Seidman, H., Asbestos-associated deaths among insulation workers in the United States, and Canada, 1967-1987 (1991) Ann NY Acad Sci, 643, pp. 1-14; Benciolini, P., La comunicazione tra gli operatori sanitari Dialoghi di bioetica e biodiritto 21 settembre 2007 (2009) Punto Omega 2, Provincia Autonoma di Trento; Carter, H.W., Clinical applications of the scanning electron microscope (SEM) in North America with emphasis on SEM's role in comparative microscopy (1980) Scan Electron Microsc, 3, pp. 115-120; Laschi, R., Pasquinelli, G., Versura, P., Scanning electron microscopy application in clinical research (1987) Scanning Microscopy, 1 (4), pp. 1771-1795; Pierini, G., Degli Esposti, P., Balbi, T., (2009) Forensic Pathology by Scanning Electron Microscopy, , CLUEB Bologna","Belpoggi, F.; Centro di Ricerca Sul Cancro Cesare Maltoni, Istituto Ramazzini, Castello di Bentivoglio, Via saliceto 3, 40010 Bentivoglio (BO), Italy; email: belpoggif@ramazzini.it",,,,,,,,11286598,,EJOUA,,"Italian","Eur. J. Oncol.",Article,Scopus,2-s2.0-77955614918
"Soffritti, M., Chiozzotto, D., Belpoggi, F.","[The role of scientific research in the identification of occupational carcinogenic agents: the contribution of the Cesare Maltoni Cancer research center of the European Ramazzini Foundation]. [Il ruolo della ricerca scientifica per l'identificazione degli agenti cancerogeni professionali: il contributo del Centro di ricerca sul cancro Cesare Maltoni della Fondazione europea Ramazzini.]",2009,"Epidemiologia e prevenzione","33","4-5 Suppl 2",,"57","67",,,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-78049427255&partnerID=40&md5=eb4508763903afd417200c9b93b20c84","Centro di ricerca sul cancro Cesare Maltoni, Fondazione europea di oncologia e scienze ambientali, Bologna, Italia.","Soffritti, M., Centro di ricerca sul cancro Cesare Maltoni, Fondazione europea di oncologia e scienze ambientali, Bologna, Italia.; Chiozzotto, D.; Belpoggi, F.","Nowadays tumours represent one of the major problems of public health, both for their epidemiological dimension as for the causes that are at their origin, represented by three important factors: people ageing, general and occupational environmental pollution, including incongruous individual behaviour, and individual genetic susceptibility. The strategies followed till today in order to check tumours have privileged the role of therapeutic interventions: the results achieved show the great limits. On the contrary, current scientific experiences indicate the need to re-orientate present strategies, developing prevention programmes for the identification of carcinogenic risks (primary prevention), and early diagnosis of preneoplastic and neoplastic lesions (secondary prevention). In this review we discuss the importance of primary prevention in tumour control and specifically we present: - the role of long-term carcinogenic bioassays on rodents (rats and mice) in order to identify and predict the carcinogenic risks and then the great value that these studies have for public health; - the two major programmes of carcinogenic bioassays: the National Toxicological Program (NTP) of the US government, and the one performed by the European Ramazzini Foundation (ERF), in Italy; - the importance of observing the experimental animals until spontaneous death in order to improve the sensitivity and specificity of the assays, a way of working followed by ERF from the beginning.",,"carcinogen; animal; bioassay; Europe; human; Italy; mortality; mouse; neoplasm; non profit organization; occupational disease; primary prevention; public health; rat; review; secondary prevention; Sprague Dawley rat; United States; Animals; Biological Assay; Carcinogens; Europe; Foundations; Humans; Italy; Mice; Neoplasms; Occupational Diseases; Primary Prevention; Public Health; Rats; Rats, Sprague-Dawley; Secondary Prevention; United States",,"Carcinogens",,,,,"Soffritti, M.email: crcdir@ramazzini.it",,,,,,,,11209763,,,20124643,"Italian","Epidemiol Prev",Review,Scopus,2-s2.0-78049427255
"Brandi, G., Di Girolamo, S., Belpoggi, F., Grazi, G., Ercolani, G., Biasco, G.","Asbestos exposure in patients affected by bile duct tumours [Esposizione all'amianto in pazienti affetti da neoplasie delle vie biliari]",2008,"European Journal of Oncology","13","3",,"171","179",,2,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-55549114370&partnerID=40&md5=1572e6e6fe00cadcdaf5abf94127bf1a","Istituto di Ematologia ed Oncologia Medica L. e A. Seràgnoli, Università di Bologna, Bologna, Italy; Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Bologna, Italy; U.O. Chirurgia dei Trapianti di Fegato e Multiorgano, Università di Bologna, Bologna, Italy; Dipartimento di Ematologia, Oncologia Medica e Microbiologia, Polichnico S. Orsola, Via Massarenti 9, 40138 Bologna, Italy","Brandi, G., Istituto di Ematologia ed Oncologia Medica L. e A. Seràgnoli, Università di Bologna, Bologna, Italy, Dipartimento di Ematologia, Oncologia Medica e Microbiologia, Polichnico S. Orsola, Via Massarenti 9, 40138 Bologna, Italy; Di Girolamo, S., Istituto di Ematologia ed Oncologia Medica L. e A. Seràgnoli, Università di Bologna, Bologna, Italy; Belpoggi, F., Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Bologna, Italy; Grazi, G., U.O. Chirurgia dei Trapianti di Fegato e Multiorgano, Università di Bologna, Bologna, Italy; Ercolani, G., U.O. Chirurgia dei Trapianti di Fegato e Multiorgano, Università di Bologna, Bologna, Italy; Biasco, G., Istituto di Ematologia ed Oncologia Medica L. e A. Seràgnoli, Università di Bologna, Bologna, Italy","Aims. Exposure to asbestos represents an important risk factor for the onset of pleural and peritoneal mesothelioma. An association with gastrointestinal and bile duct adenocarcinoma may also be possible. Patients and methods. In 2007, 55 patients with bile duct neoplasm who were admitted to our centre were investigated extensively about their exposure to known risk factors for their pathology and about exposure to asbestos. For each patient their medical history, their past, recent and current pathology was collected in detail. Information on the workplace and characteristics of their working environment, job description, use and frequency of direct and indirect exposure to asbestos, sources of non-occupational exposure, residential and daily life background was collected. Exposure to asbestos is considered significant only in cases where the latency period is equal to or longer than ten years. Results. From the medical history of the 55 cases, it emerged that 18 had been exposed to asbestos. In 3 cases the patients had been exposed by inhalation in a workplace setting, while in the other 15 cases an exposure linked to a presumable ingestion of asbestos fibres contained in the water collected in domestic asbestos-cement water tanks was postulated. Conclusions. A weak association between tumours of the bile ducts and exposure to asbestos has already been postulated in the past on the basis of studies conducted on cohorts of workers exposed to asbestos. Our analysis also indicates a possible association between exposure to asbestos and neoplasms of the biliary ducts.","Asbestos; Bile ducts; Tumours","asbestos; anamnesis; bile duct tumor; gastrointestinal carcinoma; human; latent period; peritoneum mesothelioma; pleura mesothelioma; review; risk factor; water contamination; work environment; workplace",,"asbestos, 1332-21-4",,,,"Cooke, W.E., Fibrosis of the lungs due to the inalation of asbestos dust (1924) Br Med J, 2, p. 147; Ministry of Labour and National Service, Cmnd 7621. His Majesty is Stationery Office (1949) Annual Report of the Chief Inspector of Factories for the Year 1947, , London; Albin, M., Magnani, C., Krstev, S., Asbestos and cancer: An overview of current trends in Europe (1999) Environ Health Perspect, 107, pp. 289-298; Mossman, B.T., Churg, A., Mechanism in the patogenesis of asbestosis and silicosis (1998) Am J Respir Crit Care Med, 157, pp. 1666-1680; Robledo, R., Mossman, B.T., Cellular and molecular mechanism of asbestos-induced fibrosis (1999) J Cell Physiol, 180, pp. 158-166; Manning, C.B., Vallyathan, V., Mossman, B.T., Disease caused by asbestos: Mechanism of injury and disease development (2002) Int Immunopharmacol, 2, pp. 191-200; Gamble, J.F., Asbestos and colon cancer: A weight of evidence review (1994) Environ Health Perspect, 102, pp. 1038-1050; Selikoff, I.J., Seidman, H., Asbestos-associated deaths among insulation workers in the USA and Canada, 1967-1987 (1991) Ann NY Acad Sci, 643, pp. 416-418; Puntoni, R., Vercelli, M., Merlo, F., Mortality among shipyard workers in Genoa, Italy (1979) Ann NY Acad Sci, 330, pp. 353-377; Hilt, B., Langard, S., Andersen, A., Asbestos exposure, smoking habits, and cancer incidence among production and maintenance workers in an electrochemical plant (1985) Am J Ind Med, 8, pp. 565-577; Zoloth, S., Michaes, D., Asbestos disease in sheet metal workers: The result of a proportional mortality analysis (1985) Am J Ind Med, 7, pp. 315-321; Seidman, H., Selikoff, I.J., Gelb, S.K., Mortality experience of amosite asbestos factory workers: Dose-response relationships 5 to 40 years after onset of short-term work exposure (1986) Am J Ind Med, 10, pp. 479-514; Raffin, E., Villadsen, E., Lynge, E., Colorectal cancer in asbestos cement workers in Denmark (1996) Am J Ind Med, 30, pp. 267-272; Szeszenia-Dabrowska, N., Wilczynska, U., Szymczak, W., Environmental exposure to asbestos from indiscriminate use of industrial wastes (1998) Int J Occup Med Environ Health, 11, pp. 171-177; Homa, D.M., Garabrant, D.H., Gillespie, B.W., A meta-analysis of colorectal cancer and asbestos exposure (1994) Am J Epidemiol, 139, pp. 1210-1222; Ehrlich, A., Rohl, A.N., Holstein, E.C., Asbestos bodies in carcinoma of colon in an insulation worker with asbestosis (1985) JAMA, 254, pp. 2932-2933; Ehrlich, A., Gordon, R.E., Dickman, S.H., Carcinoma of colon in asbestos-exposed workers: Analysis of asbestos content in colon tissue meta-analysis (1991) Am J Ind Med, 19, pp. 629-636; Szendroi, M., Nemeth, L., Vajta, G., Asbestos bodies in a bile duct cancer after occupational exposure (1983) Environ Res, 30 (2), pp. 270-280; Miserocchi, G., Sancini, G., Mantegazza, F., Translocation pathways for inhaled asbestos fibers (2008) Environ Health, 7, p. 4; Malker, H.S., Mc Laughlin, J.K., Malker, B.K., Biliary tract cancer and occupation in Sweden (1986) Br J Ind Med, 43 (4), pp. 257-262; Andersson, E., Hagberg, S., Nilsson, T., A case-referent study of cancer mortality among sulfate mill workers in Sweden (2001) Occup Environ Med, 58, pp. 321-324; Wingren, G., Mortality and cancer incidence in a Sweden art glassworks - an updated cohort study (2004) Int Arch Occup Environ Health, 77, pp. 599-603; Donham, K.J., Berg, J.W., Will, L.A., The effects of long-term ingestion of asbestos on the colon of F344 rats (1980) Cancer, 45 (5), pp. 1073-1084; Cantor, K.P., Drinking water and cancer (1997) Cancer Causes Control, 8, pp. 292-308; Mason, T.J., Mc Kay, F.W., Miller, R.W., Asbestos-like fibers in Duluth water supply (1974) JAMA, 228, pp. 1019-1020; Levy, B.S., Sigurdson, E., Mandel, J., Investigating possible effecs of asbestos in city water: Surveillance of gastrointestinal cancer incidence in Duluth, Minnesota (1976) Am J Epidemiol, 103, pp. 362-368; Sigurdson, E.E., Levy, B.S., Mandel, J., Cancer morbidity investigations. Lessons from the Duluth study of possible effects of asbestos in drinking water (1981) Environ Res, 25, pp. 50-61; Wigle, D.T., Cancer mortality in relation to asbestos in municipal water supplies (1977) Arch Environ Health, 32, pp. 185-190; Kanarek, M.S., Conforti, M.P., Jackson, L.A., Asbestos in drinking water and cancer incidence in the San Francisco bay area (1980) Am J Epidemiol, 112, pp. 54-72; Andersen, A., Glattre, E., Johansen, B.V., Incidence of cancer among lighthouse keepers exposed to asbestos in drinking water (1993) Am J Epidemiol, 138, pp. 682-687; Kjaerheim, K., Ulvestad, B., Martinsen, J.I., Cancer of the gastrointestinal tract and exposure to asbestos in drinking water among lighthouse keepers (Norway) (2005) Cancer Causes Control, 16, pp. 593-598; Aliyu, O.A., Cullen, M.R., Barnett, M.J., Evidence for excess colorectal cancer incidence among asbestos-exposed men in Beta-Carotene and Retinol Efficacy Trial (2005) Am J Epidemiol, 162, pp. 868-878","Brandi, G.; Dipartimento di Ematologia, Oncologia Medica e Microbiologia, Polichnico S. Orsola, Via Massarenti 9, 40138 Bologna, Italy; email: giovanni.brandi@unibo.it",,,,,,,,11286598,,EJOUA,,"Italian","Eur. J. Oncol.",Review,Scopus,2-s2.0-55549114370
"Soffritti, M., Belpoggi, F., Esposti, D.D., Falcioni, L., Bua, L.","Consequences of exposure to carcinogens beginning during developmental life",2008,"Basic and Clinical Pharmacology and Toxicology","102","2",,"118","124",,18,10.1111/j.1742-7843.2007.00200.x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-38449110761&partnerID=40&md5=c2fab9785dd1e19547ad76cffc76efe6","Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy; Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Castello di Bentivoglio, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy","Soffritti, M., Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy, Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Castello di Bentivoglio, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy; Belpoggi, F., Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy; Esposti, D.D., Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy; Falcioni, L., Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy; Bua, L., Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy","The increased incidence of cancer over the last 50-60 years may be largely attributed to two factors: the ageing of the population and the diffusion of agents and situations presenting carcinogenic risks. Today, we have entered into a new era in which populations are ever-increasingly exposed to diffuse carcinogenic risks, present not only in the occupational, but also in the general environment. We must now also consider an additional factor in the carcinogenic process, that is, the age in which exposure to carcinogenic risks begins. Apart from the paradigmatic cases of diethylstilboestrol and ionizing radiation, the available epidemiological data concerning the adult consequences of developmental exposure to carcinogens is very limited. However, important data have been provided by long-term experimental carcinogenicity bioassays conducted using rodents. This paper reports a selection of studies conducted in the laboratories of the Cesare Maltoni Cancer Research Center of the European Ramazzini Foundation in which exposure to the chemical agents vinyl acetate monomer, ethyl alcohol and aspartame was started during developmental life and continued into adulthood. The results of these studies provide supporting evidence that lifespan exposure to carcinogenic agents beginning during developmental life produces an overall increase in the carcinogenic effects observed. Moreover, when comparing prenatal and postnatal exposure, the data demonstrate that the development of cancers may appear earlier in life. © 2008 The Authors.",,"alcohol; aspartame; vinyl acetate; cancer research; cancer risk; carcinogenicity; chemical carcinogenesis; clinical feature; conference paper; developmental stage; disease exacerbation; embryotoxicity; fetus development; human; ionizing radiation; lifespan; long term exposure; nonhuman; occupational carcinogenesis; perinatal period; prenatal exposure; priority journal; radiation carcinogenesis; risk assessment; Animals; Aspartame; Carcinogens; Environmental Exposure; Ethanol; Female; Humans; Maternal-Fetal Exchange; Pregnancy; Prenatal Exposure Delayed Effects; Sweetening Agents; Vinyl Compounds; Rodentia",,"alcohol, 64-17-5; aspartame, 22839-47-0, 5910-52-1; vinyl acetate, 108-05-4; Aspartame, 22839-47-0; Carcinogens; Ethanol, 64-17-5; Sweetening Agents; vinyl acetate, 108-05-4; Vinyl Compounds",,,,"http://www.cancer.org, American Cancer Society. Cancer Statistics 2006. Available from:. Accessed 28 May 2007Soffritti, M., Vrahulaki, C., Belpoggi, F., Resoconti del Registro Tumori di Bologna e Provincia 1982-2002, , Eur J Oncol. in press; Soffritti, M., Belpoggi, F., Minardi, F., Bua, L., Maltoni, C., Megaexperiments to identify and assess diffuse carcinogenic risks (1999) Ann N Y Acad Sci, 895, pp. 34-55; (1995) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Wood Dust and Formaldehyde, , International Agency for Research on Cancer. vol. 62. IARC, Lyon, France; Minardi, F., Belpoggi, F., Soffritti, M., Results of long-term carcinogenicity bioassay on vinyl acetate monomer in Sprague-Dawley rats (2002) Ann N Y Acad Sci, 982, pp. 106-22; Belpoggi, F., Soffritti, M., Minardi, F., Results of a long-term carcinogenicity bioassay on vinyl acetate monomer in Wistar rats (2002) Eur J Oncol, 7, pp. 279-93; Maltoni, C., Ciliberti, A., Lefemine, G., Soffritti, M., Results of a long-term experimental study on the carcinogenicity of vinyl acetate monomer in mice (1997) Ann N Y Acad Sci, 837, pp. 209-38; (1998) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Alcohol Drinking, , International Agency for Research on Cancer. vol. 44. IARC, Lyon, France; Soffritti, M., Belpoggi, F., Cevolani, D., Guarino, M., Padovani, M., Maltoni, C., Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats (2002) Ann N Y Acad Sci, 982, pp. 46-69; Soffritti, M., Belpoggi, F., Degli Esposti, D., Lambertini, L., Aspartame induces lymphomas and leukaemias in rats (2005) Eur J Oncol, 10, pp. 107-16; Belpoggi, F., Soffritti, M., Padovani, M., Degli Esposti, D., Lauriola, M., Minardi, F., Results of long term carcinogenicity bioassay on Sprague-Dawley rats exposed to aspartame administered in feed (2006) Ann N Y Acad Sci, 1076, pp. 559-77; Soffritti, M., Belpoggi, F., Degli Esposti, D., Lambertini, L., Tibaldi, E., Rigano, A., First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley Rats (2006) Environ Health Perspect, 114, pp. 379-85; Soffritti, M., Belpoggi, F., Degli Esposti, D., Tibaldi, E., Lauriola, M., Lifespan exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats (2007) Environ Health Perspect, 115, pp. 1293-7; Owen, W.G., Diffuse mesothelioma and exposure to asbestos dust in the merseyside area (1964) Br Med J, 2, pp. 214-8","Soffritti, M.; Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Castello di Bentivoglio, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy; email: crcfr@ramazzini.it",,,,,,,,17427835,,BCPTB,18226064,"English","Basic Clin. Pharmacol. Toxicol.",Conference Paper,Scopus,2-s2.0-38449110761
"Soffritti, M., Belpoggi, F., Tibaldi, E., Esposti, D.D., Lauriola, M.","Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats",2007,"Environmental Health Perspectives","115","9",,"1293","1297",,64,10.1289/ehp.10271,"http://www.scopus.com/inward/record.url?eid=2-s2.0-34748884376&partnerID=40&md5=56bb900b540380e92e2beaa545b88c02","Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy","Soffritti, M., Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy; Belpoggi, F., Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy; Tibaldi, E., Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy; Esposti, D.D., Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy; Lauriola, M., Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy","Background: In a previous study conducted at the Cesare Maltoni Cancer Research Center of the European Ramazzini Foundation (CMCRC/ERF), we demonstrated for the first time that aspartame (APM) is a multipotent carcinogenic agent when various doses are administered with feed to Sprague-Dawley rats from 8 weeks of age throughout the life span. Objective: The aim of this second study is to better quantify the carcinogenic risk of APM, beginning treatment during fetal life. Methods: We studied groups of 70-95 male and female Sprague-Dawley rats administered APM (2,000, 400, or 0 ppm) with feed from the 12th day of fetal life until natural death. Results: Our results show a) a significant dose-related increase of malignant tumor-bearing animals in males (p < 0.01), particularly in the group treated with 2,000 ppm APM (p < 0.01); b) a significant increase in incidence of lymphomas/leukemias in males treated with 2,000 ppm (p < 0.05) and a significant dose-related increase in incidence of lymphomas/leukemias in females (p < 0.01), particularly in the 2,000-ppm group (p < 0.01); and c) a significant dose-related increase in incidence of mammary cancer in females (p < 0.05), particularly in the 2,000-ppm group (p < 0.05). Conclusions: The results of this carcinogenicity bioassay confirm and reinforce the first experimental demonstration of APM's multipotential carcinogenicity at a dose level close to the acceptable daily intake for humans. Furthermore, the study demonstrates that when life-span exposure to APM begins during fetal life, its carcinogenic effects are increased.","Artificial sweeteners; Aspartame; Carcinogenicity; Lymphomas/leukemias; Mammary cancers; Prenatal exposure; Sprague-Dawley","aspartame; animal experiment; animal model; animal tissue; article; breast cancer; cancer; cancer incidence; cancer risk; carcinogenicity; concentration (parameters); controlled study; female; leukemia; lifespan; lymphoma; male; nonhuman; prenatal exposure; priority journal; rat; risk assessment; sex difference; Animals; Aspartame; Carcinogens; Carcinoma; Female; Leukemia; Lymphoma; Male; Neoplasms; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Sweetening Agents; Toxicity Tests, Chronic; Animalia; Rattus",,"aspartame, 22839-47-0, 5910-52-1; Aspartame, 22839-47-0; Carcinogens; Sweetening Agents",,,,"Position of the American Dietetic Association: Use of nutritive and nonnutritive sweeteners (2004) J Am Diet Assoc, 104, pp. 225-275. , American Dietetic Association; (2005) Aspartame Information Center Homepage, , http://www.aspartame.org, Aspartame Information Center, Available:, accessed 27 October; Belpoggi, F., Soffritti, M., Bua, L., Guarino, M., Lambertini, L., Cevolani, D., Results of long-term experimental studies on the carcinogenicity of ethylene-bis-dithiocarbamate (Mancozeb) in rats (2002) Ann NY Acad Sci, 982, pp. 123-136; Belpoggi, F., Soffritti, M., Maltoni, C., Methyl-tertiary-butyl ether (MTBE), a gasoline additive, causes testicular and lymphohaematopoietic cancers in rats (1995) Toxicol Ind Health, 11, pp. 119-149; Belpoggi, F., Soffritti, M., Minardi, F., Bua, L., Cattin, E., Maltoni, C., Results of long-term carcinogenicity bioassays on tert-amyl-methyl-ether (TAME) and di-isopropyl-ether (DIPE) in rats (2002) Ann NY Acad Sci, 982, pp. 70-86; Belpoggi, F., Soffritti, M., Padovani, M., Degli Esposti, D., Lauriola, M., Minardi, F., Results of long-term carcinogenicity bioassay on Sprague-Dawley rats exposed to aspartame administered in feed (2006) Ann NY Acad Sci, 1076, pp. 559-577; Butchko, H.H., Stargel, W.W., Comer, C.P., Mayhew, D.A., Benninger, C., Blackburn, G.L., Intake of aspartame vs. the acceptable daily intake (2002) Regul Toxicol Pharmacol, 35, pp. S13-S16; Cox, DR., Regression models and life tables (1972) J Roy Stat Soc Ser B, 34, pp. 187-220; Decreto Legislativo 116. 1992. Attuazione della direttiva n. 86/609/CEE in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici [in Italian]. Supplemento ordinario alla Gazzetta Ufficiale 40:5-25EC Directive 35. 1994. Directive 94/35/EC of 30 June 1994 on sweeteners for use in foodstuffs. Official Journal L 237:3-12(2006) Opinion of the Scientific Panel AFC Related to a New Long-Term Carcinogenicity Study on Aspartame, , http://www.efsa.eu.int/science/afc/afc_opinions/1471_en.html, EFSA European Food Safety Authority, Available:, accessed 1 June; Aspartame: Commissioner's final decision (1981) Fed Reg, 46, pp. 38285-38308. , FDA Food and Drug Administration; Food additives permitted for direct addition to food for human consumption: Aspartame (1983) Fed Reg, 48, pp. 31376-31382. , FDA Food and Drug Administration; Food additives permitted for direct addition to food for human consumption: Aspartame (1996) Fed Reg, 61, pp. 33654-33656. , FDA Food and Drug Administration; Gallus, S., Scotti, L., Negri, E., Talamini, R., Franceschi, S., Montella, M., Artificial sweeteners and cancer risk in a network of case-control studies (2007) Ann Oncol, 18, pp. 40-44; Harper, A.E., Phenylalanine metabolism (1984) Aspartame Physiology and Biochemistry, pp. 77-109. , Stegink LD, Filer LJ Jr, eds, New York:Marcel Dekker; Harris, N.L., Jaffe, E.S., Vardiman, J.W., Stein, H., Diebold, J., Müller-Hermelink, H.K., WHO Classification of tumors of haematopoietic and lymphoid tissues: Introduction (2001) Tumors of Haematopoietic and Lymphoid Tissues, pp. 12-13. , Jaffe ES, Harris NL, Stein H, Vardiman JW, eds, Lyon, France:IARC Press; Haseman, J.K., Value of historical controls in the interpretation of rodent neoplasm data (1992) Drug Inf J, 26, pp. 191-200; Haseman, J.K., Data analysis: Statistical analysis and use of historical control data (1995) Regul Toxicol Pharmacol, 21, pp. 52-59; Haseman, J.K., Huff, J.E., Boorman, G.A., Use of historical control data in carcinogenicity studies in rodents (1984) Toxicol Pathol, 12, pp. 126-135; Transplacental induction of tumors and malformations in rats treated with some chemical carcinogens (1973) IARC Sci Publ, 4, pp. 100-111. , IARC; Haematopoietic system (1993) IARC Sci Publ, 122 (PART 1-4), pp. 1-27. , IARC; Ilbäck, N.G., Alzin, M., Jahrl, S., Henghardt-Barbieri, H., Busk, L., Estimated intake of the artificial sweeteners acesulfame-K, aspartame, cyclamate and saccharin in a group of Swedish diabetics (2003) Food Addit Contam, 20, pp. 99-114; Lim, U., Subar, A.M., Mouw, T., Hartge, P., Morton, L.M., Stolzenberg, R., Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies (2006) Cancer Epidemiol Biomarkers Prev, 15, pp. 1654-1659; Opperman, J.A., Aspartame metabolism in animals (1984) Aspartame Physiology and Biochemistry, pp. 141-159. , Stegink LD, Filer LJ Jr, eds, New York:Marcel Dekker; Soffritti, M., Acesulfame potassium: Soffritti responds [Letter] (2006) Environ Health Perspect, 114, pp. A516-A517; Soffritti, M., Belpoggi, F., Cevolani, D., Guarino, M., Padovani, M., Maltoni, C., Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats (2002) Ann NY Acad Sci, 982, pp. 46-69; Soffritti, M., Belpoggi, F., Degli Esposti, D., Lambertini, L., Aspartame induces lymphomas and leukaemias in rats (2005) Eur J Oncol, 10, pp. 107-116; Soffritti, M., Belpoggi, F., Degli Esposti, D., Lambertini, L., Tibaldi, E., Rigano, A., First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats (2006) Environ Health Perspect, 114, pp. 379-385; Soffritti, M., Belpoggi, F., Lambertini, L., Lauriola, M., Padovani, M., Maltoni, C., Results of long-term experimental studies on the carcinogenicity of formaldehyde and acetaldehyde in rats (2002) Ann NY Acad Sci, 982, pp. 87-105; Soffritti, M., Belpoggi, F., Padovani, M., Lauriola, M., Degli Esposti, D., Minardi, F., Life-time carcinogenicity bioassay of toluene given by stomach tube to Sprague-Dawley rats (2004) Eur J Oncol, 9, pp. 91-102; Stegink, L.D., Aspartate and glutamate metabolism (1984) Aspartame Physiology and Biochemistry, pp. 47-76. , Stegink LD, Filer LJ Jr, eds, New York:Marcel Dekker","Soffritti, M.; Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy; email: crcfr@ramazzini.it",,,,,,,,00916765,,,17805418,"English","Environ. Health Perspect.",Article,Scopus,2-s2.0-34748884376
"Belpoggi, F., Soffritti, M., Manservigi, M., Lauriola, M.","Mesothelioma following asbestos exposure in workers of sugar refinery plants: The Ramazzini Foundation case series. [Il mesotelioma da amianto tra i lavoratori degli zuccherifici: La casistica della Fondazione Ramazzini]",2007,"European Journal of Oncology","12","2",,"101","107",,,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-34548289012&partnerID=40&md5=f6d669ce5b226d7682f88cf5c6bf46cc","Centro di Ricerca Sul Cancro, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Bologna, Italy; Centro di Ricerca Sul Cancro, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Castello di Bentivoglio, Via Saliceto 3, 40010 Bentivoglio (BO), Italy","Belpoggi, F., Centro di Ricerca Sul Cancro, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Bologna, Italy; Soffritti, M., Centro di Ricerca Sul Cancro, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Bologna, Italy, Centro di Ricerca Sul Cancro, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Castello di Bentivoglio, Via Saliceto 3, 40010 Bentivoglio (BO), Italy; Manservigi, M., Centro di Ricerca Sul Cancro, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Bologna, Italy; Lauriola, M., Centro di Ricerca Sul Cancro, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Bologna, Italy","Eighteen Italian cases of mesothelioma (16 of which observed in the Emilia-Romagna Region), following exposure to asbestos present in sugar refinery plants, are reported. Seventeen cases arose in workers occupationally exposed, and one is due to family contact. All were cases of pleural mesothelioma, except one, which was peritoneal. The average latency time was 37.2 years and the average age at onset was 62 years. This study demonstrates the risk of asbestos exposure in the sugar refinery industry, which involves about 28,000 people, also in consideration of the substantial turnover in this category, including full-time and seasonal employees, to whom we must add potential family members. To assess this risk, further epidemiologic researches are necessary and, from both a scientific and ethical standpoint, may no longer be delayed.","Asbestos; Mesothelioma; Sugar refineries","asbestos; article; cancer epidemiology; cancer risk; human; mesothelioma; occupational exposure; onset age; peritoneum mesothelioma; pleura mesothelioma; risk assessment; sugar industry",,"asbestos, 1332-21-4",,,,"Guidorzi, A., Cenni sull'epopea dello zucchero, sull'industria saccarifera europea e breve storia di quella italiana http://www. agrimodena.provincia. modena.it/bietola/zucchero.pdfhttp://www.greenplanet.net/Articolo8663.htmlSelikoff, I.J., Lee, D.H.K., (1978) Asbestos and disease, , New York: Academic Press; Acquafresca, L., Esperienze operative USL 26: Cantieri di demolizione e bonifica con presenza di amianto (1992) Atti del Convegno, Le demolizioni in edilizia: Esperienze e proposte per una attività non standardizzabile, S. Giovanni in Persiceto (BO), pp. 77-92. , Regione Emilia Romagna Ed; http://www.federalimentare.it/doc.assozucchero.htmlSinibaldi, C., Lodi, P., Roncone, L., Mesotelioma pleurico da asbesto in operaio addetto all'installazione e alla manutenzione dell'impianto termo-idraulico di uno zuccherificio (1991) Acta Oncol, 12 (6), pp. 569-576; Pinto, C., Valenti, D., Maltoni, C., Mesotelioma pleurico in operaio di zuccherificio esposto ad asbesto (e a lana di roccia) (1992) Acta Oncol, 13, pp. 425-433; Maltoni, C., Pinto, C., Sinibaldi, C., Casistica dell'Istituto di Oncologia di Bologna: Quarto caso di mesotelioma pleurico in operaio di zuccherificio esposto ad asbesto (1992) Acta Oncol, 13, pp. 817-830; Pinto, C., Sinibaldi, C., Lattes, C., Mesotelioma pleurico in lavoratore di zuccherificio esposto ad asbesto (quinto caso di mesotelioma pleurico tra lavoratori di zuccherifici nella casistica deiristituto di Oncologia di Bologna) (1993) Acta Oncol, 14, pp. 89-100; Maltoni, C., Pinto, C., Valenti, D., Sesto caso di mesotelioma pleurico da asbesto fra lavoratori di zuccherifici nella casistica di mesoteliomi dell'Istituto di Oncologia di Bologna (1993) Acta Oncol, 14, pp. 311-316; Maltoni, C., Pinto, C., Sinibaldi, C., Settimo caso di mesotelioma da asbesto fra lavoratori di zuccherifici, nella casistica deiristituto di Oncologia di Bologna (1994) Acta Oncol, 15, pp. 149-154; Pinto, C., Valenti, D., Sinibaldi, C., Ottavo, nono e decimo caso di mesotelioma da asbesto tra lavoratori di zuccherifici dell' Emilia Romagna (1994) Acta Oncol, 15, pp. 355-369; Maltoni, C., Fini, A., Pinto, C., Mesotelioma pleurico da asbesto in figlia di operaio di zuccherifici dell'Emilia Romagna (1994) Acta Oncol, 15, pp. 451-464; Maltoni, C., Pinto, C., Valenti, D., Mesotheliomas following exposure to asbestos used in sugar refineries: Report of 11 Italian cases. In Mehlman MA (1994) Advances in modern environmental toxicology, 23, pp. 629-634. , Princeton, NJ: Princeton Scientific Publishing; Maltoni, C., Pinto, C., Valenti, D., Mesotheliomas following exposure to asbestos used in sugar refineries: Report of 12 italian cases (1995) Med Lav, 86 (5), pp. 478-483; Maltoni, C., Pinto, C., Valenti, D., Mesotelioma pleurico in lavoratore stagionale di uno zuccherificio della regione Marche esposto ad asbesto (1996) Eur J Oncol, 1 (2), pp. 185-190; Pinto, C., Amaducci, E., Carnuccio, R., Mesotelioma pleurico in facchino di zuccherifici della regione Emilia Romagna esposto ad asbesto (1997) Eur J Oncol, 2 (1), pp. 65-72; Pinto, C., Carnuccio, R., Sinibaldi, C., Dodicesimo caso di mesotelioma tra lavoratori di zuccherifici della Regione Emilia Romagna (1997) Eur J Oncol, 2 (3), pp. 289-294; Maltoni C, Pinto C, Valenti D, et al. Mesotheliomas following exposure to asbestos used in sugar refineries: report of the 17 Italian cases. 25° Anniversario degli Istituti di Chirurgia dell'Università di Chieti diretti dal Professor Vanni Beltrami. Chieti 1973-1998. Scritti degli allievi e degli amici: 79-85Pinto, C., Valenti, D., Amaducci, E., Tredicesimo caso di mesotelioma tra lavoratori degli zuccherifici della regione Emilia Romagna (1998) Eur J Oncol, 3 (1), pp. 59-68; Maltoni, C., Amaducci, E., Rapezzi, R., Quattordicesimo caso di mesotelioma tra lavoratori di zuccherifici della regione Emilia Romagna (1998) Eur J Oncol, 3 (3), pp. 271-273; Amaducci, E., Valenti, D., Rapezzi, R., Quindicesimo caso di mesotelioma tra i lavoratori di zuccherifici della regione Emilia Romagna (1998) Eur J Oncol, 3 (6), pp. 671-673; De Giovanni, D., Pesce, B., Pondrano, N., Asbestos in Italy (2004) Int J Occup Environ Health, 10, pp. 193-197; Peto, J., Decarli, A., La Vecchia, C., The European mesothelioma epidemic (1999) Br J Can, 79 (3-4), pp. 666-672; Das, P.B., Fletcher, A.G., Deodhare, S.G., Mesothelioma in an agricultural community of India: A clinicalpathological study (1976) Aust N Z J Surg, 46 (3), pp. 218-226; Rothschild, H., Mulvey, J.J., An increased risk for lung cancer mortality associated with sugarcane farming (1982) J Natl Cancer Inst, 68 (5), pp. 755-759; Malker, H.R., Malker, B.K., Blot, W.J., Mesothelioma among sugar refinery workers (1983) Lancet, 2, p. 858; Schneider, J., Grossgarten, K., Woitowitz, H.J., Fatal pleural mesothelioma diseases caused by familial household contacts with asbestos fiber dust (1995) Pneumologie, 49 (2), pp. 55-59; Schneider, J., Straif, K., Woitowitz, H.J., Pleural mesothelioma and household asbestos exposure (1996) Rev Environ Health, 11 (1-2), pp. 65-70; Konetzke, G.W., Beck, B., Mehnert, W.H., Occupational and non-occupational effects of asbestos (1990) Pneumologie, 44 (7), pp. 858-861; Miller, A., Mesothelioma in household members of asbestos-exposed workers: 32 United States cases since 1990 (2005) Am J Ind Med, 47 (5), pp. 458-462","Soffritti, M.; Centro di Ricerca Sul Cancro, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Castello di Bentivoglio, Via Saliceto 3, 40010 Bentivoglio (BO), Italy; email: crcfr@ramazzini.it",,,,,,,,11286598,,EJOUA,,"Italian","Eur. J. Oncol.",Article,Scopus,2-s2.0-34548289012
"Soffritti, M., Patelli, M., Esposti, D.D., Lambertini, L., Fornelli, A., Belpoggi, F.","Pleural mesothelioma in a goldsmith exposed to asbestos [Mesotelioma pleurico in artigiano orafo esposto ad asbesto]",2007,"European Journal of Oncology","12","1",,"41","46",,2,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-34248545472&partnerID=40&md5=9270352d30df32aa93771493a04abead","Centro di Ricerca Sul Cancro Cesare Maltoni, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Bologna, Italy; Dipartimento di Scienze Oncologiche, U.O. Endoscopia Toracica - Pneumologia, Ospedale Maggiore, Bologna, Italy; Dipartimento di Anatomia Patologica, Ospedale Maggiore, Bologna, Italy; Centro di Ricerca Sul Cancro Cesare Maltoni, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Castello di Bentivoglio, 40010 Bentivoglio (BO), Italy","Soffritti, M., Centro di Ricerca Sul Cancro Cesare Maltoni, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Bologna, Italy, Centro di Ricerca Sul Cancro Cesare Maltoni, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Castello di Bentivoglio, 40010 Bentivoglio (BO), Italy; Patelli, M., Dipartimento di Scienze Oncologiche, U.O. Endoscopia Toracica - Pneumologia, Ospedale Maggiore, Bologna, Italy; Esposti, D.D., Centro di Ricerca Sul Cancro Cesare Maltoni, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Bologna, Italy; Lambertini, L., Centro di Ricerca Sul Cancro Cesare Maltoni, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Bologna, Italy; Fornelli, A., Dipartimento di Anatomia Patologica, Ospedale Maggiore, Bologna, Italy; Belpoggi, F., Centro di Ricerca Sul Cancro Cesare Maltoni, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Bologna, Italy","This report deals with a case of a pleural mesothelioma arisen in a goldsmith occupationally exposed to asbestos. To our knowledge, this is the third case of mesothelioma in a goldsmith reported in the scientific literature.","Asbestos; Goldsmith; Mesothelioma","asbestos; anamnesis; article; case report; computer assisted tomography; fiberoptic bronchoscopy; human; occupational exposure; pleura mesothelioma; positron emission tomography; thoracocentesis; thoracoscopy",,"asbestos, 1332-21-4",,,,"Kern, D.G., Hanley, K.T., Roggli, V.L., Malignant mesothelioma in the jewelry industry (1992) Am J Ind Med, 21, pp. 409-416; Placidi, D., Porru, S., Alessio, L., Descrizione di tre casi di mesotelioma pleurico con insolita esposizione ad amianto (1999) Med Lav, 90, pp. 671-680; Hayes, R.B., Dosemeci, M., Riscigno, M., Cancer mortality among jewelry workers (1993) Am J Ind Med, 24, pp. 743-751; Dubrow, R., Gute, D.M., Cause-specific mortality among Rhode Island jewelry workers (1987) Am J Ind Med, 12, pp. 579-593; Kern, D.G., Frumkin, H., Asbestos-related disease in the jewelry industry: Report of two cases (1988) Am J Ind Med, 13, pp. 407-410; Dossing, M., Langer, S.W., Asbestos-induced lung injury among Danish jewelry workers (1994) Am J Ind Med, 26, pp. 755-758; Mastrantonio M, Belli S, Binazzi A, et al. La mortalità per tumore maligno della pleura nei comuni italiani (1988-1997). Roma: Istituto Superiore di Sanità, Rapporti ISTISAN 02/12, 2002Associazione Intercamerale di Coordinamento per lo Sviluppo Produttivo dell'Oreficeria. Le caratteristiche strutturali del settore dell'oreficeria, argenteria e affini. Disponibile su: http://www.infoimprese.it/metr/index.html, 2007Lemen, R.A., Asbestos-related disease risks still exist (2005) Eur J Oncol, 10 (1), pp. 9-30","Soffritti, M.; Centro di Ricerca Sul Cancro Cesare Maltoni, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Castello di Bentivoglio, 40010 Bentivoglio (BO), Italy; email: crcfr@ramazzini.it",,,,,,,,11286598,,EJOUA,,"Italian","Eur. J. Oncol.",Article,Scopus,2-s2.0-34248545472
"Belpoggi, F., Soffritti, M., Tibaldi, E., Falcioni, L., Luciano, B., Trabucco, F.","Results of long-term carcinogenicity bioassays on Coca-Cola administered to Sprague-Dawley rats",2006,"Annals of the New York Academy of Sciences","1076",,,"736","752",,8,10.1196/annals.1371.078,"http://www.scopus.com/inward/record.url?eid=2-s2.0-33845673676&partnerID=40&md5=53acf5afa8d7bf1ec2b585fd99889f31","Cesare Maltoni Cancer Research Center, European Foundation for Oncology and Environmental Sciences B. Ramazzini, 40010 Bentivoglio, Bologna, Italy; Cesare Maltoni Cancer Research Center, European Ramazzini Foundation, Castello di Bentivoglio, 40010 Bentivoglio (BO), Italy","Belpoggi, F., Cesare Maltoni Cancer Research Center, European Foundation for Oncology and Environmental Sciences B. Ramazzini, 40010 Bentivoglio, Bologna, Italy; Soffritti, M., Cesare Maltoni Cancer Research Center, European Foundation for Oncology and Environmental Sciences B. Ramazzini, 40010 Bentivoglio, Bologna, Italy, Cesare Maltoni Cancer Research Center, European Ramazzini Foundation, Castello di Bentivoglio, 40010 Bentivoglio (BO), Italy; Tibaldi, E., Cesare Maltoni Cancer Research Center, European Foundation for Oncology and Environmental Sciences B. Ramazzini, 40010 Bentivoglio, Bologna, Italy; Falcioni, L., Cesare Maltoni Cancer Research Center, European Foundation for Oncology and Environmental Sciences B. Ramazzini, 40010 Bentivoglio, Bologna, Italy; Luciano, B., Cesare Maltoni Cancer Research Center, European Foundation for Oncology and Environmental Sciences B. Ramazzini, 40010 Bentivoglio, Bologna, Italy; Trabucco, F., Cesare Maltoni Cancer Research Center, European Foundation for Oncology and Environmental Sciences B. Ramazzini, 40010 Bentivoglio, Bologna, Italy","Coca-Cola was invented in May 1886 in Atlanta, Georgia by a pharmacist who, by accident or design, mixed carbonated water with the syrup of sugar, phosphoric acid, caffeine, and other natural flavors to create what is known as ""the world's favorite soft drink."" Coca-Cola is currently sold in more than 200 countries and in early 2000, the company sold its 10 billionth unit case of Coca-Cola branded products. Given the worldwide consumption of Coca-Cola, a project of experimental bioassays to study its long-term effects when administered as substitute for drinking water on male and female Sprague-Dawley rats was planned and executed. The objective of the project was to study whether and how long-term consumption of Coca-Cola affects the basic tumorigram of test animals. The bioassays were performed on rats beginning at different ages, namely: (a) on males and females exposed since embryonic life or from 7 weeks of age; and (b) on males and females exposed from 30, 39, or 55 weeks of age. Overall, the project included 1999 rats. During the biophase, data were collected on fluid and feed consumption, body weight, and survival. Animals were kept under observation until spontaneous death and underwent complete necropsy. The results indicate: (a) an increase in body weight in all treated animals; (b) a statistically significant increase of the incidence in females, both breeders and offspring, bearing malignant mammary tumors; (c) a statistically significant increase in the incidence of exocrine ademonas of the pancreas in both male and female breeders and offspring; and (d) an increased incidence, albeit not statistically significant, of pancreatic islet cell carcinomas in females, a malignant tumor which occurs very rarely in our historical controls. On the basis of the results of this study, excessive consumption of regular soft-drinks should be generally discouraged, in particular for children and adolescents. © 2006 New York Academy of Sciences.","Carcinogenicity; Coca-Cola; Long-term bioassay; Rat","drinking water; adolescence; age distribution; animal experiment; animal model; animal tissue; autopsy; bioassay; body weight; breast cancer; breast tumor; breed; cancer incidence; carbonated beverage; carcinogen testing; carcinogenicity; chemical carcinogenesis; childhood; conference paper; controlled study; death; embryo; embryo development; female; fluid intake; food intake; groups by age; long term exposure; male; malignant neoplastic disease; nonhuman; pancreas adenoma; pancreas islet cell carcinoma; progeny; sex difference; Sprague Dawley rat; statistical significance; survival; weight gain; Animals; Beverages; Biological Assay; Carcinogenicity Tests; Female; Male; Rats; Rats, Sprague-Dawley; Animalia; Cola",,,,,,"Tannenbaum, A., The initiation and growth of tumors. I: Effects of underfeeding (1940) Am. J. Cancer, 38, pp. 335-350; Tannenbaum, A., Silverstone, H., Nutrition in relation to cancer (1953) Adv. Cancer Res., 1, pp. 451-501; Calle, E., Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults (2003) N. Engl. J. Med., 348, pp. 1625-1638; Rapp, K., Obesity and incidence of cancer: A large cohort study of over 145 000 adults in Austria (2005) Br. J. Cancer, 93, pp. 1062-1106; Soffritti, M., Mega-experiments to identify and assess diffuse carcinogenic risks (1999) Ann. N. Y. Acad. Sci., 895, pp. 43-55; Soffritti, M., Results of experimental bioassays on the chemopreventive effects of vitamin A and N-(4-hydroxyphenyl)-retinamide (HPR) on mammary cancer (1996) The Scientific Bases of Cancer Chemoprevention, pp. 241-248. , C. Maltoni, M. Soffritti & W. Davis, Eds.: International Congress Series 1120 : Elsevier. Amsterdam, The Netherlands; (2005) The Coca-cola Company Annual Report, , http://www.cocacola.com, [accessed 16 May 2006]","Soffritti, M.; Cesare Maltoni Cancer Research Center, European Ramazzini Foundation, Castello di Bentivoglio, 40010 Bentivoglio (BO), Italy; email: crcfr@ramazzini.it","Mehlman M.A.Belpoggi F.Bingham E.Landrigan P.Soffritti M.",,,,,,,00778923,1573316539; 9781573316538,ANYAA,17119251,"English","Ann. New York Acad. Sci.",Conference Paper,Scopus,2-s2.0-33845673676
"Belpoggi, F., Soffritti, M., Padovani, M., Esposti, D.D., Lauriola, M., Minardi, F.","Results of long-term carcinogenicity bioassay on Sprague-Dawley rats exposed to aspartame administered in feed",2006,"Annals of the New York Academy of Sciences","1076",,,"559","577",,21,10.1196/annals.1371.080,"http://www.scopus.com/inward/record.url?eid=2-s2.0-33845639621&partnerID=40&md5=87889dc267b317d97d158519d464b9e7","Cesare Maltoni Cancer Research Center, European Foundation of Oncology and Environmental Sciences B. Ramazzini, 40010 Bentivoglio, Bologna, Italy; Cesare Maltoni Cancer Research Center, European Ramazzini Foundation, Castello di Bentivoglio, Via Saliceto, 3, 40010 Bentivoglio, Bologna, Italy","Belpoggi, F., Cesare Maltoni Cancer Research Center, European Foundation of Oncology and Environmental Sciences B. Ramazzini, 40010 Bentivoglio, Bologna, Italy; Soffritti, M., Cesare Maltoni Cancer Research Center, European Foundation of Oncology and Environmental Sciences B. Ramazzini, 40010 Bentivoglio, Bologna, Italy, Cesare Maltoni Cancer Research Center, European Ramazzini Foundation, Castello di Bentivoglio, Via Saliceto, 3, 40010 Bentivoglio, Bologna, Italy; Padovani, M., Cesare Maltoni Cancer Research Center, European Foundation of Oncology and Environmental Sciences B. Ramazzini, 40010 Bentivoglio, Bologna, Italy; Esposti, D.D., Cesare Maltoni Cancer Research Center, European Foundation of Oncology and Environmental Sciences B. Ramazzini, 40010 Bentivoglio, Bologna, Italy; Lauriola, M., Cesare Maltoni Cancer Research Center, European Foundation of Oncology and Environmental Sciences B. Ramazzini, 40010 Bentivoglio, Bologna, Italy; Minardi, F., Cesare Maltoni Cancer Research Center, European Foundation of Oncology and Environmental Sciences B. Ramazzini, 40010 Bentivoglio, Bologna, Italy","Aspartame (APM) is one of the most widely used artificial sweeteners in the world. Its ever-growing use in more than 6000 products, such as soft drinks, chewing gum, candy, desserts, etc., has been accompanied by rising consumer concerns regarding its safety, in particular its potential long-term carcinogenic effects. In light of the inadequacy of the carcinogenicity bioassays performed in the 1970s and 1980s, a long-term mega-experiment on APM was undertaken at the Cesare Maltoni Cancer Research Center of the European Ramazzini Foundation on groups of male and female Sprague-Dawley rats (100-150/sex/group), 8 weeks old at the start of the experiment. APM was administered in feed at concentrations of 100,000, 50,000, 10,000, 2,000, 400, 80, or 0 ppm. Treatment lasted until spontaneous death of the animals. The results of the study demonstrate that APM causes: (a) an increased incidence of malignant tumor-bearing animals, with a positive significant trend in both sexes, and in particular in females treated at 50,000 ppm (P ≤ 0.01) when compared to controls; (b) an increase in lymphomas-leukemias, with a positive significant trend in both sexes, and in particular in females treated at doses of 100,000 (P ≤ 0.01), 50,000 (P ≤ 0.01), 10,000 (P ≤ 0.05), 2000 (P ≤ 0.05), and 400 ppm (P ≤ 0.01); (c) a statistically significant increased incidence, with a positive significant trend, of transitional cell carcinomas of the renal pelvis and ureter in females and particularly in those treated at 100,000 ppm (P ≤ 0.05); and (d) an increased incidence of malignant schwannomas of the peripheral nerves, with a positive trend in males (P ≤ 0.05). The results of this mega-experiment indicate that APM, in the tested experimental conditions, is a multipotential carcinogenic agent. © 2006 New York Academy of Sciences.","Aspartame; Carcinogenicity; Long-term bioassays; Rat","aspartame; carcinogen; animal experiment; bioassay; cancer incidence; carcinogen testing; carcinogenesis; carcinogenicity; conference paper; controlled study; fatality; female; kidney pelvis; leukemia; lymphoma; male; neurilemoma; nonhuman; peripheral nerve; rat; statistical significance; transitional cell carcinoma; ureter; Animal Feed; Animals; Aspartame; Biological Assay; Carcinogenicity Tests; Female; Male; Rats; Rats, Sprague-Dawley; Sweetening Agents; Animalia",,"aspartame, 22839-47-0, 5910-52-1; Aspartame, 22839-47-0; Sweetening Agents",,,,"Bright, G., Low-calorie sweeteners - From molecules to mass markets (1999) World Rev. Nutr. Diet., 85, pp. 3-9; Lindley, M.G., New developments in low-calorie sweeteners (1999) World Rev. Nutr. Diet., 85, pp. 44-51; Weihrauch, M.R., Diehl, V., Artificial sweeteners - Do they bear a carcinogenic risk? (2004) Ann. Oncol., 15, pp. 1460-1465; Butchko, H.H., Preclinical safety evaluation of aspartame (2002) Regul. Toxicol. Pharmacol., 35, pp. S7-S12; Mazur, R.H., Discovery of aspartame (1984) Aspartame Physiology and Biochemistry, pp. 3-9. , L.D. Stegink & L.J. Filer, Jr. Eds.: Dekker. New York, NY; Fry, J., The world market for intense sweeteners (1999) World Rev. Nutr. Diet., 85, pp. 201-211; (2006) Hazardous Substances Data Bank, , http://toxnet.nlm.nih.gov/, [accessed 10 May 2005]; www.foodnavigator-usa.com/news/printNewsBis.asp?id=59163, [accessed 10 May 2005](2006), http://www.aspartame.org, [accessed 10 May 2005]Butchko, H.H., Intake of aspartame vs the acceptable daily intake (2002) Regul. Toxicol. Pharmacol., 35, pp. S13-S16; Ranney, R.E., Comparative metabolism of aspartame in experimental animals and humans (1976) J. Toxicol. Environ. Health, 2, pp. 441-451; Stegink, L.D., Aspartate and glutamate metabolism (1984) Aspartame Physiology and Biochemistry, pp. 47-76. , L.D. Stegink & L.J. Filer. Jr., Eds.: Dekker. New York, NY; Harper, A.E., Phenylalanine metabolism (1984) Aspartame Physiology and Biochemistry, pp. 77-109. , L.D. Stegink & L.J. Filer. Jr., Eds.: Dekker. New York, NY; Opperman, J.A., Aspartame metabolism in animals (1984) Aspartame Physiology and Biochemistry, pp. 141-159. , L.D. Stegink & L.J. Filer. Jr., Eds.: Dekker. New York, NY; Jeffrey, A.M., Williams, G.M., Lack of DNA-damaging activity of five non-nutritive sweeteners in the rat hepatocyte/DNA repair assay (2000) Food Chem. Toxicol., 38, pp. 335-338; Rencuzogullari, E., Genotoxicity of aspartame (2004) Drug Chem. Toxicol., 27, pp. 257-268; Mukhopadhyay, M., Mukherjee, A., Chakrabarti, J., In vivo cytogenetic studies on blends of aspartame and acesulfame-K (2000) Food Chem. Toxicol., 38, pp. 75-77; Toxicology studies of aspartame (CAS No. 22839-47-0) in genetically modified (FVB Tg.AC hemizygous) and B6.129-Cdkn2atm1Rdp (N2) deficient mice and carcinogenicity studies on aspartame in genetically modified B6.129-Trp53tm1Brd(N5) haploinsufficient mice (feed studies) (2005) Genetically Modified Model Report NTP GMM1, pp. 5-66. , NATIONAL TOXICOLOGY PROGRAM; Olney, J.W., Increasing brain tumor rates: Is there a link to aspartame? (1996) J. Neuropathol. Exp. Neurol., 55, pp. 1115-1123; Aspartame: Commissioner's final decision (1981) Fed. Regist., 46, pp. 38285-38308. , U.S. FOOD AND DRUG ADMINISTRATION; Ishii, H., Incidence of brain tumors in rats fed aspartame (1981) Toxicol. Lett., 7, pp. 433-437; Ishii, H., Toxicity of aspartame and its diketopiperazine for Wistar rats by dietary administration for 104 weeks (1981) Toxicology, 21, pp. 91-94; Soffritti, M., First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats (2006) Environ. Health Perspect., 114, pp. 379-385; Soffritti, M., Aspartame induces lymphomas and leukaemias in rats (2005) Eur. J. Oncol., 10, pp. 107-116; Attuazione della direttiva n. 86/609/CEE in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici (1992) Supplemento Ordinario Alla Gazzetta Ufficiale, 40, pp. 5-25. , DECRETO LEGISLATIVO 116; Harris, N.L., WHO Classification of tumors of haematopoietic and lymphoid tissues: Introduction (2001) Tumors of Haematopoietic and Lymphoid Tissues, pp. 12-13. , E.S. Jaffe, et al., Eds.: IARC Press. Lyon","Soffritti, M.; Cesare Maltoni Cancer Research Center, European Ramazzini Foundation, Castello di Bentivoglio, Via Saliceto, 3, 40010 Bentivoglio, Bologna, Italy; email: crcfr@ramazzini.it","Mehlman M.A.Belpoggi F.Bingham E.Landrigan P.Soffritti M.",,,,,,,00778923,1573316539; 9781573316538,ANYAA,17119233,"English","Ann. New York Acad. Sci.",Conference Paper,Scopus,2-s2.0-33845639621
"Mehlman, M.A., Soffritti, M., Landrigan, P., Bingham, E., Belpoggi, F.","Annals of the New York Academy of Sciences: Introduction",2006,"Annals of the New York Academy of Sciences","1076",,,"xvii","xviii",,,10.1196/annals.1371.084,"http://www.scopus.com/inward/record.url?eid=2-s2.0-33845632853&partnerID=40&md5=f2620cc34779c1307c817c67f004378d",,"Mehlman, M.A.; Soffritti, M.; Landrigan, P.; Bingham, E.; Belpoggi, F.",[No abstract available],,"carcinogen; behavior modification; cancer prevention; chemical carcinogenesis; conference paper; environmental health; health care organization; health care planning; health promotion; lifestyle; medical examination; medical expert; medical information; occupational health; scientist",,,,,,,,"Mehlman M.A.Belpoggi F.Bingham E.Landrigan P.Soffritti M.",,,,,,,00778923,1573316539; 9781573316538,ANYAA,,"English","Ann. New York Acad. Sci.",Conference Paper,Scopus,2-s2.0-33845632853
"Soffritti, M., Belpoggi, F., Degli Esposti, D., Lambertini, L.","Results of a long-term carcinogenicity bioassay on Sprague-Dawley rats exposed to sodium arsenite administered in drinking water",2006,"Annals of the New York Academy of Sciences","1076",,,"578","591",,8,10.1196/annals.1371.075,"http://www.scopus.com/inward/record.url?eid=2-s2.0-33845608516&partnerID=40&md5=348b2b6201c80cb7fe04a58ec802851a","Cesare Maltoni Cancer Research Center, European Foundation of Oncology and Environmental Sciences B. Ramazzini, Bologna, Italy; Cesare Maltoni Cancer Research Center, European Ramazzini Foundation, Castello di Bentivoglio, Via Saliceto, 3, 40010 Bentivoglio, Bologna, Italy","Soffritti, M., Cesare Maltoni Cancer Research Center, European Foundation of Oncology and Environmental Sciences B. Ramazzini, Bologna, Italy, Cesare Maltoni Cancer Research Center, European Ramazzini Foundation, Castello di Bentivoglio, Via Saliceto, 3, 40010 Bentivoglio, Bologna, Italy; Belpoggi, F., Cesare Maltoni Cancer Research Center, European Foundation of Oncology and Environmental Sciences B. Ramazzini, Bologna, Italy; Degli Esposti, D., Cesare Maltoni Cancer Research Center, European Foundation of Oncology and Environmental Sciences B. Ramazzini, Bologna, Italy; Lambertini, L., Cesare Maltoni Cancer Research Center, European Foundation of Oncology and Environmental Sciences B. Ramazzini, Bologna, Italy","Arsenic (As) is a metal found in nature whose acute and chronic toxic effects have been known for decades. Hundreds of millions of people are at risk of exposure to As and its various chemical forms which can occur in the occupational and general environment in air, water, soil, food, and medicines. Several epidemiological studies have shown that prolonged exposure to As can induce various types of malignant tumors in humans, namely, skin, lung, liver, kidney, and bladder cancers. These effects have been observed particularly in geographic areas where people are exposed to well water with high concentrations of As. While the risks of As at high concentrations are well documented, there is still a great deal of uncertainty regarding the risk of exposure to As at very low levels. This uncertainty is due to the absence of adequate epidemiological data and the insufficiency of experimental data currently available. Given the limited evidence demonstrating the carcinogenic potential of As in animals, a long-term carcinogenicity bioassay on sodium arsenite (NaAsO2) was performed at the Cesare Maltoni Cancer Research Center (CMCRC) of the European Ramazzini Foundation (ERF). NaAsO2 was administrated with drinking water at concentrations of 200, 100, 50, or 0 mg/L, for 104 weeks to Sprague-Dawley rats (50/sex/group), 8 weeks old at the start of the study. The animals were monitored until spontaneous death at which time each animal underwent complete necropsy. Histopathological evaluation of all pathological lesions and of all organs and tissues collected was routinely performed on each animal. The results demonstrate that in our experimental conditions NaAsO2 induces sparse benign and malignant tumors among treated rats. The types of tumors observed are infrequent in the strain of Sprague-Dawley rats of the colony used in our laboratory, namely, lung adenomas and carcinomas, kidney adenomas/papillomas and carcinomas, and bladder carcinomas. Notably, an elevated incidence of these types of oncological lesions is also observed among people living in geographical areas where As is present at higher concentrations in drinking water. © 2006 New York Academy of Sciences.","Carcinogenicity; Long-term bioassays; Rat; Sodium arsenite","arsenite sodium; drinking water; animal experiment; autopsy; bioassay; bladder carcinoma; carcinogen testing; carcinogenesis; carcinogenicity; conference paper; controlled study; fatality; female; histopathology; kidney adenoma; kidney carcinoma; lung adenoma; lung carcinoma; male; nonhuman; papilloma; rat; rat strain; Animals; Arsenites; Biological Assay; Carcinogenicity Tests; Female; Male; Rats; Rats, Sprague-Dawley; Sodium Compounds; Animalia",,"arsenite sodium, 13464-37-4; Arsenites; sodium arsenite, 13768-07-5; Sodium Compounds",,,,"(2004) Monographs on the Evaluation of Carcinogenic Risks to Humans, 84. , International Agency for Research on Cancer. IARC. Lyon, France; Arsenic and arsenic compounds (2001) Environmental Health Criteria 224, , International Programme on Chemical Safety (IPCS). 2nd ed. WHO. Geneva, Switzerland; Koljonen, T., (1992) Geochemical Atlas of Finland, , Geological Survey of Finland. Espoo, Finland; Farago, M.E., Health aspects of human exposure to high arsenic concentrations in soil in south-west England (1997) Arsenic Exposure and Health Effects, pp. 210-226. , C.O. Abernathy, R.L. Calderon, W.R. Chappel, Eds.: Chapman & Hall. New York; Smedley, P.L., Kinniburgh, D.G., A review of the source, behaviour and distribution of arsenic in natural waters (2002) Appl. Geochem., 17, pp. 517-568; Matschullat, J., Arsenic in the geosphere - A review (2000) Sci. Total Environ., 249, pp. 297-312; Queirolo, F., Total arsenic, lead, cadmium, copper, and zinc in some salt rivers in the northern Andes of Antofagasta, Chile (2000) Sci. Total Environ., 255, pp. 85-95; Chilvers, D.C., Peterson, P.J., (1987) Lead, Mercury, Cadmium and Arsenic in the Environment, pp. 279-303. , T.C. Hutchinson & K.M. Meema, Eds.: John Wiley & Sons. Chichester, UK; (2005) Mineral Commodity Summaries, , US Department of Interior - US Geological Survey. US government printing office. Washington, DC; Pershagen, G., Vahter, M., (1979) Arsenic, , National Swedish Environment Protection Board. Stockholm, Sweden; Chan, P.C., Huff, J., Arsenic carcinogenesis in animals and humans: Mechanistic, experimental, and epidemiological evidence (1997) J. Environ. Sci. Health., 15, pp. 83-122; Vahter, M., Methylation of inorganic arsenic in different mammalian species and population groups (1999) Sci. Progr., 82, pp. 69-88; Ostrowsky-Wegman, P., Lymphocyte proliferation kinetics and genotoxic findings in a pilot study on individuals chronically exposed to arsenic in Mexico (1991) Mutat. Res., 250, pp. 477-482; Gonsebatt, M.E., Lymphocyte replicating ability in individuals exposed to arsenic via drinking water (1994) Mutat. Res., 313, pp. 293-299; Harrison, M.T., McCoy, K.L., Immunosuppression by arsenic: A comparison of cathepsin L inhibition and apoptosis (2001) Int. Immunopharmacol., 1, pp. 647-656; Engel, R.R., Smith, A.H., Arsenic in drinking water and mortality from vascular disease: An ecological analysis in 30 counties in the United States (1994) Arch. Environ. Health, 49, pp. 418-427; Hopenhayn-Rich, C., Chronic arsenic exposure and risk of infant mortality in two areas in Chile (2000) Environ. Health Perspect., 108, pp. 667-673; Rossman, T.G., Absence of arsenite mutagenicity in E. Coli and Chinese hamster cells (1980) Environ. Mutagen., 2, pp. 371-379; Zeiger, E., Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals (1992) Environ. Mol. Mutagen., 19 (SUPPL. 21), pp. 2-141; Lantzsch, H., Gebel, T., Genotoxicity of selected metal compounds in the SOS chromotest (1997) Mutat. Res., 389, pp. 191-197; Moore, M.M., Harrington-Brock, K., Doerr, C.L., Relative genotoxic potency of arsenic and its methylated metabolites (1997) Mutat. Res., 386, pp. 279-290; Kochhar, T.S., Effect of trivalent and pentavalent arsenic in causing chromosome alterations in cultured Chinese hamster ovary (CHO) cells (1996) Toxicol. Lett., 84, pp. 37-42; Dong, J.L., Luo, X.M., Effects of arsenic on DNA damage and repair in human fetal lung fibroblasts (1994) Mutat. Res., 315, pp. 11-15; Rasmussen, R.E., Menzel, D.B., Variation in arsenic-induced sister chromatid exchange in human lymphocytes and lymphoblastoid cell lines (1997) Mutat. Res., 386, pp. 299-306; Hutchinson, J., On some examples of arsenic-keratosis of the skin and of arsenic-cancer (1888) Trans. Pathol. Soc. London, 39, pp. 352-393; Roth, F., After-effects of chronic arsenism in Moselle wine-makers (1957) Dtsch. Med. Wochenschr., 82, pp. 211-217; Neubauer, O., Arsenical cancer: A review (1947) Br. J. Cancer, 1, pp. 192-251; Neumann, E., Schwank, R., Multiple malignant and benign epidermal and dermal tumours following arsenic (1960) Acta Derm. Venereol., 40, pp. 400-409; Yeh, S., How, S.W., Lin, C.S., Arsenical cancer of skin. Histologic study with special reference to Bowen's disease (1968) Cancer, 21, pp. 312-339; Chen, C.J., Wang, C.J., Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms (1990) Cancer Res., 50, pp. 5470-5474; Tsai, S.M., Wang, T.N., Ko, Y.C., Mortality for certain diseases in areas with high levels of arsenic in drinking water (1999) Arch. Environ. Health, 54, pp. 186-193; Hopenhayn-Rich, C., Biggs, M.L., Smith, A.H., Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina (1998) Int. J. Epidemiol., 27, pp. 561-569; (1980) Monographs on the Evaluation of Carcinogenic Risks to Humans, 23. , International Agency for Research on Cancer. IARC. Lyon, France; Smith, A.H., Marked increase in bladder and lung cancer mortality in a region of northern Chile due to arsenic in drinking water (1998) Am. J. Epidemiol., 147, pp. 660-669; Wei, M., Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors (2002) Carcinogenesis, 23, pp. 1387-1397; Hayashi, H., Dimethylarsinic acid, a main metabolite of inorganic arsenics, has tumorigenicity and progression effects in the pulmonary tumors of A/J mice (1998) Cancer Lett., 125, pp. 83-88; Chen, Y., K6/ODC transgenic mice as a sensitive model for carcinogen identification (2000) Toxicol. Lett., 116, pp. 27-35; Salim, E.I., Carcinogenicity of dimethylarsinic acid in p53 ± heterozygous knockout and wild type C57BL/6J mice (2003) Carcinogenesis, 24, pp. 335-342; Walkees, M.P., Transplacental carcinogenicity of inorganic arsenic in the drinking water: Induction of hepatic, ovarian, pulmonary and adrenal tumors in mice (2003) Toxicol. Appl. Pharmacol., 186, pp. 7-17; Yamamoto, A., Hisanaga, A., Ishinishi, L.N., Tumorigenicity of inorganic arsenic compounds following intratracheal instillations to the lungs of hamsters (1987) Int. J. Cancer, 40, pp. 220-223; Haseman, J.K., Exact sample sizes with the Fisher-Irwin test for 2 x 2 tables (1978) Biometrics, 34, pp. 106-109; Armitage, P., (1971) Statistical Methods in Medical Research, , John Wiley & Sons. New York; Gart, J.J., Chu, K.C., Tarone, R.E., Statistical issues in interpretation of chronic tests for carcinogenicity (1979) J. Natl. Cancer Inst., 62, pp. 957-974; (1998) Guidelines for Drinking-water Quality, 2nd Ed., 2. , World Health Organization. Addendum Geneva, Switzerland; (2004) Guidelines for Drinking-water Quality, 3rd Ed., 1. , World Health Organization. Geneva, Switzerland","Soffritti, M.; Cesare Maltoni Cancer Research Center, European Ramazzini Foundation, Castello di Bentivoglio, Via Saliceto, 3, 40010 Bentivoglio, Bologna, Italy; email: crcfr@ramazzini.it","Mehlman M.A.Belpoggi F.Bingham E.Landrigan P.Soffritti M.",,,,,,,00778923,1573316539; 9781573316538,ANYAA,17119234,"English","Ann. New York Acad. Sci.",Conference Paper,Scopus,2-s2.0-33845608516
"Soffritti, M., Belpoggi, F., Degli Esposti, D., Lambertini, L., Tibaldi, E., Rigano, A.","First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats",2006,"Environmental Health Perspectives","114","3",,"379","385",,111,10.1289/ehp.8711,"http://www.scopus.com/inward/record.url?eid=2-s2.0-33644771206&partnerID=40&md5=df702e3e98213adad0173987e894a577","Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy","Soffritti, M., Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy; Belpoggi, F., Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy; Degli Esposti, D., Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy; Lambertini, L., Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy; Tibaldi, E., Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy; Rigano, A., Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy","The Cesare Maltoni Cancer Research Center of the European Ramazzini Foundation has conducted a long-term bioassay on aspartame (APM), a widely used artificial sweetener. APM was administered with feed to 8-week-old Sprague-Dawley rats (100-150/sex/group), at concentrations of 100,000, 50,000, 10,000, 2,000, 400, 80, or 0 ppm. The treatment lasted until natural death, at which time all deceased animals underwent complete necropsy. Histopathologic evaluation of all pathologic lesions and of all organs and tissues collected was routinely performed on each animal of all experimental groups. The results of the study show for the first time that APM, in our experimental conditions, causes a) an increased incidence of malignant-tumor-bearing animals with a positive significant trend in males (p ≤ 0.05) and in females (p ≤ 0.01), in particular those females treated at 50,000 ppm (p ≤ 0.01); b) an increase in lymphomas and leukemias with a positive significant trend in both males (p ≤ 0.05) and females (p ≤ 0.01), in particular in females treated at doses of 100,000 (p ≤ 0.01), 50,000 (p ≤ 0.01), 10,000 (p ≤ 0.05), 2,000 (p ≤ 0.05), or 400 ppm (p ≤ 0.01); c) a statistically significant increased incidence, with a positive significant trend (p ≤ 0.01), of transitional cell carcinomas of the renal pelvis and ureter and their precursors (dysplasias) in females treated at 100,000 (p ≤ 0.01), 50,000 (p ≤ 0.01), 10,000 (p ≤ 0.01), 2,000 (p ≤ 0.05), or 400 ppm (p ≤ 0.05); and d) an increased incidence of malignant schwannomas of peripheral nerves with a positive trend (p ≤ 0.05) in males. The results of this mega-experiment indicate that APM is a multipotential carcinogenic agent, even at a daily dose of 20 mg/kg body weight, much less than the current acceptable daily intake. On the basis of these results, a reevaluation of the present guidelines on the use and consumption of APM is urgent and cannot be delayed.","Artificial sweetener; Aspartame; Carcinogenicity; Lymphomas; Malignant schwannomas; Rats; Renal pelvis carcinomas","aspartame; sweetening agent; animal model; animal tissue; article; bioassay; brain tumor; carcinogen testing; chemical carcinogenesis; concentration response; controlled study; dietary intake; experimentation; female; food analysis; histopathology; kidney dysplasia; kidney pelvis carcinoma; leukemia; lifespan; lymphoma; male; malignant neoplastic disease; malignant neurilemoma; nonhuman; precancer; priority journal; public health; rat; sex difference; statistical significance; transitional cell carcinoma; ureter carcinoma; ureter malformation; Animals; Aspartame; Carcinoma; Female; Kidney Neoplasms; Leukemia; Lymphoma; Male; Rats; Rats, Sprague-Dawley; Sweetening Agents; Ureteral Neoplasms; Animalia",,"aspartame, 22839-47-0, 5910-52-1; Aspartame, 22839-47-0; Sweetening Agents",,,,"Armitage, P., (1971) Statistical Methods in Medical Research, , New York:John Wiley & Sons; (2005), http://www.aspartame.org, Aspartame Information Center. Aspartame Information Center Homepage, Available: [accessed 27 October 2005]Bailer, A.J., Portier, C.J., Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples (1988) Biometrics, 44, pp. 417-431; Belpoggi, F., Soffritti, M., Maltoni, C., Methyl-tertiary-butyl ether (MTBE), a gasoline additive, causes testicular and lymphohaematopoietic cancers in rats (1995) Toxicol Ind Health, 11, pp. 119-149; Butchko, H.H., Stargel, W.W., Comer, C.P., Mayhew, D.A., Benninger, C., Blackburn, G.L., Preclinical safety evaluation of aspartame (2002) Regul Toxicol Pharmacol, 35, pp. S7-S12; Butchko, H.H., Stargel, W.W., Comer, C.P., Mayhew, D.A., Benninger, C., Blackburn, G.L., Intake of aspartame vs the acceptable daily intake (2002) Regul Toxicol Pharmacol, 35, pp. S13-S16; Attuazione della direttiva n. 86/609/CEE in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici (1992) Supplemento Ordinario Alla Gazzetta Ufficiale, 40, pp. 5-25. , Decreto Legislativo 116. [in Italian]; Directive 94/35/EC of 30 June 1994 on sweeteners for use in foodstuffs (1994) Official Journal L, 237, pp. 3-12. , EC Directive 35; Food additives permitted in food for human consumption: Aspartame (1974) Fed Reg, 39, pp. 27317-27319. , FDA (Food and Drug Administration); Aspartame: Commissioner's final decision (1981) Fed Reg, 46, pp. 38285-38308. , FDA (Food and Drug Administration); Food additives permitted for direct addition to food for human consumption: Aspartame (1983) Fed Reg, 48, pp. 31376-31382. , FDA (Food and Drug Administration); Food additives permitted for direct addition to food for human consumption; aspartame (1996) Fed Reg, 61, pp. 33654-33656. , FDA (Food and Drug Administration); Fry, J., The world market for intense sweeteners (1999) World Rev Nutr Diet, 85, pp. 201-211; Gart, J.J., Chu, K.C., Tarone, R.E., Statistical issues in interpretation of chronic tests for carcinogenicity (1979) J Natl Cancer Inst, 62, pp. 957-974; Harper, A.E., Phenylalanine metabolism (1984) Aspartame Physiology and Biochemistry, pp. 77-109. , (Stegink LD, Filer LJ Jr, eds). New York:Dekker; Harris, N.L., Jaffe, E.S., Vardiman, J.W., Stein, H., Diebold, J., Müller-Hermelink, H.K., WHO Classification of tumors of haematopoietic and lymphoid tissues: Introduction (2001) Tumors of Haematopoietic and Lymphoid Tissues, pp. 12-13. , (Jaffe ES, Harris NL, Stein H, Vardiman JW, eds). Lyon, France:IARC Press; (2005) TOXNET: Toxicological Data Network, , http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~mobZuL:1, Hazardous Substances Data Bank. Available: [accessed 3 August 2005]; Huff, J., Long-term chemical carcinogenesis bioassays predict human cancer hazards. Issues, controversies, and uncertainties (1999) Ann NY Acad Sci, 895, pp. 56-79; Haematopoietic system (1993) IARC Sci Publ, 122, pp. 1-27. , IARC; Formaldehyde, 2-butoxyethanol and 1-tert-butoxy-2-propanol Monogr Eval Carcinog Risks Hum, 88. , IARC (International Agency for Research on Cancer). In press; (2005) IHCWorld, , http://www.ihcworld.com/_protocols/antibody_protocols/, Information Center for Immunohistochemistry. Available: [accessed 1 April 2005]; Ishii, H., Incidence of brain tumors in rats fed aspartame (1981) Toxicol Lett, 7, pp. 433-437; Ishii, H., Koshimizu, T., Usami, S., Fujimoto, T., Toxicity of aspartame and its diketopiperazine for Wistar rats by dietary administration for 104 weeks (1981) Toxicology, 21, pp. 91-94; Jeffrey, A.M., Williams, G.M., Lack of DNA-damaging activity of five non-nutritive sweeteners in the rat hepatocyte/DNA repair assay (2000) Food Chem Toxicol, 38, pp. 335-338; Kitahori, Y., Kitamura, M., Konoshi, N., Matsuda, H., Tao, M., Matsui, E., Carcinogenicity study of monosodium aspartate in Fisher 344 rats: 100 weeks treatment (1996) J Toxicol Pathol, 9, pp. 161-168; Kitamura, M., Konishi, N., Kitahori, Y., Fukushima, Y., Yoshioka, N., Hiasa, Y., Promoting effect of monosodium aspartate, but not glycine, on renal pelvis and urinary bladder carcinogenesis in rat induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (1996) Toxicol Pathol, 24, pp. 573-579; Kotsonis, F.N., Hjelle, J.J., The safety assessment of aspartame: Scientific and regulatory considerations (1996) The Clinical Evaluation of a Food Additive: Assessment of Aspartame, pp. 23-41. , (Tschanz C, Butchko HH, Stargel WW, Kotsonis FN, eds). Boca Raton, FL:CRC Press; Maltoni, C., Ciliberti, A., Cotti, G., Conti, B., Belpoggi, F., Benzene, an experimental multipotential carcinogen: Results of the long-term bioassays performed at the Bologna Institute of Oncology (1989) Environ Health Perspect, 82, pp. 109-124; Maltoni, C., Lefemine, G., Belpoggi, F., Soffritti, M., Lenzi, A., Ciliberti, A., Risultati di saggi sperimentali di cancerogenicità di acque minerali contenute in bottiglie di PVC, su ratti Sprague-Dawley (1997) Eur J Oncol, 6, pp. 531-551. , [in Italian]; Mazur, R.H., Discovery of aspartame (1984) Aspartame Physiology and Biochemistry, pp. 3-9. , (Stegink LD, Filer LJ Jr, eds). New York:Dekker; Molinary, S.V., Preclinical studies of aspartame in non primate animals (1984) Aspartame Physiology and Biochemistry, pp. 289-306. , (Stegink LD, Filer LJ Jr, eds). New York:Dekker; Mukhopadhyay, M., Mukherjee, A., Chakrabarti, J., In vivo cytogenetic studies on blends of aspartame and acesulfame-K (2000) Food Chem Toxicol, 38, pp. 75-77; Opperman, J.A., Aspartame metabolism in animals (1984) Aspartame Physiology and Biochemistry, pp. 141-159. , (Stegink LD, Filer LJ Jr, eds). New York:Dekker; Piegorsch, W.W., Bailer, A.J., (1997) Statistics for Environmental Biology and Toxicology, , London:Chapman; Portier, C.J., Bailer, A.J., Testing for increased carcinogenicity using a survival-adjusted quantal response test (1989) Fundam Appl Toxicol, 12, pp. 731-737; Rall, D.P., Can laboratory animal carcinogenicity studies predict cancer in exposed children? (1995) Environ Health Perspect, 103 (SUPPL. 6), pp. 173-175; Ranney, R.E., Opperman, J.A., Maldoon, E., McMahon, F.G., Comparative metabolism of aspartame in experimental animals and humans (1976) J Toxicol Environ Health, 2, pp. 441-451; Soffritti, M., Belpoggi, F., Cevolani, D., Guarino, M., Padovani, M., Maltoni, C., Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats (2002) Ann NY Acad Sci, 982, pp. 46-69; Soffritti, M., Belpoggi, F., Degli Esposti, D., Lambertini, L., Aspartame induces lymphomas and leukaemias in rats (2005) Eur J Oncol, 10, pp. 107-116; Soffritti, M., Belpoggi, F., Lambertini, L., Lauriola, M., Padovani, M., Maltoni, C., Results of long-term experimental studies on the carcinogenicity of formaldehyde and acetaldhyde in rats (2002) Ann NY Acad Sci, 982, pp. 87-105; Soffritti, M., Belpoggi, F., Minardi, F., Bua, L., Maltoni, C., Mega-experiments to identify and assess diffuse carcinogenic risks (1999) Ann NY Acad Sci, 895, pp. 34-55; Soffritti, M., Belpoggi, F., Minardi, F., Maltoni, C., Ramazzini Foundation cancer program: History and major projects, life-span carcinogenicity bioassay design, chemicals studied, and results (2002) Ann NY Acad Sci, 982, pp. 26-45; Soffritti, M., Belpoggi, F., Minardi, F., Pinto, C., Maltoni, C., Chemopreventive effects of vitamin A (retinyl acetate and palmitate) and N-(4-hydroxyphenyl)retinamide in rats, with reference to mammary carcinoma (1992) Progress and Perpectives in Chemoprevention of Cancer, 79, pp. 47-60. , Serono Symposia Publications from Raven Press (De Palo G, Sporn MB, Veronesi U, eds). New York:Raven Press 79; Soffritti, M., Belpoggi, F., Padovani, M., Lauriola, M., Degli Esposti, D., Minardi, F., Life-time carcinogenicity bioassay of toluene given by stomach tube to Sprague-Dawley rats (2004) Eur J Oncol, 9, pp. 91-102; Soffritti, M., Maltoni, C., Maffei, F., Biagi, R., Formaldehyde: An experimental multipotent carcinogen (1989) Toxicol Ind Health, 5, pp. 699-730; Stegink, L.D., Aspartate and glutamate metabolism (1984) Aspartame Physiology and Biochemistry, pp. 47-76. , (Stegink LD, Filer LJ Jr, eds). New York:Marcel Dekker; Tomatis, L., Aitio, A., Wilbourn, J., Shuker, L., Human carcinogens so far identified (1989) Jpn J Cancer Res, 80, pp. 795-807","Soffritti, M.; Cesare Maltoni Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Via Saliceto 3, 40010 Bentivoglio, Bologna, Italy; email: crcfr@ramazzini.it",,,,,,,,00916765,,,16507461,"English","Environ. Health Perspect.",Article,Scopus,2-s2.0-33644771206
"Soffritti, M., Belpoggi, F., Esposti, D.D., Lambertini, L.","Aspartame induces lymphomas and leukaemias in rats",2005,"European Journal of Oncology","10","2",,"107","116",,49,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-25444468909&partnerID=40&md5=586efffdec30587e43a9133ba9d59b3a","Cancer Research Centre, European Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy; Centro di Ricerca sul Cancro, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Castello di Bentivoglio, 40010 Bentivoglio (BO), Italy","Soffritti, M., Cancer Research Centre, European Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy, Centro di Ricerca sul Cancro, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Castello di Bentivoglio, 40010 Bentivoglio (BO), Italy; Belpoggi, F., Cancer Research Centre, European Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy; Esposti, D.D., Cancer Research Centre, European Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy; Lambertini, L., Cancer Research Centre, European Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy","Aspartame, a widely used artificial sweetener, was administered with feed to male and female Sprague-Dawley rats (100-150/sex/group), 8 weeks-old at the start of the experiment, at concentrations of 100,000; 50,000; 10,000; 2,000; 400; 80 and 0 ppm. Treatment lasted until spontaneous death of the animals. In this report we present the first results showing that aspartame, in our experimental conditions, causes a statistically significant, dose-related increase in lymphomas and leukaemias in females. No statistically significant increase in malignant brain tumours was observed among animals from the treated groups as compared to controls.","Artificial sweetener; Aspartame; Carcinogenesis; Leukaemia; Lymphoma; Rats","aspartame; animal experiment; animal model; article; brain tumor; controlled study; female; leukemia; lymphoma; male; nonhuman; rat; survival",,"aspartame, 22839-47-0, 5910-52-1",,,,"Butchko, H.H., Stargel, W.W., Comer, C.P., Preclinical safety evaluation of aspartame (2002) Regul Toxicol Pharmacol, 35, pp. S7-S16; (2004), http://www.aspartame.org, Aspartame Information CenterRanney, R.E., Opperman, J.A., Maldoon, E., Comparative metabolism of aspartame in experimental animals and humans (1976) Toxicol Environ Health, 2, pp. 441-451; Aspartame: Commissioner's final decision (1981) Fed Regist, 46, pp. 38285-38308; Repubblica Italiana. Decreto Legislativo 116. Attuazione della direttiva n. 86/609/CEE in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici. Supplemento ordinario alla Gazzetta Ufficiale 1992; 40: 5-25Bailer, A.J., Portier, C.J., Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples (1988) Biometrics, 44, pp. 417-431; Portier, C.J., Bailer, A.J., Testing for increased carcinogenicity using a survival-adjusted quantal response test (1989) Fundam Appl Toxicol, 12, pp. 731-737; Piergorsh, W.W., Bailer, A.J., (1997) Statistics for Environmental Biology and Toxicology, , London: Chapman; Soffritti, M., Belpoggi, F., Lambertini, L., Results of long-term experimental studies on the carcinogenicity of formaldehyde and acetaldehyde in rats (2002) Ann NY Acad Sci, 982, pp. 87-105. , Mehlman MA, Bingham E, Landrigan PJ, et al. Carcinogenesis bioassays and protecting public health. Commemorating the life work of Cesare Maltoni and colleagues; Harris, N.L., Jaffe, E.S., Vardiman, J.W., WHO classification of tumours of haematopoietic and lymphoid tissues. Introduction (2001) Tumours of Haematopoietic and Lymphoid Tissues, pp. 12-13. , Jaffe ES, Harris NL, Stein H, et al. Lyon: IARC Press; Soffritti, M., Belpoggi, F., Cevolani, D., Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats (2002) Ann NY Acad Sci, 982, pp. 46-69. , Mehlman MA, Bingham E, Landrigan PJ, et al. Carcinogenesis bioassays and protecting public health. Commemorating the life work of Cesare Maltoni and colleagues; Belpoggi, F., Soffritti, M., Maltoni, C., Methyl-tertiary-butyl ether (MTBE), a gasoline additive, causes testicular and lymphohaematopoietic cancers in rats (1995) Toxicol Ind Health, 11, pp. 119-149; Soffritti, M., Maltoni, C., Maffei, F., Formaldehyde: An experimental multipotent carcinogen (1989) Toxicol Ind Health, 5, pp. 699-730; Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxy-2-Propanol, 88. , http://www.iarc.fr, in press; Huff, J., Long-term chemical carcinogenesis bioassays predict human cancer hazards. Issues, controversies, and uncertainties (1999) Ann NY Acad Sci, 895, pp. 56-79. , Bailer JA, Maltoni C, Bailar III JC, et al. Uncertainty in the risk assessment of environmental and occupational hazards; Tomatis, L., Aitio, A., Wilbourn, J., Human carcinogens so far identified (1989) Jpn J Cancer Res, 80, pp. 795-807; Rall, D.P., Can laboratory animal carcinogenicity studies predict cancer in exposed children? (1995) Environ Health Perspect, 103 (SUPPL. 6), pp. 173-175","Soffritti, M.; Centro di Ricerca sul Cancro, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Castello di Bentivoglio, 40010 Bentivoglio (BO), Italy; email: crcfr@ramazzini.it",,,,,,,,11286598,,EJOUA,,"English","Eur. J. Oncol.",Article,Scopus,2-s2.0-25444468909
"Belpoggi, F., Padovani, M., Soffritti, M.","Atmospheric pollution of urban areas and cancer risk [Inquinamento atmosferico delle aree urbane e rischio di cancro]",2005,"European Journal of Oncology","10","1",,"31","35",,,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-22844450864&partnerID=40&md5=5a73ac5a10b6912d2650b211bf6a0d5e","Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Bologna, Italy; Centro di Ricerca Sul Cancro, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Via Saliceto 3, 40010 Bentivoglio (BO), Italy","Belpoggi, F., Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Bologna, Italy; Padovani, M., Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Bologna, Italy; Soffritti, M., Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Bologna, Italy, Centro di Ricerca Sul Cancro, Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Via Saliceto 3, 40010 Bentivoglio (BO), Italy","Atmospheric pollution represents, above all in industrialized countries, one of the most important public health problems. It has been estimated that atmospheric pollution constitutes the main environmental risk factor and the eighth cause of death in Europe. It has been reported that fine particulate matter in the urban environment causes about 100,000 deaths per year and, in particular, that each 10 μg/m3 elevation in PM2.5 is related with approximately an 8% increased risk of lung cancer mortality. The present publication is aimed at drawing people's attention to data which has long been available and to other more recently known data regarding possible health risks (in particular carcinogenic) caused by the exposure to atmospheric pollutants, and, moreover, to propose measures for possible interventive strategies.","Atmospheric pollution; Cancer; Fuels; Gasoline; Octane enhancers","air pollution; cancer risk; data analysis; death; environmental exposure; Europe; exhaust gas; human; lung cancer; pollutant; review; urban area",,,,,,"Ezzati, M., Lopez, A.D., Rodgers, A., Selected major risk factors and global and regional burden of disease (2002) Lancet, 360, pp. 1347-1360; (2002) The World Health Report 2002 - Reducing Risks, Promoting Healthy Life, , http://www.who.int/whr/, Geneva: WHO; (2003), http://www.epa.gov/ttn/atw/nata/34poll.htmlSamet, J.M., Dominici, F., Curriero, F., Fine paniculate matter, air pollution and mortality in 20 US cities, 1987-1994 (2000) N Engl J Med, 343, pp. 1742-1749; Bell, M., Devis, D.L., Reassessment of the lethal London fog of 1952: Novel indicators of acute and chronic consequences of acute exposure to air pollution (2001) Environ Health Perspect, 109, pp. 389-394; Bell, M.L., McDermott, A., Zeger, S.L., Ozone and short-term mortality in 95 US urban communities, 1987-2000 (2004) JAMA, 292 (19), pp. 2372-2378; Dockery, D.W., Pope, C.A., Xu, X., An association between air pollution and mortality in six US cities (1993) N Engl Med, 329, pp. 1753-1759; Pope III, C.A., Burnett, R.T., Thun, M.J., Lung cancer, cardiopulmonary mortality, and long-term exposure to fine paniculate air pollution (2002) JAMA, 287, pp. 1132-1141; Maltoni, C., Ciliberti, A., Pinto, C., Results of long-term experimental carcinogenicity studies of the effects of gasoline, correlated fuels, and major gasoline aromatics on rats (1997) Ann NY Acad Sci, 837, pp. 15-52; Maltoni, C., Ciliberti, A., Cotti, G., Benzene, an experimental multipotential carcinogen: Results of the long-term bioassays performed at the Bologna Institute of Oncology (1989) Environ Health Perspect, 82, pp. 109-124; Soffritti, M., Belpoggi, F., Padovani, M., Lifetime carcinogenicity bioassays of toluene given by stomach tube to Sprague-Dawley rats (2004) Eur J Oncol, 9 (2), pp. 91-102; Soffritti, M., Belpoggi, F., Cevolani, D., Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats (2002) Ann NY Acad Sci, 982, pp. 46-69; Belpoggi, F., Soffritti, M., Filippini, F., Results of long-term experimental studies on the carcinogenicity of methyl-tert-butyl ether (1997) Ann NY Acad Sci, 837, pp. 77-95; Maltoni, C., Belpoggi, F., Soffritti, M., Comprehensive long-term experimental project of carcinogenicity bioassays on gasoline oxygenated additives: Plan and first report of results from the study on ethyl-tertiary butyl ether (ETBE) (1999) Eur J Oncol, 4 (5), pp. 493-508; Belpoggi, F., Soffritti, M., Minardi, F., Results of long-term carcinogenicity bioassays on tert-amyl-methyl-ether (TAME) and di-isopropyl-ether (DIPE) in rats (2002) Ann NY Acad Sci, 982, pp. 70-86; Biggeri, A., Bellini, P., Terracini, B., Metanalisi italiana degli studi sugli effetti a breve termine dell'inquinamento atmosferico 1996-2000 (2004) Epidemiol Prev, 28 (SUPPL. 4-5); Pope, C.A., Air pollution and health. Good news and bad (2004) N Engl J Med, 355, pp. 1132-1134","Belpoggi, F.; Fondazione Europea di Oncologia e Scienze Ambientali B. Ramazzini, Bologna, Italy",,,,,,,,11286598,,EJOUA,,"Italian","Eur. J. Oncol.",Review,Scopus,2-s2.0-22844450864
"Soffritti, M., Belpoggi, F., Padovani, M., Lauriola, M., Esposti, D.D., Minardi, F.","Life-time carcinogenicity bioassays of toluene given by stomach tube to Sprague-Dawley rats",2004,"European Journal of Oncology","9","2",,"91","102",,10,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-9344237107&partnerID=40&md5=abd9a3ea283ea590dd59cfc261cd5619","Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy; Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy","Soffritti, M., Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy, Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; Belpoggi, F., Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy; Padovani, M., Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy; Lauriola, M., Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy; Esposti, D.D., Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy; Minardi, F., Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy","Toluene was administered by stomach tube, in olive oil solution, to male and female Sprague-Dawley rats, 7 weeks old at the start of the experiment, at a concentration of 0, 500, 800 mg/kg b.w., 4 days weekly, for 104 weeks; the animals were kept under observation until natural death or 130 weeks (Experiment BT 903 and BT 910). Overall, in our experimental conditions, toluene has been shown to cause an increase in: 1) total malignant tumours; 2) malignant tumours of the subcutaneous tissue; 3) malignant mammary tumours; 4) carcinomas of the oral cavity, lips and tongue; and 5) haemolymphoreticular neoplasias. On the basis of these data, toluene should be considered a potential carcinogenic agent for exposed populations.","Carcinogenicity; Life-time bioassay; Rat; Toluene","gasoline; olive oil; tert butyl methyl ether; toluene; animal experiment; animal model; article; bioassay; breast carcinoma; carcinogenicity; contamination; controlled study; female; hemolymph; lifespan; male; malignant neoplastic disease; malignant transformation; mouse; mouth carcinoma; nonhuman; petrochemical industry; stomach tube; subcutaneous tissue",,"gasoline, 86290-81-5; olive oil, 8001-25-0; tert butyl methyl ether, 1634-04-4; toluene, 108-88-3",,,,"Cier, H.E., Toluene (1969) Kirk-Othmer Encyclopaedia of Chemical Technology, , New York, Interscience Publishers; Ozokwelu, E.D., Toluene (1997) Kir-Othmer Encyclopaedia of Chemical Technology, , New York, John Wiley & Sons; Fabri, R., Graeser, U., Simo, T.A., Toluene (1996) Ullmann's Encyclopedia of Industrial Chemistry, 5th Rev. Ed., A27, pp. 147-157. , Gerhartz W and Yamamoto YS, eds. Wheinheim VCH Publishers; Merian, E., Zander, M., Volatile aromatics (1982) Handbook of Environmental Chemistry, Vol. 3, Part B. Anthropogenic Compounds, 3, pp. 117-161. , Hutzinger O. Berlin: Springer; (1997) Hazardous Substances Data Bank (HSDB), , Bethesda, MD, record No. 131; Belpoggi, F., Soffritti, M., Maltoni, C., Methyl-tertiary-butyl ether (MTBE). A gasoline additive causes testicular and haematopoietic cancers in rats (1995) Toxicol Ind Health, 11, pp. 119-149; Belpoggi, F., Soffritti, M., Filippini, F., Results of long-term carcinogenicity of methyl-tertiary-butyl ether (1997) Ann NY Acad Sci, 837, pp. 77-95; Bird, M.G., Burleigh-Flayer, H.D., Chun, J.S., Oncogenicity studies of inhaled methyl-tertiary-butyl ether (MTBE) in CD-1 mice and F-344 rats (1997) J Appl Toxicol, 17 (S1), pp. S45-S55; (1989) Monographs on the Evaluation of the Carcinogenic Risk of Chemical to Humans. Vol. 47. Some Organic Solvents, Resin Monomers and Related Compounds, Pigments and Occupational Exposures in Paint Manufacture and Painting, 47. , Lyon: IARC; (1983) Health Assessment Document for Toluene, , (Publ. No. PB84-100056). Washington, DC: US Department of Commerce, National Technical Information Service; (1976) Vapor-Phase Organic Pollutants, , Washington, DC: National Academy of Sciences; Merian, E., The environmental chemistry of volatile hydrocarbons (1982) Toxicol Environ Chem, 5, pp. 167-175; (2000) Toluene, , http://www.epa.gov/cgi-bin/broker, Toxic Release Inventory (TRI) Chemicals. TRI on-site and off-site reported releases (in pounds), for facilities in all industries, for all chemicals, US; (1985) Toluene (Environmental Health Criteria 52), , Geneva: World Health Organization; Wilson, J.T., Enfield, C.G., Dunlap, W.J., Transport and fate of selected organic pollutants in a sandy soil (1981) J Environ Qual, 10, pp. 501-506; Wilson, J.T., McNabb, J.F., Wilson, R.H., Biotransformation of selected organic pollutants in ground water (1983) Dev Ind Microbiol, 24, pp. 225-233; Hollifield, H.C., Breder, C.V., Dannison, J.L., Container-derived contamination of maple syrup with methyl methacrylate, toluene, and styrene as determined by headspace gas-liquid chromatography (1980) J Assoc Off Anal Chem, 63, pp. 173-177; Löf, A., Wigaeus Hjelm, E., Colmsjö, A., Toxicokinetics of toluene and urinary excretion of hippuric acid after human exposure to 2H8-toluene (1993) Br J Ind Med, 50, pp. 55-59; Baelum, J., Molhave, L., Honoeè-Hansen, S., Hepatic metabolism of toluene after gastrointestinal uptake in humans (1993) Scand J Work Environ Health, 19, pp. 55-62; Henderson, H.F., Aromatic hydrocarbons-benzene and other alkylbenzenes. Toluene (2001) Patty's Toxicology, , Bingham E, Cohorssen B, Powell CH, Eds. New York: John Wiley & Sons; (1999) Monographs on the Evaluation of the Carcinogenic Risk of Chemical to Humans. Vol. 71. Part II. Re-Evaluation of Some Organic Chemicals, Hydrazine and Hydrogenperoxide, 71. , Lyon: IARC; Gibson, J.E., Hardisty, J.F., Chronic toxicity and oncogenicity bioassay of inhaled toluene in Fisher-344 rats (1983) Fundam Appl Toxicol, 3, pp. 315-319; (1990) Toxicology and Carcinogenesis Studies of Toluene (CAS No. 108-88-3) in F344/N Rats and B6C3F1 Mice (Inhalation Studies) (NTP TR 371), , NIH Publ. No. 90-2826, Research Triangle Park, NC; Huff, J., Absence of carcinogenic activity in Fisher rats and B6C3F1 mice following 103-week inhalation exposure to toluene (2003) Int J Occup Environ Health, 9, pp. 138-146; Gerin, M., Semiatycki, J., Desy, M., Associations between several sites of cancer and occupational exposure to benzene, toluene, xylene, and styrene: Results of a case-control study in Montreal (1998) Am J Ind Med, 34, pp. 144-156; Goldberg, M.S., Parent, M.E., Semiatycki, J., A case-control study of the relationship between the risk of colon cancer in men and exposures to occupational agents (2001) Am J Ind Med, 39, pp. 531-546; Wiebelt, H., Becker, N., Mortality in a cohort of toluene exposed employees (rotogravure printing plant workers) (1999) J Occup Environ Med, 41, pp. 1134-1139; Linet, M.S., Yin, S.N., Travis, L.B., Clinical features of Haematopoietic malignancies and related disorders among benzene-exposed workers in China (1996) Environ Health Perspect, 104 (SUPPL. 6), pp. 1353-1364; Maltoni, C., Conti, B., Cotti, G., Benzene: A multipotential carcinogen. Results of long-term bioassays performed at the Bologna Institute of Oncology (1983) Am J Ind Med, 4, pp. 589-630; Maltoni, C., Conti, B., Cotti, G., Experimental studies on benzene carcinogenicity at the Bologna Institute of Oncology: Current results and ongoing research (1985) Am J Ind Med, 7, pp. 415-446; Maltoni, C., Ciliberti, A., Pinto, C., Results of long-term experimental carcinogenicity of the effects of gasoline, correlated fuels, and major gasoline aromatics on rats (1997) Ann NY Acad Sci, 837, pp. 15-52. , Bingham E & Rall DP, Eds. Preventive strategies for living in a chemical world; Mandel, N., Evaluation of survival data on two new rank order statistics arising in its consideration (1966) Cancer Chemother, 50, pp. 163-170; Cox, D.R., Regression models and life-tables (1972) J R Stat Soc, 24, pp. 187-220; Huff, J., Chemicals studied and evaluated in long-term carcinogenesis bioassays by both the Ramazzini Foundation and the National Toxicology Program: In tribute to Cesare Maltoni and David Rall (2002) Ann N Y Acad Sci, 982, pp. 208-230; Soffritti, M., Belpoggi, F., Minardi, F., Maltoni, C., Ramazzini Foundation cancer program: History and major projects, life-span carcinogenicity bioassay design, chemicals studied, and results (2002) Ann N Y Acad Sci, 982, pp. 26-45","Soffritti, M.; Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy",,,,,,,,11286598,,EJOUA,,"English","Eur. J. Oncol.",Article,Scopus,2-s2.0-9344237107
"Soffritti, M., Minardi, F., Bua, L., Degli Esposti, D., Belpoggi, F.","First experimental evidence of peritoneal and pleural mesotheliomas induced by fluoro-edenite fibres present in Etnean volcanic material from Biancavilla (Sicily, Italy)",2004,"European Journal of Oncology","9","3",,"169","175",,25,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-12444257328&partnerID=40&md5=e6b0b7ef50fd6e2e34cb52a01a8bc4a5","Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy; Centro di Ricerca sul Cancro, Fondazione Europea Oncol. S. A. B.R., Castello di Bentivoglio, 40010 Bentivoglio (BO), Italy","Soffritti, M., Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy, Centro di Ricerca sul Cancro, Fondazione Europea Oncol. S. A. B.R., Castello di Bentivoglio, 40010 Bentivoglio (BO), Italy; Minardi, F., Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy; Bua, L., Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy; Degli Esposti, D., Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy; Belpoggi, F., Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy","A total of 17 cases of pleural mesothelioma were ascertained in the town of Biancavilla (Sicily, Italy), on the south-west slopes of the volcano Etna, from 1980 to 1997. Occupational exposure to asbestos was considered possible in only 2 of them, though it could not be excluded in 5 other cases: for the remaining 10 cases the hypothesis of environmental exposure was deemed reasonable. On the basis of this evaluation, a mineralogic study was started in the area of Biancavilla, where incohesive volcanic material has largely been used in the building industry and road paving since the 1960s-1970s. This study led to the identification of the new fluoro-edenite amphibole with prismatic, acicular and fibrous asbestiform morphologies. With a view to acquiring more detailed information on the possible causal relationship between exposure to this mineral and the onset of mesotheliomas, the mineral was tested, by a single intraperitoneal or intrapleural injection, on groups of 80 Sprague-Dawley rats (40 males and 40 females) (fibrous fluoroedenite) and on a group of 30 rats (15 males and 15 females) (powdered prismatic fluoro-edenite), 8 weeks old at the start of the study, at a dose of 25 mg in 1 cc of water; 1 cc of water was administered by intraperitoneal injection to 80 rats (controls). One hundred and nine weeks after the treatment, a high incidence of peritoneal and, to a lesser extent, pleural mesotheliomas was observed in the animals treated with fibrous fluoroedenite; this incidence is comparable to that obtained with various kinds of asbestos. Up to now no cases of mesothelioma have been observed in the group treated with prismatic fluoro-edenite, or in the control group.","Asbestiform amphiboles; Carcinogenicity; Fluoro-edenite; Lava stone; Mesothelioma; Rat","amphibole; asbestos; fluoroedenite; mineral; unclassified drug; animal model; animal tissue; article; building industry; carcinogenicity; controlled study; environmental exposure; female; histopathology; Italy; male; mesothelioma; nonhuman; occupational exposure; peritoneum mesothelioma; peritoneum tumor; pleura mesothelioma; pleura tumor; rat; volcano",,"amphibole, 1318-09-8; asbestos, 1332-21-4",,,,"Di Paola, M., Mastrantonio, M., Carboni, M., (1996) La Mortalità per Tumore Maligno della Pleura in Italia Negli Anni 1988-1992, , Roma: Istituto Superiore di Sanità, Rapporti ISTISAN 96/40; Paoletti, L., Battisti, D., Bruno, C., Unusually high incidence of malignant pleural mesothelioma in a town of eastern Sicily: An epidemiological and environmental study (2000) Arch Environ Health, 55, pp. 392-398; Pasetto, R., Bruni, B., Bruno, C., Problematiche sanitarie della fibra anfibolica di Biancavilla. Aspetti epidemiologici, clinici e sperimentali (2004) Notiziario Istituto Superiore di Sanità, 17 (1), pp. 8-12; Gianfagna, A., Paoletti, L., Ventura, P., Segnalazione di fibre di amianto anfibolico nei prodotti lavici metasomatizzati di Monte Calvario, Biancavilla (Sicilia orientale). Plinius, suppl. (1997) Eur J Mineral, 18, pp. 117-119; Gianfagna, A., Oberti, R., Fluoro-edenite from Biancavilla (Catania, Sicily, Italy): Crystal chemistry of a new amphibole end-member (2001) Am Mineral, 86, pp. 1489-1493; Gianfagna, A., Ballirano, P., Bellatreccia, F., Characterization of amphibole fibres linked to mesothelioma in the area of Biancavilla, Eastern Sicily, Italy (2003) Mineralogical Magazine, 67 (6), pp. 1221-1229; Comba, P., Gianfagna, A., Paoletti, L., Pleural mesothelioma cases in Biancavilla are related a new fluoro-edenite fibrous amphibole (2003) Arch Environ Health, 58, pp. 229-232; Maltoni, C., Minardi, F., Recent results of carcinogenicity bioassays of fibres and other particulate materials (1989) Non-occupational Exposure to Mineral Fibres, pp. 46-53. , Bignon J, Peto J, Saracci R. Lyon: IARC Scientific Publications No. 90","Soffritti, M.; Centro di Ricerca sul Cancro, Fondazione Europea Oncol. S. A. B.R., Castello di Bentivoglio, 40010 Bentivoglio (BO), Italy; email: crcfr@tin.it",,,,,,,,11286598,,EJOUA,,"English","Eur. J. Oncol.",Article,Scopus,2-s2.0-12444257328
"Minardi, F., Belpoggi, F., Soffritti, M., Ciliberti, A., Lauriola, M., Cattin, E., Maltoni, C.","Results of long-term carcinogenicity bioassay on vinyl acetate monomer in Sprague-Dawley rats",2002,"Annals of the New York Academy of Sciences","982",,,"106","122",,12,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0036965138&partnerID=40&md5=48bc099a13688a5f5c680b2db1e9df17","Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy","Minardi, F., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Belpoggi, F., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Soffritti, M., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy, Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; Ciliberti, A., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Lauriola, M., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Cattin, E., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Maltoni, C., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy","Vinyl acetate monomer (VAM) was administered in drinking water supplied ad libitum at doses of 5,000, 1,000, and 0 ppm (v/v) to 17-week-old Sprague-Dawley rats (breeders) and to 12-day embryos (offspring). Treatment lasted for 104 weeks; thereafter, animals were kept under control conditions until spontaneous death. VAM was found to cause an increase in total malignant tumors and in carcinomas and/or precursor lesions of the oral cavity, lips, tongue, esophagus, and forestomach. Based on these data, VAM must be considered a multipotent carcinogen.","Carcinogenicity; Long-term bioassay; Rat; Vinyl acetate monomer","carcinogen; drinking water; vinyl acetate; animal model; bioassay; cancer; cancer research; chemical carcinogenesis; conference paper; controlled study; digestive system tumor; embryo; esophagus tumor; female; head and neck tumor; lip tumor; long term exposure; male; mouth tumor; nonhuman; rat; stomach tumor; tongue tumor; Animals; Biological Assay; Body Weight; Carcinogens; Female; Male; Neoplasms; Rats; Rats, Sprague-Dawley; Reference Values; Vinyl Compounds; Animalia",,"vinyl acetate, 108-05-4; Carcinogens; vinyl acetate, 108-05-4; Vinyl Compounds",,,,"(1995) Monographs on the Evaluation of the Carcinogenic Risks to Humans, Vol. 63. Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals, 63. , IARC. Lyon, France; Roscher, G., Hofmann, E., Armstrong Adey, K., Vinyl acetate (1983) Ullmann's Encyclopaedia of Industrial Chemistry, 4th Edit., 23, pp. 597-618. , W. Gerhartz, C. Mayer, D. Moegling, et al., Eds. VCH Publishers. New York; Daniels, W., Vinyl acetate monomer (1983) Kirk-Othmer Encyclopedia of Chemical Technology, 3rd Edit., 23, pp. 817-848. , H.F. Mark, D. F. Othmer & C.G. Overberger, et al., Eds. John Wiley & Sons. New York; (1993) Vinyl Acetate, , Ispra, JRC-CEC, last update: 02.09.1993; Sax, N.I., Lewis, R.W., (1987) Hawley's Condensed Chemical Dictionary. 11th Edit., 491, pp. 945-946. , Van Nostrand Reinhold. New York; Rosato, D.V., (1993) Rosato's Plastics Encyclopedia and Dictionary, 573, pp. 235-236. , New York; (1992) Toxicological Profile for Vinyl Acetate, , Clement International Corp. Contract No. 205-88-0608. United States Department of Health and Human Services. Washington DC; Pellizzari, E.D., Analysis for organic vapor emissions near industrial and chemical waste disposal sites (1982) Environ. Sci. Technol., 16, pp. 781-785; Stepanyan, I.S., Padaryan, G.M., Airapetyan, L.K., Ionization-chromatographic method for determining some components of waste waters from the plant ""Polivinilatsetat."" (1970) Prom. Arm., 9, pp. 76-78. , in Russian; McNeal, T.P., Hollifield, H.C., Determination of volatile chemicals released from microwave-heat-susceptor food packaging (1993) J. Assoc. Off. Anal. Chem. Int., 76, pp. 1268-1275; Guerin, J.C., Chemical composition of cigarette smoke (1970) Banbury Report: A Safe Cigarette?, 3, pp. 191-204. , G.B. Gori & F.G. Book, Eds. CSH Press. Cold Spring Harbor, NY; Simon, P., Filser, V.G., Bolt, H.M., Metabolism and pharmacokinetics of vinyl acetate (1985) Arch. Toxicol., 57, pp. 19-23; Filov, V.A., The fate of complex esters of vinyl alcohol and fatty acid in the body (1959) Gig. Tr. Zabol., G3G, pp. 42-46; (1985) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 36. Allyl Compounds, Aldehydes, Epoxides and Peroxides, 36. , IARC. Lyon; Maltoni, C., Lefemine, G., Carcinogenicity bioassays of vinyl chloride. I. Research plan and early results (1974) Environ. Res., 7, pp. 387-405; Maltoni, C., Lefemine, G., Chieco, P., Vinyl chloride carcinogenensis: Current results and perspectives (1974) Med. Lav., 65, pp. 421-444; Maltoni, C., Lefemine, G., Carcinogenicity bioassays of vinyl chloride: Current results (1975) Ann. N.Y. Acad. Sci., 246, pp. 195-218; Bogdanffy, M.S., Dreef-Van Der Meulen, H.C., Beems, R.B., Chronic toxicity and oncogenicity inhalation study with vinyl acetate in the rat and mouse (1994) Fundam. Appl. Toxicol., 23, pp. 215-229; Lijinski, W., Reuber, M.D., Chronic toxicity studies of vinyl acetate in Fischer rats (1983) Toxicol. Appl. Pharmacol., 68, pp. 43-53; Bogdanffy, M.S., Tyler, T.R., Vinegar, M.B., Chronic toxicity and oncogenicity study with vinyl acetate in the rat: In utero exposure in drinking water (1994) Fundam. Appl. Toxicol., 23, pp. 206-214; (1997) Carcinogenesis Study of Vinyl Acetate (Drinking Water Study) in Rats and Mice, with Cover Letter from Japan Bioassay Research Center Dated 1/31/97, , EPA/OTS, FYI-OTS-0297-1286. Washington, DC; Waxweiler, R.J., Smith, A.H., Falk, H., Excess lung cancer in a synthetic chemical plant (1981) Environ. Health Perspect., 41, pp. 159-165; Ott, M.G., Teta, M.J., Greenberg, H.L., Lymphatic and hematopoietic tissue cancer in a chemical manufacturing environment (1989) Am. J. Ind. Med., 16, pp. 631-643; Maltoni, C., Ciliberti, A., Lefemine, G., Results of a long-term experimental study on the carcinogenicity of vinyl acetate monomer in mice (1997) Ann. N.Y. Acad. Sci., 837, pp. 209-238. , Preventive Strategies for Living in a Chemical World. E. Bingham & D.P. Rall, Eds; Soffritti, M., Belpoggi, F., Minardi, F., (2002) Results of a Long-Term Carcinogenicity Bioassay on Vinyl Acetate Monomer in Wistar Rats, , In press; Soffritti, M., Belpoggi, F., Cevolani, D., Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats (2002) Ann. N.Y. Acad. Sci., 982, pp. 46-69; Noble, A.C., Flat, R.A., Forrey, R.R., Wine headspace analysis. Reproducibility and application to varietal classification (1980) J. Agric. Food Chem., 28, pp. 346-353; Mantel, A., Rauzy, S., Dosages des monomers et solvents legers dans les matériaux plastiques en contact avec l'eau et dans l'eau en contact avec ces materiaux (1983) Rev. Fr. Sci. Eau, 2, pp. 255-256","Soffritti, M.; Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; email: crcfr@tin.it",,,,,,,,00778923,,ANYAA,12562631,"English","Ann. New York Acad. Sci.",Conference Paper,Scopus,2-s2.0-0036965138
"Soffritti, M., Belpoggi, F., Lambertini, L., Lauriola, M., Padovani, M., Maltoni, C.","Results of long-term experimental studies on the carcinogenicity of formaldehyde and acetaldehyde in rats",2002,"Annals of the New York Academy of Sciences","982",,,"87","105",,56,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0036965158&partnerID=40&md5=db9dcd309abc50ee6eb319e7b8edfcb9","Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy","Soffritti, M., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy, Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; Belpoggi, F., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Lambertini, L., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Lauriola, M., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Padovani, M., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Maltoni, C., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy","Formaldehyde was administered for 104 weeks in drinking water supplied ad libitum at concentrations of 1500, 1000, 500, 100, 50, 10, or 0 mg/L to groups of 50 male and 50 female Sprague-Dawley rats beginning at seven weeks of age. Control animals (100 males and 100 females) received tap water only. Acetaldehyde was administered to 50 male and 50 female Sprague-Dawley rats beginning at six weeks of age at concentrations of 2,500, 1,500, 500, 250, 50, or 0 mg/L. Animals were kept under observation until spontaneous death. Formaldehyde and acetaldehyde were found to produce an increase in total malignant tumors in the treated groups and showed specific carcinogenic effects on various organs and tissues.","Acetaldehyde; Carcinogenicity; Formaldehyde; Long-term bioassay; Rat","acetaldehyde; carcinogen; drinking water; formaldehyde; animal model; bioassay; breast tumor; cancer; cancer research; chemical carcinogenesis; conference paper; controlled study; female; hematopoietic system tumor; intestine tumor; long term exposure; male; nonhuman; rat; stomach tumor; testis tumor; Acetaldehyde; Animals; Carcinogens; Female; Formaldehyde; Male; Neoplasms; Rats; Rats, Sprague-Dawley; Animalia",,"acetaldehyde, 75-07-0; formaldehyde, 50-00-0; Acetaldehyde, 75-07-0; Carcinogens; Formaldehyde, 50-00-0",,,,"Reuss, G., Disteldorf, W., Grundler, O., Hilt, A., Formaldehyde (1988) Ullmann's Encyclopedia of Industrial Chemistry, 5th Rev. Edit., A11, pp. 619-651. , W. Gerhartz, Y.S. Yamamoto, B. Elvers, J.F. Rounsaville & G. Schulz, Eds. VCH Publishers. New York; Gerberich, H.R., Seaman, G.C., Formaldehyde (1994) Kirk-Othmer Encyclopedia of Chemical Technology, 11, pp. 929-951. , J.I. Kroschwitz & M. Howe-Grant, Eds. John Wiley & Sons. New York; Smith, R., Environmental economics and the new paradigm (1993) Chem. Ind. Newsl., NOV.-DEC., p. 8; Formaldehyde (1989) Environmental Health Criteria, 89. , International Program on Chemical Safety. Geneva; Wood dust and formaldehyde (1995) Monographs on the Evaluation of Carcinogenic Risks to Humans, 62, pp. 217-362. , IARC. Lyon; Preuss, P.W., Dailey, R.L., Lehman, E.S., Exposure to formaldehyde (1985) Adv. Chem. Ser., 210, pp. 247-259. , Formaldehyde. Analytical Chemistry and Toxicology. V. Turoski, Ed; Gammage, R.G., Travis, C.C., Formaldehyde exposure and risk in mobile homes (1989) The Risk Assessment of Environmental and Human Health Hazard: A Textbook of Case Studies, pp. 601-611. , D.J. Paustenbach, Ed. John Wiley & Sons. New York; (1980) Formaldehyde: An Assessment of Its Health Effects, , National Academy Press. Washington, D.C; Health effects of formaldehyde (1981) Formaldehyde and Other Aldehydes, pp. 175-220. , National Academy Press. Washington, D.C; Olson, R.N., (1998) A Study of the Effects of Oxygenated Gasoline on Particulate Concentrations in Salt Lake and Utah Counties During the Winter Season, 1994-95, , http://members.mint.net/troberts/julian/DADW120.html, Air Monitoring Center Study 126-95, State of Utah, Division of Air Quality; Medinsky, M.A., Dorman, D.C., Assessing risks of low-level methanol exposure (1994) CIIT Act., 14, pp. 1-7; Auerbach, C., Moutschen-Dahmen, M., Moutschen, J., Genetic and cytogenetical effects of formaldehyde and related compounds (1977) Mutat. Res., 39, pp. 317-362; Formaldehyde (1982) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Some Industrial Chemicals and Dyestuffs, 29, pp. 354-389. , IARC. Lyon; Swemberg, J.A., Barrow, C.S., Boreiko, C.J., Non linear biological responses to formaldehyde and their implications for carcinogenic risk assessment (1983) Carcinogenesis, 4, pp. 945-952; Report on the consensus workshop on formaldehyde (1984) Environ. Health Perspect., 58, pp. 323-381; Migliore, L., Ventura, L., Barale, R., Micronuclei and nuclear anomalies induced in the gastro-intestinal epithelium of rats treated with formaldehyde (1989) Mutagenesis, 4, pp. 327-334; Dallas, C.E., Scott, M.J., Ward, J.B., Cytogenetic analysis of pulmonary lavage and bone marrow cells of rats repeated formaldehyde inhalation (1992) J. Appl. Toxicol., 12, pp. 199-203; Kerns, W.D., Pavkov, K.L., Donofrio, K.L., Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure (1983) Cancer Res., 43, pp. 4382-4392; Dalbey, C.E., Formaldehyde and tumors in hamster respiratory tract (1982) Toxicology, 24, pp. 9-14; Till, H.P., Woutersen, R.A., Feron, V.J., Two-year drinking-water study of formaldehyde in rats (1989) Food Chem. Toxicol., 27, pp. 77-87; Soffritti, M., Maltoni, C., Maffei, F., Biagi, R., Formaldehyde: An experimental multipotential carcinogen (1989) Toxicol. Ind. Health, 5, pp. 699-730; Hagermeyer, H.J., Acetaldehyde (1978) Kirk-Othmer Encyclopedia of Chemical Technology, 3rd Edit., 1, pp. 97-112. , M. Grayson, Ed. John Wiley & Sons. New York; Hagemeyer, H.J., Acetaldehyde (1991) Kirk-Othmer Encyclopedia of Chemical Technology, 4th Edit., 1, pp. 94-109. , J.I. Kroschwitz & M. Howe-Grant, Eds. John Wiley & Sons. New York; Acetaldehyde (1979) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Some Monomers, Plastics and Synthetic Elastomers, and Acrolein, 19, pp. 341-366. , IARC. Lyon; (1998) Hazardous Substances Data Bank (HSDB) Database, , Bethesda, MD [Record No. 230]; Jira, R., Laib, R.J., Bolt, H.M., Acetaldehyde (1985) Encyclopedia of Industrials Chemistry, A1, pp. 31-44. , W. Gerhartz & Y.S. Yamamoto, Eds.. VCH Publishers. Deerfield Beach, FL; Hoffmann, D., Brunnemann, K.D., Gori, G.B., On the carcinogenicity of marijuana smoke (1975) Rev. Adv. Phytochem., 9, pp. 63-81; Lynch, C., Lim, C.K., Thomas, M., Assay of blood and tissue aldehydes by HPLC analysis of their 2,4-dinitrophenylhydrazine adducts (1983) Clin. Chim. Acta, 130, pp. 117-122; Pellizzari, E.D., Hartwell, T.D., Harris, B.S.H., Purgeable organic compounds in mother's milk (1982) Bull. Environ. Contain. Toxicol., 28, pp. 322-328; Eriksson, C.J., Human blood acetaldehyde concentration during ethanol oxidation (1983) Pharmacol. Biochem. Behav., 18 (SUPPL. 1), pp. 141-150; Brien, J.F., Loomis, C.W., Pharmacology of acetaldehyde (1983) Can. J. Physiol. Pharmacol., 61, pp. 1-22; Acetaldehyde (1985) Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Allyl Compounds, Aldehydes, Epoxides and Peroxides, 36, pp. 99-132. , IARC. Lyon; Acetaldehyde (1999) Monographs on the Evaluation of the Carcinogenic Risk to Humans, Re-Evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide (Part Two), 71, pp. 319-335. , IARC. Lyon; Fang, J.L., Vaca, C.E., Detection of DNA adducts of acetaldehyde in peripheral white blood cells of alcohol abusers (1997) Carcinogenesis, 18, pp. 627-632; Woutersen, R.A., Appelman, L.M., Van Gardener-Hoetmer, A., Inhalation toxicity of acetaldehyde in rats. III. Cacinogenicity study (1986) Toxicology, 41, pp. 213-231; Feron, V.J., Til, H.P., De Vrijer, F., Aldehydes: Occurrence, carcinogenic potential, mechanism of action and risk assessment (1991) Mutat. Res., 259, pp. 363-385; Soffritti, M., Belpoggi, F., Cevolani, D., Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats (2002) Ann. N.Y. Acad. Sci., 982 (THIS VOLUME)","Soffritti, M.; Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; email: crcfr@tin.it",,,,,,,,00778923,,ANYAA,12562630,"English","Ann. New York Acad. Sci.",Conference Paper,Scopus,2-s2.0-0036965158
"Belpoggi, F., Soffritti, M., Minardi, F., Ciliberti, A., Padovani, M., Cattin, E., Maltoni, C.","Results of a long-term carcinogenicity bioassay on vinyl acetate monomer in Wistar rats",2002,"European Journal of Oncology","7","4",,"279","293",,2,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0038203180&partnerID=40&md5=c4e9eb76b7bcd3f4d8b7f8dad862b8bb","Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy; Institute of Oncology F. Addarii, S. Orsola-Malpighi Hospital, Bologna, Italy; Centro di Ricerca sul Cancro, Fond. Europ. Oncol./Sci. A. B. R., 40010 Bentivoglio (BO), Italy","Belpoggi, F., Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy; Soffritti, M., Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy, Centro di Ricerca sul Cancro, Fond. Europ. Oncol./Sci. A. B. R., 40010 Bentivoglio (BO), Italy; Minardi, F., Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy; Ciliberti, A., Institute of Oncology F. Addarii, S. Orsola-Malpighi Hospital, Bologna, Italy; Padovani, M., Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy; Cattin, E., Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy; Maltoni, C., Cancer Research Centre, Europ. Ramazzini Found. Oncol./E. S., Bologna, Italy","Vinyl acetate monomer (VAM) was administered in drinking water, supplied ad libitum, at doses of 5,000, 1,000, and 0 ppm (v/v), to Wistar rats, 17-week-old (breeders) and to 12-day-embryos (offspring) at the start of the experiment. The treatment lasted for 104 weeks, and then the animals were kept under control until spontaneous death. VAM has been shown to cause an increase in: 1) total malignant tumours; 2) carcinomas and/or precursor lesions of the oral cavity, tongue, oesophagus, and forestomach; and 3) uterine tumours. On the basis of these data, VAM must be considered a multipotent carcinogen.","Carcinogenicity; Long-term bioassay; Rat; Vinyl acetate monomer","carcinogen; drinking water; vinyl acetate; acanthoma; angiosarcoma; animal experiment; animal model; animal tissue; article; bile duct carcinoma; bioassay; body weight; carcinogenicity; controlled study; dysplasia; esophagus carcinoma; esthesioneuroblastoma; female; fibroadenoma; fibroma; forestomach; histopathology; leiomyosarcoma; leukemia; Leydig cell tumor; lipoma; liposarcoma; liver cell carcinoma; lymphoma; male; malignant neoplastic disease; meningioma; mouth carcinoma; nephroblastoma; nonhuman; oligodendroglioma; osteosarcoma; pancreas islet cell carcinoma; plastic industry; rat; rat strain; squamous cell carcinoma; stomach carcinoma; thymoma; thyroid follicular carcinoma; tongue carcinoma; uterus tumor",,"vinyl acetate, 108-05-4",,,,"(1995) Monographs on the Evaluation of the Carcinogenic Risks to Humans. Vol. 63. Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals, 63. , Lyon: IARC; Maltoni, C., Ciliberti, A., Lefemine, G., Results of a long-term experimental study on the carcinogenicity of vinyl acetate monomer in mice (1997) Ann NY Acad Sci, 837, pp. 209-238. , In Bingham E & Rall DP, Eds. Preventive strategies for living in a chemical world; Minardi, F., Belpoggi, F., Soffritti, M., Results of a long-term carcinogenicity bioassay on vinyl acetate monomer in Sprague-Dawley rats (2002) Ann NY Acad Sci, 982, pp. 106-122. , Mehlman MA, Bingham E, Landrigan PJ, et al., Eds. Carcinogenesis bioassays and protecting public health: commemorating the lifework of Cesare Maltoni and colleagues; Roscher, G., Hofmann, E., Armstrong Adey, K., Vinyl acetate (1983) Ullmann's Encyclopaedia of Industrial Chemistry, 4th Ed., 23, pp. 597-618. , Gerhartz W, Mayer C, Moegling D, et al., Eds. New York: VCH Publishers; Daniels, W., Vinyl acetate monomer (1983) Kirk-Othmer Encyclopedia of Chemical Technology, 3rd Ed., 23, pp. 817-848. , Mark HF, Othmer DF, Overberger CG, et al. Eds. New York: John Wiley & Sons; (1993) Vinyl Acetate, , Ispra, JRC-CEC, last update: 02.09; (1994) Directory of World Chemical Producers 1995-1996. Standard Edition: 706, , Dallas, TX; Sax, N.I., Lewis, R.W., (1987) Hawley's Condensed Chemical Dictionary. 11th Ed., pp. 945-946. , 491, 1222. New York: Van Nostrand Reinhold, NY; Rosato, D.V., (1993) Rosato's Plastics/Encyclopedia and Dictionary, 573, pp. 235-236. , New York: Hanser Ed; (1992) Toxicological Profile for Vinyl Acetate, , Clement International Corp. Contract No. 205-88-0608. United States Department of Health and Human Services. Washington, DC; Pellizzari, E.D., Analysis for organic vapor emissions near industrial and chemical waste disposal sites (1982) Environ Sci Technol, 16, pp. 781-785; Stepanyan, I.S., Padaryan, G.M., Airapetyan, L.K., Ionization-chromatographic method for determining some components of waste waters from the plant ""Polivinilatsetat"" (1970) Prom Arm, 9, pp. 76-78. , in Russian; McNeal, T.P., Hollifield, H.C., Determination of volatile chemicals released from microwave-heat-susceptor food packaging (1993) J Assoc Off Anal Chem Int, 76, pp. 1268-1275; Guerin, J.C., Chemical composition of cigarette smoke (1970) Banbury Report: A Safe Cigarette?, 3, pp. 191-204. , Gori GB, Bock FG, Eds. Cold Spring Harbor, NY: CSH Press; Maltoni, C., Lefemine, G., Carcinogenicity bioassays of vinyl chloride. I. Research plan and early results (1974) Environ Res, 7, pp. 387-405; Maltoni, C., Lefemine, G., Chieco, P., Vinyl chloride carcinogenesis: Current results and perspectives (1974) Med Lav, 65, pp. 421-444; Maltoni, C., Lefemine, G., Carcinogenicity bioassays of vinyl chloride: Current results (1975) Ann NY Acad Sci, 246, pp. 195-218; Bogdanffy, M.S., Dreef-van der Meulen, H.C., Beems, R.B., Chronic toxicity and oncogenicity inhalation study with vinyl acetate in the rat and mouse (1994) Fundam Appl Toxicol, 23, pp. 215-229; Lijinski, W., Reuber, M.D., Chronic toxicity studies of vinyl acetate in Fischer rats (1983) Toxicol Appl Pharmacol, 68, pp. 43-53; Bogdanffy, M.S., Tyler, T.R., Vinegar, M.B., Chronic toxicity and oncogenicity study with vinyl acetate in the rat: In utero exposure in drinking water (1994) Fundam Appl Toxicol, 23, pp. 206-214; (1997) Carcinogenesis Study of Vinyl Acetate (Drinking Water Study) in Rats and Mice, with Cover Letter from Japan Bioassay Research Center Dated 1/31/97, , EPA/OTS, FYI-OTS-0297-1286. Washington, DC; Waxweiler, R.J., Smith, A.H., Falk, H., Excess lung cancer in a synthetic chemical plant (1981) Environ Health Perspect, 41, pp. 159-165; Ott, M.G., Teta, M.J., Greenberg, H.L., Lymphatic and hematopoietic tissue cancer in a chemical manufacturing environment (1989) Am J Ind Med, 16, pp. 631-643; Noble, A., Flat, C.R.A., Forrey, R.R., Wine headspace analysis. Reproducibility and application to varietal classification (1980) J Agric Food Chem, 28, pp. 346-353; Montiel, A., Rauzy, S., Dosage des monomères et solvants légers dans les matériaux plastiques en contact avec l'eau et dans l'eau en contact avec ces matériaux (1983) Rev Fr Sci Eau, 2, pp. 255-266","Soffritti, M.; Centro di Ricerca sul Cancro, Fond. Europ. Oncol./Sci. A. B. R., 40010 Bentivoglio (BO), Italy",,,,,,,,11286598,,EJOUA,,"English","Eur. J. Oncol.",Article,Scopus,2-s2.0-0038203180
"Belpoggi, F., Soffritti, M., Guarino, M., Lambertini, L., Cevolani, D., Maltoni, C.","Results of long-term experimental studies on the carcinogenicity of ethylene-bis-dithiocarbamate (Mancozeb) in rats",2002,"Annals of the New York Academy of Sciences","982",,,"123","136",,44,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0036960389&partnerID=40&md5=1a83721102304ea512801e696775126a","Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy","Belpoggi, F., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Soffritti, M., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy, Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; Guarino, M., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Lambertini, L., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Cevolani, D., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Maltoni, C., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy","Mancozeb, an ethylene-bis-dithiocarbamate (EBDC), has been one of the most commonly used fungicides in commercial use for several decades. Nevertheless, up to now, no adequate published experimental studies on the carcinogenicity of Mancozeb have been published. Because of the importance of the compound and of the number of people potentially exposed (workers engaged in the production and use of the fungicide, people living in agricultural areas where the compound is sprayed, and people consuming polluted products), a long-term experimental study of Mancozeb was begun at the Cancer Research Center of the Ramazzini Foundation. Groups of 150 male and female Sprague-Dawley rats, 8 weeks old at the start of the treatment, were administered Mancozeb at the concentration of 1000, 500, 100, 10, and 0 ppm in feed supplied ad libitum for 104 weeks. At the end of the treatment, animals were kept under controlled conditions until spontaneous death. Mancozeb caused an increase in (1) total malignant tumors, (2) malignant mammary tumors, (3) Zymbal gland and ear duct carcinomas, (4) hepatocarcinomas, (5) malignant tumors of the pancreas, (6) malignant tumors of the thyroid gland, (7) osteosarcomas of the bones of the head, and (8) hemolymphoreticular neoplasias. On the basis of these data, Mancozeb must be considered a multipotent carcinogenic agent.","Carcinogenicity; Ethylene-bis-dithiocarbamate; Long-term bioassay; Mancozeb; Rat","carcinogen; mancozeb; animal model; bioassay; cancer; cancer research; chemical carcinogenesis; conference paper; controlled study; digestive system tumor; female; head and neck tumor; hematopoietic system tumor; leukemia; liver cell carcinoma; long term exposure; lymphoma; male; nonhuman; osteosarcoma; pancreas tumor; rat; thyroid tumor; Animals; Carcinogens; Dose-Response Relationship, Drug; Female; Fungicides, Industrial; Male; Maneb; Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Zineb; Animalia",,"mancozeb, 8018-01-7; Carcinogens; Fungicides, Industrial; mancozeb, 8018-01-7; Maneb, 12427-38-2; Zineb, 12122-67-7",,,,"(1987) Guidance for the Reregistration of Pesticide Products Containing Mancozeb as the Active Ingredient, , April 1987. EPA Office of Pesticide Programs. Washington, DC; (1991) Monographs on the Evaluation of the Carcinogenic Risks to Humans. Vol. 53. Insecticides, 53. , IARC. Lyon; (1988) Dithiocarbamate Pesticides, Ethylenethiourea, and Propylenethiourea: A General Introduction. Environmental Health Criteria, 78. , WHO. Geneva; Battelle's Agrochemical Data Bank. 1983(1984) Health and Environmental Effects Profile for Mancozeb, , Report No.: EPA/600/X-84/129. Washington D.C; Ligocki, M.P., Pankow, J.F., Measurements of the gas/particle distribution of atmospheric organic compounds (1989) Environ. Sci. & Technol., 23, pp. 75-83; Houeto, P., Bindoula, G., Hoffman, J.R., Ethylenebisdithiocarbamates and ethylenethiourea: Possible human health hazards (1995) Environ. Health Perspect., 103, pp. 568-573; Newsome, W.H., Laver, G.W., Effects of boiling on the formation of ethylenethiourea in zineb-treated foods (1973) Bull. Environ. Contam. Toxicol., 10, pp. 151-154; Warting, C.R., (1979) The Pesticide Manual. A World Compendium, 324. VI Edit., , British Crop Protection Council. Croydon; Lu, M.H., Kennedy G.L., Jr., Teratogenic evaluation of mancozeb in the rat following inhalation exposure (1986) Toxicol. Appl. Pharmacol., 84, pp. 355-368; Larsson, K.S., Arnander, C., Cekanova, E., Kjellberg, M., Studies of teratogenic effects of the dithiocarbamates maneb, mancozeb, and propineb (1976) Teratology, 14, pp. 171-184; Jabloicka, J., Polakova, H., Karelova, J., Vargova, M., Analysis of chromosome aberrations and sister-chromatid exchanges in peripheral blood lymphocytes of workers with occupational exposure to the mancozeb-containing fungicide Novozir Mn80 (1989) Mutat. Res., 224, pp. 143-146; Pesticide residues in food. 1993 (1993) Joint FAO/WHO Meeting on Pesticide Residues. Part II: Mancozeb, pp. 257-289. , WHO/PCS/94.4. Available from the International Programme on Chemical Safety. WHO, Geneva, CH; (1992) Toxicology and Carcinogenesis Studies of Ethylene Thiourea (CAS No. 96-45-7) in F344/N Rats and B6C3F1 Mice (Feed Studies), , NTP Technical Report 388. Bethesda, MD; Soffritti, M., Belpoggi, F., Cevolani, D., Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats (2002) Ann. N.Y. Acad. Sci., 982, pp. 46-69; Soffritti, M., Belpoggi, F., Minardi, F., Maltoni, C., Ramazzini foundation cancer program: History and major projects, life-span carcinogenicity bioassay design (2002) Ann. N. Y. Acad. Sci., 982, pp. 26-45","Soffritti, M.; Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; email: crcfr@tin.it",,,,,,,,00778923,,ANYAA,12562632,"English","Ann. New York Acad. Sci.",Conference Paper,Scopus,2-s2.0-0036960389
"Soffritti, M., Belpoggi, F., Cevolani, D., Guarino, M., Padovani, M., Maltoni, C.","Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats",2002,"Annals of the New York Academy of Sciences","982",,,"46","69",,54,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0036965323&partnerID=40&md5=2afcb5026912c8ffda69bd1f0ff9815f","Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy","Soffritti, M., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy, Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; Belpoggi, F., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Cevolani, D., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Guarino, M., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Padovani, M., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Maltoni, C., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy","Methyl alcohol was administered in drinking water supplied ad libitum at doses of 20,000, 5,000, 500, or 0 ppm to groups of male and female Sprague-Dawley rats 8 weeks old at the start of the experiment. Animals were kept under observation until spontaneous death. Ethyl alcohol was administered by ingestion in drinking water at a concentration of 10% or 0% supplied ad libitum to groups of male and female Sprague-Dawley rats; breeders and offspring were included in the experiment. Treatment started at 39 weeks of age (breeders), 7 days before mating, or from embryo life (offspring) and lasted until their spontaneous death. Under tested experimental conditions, methyl alcohol and ethyl alcohol were demonstrated to be carcinogenic for various organs and tissues. They must also be considered multipotential carcinogenic agents. In addition to causing other tumors, ethyl alcohol induced malignant tumors of the oral cavity, tongue, and lips. These sites have been shown to be target organs in man by epidemiologic studies.","Carcinogenicity; Ethyl alcohol; Long-term bioassay; Methyl alcohol; Rat","alcohol; carcinogen; drinking water; methanol; animal model; bioassay; cancer; cancer research; chemical carcinogenesis; conference paper; head and neck cancer; lip cancer; long term exposure; mouth cancer; nonhuman; rat; target organ; tongue cancer; Animals; Carcinogens; Ethanol; Female; Male; Methanol; Models, Animal; Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Water Supply; Animalia",,"alcohol, 64-17-5; methanol, 67-56-1; Carcinogens; Ethanol, 64-17-5; Methanol, 67-56-1",,,,"Maltoni, C., Ciliberti, A., Pinto, C., Results of long-term experimental carcinogenicity studies of the effects of gasoline, correlated fuels, and major gasoline aromatics on rats (1997) Ann. N.Y. Acad. Sci., 837, pp. 15-52; Maltoni, C., Ciliberti, A., Cotti, G., Benzene, an experimental multipotential carcinogen: Results of the long-term bioassays performed at the Bologna Institute of Oncology (1989) Environ. Health Perspect., 82, pp. 109-124; Belpoggi, F., Soffritti, M., Maltoni, C., Methyl-tertiary-butyl ether (MTBE), a gasoline additive, causes testicular and lymphohaematopoietic cancers in rats (1995) Toxicol. Ind. Health, 11, pp. 119-149; Maltoni, C., Belpoggi, F., Soffritti, M., Comprehensive long-term experimental project of carcinogenicity bioassays on gasoline oxygenated additives: Plan and first report of results from the study on ethyl-tertiary butyl ether (ETBE) (1999) Eur. J. Oncol., 4, pp. 493-508; Soffritti, M., Maltoni, C., Maffei, F., Formaldehyde: An experimental multipotential carcinogen (1989) Toxicol. Ind. Health, 5, pp. 699-730; Methanol (1997) Environmental Health Criteria, 196. , WHO. Geneva; Grayson, M., (1981) Kirk-Othmer Encyclopedia of Chemical Technology, 3rd Edit., 15, pp. 398-405. , John Wiley & Sons. New York; Elvers, B., Hawkins, S., Schulz, G., (1990) Ullmann's Encyclopedia of Industrial Chemistry, 5th Edit., 16 A, pp. 465-486. , VCH-Verlag; (1992) Chemical Economics Handbook: Marketing Research Report on Methanol, , SRI International. Menlo Park, CA; (1995) Alternative Fuels in the Automotive Market, , Brussels, CONCAWE, 67 pp (Report No. 2/95, prepared for the Concawe Automotive Emission Management Group by its Technical Coordinator, R.C. Hutcheson); Fiedler, E., Grossmann, G., Kersebohm, B., Methanol (1990) Ullmann's Encyclopedia of Industrial Chemistry, 5th Edit., 16 A, pp. 465-486. , B. Weinheim, S. Elvers, G. Hawkins & G. Schutz, Eds. VCH Verlag. Weinheim, Germany; Axelrod, J., Daly, J., Pituitary gland: Enzymic formation of methanol from S-adenosylmetionine (1965) Science, 158, pp. 892-893; (1988) Solvent in Common Use: Health Risks to Workers, pp. 1-7. , Royal Society of Chemistry. Cambridge. Publication EUR/11553; Leaf, G., Zatman, L.J., A study of the conditions under which methanol may exert a toxic hazard in industry (1952) Br. J. Ind. Med., 9, pp. 19-31; Eriksen, S.P., Kulkarni, A.B., Methanol in normal human breath (1963) Science, 141, pp. 639-640; Larsson, B.T., Gas chromatography of organic volatiles in human breath and saliva (1965) Acta Med. Scand., 19, pp. 159-164; Krotoszynski, B.K., Bruneau, G.M., O'Neill, H.J., Measurement of chemical inhalation exposure in urban populations in the presence of endogenous effluents (1979) J. Anal. Toxicol., 3, pp. 225-234; Jones, A.W., Skagerberg, S., Yonekurat, T., Sato, A., Metabolic interaction between endogenous ethanol studied in human volunteers by analysis of breath (1990) Pharmacol. Toxicol., 66, pp. 62-65; Pellizzari, E.D., Hartwell, T.D., Harris B.S.H. III, Purgeable organic compounds in mother's milk (1982) Bull. Environ. Contam. Toxicol., 28, pp. 322-328; Kavet, R., Nauss, K.M., The toxicity of inhaled methanol vapors (1990) CRC Crit. Rev. Toxicol., 21, pp. 21-50; Owens, L.D., Gilbert, R.G., Griebel, G.E., Menzies, J.D., Identification of plant volatiles that stimulates microbial respiration and growth in soil (1969) Phytopathology, 59, pp. 1468-1472; Holzer, G., Shanfield, H., Zlatkis, A., Collection and analysis of trace emissions from natural sources (1977) J. Chromatogr., 142, pp. 755-764; Graedel, T.E., Hawkins, D.T., Claxton, L.D., (1986) Atmospheric Chemical Compounds: Sources, Occurrence and Bioassay, 557, pp. 512-514. , Academic Press. New York. London; (1994) 1992 Toxic Release Inventory: Public Data, , US Environmental Protection Agency (EPA 745/R-94-001). Washington, DC; Medinsky, M.A., Dorman, D.C., Assessing risks of low-level methanol exposure (1994) CIIT Act., 14, pp. 1-7; Gold, M.D., Moulif, C.E., Effects of emission standards on methanol vehicle-related ozone, formaldehyde and methanol exposure (1988) 81st Meeting of Air Pollution Control Association, , Dallas, TX, June 19-24, Pittsburgh, PA; (1976) Frequency of Organic Compounds Identified in Water, , Washington, DC, US Environmental Protection Agency (EPA 600/4-76-062); Kirchner, J.G., Miller, J.M., Volatile water-soluble and oil constituents of Valencia orange juice (1957) J. Agric. Food Chem., 5, pp. 283-291; Francot, P., Geoffroy, P., Le méthanol dans les jus de fruits, les boissons fermentées des alcools et spiriteux (1956) Rev. Ferment. Ind. Aliment., 11, pp. 279-287; Monte, W.C., Aspartame: Methanol and the public health (1984) J. Appl. Nutr., 36, pp. 42-54; Greizerstein, H.B., Congener contents of alcoholic beverages (1981) J. Stud. Alcohol, 42, pp. 1030-1037; Gilger, A.P., Potts, A.M., Studies on the visual toxicity of methanol. V. The role of acidosis in experimental methanol poisoning (1955) Am. J. Ophthalmol., 39, pp. 63-86; (1987) Toxicological Research of Methanol as a Fuel for Power Station: Summary Report on Test with Monkeys, Rats and Mice, pp. 1-296. , Tokyo; Katoh, M., New Energy Development Organization data (1989) Methanol Vapors and Health Effects Workshop: What we Know and What we Need to Know - Summary Report, , Washington, DC, ILSI Risk Science Institute/US Environmental Protection Agency/Health Effects Institute/American Petroleum Institute, A-7; Mellan, I., (1950) Industrial Solvents: 454, , Reinhold. New York; Walsh, B., Grant, M., (1985) Public Health Implications of Alcohol Production and Trade, , (WHO Offset Publication No. 88). World Health Organization. Geneva; Berg, C., (2001) World Ethanol Production 2001, , http://www.distill.com/world_ethanol_production.htm; Mellan, I., (1950) Industrial Solvents: 460-466, , Reinhold. New York; Armstrong, S.R., (1999) Ethanol, Brief Report on its Use in Gasoline, , Cambridge Environmental, Inc. Cambridge, MA; Grosjean, E., Grosjean, D., Gunawardena, R., Rasmussen, R.A., (1998) Environ. Sci. Technol., 32, p. 736; (1998) Evaluation of the Fate and Transport of Ethanol in the Environment, , Prepared for the American Methanol Institute; (1997) Interagency Assessment of Oxygenate Fuels, , Executive Office of the President; Pohorecky, L.A., Brick, J., Pharmacology of ethanol (1988) Pharmacol. Ther., 36, pp. 335-427; Ritchie, J.M., The aliphatic alcohols (1980) The Pharmacological Basis of Therapeutics. 6th Edit., pp. 376-390. , Macmillan. New York; Holford, N.H.G., Clinical pharmacokinetics of ethanol (1987) Clin. Pharmacokinet., 13, pp. 273-292; (1988) Monographs on the Evaluation of Carcinogenic Risks to Humans, 44. , IARC, Lyon, France","Soffritti, M.; Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; email: crcfr@tin.it",,,,,,,,00778923,,ANYAA,12562628,"English","Ann. New York Acad. Sci.",Conference Paper,Scopus,2-s2.0-0036965323
"Belpoggi, F., Soffritti, M., Minardi, F., Bua, L., Cattin, E., Maltoni, C.","Results of long-term carcinogenicity bioassays on tert-amyl-methyl-ether (TAME) and di-isopropyl-ether (DIPE) in rats",2002,"Annals of the New York Academy of Sciences","982",,,"70","86",,13,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0036960357&partnerID=40&md5=41d2aece0011005d8b46b16f76026547","Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy","Belpoggi, F., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Soffritti, M., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy, Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; Minardi, F., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Bua, L., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Cattin, E., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Maltoni, C., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy","Tert-amyl-methyl ether (TAME) was administered by gavage in extra virgin olive oil solution at concentrations of 750, 250, or 0 mg/kg bw to groups of 100 male and 100 female Sprague-Dawley rats 8 weeks old at the start of the experiment. Di-isopropyl ether (DIPE) was administered in the same manner at the doses of 1000, 250, or 0 mg/kg body weight to groups of 100 male and 100 female Sprague-Dawley rats. TAME and DIPE were each delivered in 1-mL solution 4 days a week for 78 weeks. Control animals received 1 mL of extra virgin olive oil without TAME or DIPE. At the end of the treatment period, all animals were kept under observation until spontaneous death. Under these test conditions, TAME and DIPE were found to be potential carcinogenic agents for various organs and tissues.","Carcinogenicity; Di-isopropyl-ether; Long-term bioassay; Oxygenated gasoline additives; Rat; tert-amyl-methyl-ether","carcinogen; diisopropylether; ether derivative; gasoline; olive oil; tert amyl methyl ether; unclassified drug; animal model; benign tumor; bioassay; brain tumor; cancer; cancer research; chemical carcinogenesis; conference paper; controlled study; gastrointestinal tumor; head and neck tumor; hematopoietic system tumor; long term exposure; malignant neoplastic disease; nonhuman; rat; testis tumor; uterus tumor; vagina tumor; Air Pollutants; Animals; Biological Assay; Carcinogens; Ethers; Female; Male; Methyl Ethers; Neoplasms, Experimental; Rats; Animalia",,"gasoline, 86290-81-5; olive oil, 8001-25-0; Air Pollutants; Carcinogens; diisopropyl ether, 108-20-3; Ethers; Methyl Ethers; tertiary-amyl methyl ether, 994-05-8",,,,"Belpoggi, F., Methyl-tertiary-butyl ether (MTBE), a gasoline additive, causes testicular and lymphohaematopoietic cancers in rats (1995) Toxicol. Ind. Health, 11, pp. 119-149; Belpoggi, F., Results of long-term experimental studies on the carcinogenicity of methyl-tert-butyl ether (1997) Ann. N.Y. Acad. Sci., 837, pp. 77-95; Belpoggi, F., Pathological characterization of testicular tumours and lymphomas-leukaemias, and of their precursors observed in Sprague-Dawley rats exposed to methyl-tertiary-butyl-ether (MTBE) (1998) Eur. J. Oncol., 3, pp. 201-206; Burleigh-Flayer, H.D., Methyl-tertiary-butyl ether: Vapor inhalation oncogenicity study in CD-1 mice (1992) BRRC Report 91N0013A, , Union Carbide, Bushy Run Research Center, Export, PA; Chun, J.S., Methyl-tertiary-butyl ether: Vapor inhalation oncogenicity study in Fisher-344 rats (1992) BRRC Report 91N0013B, , Union Carbide, Bushy Run Research Center, Export, PA; Squillace, P.J., Preliminary assessment of the occurrence and possible sources of MTBE in groundwater in the United States, 1993-1994 (1996) Environ. Sci. Technol., 30, pp. 227-233; Mehlman, M.A., Methyl-tertiary-butyl-ether (MTBE) misclassified (2001) Am. J. Ind. Med., 39, pp. 505-508; Maltoni, C., Comprehensive long-term experimental project of carcinogenicity bioassays on gasoline oxygenated additives: Plan and first report of results from the study on ethyl-tertiary butyl ether (ETBE) (1999) Eur. J. Oncol., 4, pp. 493-508; Withe, R.D., Health effects of inhaled tertiary amyl methyl ether and ethyl tertiary butyl ether (1995) Toxicol. Lett. (Elsevier Science Ireland), 82-83, pp. 719-724; Patty, F.A., (1963) Industrial Hygiene and Toxicology, 2nd Edit., Revised. Vol. II. Toxicology, 2. , Interscience Publishers, Wiley & Sons, Inc. New York; Zogorski, J.S., (1996) Fuel Oxygenate and Water Quality: Current Understanding of Sources, Occurrence in Natural Waters, Environmental Behavior, Fate, and Significance, , U.S. Geological Survey. Rapid City, South Dakota; Froines, J.R., (1998) An Evaluation of the Scientific Peer-Reviewed Research and Literature on the Human Health Effects of MTBE, its Metabolites, Combustion Products and Substitute Compounds. Report to the Legislature of the State of California, 2, p. 179. , Human Health Effects; Soffritti, M., Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats (2002) Ann. N.Y. Acad. Sci., 982 (THIS VOLUME)","Soffritti, M.; Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; email: crcfr@tin.it",,,,,,,,00778923,,ANYAA,12562629,"English","Ann. New York Acad. Sci.",Conference Paper,Scopus,2-s2.0-0036960357
"Soffritti, M., Belpoggi, F., Minardi, F., Maltoni, C.","Ramazzini Foundation cancer program: History and major projects, life-span carcinogenicity bioassay design, chemicals studied, and results",2002,"Annals of the New York Academy of Sciences","982",,,"26","45",,34,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0036960610&partnerID=40&md5=b9b49c5c3c1398dee925f8b2ed21b604","Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy","Soffritti, M., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy, Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; Belpoggi, F., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Minardi, F., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy; Maltoni, C., Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bologna, Italy","The Ramazzini Foundation research program was started over thirty years ago. The features of this program are: (1) systematic and integrated project design; (2) consistency over time; (3) homogeneity of approach: key members of the team remain unchanged; and (4) choice to work on new frontiers of scientific research. The program centers mainly on three projects: Project 1: experimental carcinogenicity bioassays; Project 2: experimental anticarcinogenesis assays to identify factors and active principles (compounds) capable of opposing the onset of tumors while being suitable for preventive/chemopreventive intervention; Project 3: epidemiological studies, both descriptive and analytical, on tumor incidence and mortality in persons professionally and environmentally exposed to industrial carcinogenic risks. The project involving experimental carcinogenicity bioassays for the identification of exogenous carcinogens (environmental and industrial above all) began in 1966. This project has included 398 experimental bioassays on 200 compounds/agents using some 148,000 animals monitored until their spontaneous death. Among the studies already concluded, 47 agents have shown ""clear evidence"" of carcinogenicity. The results have demonstrated for the first time that (1) vinyl chloride can cause liver angiosarcoma as well as other tumors; (2) benzene is carcinogenic in experimental animals for various tissues and organs; (3) formaldehyde may produce lymphomas and leukemias; and (4) methyl-tert-butyl ether (MTBE), the most common oxygenated additive used in gasolines, can cause lymphomas/leukemias. Many of the results achieved have led to the introduction of norms and measures of primary prevention.","Benzene; Carcinogenicity; Long-term bioassay; MTBE; Ramazzini Foundation; Rat; Vinyl chloride; Xylenes","aldehyde; alpha interferon; anastrozole; antiestrogen; antineoplastic agent; aromatase inhibitor; aromatic hydrocarbon; benzene; carcinogen; conjugated estrogen; cyclophosphamide; fluorouracil; formestane; fulvestrant; gonadorelin antagonist; leuprorelin; mancozeb; medroxyprogesterone acetate; methotrexate; pesticide; raloxifene; retinol acetate; retinol palmitate; tamoxifen; tert butyl methyl ether; toremifene; trichloroethylene; unindexed drug; vinyl chloride; xylene; angiosarcoma; animal model; bioassay; breast tumor; cancer; cancer mortality; cancer prevention; cancer research; cause of death; chemical carcinogenesis; conference paper; hematopoietic system tumor; human; leukemia; liver cancer; liver tumor; long term exposure; lymphoma; nonhuman; rat; Animals; Biological Assay; Carcinogens; Foundations; History, 20th Century; Humans; Neoplasms; Research; Animalia",,"anastrozole, 120511-73-1; benzene, 71-43-2; cyclophosphamide, 50-18-0; fluorouracil, 51-21-8; formestane, 566-48-3; fulvestrant, 129453-61-8; leuprorelin, 53714-56-0, 74381-53-6; mancozeb, 8018-01-7; medroxyprogesterone acetate, 71-58-9; methotrexate, 15475-56-6, 59-05-2, 7413-34-5; raloxifene, 82640-04-8, 84449-90-1; retinol acetate, 127-47-9; retinol palmitate, 79-81-2; tamoxifen, 10540-29-1; tert butyl methyl ether, 1634-04-4; toremifene, 89778-26-7; trichloroethylene, 79-01-6; vinyl chloride, 75-01-4; xylene, 1330-20-7; Carcinogens","premarin",,,"Maltoni, C., Lefemine, G., Ciliberti, A., Experimental research on vinyl chloride carcinogenesis (1984) Archives of Research on Industrial Carcinogenesis, 2. , C. Maltoni & M.A. Mehlman, Eds. Princeton Scientific Publishing. Princeton, NJ; Maltoni, C., Oncogenicity bioassays of vinyl chloride: Plan, current results, and perspectives (1974) Proceedings of the 2nd International Symposium of Medichem on Chromosome Aberrations by Industrial Chemicals and Vinyl Chloride Toxicity, pp. 65-79. , Milano, Italy, October 28-29, 1974; Maltoni, C., Lefemine, G., Cotti, G., Experimental research on vinylidene chloride carcinogenesis (1985) Archives of Research on Industrial Carcinogenesis, 3. , C. Maltoni & M.A. Mehlman, Eds. Princeton Scientific Publishing. Princeton, NJ; Maltoni, C., Ciliberti, A., Cotti, G., Experimental research on acrylonitrile carcinogenesis (1987) Archives of Research on Industrial Carcinogenesis, 6. , C. Maltoni & M.A. Mehlman, Eds. Princeton Scientific Publishing. Princeton, NJ; Maltoni, C., Ciliberti, A., Lefemine, G., Results of a long-term experimental study on the carcinogenicity of vinyl acetate monomer in mice (1997) Ann. N.Y. Acad. Sci., 837, pp. 209-238; Minardi, F., Belpoggi, F., Soffritti, M., Results of long-term carcinogenicity bioassay on vinyl acetate monomer in Sprague-Dawley rats (2002) Ann. N.Y. Acad. Sci., 982 (THIS VOLUME); Conti, B., Maltoni, C., Perino, G., Long-term carcinogenicity bioassays on styrene administered by inhalation, ingestion and injection and styrene oxide administered by ingestion, on Sprague-Dawley rats, and para-methylstyrene administered by ingestion in Sprague-Dawley rats and Swiss mice (1988) Ann. N.Y. Acad. Sci., 534, pp. 203-234; Minardi, F., Cortesi, L., Maltoni, C., Subcutaneous sarcomatogenicity bioassays in the identification of environmental carcinogens: Some results (1991) Acta Oncol., 12, pp. 365-372; Maltoni, C., Lefemine, G., Cotti, G., Experimental research on trichloroethylene carcinogenesis (1986) Archives of Research on Industrial Carcinogenesis, 5. , C. Maltoni & M.A. Mehlman, Eds. Princeton Scientific Publishing. Princeton, NJ; Soffritti, M., Maltoni, C., Maffei, F., Biagi, R., Formaldehyde: An experimental multipotential carcinogen (1989) Toxicol. Ind. Health, 5, pp. 699-730; Soffritti, M., Belpoggi, F., Lambertini, L., Results of long-term experimental studies on the carcinogenicity of formaldehyde and acetaldehyde in rats (2002) Ann. N.Y. Acad. Sci., 982 (THIS VOLUME); Belpoggi, F., Soffritti, M., Bua, L., Results of long-term experimental studies on the carcinogenicity on ethylene-bis-dithiocarbamate (Mancozeb) in rats (2002) Ann. N.Y. Acad. Sci., 982 (THIS VOLUME); Maltoni, C., Scarnato, C., Le prime prove sperimentali dell'azione cancerogena del benzene (1977) Gli Ospedali della Vita, 4, pp. 111-113; Maltoni, C., Ciliberti, A., Cotti, G., Benzene, an experimental multipotential carcinogen: Results of the long-term bioassays performed at the Bologna Institute of Oncology (1989) Environ. Health Perspect., 82, pp. 109-124; Soffritti, M., Belpoggi, F., Cevolani, D., Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats (2002) Ann. N.Y. Acad. Sci., 982 (THIS VOLUME); Belpoggi, F., Soffritti, M., Maltoni, C., Methyl-tertiary-butyl ether (MTBE) - A gasoline additive - Causes testicular and lymphohaematopoietic cancers in rats (1995) Toxicol. Ind. Health, 11, pp. 119-149; Belpoggi, F., Soffritti, M., Minardi, F., Results of long-term carcinogenicity bioassays on tert-amyl-methyl-ether (TAME) and di-isopropyl-ether (DIPE) in rats (2002) Ann. N.Y. Acad. Sci., 982 (THIS VOLUME); Maltoni, C., Minardi, F., Recent results of carcinogenicity bioassays of fibres and other particulate materials (1989) Non Occupational Exposure to Mineral Fibres, 90, pp. 46-53. , V. Bignon, V. Peto & R. Saracci, Eds. IARC Scientific Publication. Lyon, France; Minardi, F., Maltoni, C., Results of recent experimental research on the carcinogenicity of natural and modified asbestos (1988) Ann. N.Y. Acad. Sci., 534, pp. 754-761; Minardi, F., Maltoni, C., Results of long-term carcinogenicity bioassays of rockwool on Sprague-Dawley rats (1998) Eur. J. Oncol., 3, pp. 251-260; Minardi, F., Maltoni, C., Results of long-term carcinogenicity bioassays of ceramic fibres (""Fiberfrax"") on Sprague-Dawley rats (1998) Eur. J. Oncol., 3, pp. 241-249; Minardi, F., Belpoggi, F., Franch, A., La cancerogenesi da talco grezzo contaminato con amianto: Primi risultati dei saggi sperimentali dell'Istituto di Oncologia di Bologna (1990) Recenti Progressi nelle Conoscenze e nel Controllo dei Tumori, pp. 279-293. , E. Triggiani, G. Sammarco, G. Liguori, et al., Eds. Monduzzi Editore. Bologna; Soffritti, M., Belpoggi, F., Minardi, F., Mega-experiments to identify and assess diffuse carcinogenic risks. Uncertainty in the risk assessment of environmental and occupational hazards (1999) An International Workshop (24-26 September 1998) Ann. N.Y. Acad. Sci., 895, pp. 34-55; Soffritti, M., Belpoggi, F., Minardi, F., Mega-experiments on the carcinogenicity of γ-radiation on Sprague-Dawley rats at the Cancer Research Centre of the European Ramazzini Foundation of Oncology and Enviromental Sciences: Plan and report of early results on mammary carcinogenesis (1999) Eur. J. Oncol., 4, pp. 509-522; Maltoni, C., Conti, B., Cotti, G., Belpoggi, F., Experimental studies on benzene carcinogenicity at the Bologna Institute of Oncology: Current results and ongoing research (1985) Am. J. Ind. Med, 7, pp. 415-446; Maltoni, C., Ciliberti, A., Pinto, C., Results of long-term experimental carcinogenicity studies on the effects of gasoline, correlated fuels, and major gasoline aromatics on rats (1997) Ann. N.Y. Acad. Sci., 837, pp. 15-52; (1986) Toxicology and Carcinogenesis Studies of Xylenes (Mixed) (Cas No. 1330-20-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies), , Technical Report Series No. 327; Soffritti, M., Minardi, F., Maltoni, C., Risultati degli studi sperimentali sugli effetti chemiopreventivi della vitamina A e di un LHRH agonista-antagonista (il leuprolide) (1996) Atti del XXII Congresso Nazionale di Oncologia - 1° Forum di Oncologia dei Paesi Mediterranei, pp. 39-42. , Recenti Progressi nel Controllo Farmacologico dei Tumori. G. Colucci, C. Maltoni & E. Maiello, Eds. (Bari, 27-30 Novembre 1996); Maltoni, C., Minardi, F., Pinto, C., Gli effetti chemiopreventivi del Tamoxifene sul cancro mammario: Risultati sperimentali (1996) Atti del XXII Congresso Nazionale di Oncologia - 1° Forum di Oncologia dei Paesi Mediterranei, pp. 31-37. , Recenti Progressi nel Controllo Farmacologico dei Tumori. G. Colucci, C. Maltoni & E. Maiello, Eds. (Bari, 27-30 Novembre 1996); Maltoni, C., Minardi, F., Pinto, C., Results of three life-span experimental carcinogenicity and anticarcinogenicity studies on tamoxifen in rats (1997) Ann. N.Y. Acad. Sci., 837, pp. 469-512; Minardi, F., Bua, L., Santi, A., Experimental studies on the chemopreventive effects of medroxyprogesterone acetate (MPA) on mammary cancer using a human-equivalent animal model (1996) Proceedings of the International Forum, pp. 235-240. , The Scientific Bases of Cancer Chemoprevention. Bologna. 31 March-2 April 1996; Soffritti, M., Mobiglia, A., Pinto, C., Results of experimental bioassays on the chemopreventive effects of vitamin A and N-(4-hydroxyphenyl)-retinamide (HPR) on mammary cancer (1996) Proceedings of the International Forum, pp. 241-248. , The Scientific Bases of Cancer Chemoprevention. Bologna. 31 March-2 April 1996; Maltoni, C., Occupational carcinogenesis (1974) International Symposium, Cancer Detection and Prevention, pp. 19-26. , C. Maltoni, Y. Fassing, E.C. Hammond, et al., Eds. Excerpta Medica. Amsterdam; Ciliberti, A., Lefemine, G., Belpoggi, F., Incidenza spontanea dei tumori epatici (epatocarcinomi ed angiosarcomi) e dei loro precursori in ratti Sprague-Dawley tenuti sotto osservazione fino a morte naturale (1994) XIX Congresso Nazionale di Oncologia (Foggia, 26-28 Maggio 1994), 1, pp. 31-37. , I Tumori Primitivi e Secondari del Fegato. C. Natale, R. Laricchiuta, D. Perfetto, et al., Eds. Monduzzi Editore. Bologna; Maltoni, C., Lambertini, L., Cevolani, D., I mesoteliomi da amianto usato nelle ferrovie: Resoconto di 199 casi (2002) Eur. J. Oncol., 7, pp. 51-55; Maltoni, C., Pinto, C., Valenti, D., Mesotheliomas following exposure to asbestos used in sugar refineries: Report of 17 Italian cases (1998) 25° Anniversario degli Istituti di Chirurgia dell'Università di Chieti Diretti dal Professor Vanni Beltrami, , Chieti 1973-1998. Vecchio Faggio, Ed. Scritti degli allievi e degli amici","Soffritti, M.; Cancer Research Center, Eur. Ramazzini Found. for O./E. S., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; email: crcfr@tin.it",,,,,,,,00778923,,ANYAA,12562627,"English","Ann. New York Acad. Sci.",Conference Paper,Scopus,2-s2.0-0036960610
"Maltoni, C., Soffritti, M., Belpoggi, F.","The scientific and methodological bases of experimental studies for detecting and quantifying carcinogenic risks",1999,"Annals of the New York Academy of Sciences","895",,,"10","26",,14,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0033452010&partnerID=40&md5=da61c52c0c16020fd5249e2bbc7ca497","Europ. Ramazzini Found. for Oncol., Bologna, Italy; Cancer Research Center, Europ. Ramazzimi Found. for Oncol., Bentivoglio Castle, 40010 Bentivoglio BO, Italy","Maltoni, C., Europ. Ramazzini Found. for Oncol., Bologna, Italy, Cancer Research Center, Europ. Ramazzimi Found. for Oncol., Bentivoglio Castle, 40010 Bentivoglio BO, Italy; Soffritti, M., Europ. Ramazzini Found. for Oncol., Bologna, Italy; Belpoggi, F., Europ. Ramazzini Found. for Oncol., Bologna, Italy","This paper outlines the aims and potential scope of experimental research for risk identification and assessment in industrial carcinogenesis (environmental and occupational). It then reviews the basic, general, and specific requisites of a rigorously scientific nature that are required to render experiments to be more appropriate and better geared to the information they seek. A range of experimental approaches to risk assessment are illustrated by results achieved in the Cancer Research Centre of the Ramazzini Foundation (CRC/RF). The paper ends with a call for closer relations and integration among experimental, epidemiologic, and biostatistical studies.",,"benzene; cadmium sulfide; carcinogen; crocidolite; environmental chemical; ethylbenzene; industrial chemical; iron oxide; lead chromate; silicon dioxide; titanium dioxide; toluene; vinyl chloride; vinylidene chloride; xylene; zinc derivative; bioassay; cancer classification; cancer localization; cancer risk; carcinogen testing; chronology; conference paper; experimental model; human; medical research; methodology; nonhuman; quantitative assay; Carcinogens; Cell Transformation, Neoplastic; Environmental Health; Environmental Pollutants; Epidemiologic Studies; Humans; Neoplasms; Occupational Health; Research Design; Risk Assessment; Animalia",,"Carcinogens; Environmental Pollutants",,,,"Maltoni, C., Lefemine, G., Ciliberti, A., Cotti, G., Carretti, D., Carcinogenicity bioassays of vinyl chloride monomer: A model of risk assessment on experimental basis (1981) Environ. Health Perspect., 41, pp. 3-29; Maltoni, C., The contribution of experimental (animal) studies to the control of industrial carcinogenesis (1995 Herbert Stokinger Lecture) (1995) Appl. Occup. Environ. Hyg., 10, pp. 749-760; Maltoni, C., Soffritti, M., Belpoggi, F., Minardi, F., Palazzini, A., La ricerca primaria in oncologia con particolare riguardo agli studi sperimentali (1999) Gli Ospedali della Vita, 25, pp. 19-37; Tannenbaum, A., Maltoni, C., Neoplastic response of various tissues to the administration of urethan (1962) Cancer Research, 22, pp. 1105-1112; Maltoni, C., Soffritti, M., Belpoggi, F., Mega-experiments enhancing the evaluation of diffuse exogenous carcinogenic risks (1998) Eur. J. Oncol., 3, pp. 5-10; Soffritti, M., Belpoggi, F., Minardi, F., Bua, L., Maltoni, C., Mega-experiments to identify and assess diffuse carcinogenic risks (1999) Ann. N.Y. Acad. Sci., 895. , this volume; Maltoni, C., Morisi, L., Chieco, P., Experimental approach to the assessment of the carcinogenic risk of industrial inorganic pigments (1982) Advances in Modern Environmental Toxicology. Occupational Health Hazards of Solvents, 2, pp. 77-92. , A. Englund, K. Ringen & M. Mehlman, Eds. Princeton Scientific Publishers, Princeton; Maltoni, C., Minardi, F., Morisi, L., Belpoggi, F., Early results of long-term carcinogenicity bioassays of silica-coated lead chromate pigment, by subcutaneour injection on Sprague-Dawley rats (1982) Acta Oncol., 3, pp. 89-94; Maltoni, C., Minardi, F., Recent results of carcinogenicity bioassays of fibers and other particulate materials (1989) Non-Occupational Exposure to Mineral Fibres, pp. 46-53. , J. Bignon, J. Peto & R. Saracci, Eds. IARC Scientific Publications N. 90, Lyon; Minardi, F., Maltoni, C., Results of long-term carcinogenicity bioassays of ceramic fibres (""Fiberfrax"") on Sprague-Dawley rats (1998) Eur. J. Oncol., 3, pp. 241-249; Maltoni, C., Lefemine, G., Ciliberti, A., Cotti, G., Carretti, D., Experimental research on vinyl chloride carcinogenesis (1984) Archives of Research on Industrial Carcinogenesis, 2. , C. Maltoni & M.A. Mehlman, Eds.: Princeton Scientific Publishers, Princeton; Maltoni, C., Ciliberti, A., Cotti, G., Conti, B., Belpoggi, F., Benzene, an experimental multipotential carcinogen: Results of the long-term bioassays performed at the Bentivoglio Institute of Oncology (1989) Environ. Health Perspecl., 82, pp. 109-124; Maltoni, C., Lefemine, G., Cotti, G., Patella, V., Experimental research on vinylidene chloride carcinogenesis (1985) Archives of Research on Industrial Carcinogenesis, 3. , C. Maltoni & M.A. Mehlman, Eds.: Princeton Scientific Publishers, Princeton; Maltoni, C., Soffritti, M., Pinto, C., Carmentano, P., Palazzini, A., Minardi, F., Models of development, environmental and cancer (1990) Update in Oncology, pp. 107-158. , F. Pannuti & G. Robustelli della Cuna, Eds. Edizioni Medico-Scientifiche, Pavia; Maltoni, C., Ciliberti, A., Pinto, C., Soffritti, M., Belpoggi, F., Menarini, L., Results of long-term experimental carcinogenicity studies of the effects of gasoline, correlated fuels, and major gasoline aromatics on rats (1997) Ann. N.Y. Acad. Sci., 837, pp. 15-52. , Preventive Strategies for Living in a Chemical World E. Bingham & D.P. Rall, Eds","Maltoni, C.; Cancer Research Center, Ramazzimi Found. Oncol. Envir. Sci., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; email: crcfr@tin.it",,,,,,,,00778923,,ANYAA,10676406,"English","Ann. New York Acad. Sci.",Conference Paper,Scopus,2-s2.0-0033452010
"Soffritti, M., Belpoggi, F., Minardi, F., Bua, L., Maltoni, C.","Mega-experiments to identify and assess diffuse carcinogenic risks",1999,"Annals of the New York Academy of Sciences","895",,,"34","55",,15,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0033403085&partnerID=40&md5=d02a45d74ddede5a1e907744485b1a92","Cancer Research Center, European Ramazzini Foundation, Oncology and Environment Sciences, Bentivoglio Castle, 40010, Bentivoglio (BO), Italy; Europ. Ramazzini Found. for Oncol., Oncology and Environment Sciences, Bologna, Italy","Soffritti, M., Cancer Research Center, European Ramazzini Foundation, Oncology and Environment Sciences, Bentivoglio Castle, 40010, Bentivoglio (BO), Italy; Belpoggi, F., Europ. Ramazzini Found. for Oncol., Oncology and Environment Sciences, Bologna, Italy; Minardi, F., Europ. Ramazzini Found. for Oncol., Oncology and Environment Sciences, Bologna, Italy; Bua, L., Europ. Ramazzini Found. for Oncol., Oncology and Environment Sciences, Bologna, Italy; Maltoni, C., Europ. Ramazzini Found. for Oncol., Oncology and Environment Sciences, Bologna, Italy","Diffuse carcinogenic risks, that is, those of low potency involving large areas of population and sometimes all mankind, pose a serious public health problem. Controlling these risks might help to reduce the incidence of, and mortality from, cancer. Because of their low expected carcinogenic potential, these risks are difficult to expose or assess. Epidemiologic investigation is of limited use in this field and yields its data too late to be useful. Experimental studies offer the only possible approach for assessing such risks. To increase experimental sensitivity and consistency of results, mega-experiments must be designed. That is, experiments that use a large number of animals with a well-known basic tumorigram, that extend the exposure and the biophase for as long as possible, that carefully observe the effects, and that are performed with suitable standardized methods. In the last 15 years the Ramazzini Foundation, in its Cancer Research Center at Bentivoglio, has conducted or planned five mega-experiments. Initial results indicate the great potential of these methods for identifying and assessing diffuse risks.",,"alpha tocopherol; ascorbic acid; carcinogen; polyvinylchloride; retinol acetate; retinol palmitate; cancer; cancer prevention; cancer risk; conference paper; electromagnetic field; experimental animal; gamma radiation; ionizing radiation; methodology; microwave radiation; nonhuman; risk assessment; standardization; Carcinogens; Environmental Health; Humans; Neoplasms; Public Health; Research Design; Risk Assessment; Sample Size; Sensitivity and Specificity; Time Factors; Animalia",,"Carcinogens",,,,"Pott, P., (1775) Chirurgical Observations Relative to the Cataract, the Polypus of the Nose, the Cancer of the Scrotum, the Different Kinds of Ruptures and the Mortification of the Toes and Feet, , Hawes, Clarke & Collins, London; Harting, F.H., Hesse, W., Lung cancer, the disease of miners in the Schneeberg mines (1879) Vierteljahreschrift für Gerichtliche Medizin, 30, pp. 296-309; Peller, S., Lung cancer among mine workers in Joachimsthal (1939) Hum. Biol., 11, pp. 130-143; Unna, P.G., Carcinom der seemanshaut (1894) Histopathologie der Hautkrankheiten, , Hirschwald, Berlin; Rehn, L., Blasengeschwülste bei Fuchsin-Arbeitern (1895) Arch. Clin. Chir., 50, pp. 588-600; Frieben, A., Demonstration eines cancroids des rechten handrückens, das sich nach hangdauernder einwirkung von röntgenstrahlen entwickelt hatte (1902) Fortschr Röntgenstr, 6, p. 106; Wolback, S.R., The pathological histology of chronic X-ray dermatitis and early X-ray carcinoma (1909) J. Med. Res., 21, pp. 415-449; Passey, R.D., Experimental soot cancer (1922) Br. Med. J., 2, p. 539; Hueper, W.C., Wiley, F.H., Wolfe, H.D., Experimental production of bladder tumors in dogs by administration of beta-naphthylamine (1938) J. Ind. Hyg. Tox., 20, pp. 46-84; March, H.C., Leukemia in radiologists (1944) Radiology, 4, pp. 275-278; March, H.C., Leukemia in radiologists in a 20 year period (1950) Am. J. Med. Sci., 220, pp. 282-286; Barnett, G.P., (1948) Annual Report of the Chief Inspector of Factories for the Year 1948, p. 93. , H.M.S.O. London; Case, R.A.M., Hosker, M.E., McDonald, D.B., Pearson, J.T., Tumours of the urinary bladder workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part I. The role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylaminc (1954) Br. J. Ind. Med., 11, pp. 75-104; Case, R.A.M., Pearson, J.T., Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part II. Further consideration of the role of aniline and of the manufacture of auramine and magenta (fuchsine) as possible causative agents (1954) Br. J. Ind. Med., 11, pp. 213-216; Case, R.A.M., Hosker, M.E., Tumour of the urinary bladder as an occupational disease in the rubber industry in England and Wales (1954) Br. J. Prev. Soc. Med., 8, pp. 39-50; Mancuso, T.F., Hueper, W.C., Occupational cancer and other health hazards in a chromate plant: A medical appraisal. I. Lung cancers in chromate workers (1951) Ind. Med. Surg., 20, pp. 358-363; Spitz, S., Maguigan, W.H., Dobriner, K., The carcinogenic action of benzidine (1950) Cancer, 3, pp. 789-804; Hueper, W.C., Experimental studies in metal cancerogenesis. I. Nickel cancers in rats (1952) Texas Rep. Biol. Med., 10, pp. 167-186; Sunderman, F.W., Donnelly, A.J., West, B., Kincaid, J.F., Nickel poisoning. IX. Carcinogenesis in rats exposed to nickel carbonyl (1959) Arch. Ind. Health, 20, pp. 36-41; Hueper, W.C., Experimental studies in metal cancerogenesis. X. Cancerogenic effects of chromite ore roast deposited in muscle tissue and pleural cavity of rats (1958) Arch. Ind. Health, 18, pp. 284-291; Selikoff, I.J., Hammond, E.C., Seidman, H., Mortality experience of insulation workers in the United States and Canada, 1943-1976 (1979) Health Hazards of Asbestos Workers, 330, pp. 91-116. , I.J. Selikoff & B.C. Hammond, Eds. Ann. N.Y. Acad. Sci; Kato, H., Schull, W.J., Studies of the mortality of A-bomb survivors. 7. Mortality, 1950-1978: Part 1. Cancer mortality (1982) Radiat. Res., 90, pp. 395-432; Maltoni, C., Lefemine, G., Ciliberti, A., Cotti, G., Carretti, D., Carcinogenicity bioassays of vinyl chloride monomer: A model of risk assessment on experimental basis (1981) Environ. Health Perspect., 41, pp. 3-29; Maltoni, C., Lefemine, G., Ciliberti, A., Cotti, G., Carretti, D., Experimental research on vinyl chloride carcinogenesis (1984) Archives of Research on Industrial Carcinogenesis, 2. , C. Maltoni & M.A. Mehlman, Eds.: Princeton Scientific Publishers, Princeton; Huff, J.E., Cirvello, J., Haseman, J., Bucher, J., Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents (1991) Environ. Health Perspect, 93, pp. 247-270; Fung, V.A., Barrett, J.C., Huff, J., The carcinogenesis bioassays in perspective: Application in identifying human cancer hazards (1995) Environ. Health Perspect, 103, pp. 680-683; Maltoni, C., Soffritti, M., Pinto, C., Carmentano, P., Palazzini, A., Minardi, F., Models of development, environment and cancer (1991) Update in Oncology, pp. 107-158. , F. Pannuti & G. Robustelli della Cuna, Eds. Edizioni Medico-Scientifiche, Pavia; Maltoni, C., Soffritti, M., Belpoggi, F., Minardi, F., Palazzini, A., La ricerca primaria in oncologia con particolare riguardo agli studi sperimentali (1999) Gli Ospedali della Vita, 25, pp. 19-37; Selikoff, I.J., Hammond, E.C., Churg, J., Asbestos exposure, smoking and neoplasia (1968) J.A.M.A., 204 (2), pp. 106-112; Berger, M.R., Schmähl, D., Zerban, H., Combination experiments with very low doses of three genotoxic N-nitrosamines with similar organotropic carcinogenicity in rats (1987) Carcinogenesis, 8, pp. 1635-1643; Maltoni, C., Lefemine, G., Belpoggi, F., Soffritti, M., Lenzi, A., Ciliberti, A., Minardi, F., Risultati di saggi sperimentali di cancerogenicità di acque minerali contenute in bottiglie di PVC (1997) Eur. J. Oncol., 2, pp. 531-551. , su ratti Sprague-Dawley","Soffritti, M.; Cancer Research Center, Ramazzini Found. Onc. Environm. Sci., Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; email: crcfr@tin.it",,,,,,,,00778923,,ANYAA,10676408,"English","Ann. New York Acad. Sci.",Conference Paper,Scopus,2-s2.0-0033403085
"Soffritti, M., Belpoggi, F., Lenzi, A., Maltoni, C.","Results of long-term carcinogenicity studies of chlorine in rats",1997,"Annals of the New York Academy of Sciences","837",,,"189","208",,12,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0031587507&partnerID=40&md5=bc506d4213eff50f3102ef91f0d4279c","Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; European B. Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy","Soffritti, M., Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; Belpoggi, F., European B. Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy; Lenzi, A., European B. Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy; Maltoni, C., European B. Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy","Four groups, each of 50 male and 50 female Sprague-Dawley rats, of the colony used in the Cancer Research Center of Bentivoglio of the Ramazzini Foundation, 12 weeks old at the start of the study, received drinking water containing sodium hypochlorite, resulting in concentrations of active chlorine of 750, 500, and 100 mg/l (treated groups), and tap water (active chlorine < 0.2 mg/l) (control group), respectively, for 104 weeks. Among the female rats of the treated groups, an increased incidence of lymphomas and leukemias has been observed, although this is not clearly dose related. Moreover, sporadic cases of some tumors, the occurrence of which is extremely unusual among the untreated rats of the colony used (historical controls), were detected in chlorine-exposed animals. The results of this study confirm the results of the experiment of the United States National Toxicology Program (1991), which showed an increase of leukemia among female Fischer 344/N rats following the administration of chlorine (in the form of sodium hypochlorite and chloramine) in their drinking water. The data here presented call for further research aimed at quantifying the oncogenic risks related to the chlorination of drinking water, to be used as a basis for consequent public health measures.",,"chlorine; drinking water; hypochlorite sodium; animal experiment; animal tissue; carcinogenicity; chlorination; conference paper; controlled study; dose response; female; leukemia; lymphoma; male; nonhuman; public health; rat; Animals; Body Weight; Carcinogens; Chlorine; Drinking; Feeding Behavior; Female; Male; Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Sodium Hypochlorite; Time Factors; Water Supply; Animalia",,"Carcinogens; Chlorine, 7782-50-5; Sodium Hypochlorite, 7681-52-9",,,,"(1994) OECD Environmental Performance Review, , Italy Paris; Ottavi, C., La gestione razionale del ciclo di utilizzazione antropica dell'acqua (1994) Atti del Convegno della Sezione Italiana Acque Sotterranee dell'Associazione Mineraria Subalpina e dell'Associazione Idrotecnica., , Italiana Sez. Piemonte, Liguria, Valle d'Aosta, su: ""Gestione integrata delle risorse idriche."" Lerici, Italy; (1977) Drinking Water and Health., 1. , National Academy Press, Washington; (1991) Monographs on the Evaluation of Carcinogenic Risk to Humans, Vol. 52. Chlorinated Drinking Water, Chlorination By-products, some Other Halogenated Compounds, Cobalt and Cobalt Compounds, 52. , IARC. Lyon; Symons, J.M., Bellar, T.A., Carswell, J.K., National organics reconaissance survey for halogenated organic (1975) J. Am. Water Works Assoc., 67, pp. 634-646; Brass, H.J., Feige, M.A., Halloran, T., The national organic monitoring survey: Sampling and analyses for purgeable organic compounds (1977) Drinking Water Quality Enhancement through Source Protection, pp. 393-416. , R. Pojasek, Ed.: Ann Arbor Sci. Publ. Ann Arbor, MI; Morris, R.D., Audet, A.M., Angelillo, I.F., Chlorination, chlorination by-products, and cancer: A meta-analysis (1992) Am. J. Public Health, 82, pp. 955-963; Cantor, H.P., Hoover, R., Mason, T.J., Associations of cancer mortality with halomethanes in drinking water (1978) J. Natl. Cancer Inst., 61, pp. 979-985; Hogan, M.D., Chi, P.Y., Hoel, D.G., Association between chloroform levels in finished drinking water supplies and various site-specific cancer mortality rates (1979) J. Environ. Pathol. Toxicol., 2, pp. 873-887; Druckrey, H., Chlorinated drinking water toxicity tests, involving seven generations of rats (1968) Food Cosmet. Toxicol., 6, pp. 147-154; (1991) Toxicology and Carcinogenesis Studies of Chlorinated and Chloraminated Water (Deionized and Charcoal-filtered) in F344/N Rats and B6C3F1 Mice, , TR392. DHHS Publ. No. (NIH) 91-2847. National Institutes of Health. Bethesda, MD; (1979) Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, Vol. 20. some Halogenated Hydrocarbons, 20. , IARC. Lyon; Roe, F.J.C., Palmer, A.K., Worden, A.N., Safety evaluation of toothpaste containing chloroform. I. Long-term studies in mice (1979) J. Environ. Pathol. Toxicol., 2, pp. 799-819; Jorgenson, T.A., Meierhenry, E.F., Rushbrook, C.J., Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice (1985) Fundam. Appl. Toxicol., 5, pp. 760-769; Tumasonis, C.F., Mcmartin, D.N., Bush, B., Lifetime toxicity of chloroform and bromodichloromethane when administered over a lifetime in rats (1985) Ecotoxicol. Environ. Saf., 9, pp. 233-240; (1985) Toxicology and Carcinogenesis Studies of Chlorodibromomethane in F344/N Rats and B6C3F1 Mice., , TR 282. DHHS Publ. No. (NIH) 85-2538. National Institutes of Health. Bethesda, MD; (1987) Toxicology and Carcinogenesis Studies of Bromodichloromethane in F344/N Rats and B6C3F1 Mice, , TR 321. DHHS Publ. No. (NIH) 88-2537. National Institutes of Health. Bethesda, MD; (1989) Toxicology and Carcinogenesis Studies of Bromoform in F344/N Rats and B6C3F1 Mice. TR 350., , DHHS Publ. No. (NIH) 89-2805. National Institutes of Health. Bethesda, MD","Soffritti, M.; Cancer Research Center, European Ramazzini Foundation, Oncology and Environmental Sciences, 40010 Bentivoglio (BO), Italy",,,,,,,,00778923,,ANYAA,9472341,"English","Ann. New York Acad. Sci.",Conference Paper,Scopus,2-s2.0-0031587507
"Maltoni, C., Ciliberti, A., Pinto, C., Soffritti, M., Belpoggi, F., Menarini, L.","Results of long-term experimental carcinogenicity studies of the effects of gasoline, correlated fuels, and major gasoline aromatics on rats",1997,"Annals of the New York Academy of Sciences","837",,,"15","52",,31,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0031587502&partnerID=40&md5=be15599df26fcf5278fc4276655747d1","Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bentivoglio Castle, 40010 Bentivoglio (BO), Italy","Maltoni, C., Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; Ciliberti, A., Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; Pinto, C., Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; Soffritti, M., Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; Belpoggi, F., Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; Menarini, L., Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bentivoglio Castle, 40010 Bentivoglio (BO), Italy","Unleaded gasoline, with high aromatic content, leaded gasoline, gasoil (diesel), kerosene, toluene, xylenes, ethylbenzene, and 1,2,4-trimethyl-benzene were submitted to long-term experimental carcinogenicity bioassays. The mixtures and the compounds were administered by stomach tube, in olive oil, once daily, 4 days weekly, for 104 weeks, to male and female Sprague-Dawley rats. The animals were kept under control until the end of the experiments. With varying degrees of evidence, all the tested materials were found to increase the total number of malignant tumors and of some site-specific tumors. They must therefore be considered carcinogenic. On the basis of our results the rank of carcinogenic potency of the tested aromatic hydrocarbons increases in the following order: 1,2,4-trimethylbenzene, ethylbenzene, xylenes, toluene (benzene).",,"aromatic hydrocarbon; diesel fuel; ethylbenzene; gasoline; kerosene; toluene; xylene; animal experiment; animal tissue; carcinogenicity; conference paper; controlled study; female; male; nonhuman; rat; Animals; Benzene Derivatives; Biological Assay; Carcinogens; Female; Gasoline; Kerosene; Male; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Rats; Toluene; Xylenes; Animalia",,"Benzene Derivatives; Carcinogens; ethylbenzene, 100-41-4; Gasoline; Kerosene; Toluene, 108-88-3; Xylenes",,,,"Maltoni, C., Scarnato, C., Le prime prove sperimentali dell'azione cancerogena del benzene (1977) Osp. Vita, 4, pp. 111-113; Maltoni, C., Scarnato, C., First experimental demonstration of the carcinogenic effects of benzene. Long-term bioassays on Sprague-Dawley rats by oral administration (1979) Med. Lav., 70, pp. 352-357; Maltoni, C., Conti, B., Cotti, G., Benzene: A multipotential carcinogen. Results of long-term bioassays performed at the Bologna Institute of Oncology (1983) Am. J. Ind. Med., 4, pp. 589-630; Maltoni, C., Conti, B., Cotti, G., Experimental studies on benzene carcinogenicity at the Bologna Institute of Oncology: Current results and ongoing research (1985) Am. J. Ind. Med., 7, pp. 415-446; Huff, J.E., Toxicology and carcinogenesis studies of benzene (CAS No. 71-43-2) in F344/N rats and B6C3F1 mice (gavage studies) (1986) Technical Report No. 289., 289. , National Toxicology Program. US Department of Health and Human Services. Washington, DC; Maltoni, C., Ciliberti, A., Cotti, G., Benzene, an experimental multipotential carcinogen: Results of the long-term bioassays performed at the Bologna Institute of Oncology (1989) Environ. Health Perspect, 82, pp. 109-124; Kitchen, D.N., Neoplastic renal effects of unleaded gasoline in Fischer 344 rats (1984) Advances in Modem Environmental Toxicology, Renal Effects of Petroleum Hydrocarbons, 7, pp. 65-72. , M. A. Mehlman, G. P. Hemstreet III, J. J. Thrope & N. K. Weaver, Eds.: Princeton Scientific Publishers. Princeton, NJ; (1989) Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 47. some Organic Solvents, Resin Monomers and Related Compounds, Pigments and Occupational Exposure in Paint Manufacture, 47. , IARC. Lyon; (1990) Toxicology and Carcinogenesis Studies of Toluene (CAS No. 108-88-3) in F344/N Rats and B6C3F1 Mice (Inhalation Studies), , NTP TR 371, NIH Publ. No. 90-2826. US Department of Health and Human Services. Research Triangle Park, NC; (1986) Toxicology and Carcinogenesis Studies of Xylenes (Mixed) (60% M-xylene, 14% P-xylene, 9% O-xylene, and 17% Ethylbenzene) (CAS No. 1330-20-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies), , NTP TR 327, NIH Publ. No. 87-2583. US Department of Health and Human Services. Research Triangle Park, NC; Huff, J.E., Eastin, W., Roycroft, J., Carcinogenesis studies of benzene, methylbenzene, and dimethylbenzenes (1988) Ann. N.Y. Acad. Sci., 534, pp. 427-440","Maltoni, C.; Cancer Research Center, European Ramazzini Foundation, Oncology and Environmental Sciences, 40010 Bentivoglio (BO), Italy",,,,,,,,00778923,,ANYAA,9472329,"English","Ann. New York Acad. Sci.",Conference Paper,Scopus,2-s2.0-0031587502
"Maltoni, C., Minardi, F., Pinto, C., Belpoggi, F., Bua, L.","Results of three life-span experimental carcinogenicity and anticarcinogenicity studies on tamoxifen in rats",1997,"Annals of the New York Academy of Sciences","837",,,"469","512",,5,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0031587504&partnerID=40&md5=b159cbd819a688ee9b12644361c27091","Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; European B. Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy","Maltoni, C., Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; Minardi, F., European B. Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy; Pinto, C., European B. Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy; Belpoggi, F., European B. Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy; Bua, L., European B. Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy","Tamoxifen was submitted to carcinogenicity bioassays on Sprague-Dawley rats (of the colony used at the Cancer Research Center in the Castle of Bentivoglio of the European Ramazzini Foundation of Oncology and Environmental Sciences) at the dose of 3.3 mg/kg b.w., by stomach tube, in three experiments. In the first experiment the drug was administered once daily, 6 days a week to male and female rats, 8 weeks old at start for their life span. In the second experiment, the drug was administered to female rats, 12 weeks old at start, once daily for 8 consecutive days every 8 weeks for their life span. In the third experiment the drug was administered to female rats, 56 weeks old at start, 6 times weekly for 40 weeks; and then the animals were kept alive for their life span. In the first experiment, a mild increase in hepatocarcinomas with low grading was detected. In the first and second experiments, a borderline increase in uterine malignancies was found. No carcinogenic effect was observed in the third experiment. In the three experiments, tamoxifen showed a strong, long-lasting chemopreventive effect on mammary benign tumors and cancers. The presented data also indicate that tamoxifen treatment reduces the incidence of other tumors: pituitary adenomas, adrenal pheochromocytomas, islet cell pancreatic tumors, Leydig cell testicular tumors, and polyps of the uterus.",,"antiestrogen; tamoxifen; animal experiment; breast tumor; carcinogenicity; conference paper; female; hypophysis adenoma; intragastric drug administration; leydig cell tumor; lifespan; liver cell carcinoma; male; nonhuman; pancreas islet cell tumor; pheochromocytoma; rat; uterus cancer; Animals; Body Weight; Chemoprevention; Female; Longevity; Male; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Tamoxifen; Uterine Neoplasms; Animalia",,"Tamoxifen, 10540-29-1",,,,"Cole, M.P., Jones, C.T.A., Todd, I.D.H., A new anti-oestrogenic agent in late breast cancer. an early clinical appraisal of ICI 46474 (1971) Br. J. Cancer, 25, pp. 270-275; Furr, B.J.A., Jordan, V.C., The pharmacology and clinical uses of tamoxifen (1984) Pharmacol. & Ther., 25, pp. 127-205; Jordan, V.C., Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata (1976) Eur. J. Cancer, 12, pp. 419-424; Randomized trial of chemo-endocrine therapy and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastases (1984) Lancet, 1, pp. 1256-1260; Senanayake, F., Adjuvant hormonal chemotherapy in early breast cancer: Early results from a controlled trial (1984) Lancet, 2, pp. 1148-1149; Cummings, F.J., Gray, R., Davis, T.E., Adjuvant tamoxifen treatment of elderly women with stage II breast cancer. a double blind comparison with placebo (1985) Ann. Intern. Med., 103, pp. 324-329; Palshof, T., Carstensen, B., Mouridsen, H.T., Adjuvant endocrine therapy in pre- And postmenopausal women with operable breast cancer (1985) Rev. Endocrine Rel. Cancer, 17 (SUPPL.), pp. 43-50; Rose, C., Thorpe, S.M., Andersen, K.W., Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high estrogen receptor values (1985) Lancet, 1, pp. 16-19; Adjuvant tamoxifen in the management of operable breast cancer: The Scottish trial (1987) Lancet, 2, pp. 171-175; Delozier, T., Julien, J.-P., Juret, P., Adjuvant tamoxifen in postmenopausal breast cancer: Preliminary results of a randomized trial (1987) Breast Cancer Res. Treat., 7, pp. 105-110; Pritchard, K., Meakin, J.W., Boyd, N.F., Adjuvant tamoxifen in postmenopausal women with axillary node positive breast cancer: An update (1987) Adjuvant Therapy of Cancer, pp. 391-400. , S. E. Salmon, Ed.: Grune and Stratum. Orlando, FL; Rutqvist, I.E., Cedermark, B., Glas, U., The Stockholm trial on adjuvant tamoxifen in early breast cancer (1987) Breast Cancer Res. Treat., 10, pp. 255-266; Bianco, A.R., Gallo, C., Marinelli, S., Adjuvant therapy with tamoxifen in operable breast cancer: 10 year results of the Naples (GUN) study (1988) Lancet, 2, pp. 1095-1099","Maltoni, C.; Cancer Research Center, Euro Ramazz. Fdn Oncol Environm Sci, Bentivoglio Castle, 40010 Bentivoglio (BO), Italy",,,,,,,,00778923,,ANYAA,9472359,"English","Ann. New York Acad. Sci.",Conference Paper,Scopus,2-s2.0-0031587504
"Belpoggi, F., Soffritti, M., Filippini, F., Maltoni, C.","Results of long-term experimental studies on the carcinogenicity of methyl tert-butyl ether",1997,"Annals of the New York Academy of Sciences","837",,,"77","95",,46,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0031587498&partnerID=40&md5=e4969acc7bfdf6f2ae45bce7f5faaffc","Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; European B. Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy","Belpoggi, F., Cancer Research Center, European Ramazzini Foundation of Oncology and Environmental Sciences, Bentivoglio Castle, 40010 Bentivoglio (BO), Italy; Soffritti, M., European B. Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy; Filippini, F., European B. Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy; Maltoni, C., European B. Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy","Methyl-tert-butyl ether (MTBE) was submitted to long-term carcinogenicity bioassays on Sprague-Dawley rats. The test compound was delivered in olive oil by stomach tube (gavage), at the doses of 1000, 250, and 0 mg/kg b.w. to groups of 60 males and 60 females, once daily, 4 times weekly, for 104 weeks. All animals were kept under control until spontaneous death. MTBE was found to cause in males an increased incidence of Leydig cell testicular tumors in the group treated with the higher dose, and in females a dose-related increase of leukemias, an increase of dysplastic proliferations of lymphoreticular tissues, and also an increase of uterine sarcomas at the lower tested dose. On the basis of the presented data, MTBE must be considered a potential carcinogen.",,"tert butyl methyl ether; animal experiment; bioassay; carcinogenicity; conference paper; female; leukemia; leydig cell tumor; male; nonhuman; rat; reticuloendothelial system; uterus sarcoma; Animals; Biological Assay; Body Weight; Carcinogens; Drinking Behavior; Feeding Behavior; Female; Gasoline; Male; Methyl Ethers; Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Survival Analysis; Time Factors; Animalia",,"Carcinogens; Gasoline; Methyl Ethers; methyl tert-butyl ether, 1634-04-4",,,,"Belpoggi, F., Soffritti, M., Maltoni, C., Methyl-tertiary-butyl ether (MTBE). a gasoline additive causes testicular and lymphohematopoietic cancers in rats (1995) Toxicol. Ind. Health, 11, pp. 119-149; Hoel, D.G., Walburg, H.E., Statistical analysis of survival experiments (1972) J. Natl. Cancer Inst., 49, pp. 361-372; Mantel, N., Evaluation of survival data on two new rank order statistics arising in its consideration (1966) Cancer Chemother. Rep., 50, pp. 163-170; Cox, D.R., Regression models and life-tables (with discussion) (1972) J. R. Stat. Soc. B., 24, pp. 187-220","Belpoggi, F.; Cancer Research Center, European Ramazzini Foundation, Oncology and Environmental Sciences, 40010 Bentivoglio (BO), Italy",,,,,,,,00778923,,ANYAA,9472331,"English","Ann. New York Acad. Sci.",Conference Paper,Scopus,2-s2.0-0031587498
"Barbin, A., Froment, O., Boivin, S., Marion, M.-J., Belpoggi, F., Maltoni, C., Montesano, R.","p53 Gene mutation pattern in rat liver tumors induced by vinyl chloride",1997,"Cancer Research","57","9",,"1695","1698",,55,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0030916130&partnerID=40&md5=4128dd1a1d86cafdb081db4be6b29dca","IARC, 150, Cours Albert Thomas, 69372 Lyon Cedex 08, France; Inst. Natl. S. et de la Rech. Med., Unité 271, 151, Cours Albert Thomas, 69424 Lyon Cedex 03, France; Cancer Research Center, Europ. Ramazzini Found. Oncol. E., Castle of Bentivoglio, 40010 Bentivoglio Bologna, Italy; Inst. de Pathol. et de Genet., 41, Allée des Templiers, 6280 Gerpinnes (Loverval), Belgium","Barbin, A., IARC, 150, Cours Albert Thomas, 69372 Lyon Cedex 08, France; Froment, O., IARC, 150, Cours Albert Thomas, 69372 Lyon Cedex 08, France, Inst. de Pathol. et de Genet., 41, Allée des Templiers, 6280 Gerpinnes (Loverval), Belgium; Boivin, S., Inst. Natl. S. et de la Rech. Med., Unité 271, 151, Cours Albert Thomas, 69424 Lyon Cedex 03, France; Marion, M.-J., Inst. Natl. S. et de la Rech. Med., Unité 271, 151, Cours Albert Thomas, 69424 Lyon Cedex 03, France; Belpoggi, F., Cancer Research Center, Europ. Ramazzini Found. Oncol. E., Castle of Bentivoglio, 40010 Bentivoglio Bologna, Italy; Maltoni, C., Cancer Research Center, Europ. Ramazzini Found. Oncol. E., Castle of Bentivoglio, 40010 Bentivoglio Bologna, Italy; Montesano, R., IARC, 150, Cours Albert Thomas, 69372 Lyon Cedex 08, France","Vinyl chloride (VC) induces angiosarcomas of the liver (ASL) and hepatocellular carcinomas (HCCs) in humans and rodents. We examined the presence of p53 gene mutations in ASL and HCC induced by VC in Sprague Dawley rats; 25 ASL and eight HCCs were analyzed for point mutations in exons 5-8, using PCR amplification, single-strand conformation polymorphism analysis, and direct DNA sequencing. Mutations were found in 11 (44%) of the ASL and in 1 HCC. A 12-base pair deletion was found in one tumor; all others were base pair substitutions. Nine of the point mutations were observed at A:T base pairs (5 A:T → T:A; 2 A:T → G:C, and 2 A:T → C:G), and of three G:C → A:T transitions, only one was at a CpG site. In ASL, four mutations were found in exon 5, two in exon 6, and six in exon 7; the base pair substitution found in one HCC was in exon 8. One ASL exhibited two point mutations, including a silent one. Two ASL exhibited the same mutation in codon 203 and two other samples in codon 253. Codon 235 was found to be mutated in three ASL. These data show that p53 is often mutated in ASL induced by VC in rats and, as observed in ASL in humans exposed to VC, the majority of the missense mutations involved A:T base pairs. The characteristic patterns of mutations found suggest that a common mechanism operates in VC-induced p53 mutagenesis in both species, and these mutations are consistent with the formation of DNA etheno adducts by VC in the liver. The A:T → T:A transversion observed in the first nucleotide of codon 253 in two rat ASL in equivalent to the A:T → T:A transversion characterized previously in codon 255 in one human ASL associated with VC exposure.",,"vinyl chloride; animal model; article; cancer genetics; gene amplification; gene mutation; liver tumor; nonhuman; nucleic acid base substitution; point mutation; polymerase chain reaction; priority journal; rat; single strand conformation polymorphism; Animals; Chromosome Mapping; DNA, Neoplasm; Exons; Genes, p53; Hemangiosarcoma; Liver Neoplasms; Liver Neoplasms, Experimental; Polymorphism, Single-Stranded Conformational; Rats; Rats, Sprague-Dawley; Vinyl Chloride",,"DNA, Neoplasm; Vinyl Chloride, 75-01-4",,,,"Popper, H., Thomas, L.B., Telles, N.C., Falk, H., Selikoff, I.J., Development of hepatic angiosarcoma in man induced by vinyl chloride, Thorotrast, and arsenic: Comparison with cases of unknown etiology (1978) Am. J. Pathol., 92, pp. 349-369; Fleming, L.E., Beckett, W.S., Occupational and environmental disease of the gastrointestinal system (1992) Environmental and Occupational Medicine, pp. 633-647. , W. N. Rom (ed.), Boston: Little, Brown & Co; Maltoni, C., Lefemine, G., Ciliberti, A., Cotti, G., Caretti, D., Experimental research on vinyl chloride carcinogenesis (1984) Archives of Research on Industrial Carcinogenesis, 2. , C. Maltoni and M. A. Mehlman (eds.), Princeton, NJ: Princeton Scientific Publishers, Inc; Some monomers, plastic and synthetic elastomers, and acrolein (1979) IARC Monogr. Eval. Carcinog. Risk Chem. Hum., 19, pp. 377-438; Barbin, A., Brésil, H., Croisy, A., Jacquignon, P., Malaveille, C., Montesano, R., Bartsch, H., Liver-microsome-mediated formation of alkylating agents from vinyl bromide and vinyl chloride (1975) Biochem. Biophys. Res. Commun., 67, pp. 596-603; Guengerich, F.P., Kim, D.-H., Iwasaki, M., Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects (1991) Chem. Res. Toxicol., 4, pp. 168-179; Bartsch, H., Barbin, A., Marion, M.J., Nair, J., Guichard, Y., Formation, detection, and role in carcinogenesis of ethenobases in DNA (1994) Drug Metab. Rev., 26, pp. 349-371; Grollman, A.P., Shibutani, S., Mutagenic specificity of chemical carcinogens as determined by studies of single DNA adducts (1994) DNA Adducts: Identification and Biological Significance, pp. 385-397. , K. Hemminki, A. Dipple, D. E. G. Shuker, F. F. Kadlubar, D. Segerbäck, and H. Bartsch (eds.), IARC Scientific Publ. No. 125. Lyon, France: IARC; Cheng, K.C., Preston, B.D., Cahill, D.S., Dosanjh, M.K., Singer, B., Loeb, L.A., The vinyl chloride DNA derivative N2,3-ethenoguanine produces G→A transitions in Escherichia coli (1991) Proc. Natl. Acad. Sci. USA, 88, pp. 9974-9978; Moriya, M., Zhang, W., Johnson, F., Grollman, A.P., Mutagenic potency of exocyclic DNA adducts: Marked differences between Escherichia coli and simian kidney cells (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 11899-11903; Basu, A.K., Wood, M.K., Niedernhofer, L.J., Ramos, L.A., Essigmann, J.M., Mutagenic and genotoxic effects of three vinyl chloride-induced DNA lesions. 1,N6-ethenoadenine, 3,N4-ethenocytosine, and 4-amino-5-(imidazol-2-yl)imidazole (1993) Biochemistry, 32, pp. 12793-12801; Pandya, G.A., Moriya, M., 1,N6-Ethenodeoxyadenosine, a DNA adduct highly mutagenic in mammalian cells (1996) Biochemistry, 35, pp. 11487-11492; Hollstein, M., Marion, M.J., Lehman, T., Welsh, J., Harris, C.C., Martel-Planche, G., Kusters, I., Montesano, R., p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers (1994) Carcinogenesis, 15, pp. 1-3. , Lond; Trivers, G.E., Cawley, H.L., Debenedetti, V.M., Hollstein, M., Marion, M.J., Bennett, W.P., Hoover, M.L., Harris, C.C., Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride (1995) J. Natl. Cancer Inst., 87, pp. 1400-1407; Boivin, S., Pedron, S., Bertrand, S., Desmoulière, A., Martel-Planche, G., Bancel, B., Monlesano, R., Marion, M.J., Myofibroblast-like cells exhibiting a mutated p53 gene isolated from a liver human tumor of a worker exposed to vinyl chloride (1997) Cells of the Hepatic Sinusoïd, 6. , E. Wisse, D. L. Knook, and C. Balahaud (eds.), Leiden: Kupffer Cell Foundation, in press; Hollstein, M., Shomer, B., Greenblatt, M., Soussi, T., Hovig, E., Montesano, R., Harris, C.C., Somatic point mutations in the p53 gene of human tumors and cell lines: Updated compilation (1996) Nucleic Acids Res., 24, pp. 141-146; Soini, Y., Welsh, J.A., Ishak, K.G., Bennett, W.P., p53 mutations in primary hepatic angiosarcomas not associated with vinyl chloride exposure (1995) Carcinogenesis, 16, pp. 2879-2881. , Lend; Andersson, M., Jönsson, M., Nielsen, L.E., Vyberg, M., Visfeldt, J., Storm, H.H., Wallin, H., Mutations in the tumor suppressor gene p53 in human liver cancer induced by α-particles (1995) Cancer Epidemiol., Biomarkers & Prev., 4, pp. 765-770; Greenblatt, M.S., Bennett, W.P., Hollstein, M., Harris, C.C., Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis (1994) Cancer Res., 54, pp. 4855-4878; Harris, C.C., The 1995 Walter Hubert Lecture: Molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene (1996) Br. J. Cancer, 73, pp. 261-269; Froment, O., Boivin, S., Barbin, A., Bancel, B., Trépo, C., Marion, M.J., Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride (1994) Cancer Res., 54, pp. 5340-5345; Shafritz, D.A., Shouval, D., Sherman, H.I., Hadziyannis, S.J., Kew, M.C., Integration of hepatitis B virus into the genome of liver cells in chronic liver disease and hepatocellular carcinoma (1981) N. Engl. J. Med., 305, pp. 1067-1073; Soussi, T., Caron De Fromentel, C., Breugnot, C., May, E., Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein (1988) Nucleic Acids Res., 16, p. 11384; Hulla, J.E., Schneider, R.P., Structure of the rat p53 tumor suppressor gene (1993) Nucleic Acids Res., 21, pp. 713-717; Vancutsem, P.M., Lazarus, P., Williams, G.M., Frequent and specific mutations of the rat p53 gene in hepatocarcinomas induced by tamoxifen (1994) Cancer Res., 54, pp. 3864-3867; Makino, H., Ishizaka, Y., Tsujimoto, A., Nakamura, T., Onda, M., Sugimura, T., Nagao, M., Rat p53 gene mutations in primary Zymbal gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 4850-4854; Weghorst, C.M., Dragnev, K.H., Buzard, G.S., Thorne, K.L., Vandeborne, G.F., Vincent, K.A., Rice, J.M., Low incidence of point mutations detected in the p53 tumor suppressor gene from chemically induced rat renal mesenchymal tumors (1994) Cancer Res., 54, pp. 215-219; Wang, D., Weghorst, C.M., Calvert, R.J., Stoner, G.D., Mutations in the p53 tumor suppressor gene in rat esophageal papillomas induced by N-nitrosomethylbenzylamine (1996) Carcinogenesis, 17, pp. 625-630. , Lond; Hulla, J.E., The rat genome contains a p53 pseudogene: Detection of a processed pseudogene using PCR (1992) PCR Methods Appl., 1, pp. 251-254; Ciotta, C., Dogliotti, E., Bignami, M., Mutation analysis of two newly identified rat p53 pseudogenes (1995) Mutagenesis, 10, pp. 123-128; Lin, Y., Chan, S.-H., Cloning and characterization of two processed p53 pseudogenes from the rat genome (1995) Gene, 156, pp. 183-189. , Amst; Weghorst, C.M., Buzard, G.S., Calvert, R.J., Hulla, J.E., Rice, J.M., Cloning and sequence of a processed p53 pseudogene from rat: A potential source of false ""mutations"" in PCR fragments of tumor DNA (1995) Gene, 166, pp. 317-322. , Amst; Montesano, R., Kirby, G.M., Chemical carcinogens in human liver cancer (1994) Primary Liver Cancer: Etiological and Progression Factors, pp. 57-77. , C. Bréchot (ed.), Boca Raton, FL: CRC Press, Inc; Guichard, Y., El Ghissassi, F., Nair, J., Bartsch, H., Barbin, A., Formation and accumulation of DNA ethenobases in adult Sprague-Dawley rats exposed to vinyl chloride (1996) Carcinogenesis, 17, pp. 1553-1559. , Lond; Planche-Martel, G., Likhachev, A., Wild, C.P., Montesano, R., Modulation of repair of O6-melhylguanine in parenchymal and nonparenchymal liver cells of rats treated with dimethylnitrosamine (1985) Cancer Res., 45, pp. 4768-4773; Swenberg, J.A., Scheller, N.A., Ranasinghe, A., Upton, P.B., Christova-Gueorguieva, N.I., Bogdanffy, M.S., Molecular dosimetry of N2,3-ethenoguanine in DNA of vinyl fluoride-exposed rats: Relationship to hemangiosarcoma (1996) Fundam. Appl. Toxicol., 30, p. 235; Brash, D.E., Rudolph, J.A., Simon, J.A., Lin, A., McKenna, G.J., Baden, H.P., Halperin, A.J., Ponten, J., A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma (1991) Proc. Natl. Acad. Sci. USA, 88, pp. 10124-10128; Kress, S., Sutter, C., Strickland, P.T., Mukhtar, H., Schweizer, J., Schwarz, M., Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin (1992) Cancer Res., 52, pp. 6400-6403; Ziegler, A., Leffell, D.J., Kunala, S., Sharma, H.W., Gailani, M., Simon, J.A., Halperin, A.J., Bale, A.E., Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 4216-4220; Nataraj, A.J., Black, H.S., Ananthaswamy, H.N., Signature p53 mutation at DNA cross-linking sites in 8-methoxypsoralen and ultraviolet A (PUVA)-induced murine skin cancers (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 7961-7965; Hsu, I.C., Metcalf, R.A., Sun, T., Welsh, J.A., Wang, N.J., Harris, C.C., Mutational hot-spot in the p53 gene in human hepatocellular carcinomas (1991) Nature, 350, pp. 427-428. , Lond; Aguilar, F., Harris, C.C., Sun, T., Hollstein, M., Cerutti, P., Geographic variation of p53 mutational profile in nonmalignant human liver (1994) Science, 264, pp. 1317-1319. , Washington DC; Hainaut, P., Soussi, T., Shomer, B., Hollstein, M., Greenblatt, M., Hovig, E., Harris, C.C., Montesano, R., Database of p53 gene somatic mutations in human tumors and cell lines: Updated compilation and future prospects (1997) Nucleic Acids Res., 23, pp. 151-157; Zhang, W., Johnson, F., Grollman, A.P., Shibutani, S., Miscoding by the exocyclic and related DNA adducts 3,N4-etheno-2′-deoxycytidine, 3,N4-ethano-2′-deoxycytidine, and 3-(2-hydroxyethyl)-2′-deoxyuridine (1995) Chem. Res. Toxicol., 8, pp. 157-163; Singer, B., Kusmierek, J.T., Folkman, W., Chavez, F., Dosanjh, M.K., Evidence for the mutagenic potential of the vinyl chloride induced adduct, N2,3-etheno-deoxyguanosine, using a site-directed kinetic assay (1991) Carcinogenesis, 12, pp. 745-747. , Lond","Barbin, A.; IARC, 150, Cours Albert Thomas, 69372 Lyon Cedex 08, France",,,,,,,,00085472,,CNREA,9135010,"English","Cancer Res.",Article,Scopus,2-s2.0-0030916130
"Belpoggi, F., Soffritti, M., Maltoni, C.","Methyl-tertiary-butyl ether (MTBE) - A gasoline additive - Causes testicular and lymphohaematopoietic cancers in rats",1995,"Toxicology and Industrial Health","11","2",,"119","149",,129,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0028824089&partnerID=40&md5=3388c3080bd92d0019a7c092efd8dc3c","Institute of Oncology, Viale Ercolani, 4/2, 40138 Bologna, Italy","Belpoggi, F., Institute of Oncology, Viale Ercolani, 4/2, 40138 Bologna, Italy; Soffritti, M., Institute of Oncology, Viale Ercolani, 4/2, 40138 Bologna, Italy; Maltoni, C., Institute of Oncology, Viale Ercolani, 4/2, 40138 Bologna, Italy","In the framework of a series of experiments conducted to evaluate the carcinogenic effects of oxygenated gasoline additives, MTBE was analyzed in an oral lifetime carcinogenicity study using 8-week-old male and female Sprague-Dawley rats. These experiments were part of a large research project on gasoline carcinogenicity performed at the Bentivoglio (BT) Castle Cancer Research Center of the Ramazzini Foundation and of the Bologna Institute of Oncology. MTBE, dissolved in oil, was administered by stomach tube at the doses of 1000, 250, or 0 mg/kg b.w., once daily, four days weekly, for 104 weeks. The animals were maintained until natural death. The last animal died 166 weeks after the start of the experiment, i.e., at 174 weeks of age. Under the tested experimental conditions, MTBE was shown to cause an increase in Leydig interstitial cell tumors of the testes and a dose-related increase in lymphomas and leukemias in female rats.","leukemia; Leydig cell testicular tumor; MTBE; rat","gasoline; tert butyl methyl ether; animal experiment; article; cancer research; cancer survival; chemical carcinogenesis; female; leukemia; leydig cell tumor; lymphoma; male; nonhuman; rat; Animal; Carcinogens; Ethers; Female; Gasoline; Intubation, Gastrointestinal; Leukemia, Experimental; Lymphoma; Male; Rats; Rats, Sprague-Dawley; Sex Factors; Solvents; Support, Non-U.S. Gov't; Testicular Neoplasms; Vehicle Emissions",,"gasoline, 86290-81-5; tert butyl methyl ether, 1634-04-4; Carcinogens; Ethers; methyl tert-butyl ether, 1634-04-4; Solvents; Vehicle Emissions",,,,,"Maltoni, C.; Institute of Oncology, Viale Ercolani, 4/2, 40138 Bologna, Italy",,,,,,,,07482337,,TIHEE,7491630,"English","TOXICOL. IND. HEALTH",Article,Scopus,2-s2.0-0028824089
"Maltoni, C., Ciliberti, A., Cotti, G., Conti, B., Belpoggi, F.","Benzene, an experimental multipotential carcinogen: Results of the long-term bioassays performed at the Bologna Institute of Oncology",1989,"Environmental Health Perspectives","82",,,"109","124",,107,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0024458311&partnerID=40&md5=677e71f75bad128479e739420ac93411","Bentivoglio Experimental Unit, Institute of Oncology, Bologna, Italy","Maltoni, C., Bentivoglio Experimental Unit, Institute of Oncology, Bologna, Italy; Ciliberti, A., Bentivoglio Experimental Unit, Institute of Oncology, Bologna, Italy; Cotti, G., Bentivoglio Experimental Unit, Institute of Oncology, Bologna, Italy; Conti, B., Bentivoglio Experimental Unit, Institute of Oncology, Bologna, Italy; Belpoggi, F., Bentivoglio Experimental Unit, Institute of Oncology, Bologna, Italy","In 1976, a systematic and integrated project of long-term carcinogenicity bioassays began at the Bentivoglio Experimental Unit of the Bologna Institute of Oncology. The Bologna experiments proved for the first time that benzene is an experimental carcinogen. These experiments demonstrated that benzene is carcinogenic when administered by ingestion and by inhalation and that it causes tumors in the various tested animal models (Sprague-Dawley rats, Wistar rats, Swiss mice, and RF/J mice). They also showed that benzene is a multipotential carcinogen, as it produces a variety of neoplasias in one or more of the tested animal models, including Zymbal gland carcinomas, carcinomas of the oral cavity, nasal cavities, skin, forestomach, and mammary glands, as well as angiosarcomas of the liver, hemolymphoreticular neoplasias, tumors of the lung, and possibly hepatomas. The Bologna experiments also indicated a clear-cut dose-response relationship in benzene carcinogenesis. This report presents the up-to-date results of the Bologna project. The need for more experimental research aimed at assessing the carcinogenic effects of low doses of benzene, of chemical mixtures containing benzene, and of benzene substitutes is emphasized. Also recommended are more comprehensive epidemiological investigations, extended to all types of malignancies, with particular regard to lung carcinomas.",,"benzene; animal experiment; animal model; bioassay; breast adenocarcinoma; carcinogenicity; leukemia; liver cancer; mammal; mouse; mouth cancer; nonhuman; nose cavity cancer; pheochromocytoma; review; skin cancer; stomach cancer; Administration, Inhalation; Administration, Oral; Animal; Benzene; Carcinogens; Dose-Response Relationship, Drug; Female; Male; Mice; Neoplasms, Experimental; Rabbits; Rats; Rats, Inbred Strains; Support, Non-U.S. Gov't",,"benzene, 71-43-2; Benzene, 71-43-2; Carcinogens",,,,,,,,,,,,,00916765,,EVHPA,2792037,"English","ENVIRON. HEALTH PERSPECT.",Article,Scopus,2-s2.0-0024458311
"Maltoni, C., Conti, B., Cotti, G., Belpoggi, F.","Experimental studies on benzene carcinogenicity at the bologna institute of oncology: Current results and ongoing research",1985,"American Journal of Industrial Medicine","7","5-6",,"415","446",,49,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0021813795&partnerID=40&md5=c339459cb9406c61f0120e15841cbbbf","Institute of Oncology, 40138 Bologna, Italy","Maltoni, C., Institute of Oncology, 40138 Bologna, Italy; Conti, B., Institute of Oncology, 40138 Bologna, Italy; Cotti, G., Institute of Oncology, 40138 Bologna, Italy; Belpoggi, F., Institute of Oncology, 40138 Bologna, Italy","In 1977 Maltoni and Scarnato were the first to demonstrate that benzene is an experimental carcinogen in rats. With that and other experiments. Maltoni et al. have shown that benzene administered by ingestion (stomach tube) or inhalation is a multipotential carcinogen in rats (of two different strains) and mice and produces a variety of tumors, namely: Zymbal gland carcinomas, oral and nasal cavity carcinomas, skin carcinomas, acanthomas, dysplasias and carcinomas of forestomach, mammary malignant tumors, hepatomas, liver angiosarcomas, hemolymphoreticular neoplasias, and pulmonary tumors. The incidence of Zymbal gland carcinomas and carcinomas of the oral and nasal cavities is affected by the length of treatment by inhalation and by the age of animals. However, the available epidemiological and experimental data at present do not provide precise information on the risk of doses around or below 10 ppm. Long-term carcinogenicity bioassays at 50, 25, 10, 5 and 1 ppm may be helpful for scientific risk assessment. In addition, these experiments have shown that toluene, xylene, and ethylbenzene, at high concentrations, cause an increase in the number of total malignant tumors.",,"benzene; ethylbenzene; toluene; xylene; animal experiment; carcinogenesis; clinical article; intoxication; nonhuman; oncology; rat; research; review; Animal; Benzene; Benzene Derivatives; Comparative Study; Female; Male; Mice; Neoplasms, Experimental; Rats; Rats, Inbred Strains; Support, Non-U.S. Gov't; Toluene; Xylenes",,"benzene, 71-43-2; ethylbenzene, 100-41-4; toluene, 108-88-3; xylene, 1330-20-7; Benzene Derivatives; Benzene, 71-43-2; ethylbenzene, 100-41-4; Toluene, 108-88-3; Xylenes",,,,,,,,,,,,,02713586,,AJIMD,4003403,"English","AM. J. IND. MED.",Article,Scopus,2-s2.0-0021813795
